Variant and risk allele,P-value,P-value annotation,RAF,OR,Beta,CI,Mapped gene,Reported trait,Trait(s),Study accession,Location
rs548509555-<b>TA</b>,8 x 10-9,,0.2,'-,0.032 unit increase,NR,'-,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,13:57027767
rs527504-<b>A</b>,4 x 10-9,,0.19,'-,0.032 unit decrease,NR,"TMEM54, RNF19B",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,1:32926826
rs1859259-<b>T</b>,1 x 10-9,,0.58,'-,0.025 unit decrease,NR,ADGRG5,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,16:57562640
rs77406149-<b>G</b>,3 x 10-10,,0.2,'-,0.035 unit increase,NR,STXBP4,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,17:54998886
rs79058858-<b>T</b>,1 x 10-8,,0.0052,'-,0.16 unit increase,NR,FLT3LG,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,19:49476532
rs117587217-<b>C</b>,1 x 10-8,,0.016,'-,0.1 unit decrease,NR,'-,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,21:15258852
rs2842873-<b>T</b>,2 x 10-36,,0.37,'-,0.056 unit decrease,NR,"PMF1-BGLAP, PMF1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,1:156234862
rs4683900-<b>T</b>,8 x 10-19,,0.73,'-,0.042 unit increase,NR,SENP7,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,3:101415852
rs2853677-<b>A</b>,2 x 10-9,,0.7,'-,0.027 unit increase,NR,TERT,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,5:1287079
rs56116444-<b>G</b>,9 x 10-81,,0.31,'-,0.086 unit decrease,NR,"NREP, STARD4-AS1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,5:111726150
rs11251-<b>T</b>,3 x 10-11,,0.54,'-,0.028 unit increase,NR,CD164,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,6:109368704
rs4709819-<b>A</b>,1 x 10-30,,0.41,'-,0.049 unit increase,NR,'-,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,6:164042323
rs11769630-<b>A</b>,4 x 10-19,,0.13,'-,0.057 unit decrease,NR,"SPATA48, IKZF1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,7:50218107
rs2979469-<b>C</b>,5 x 10-8,,0.88,'-,0.035 unit decrease,NR,RBPMS,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,8:30427575
rs227079-<b>A</b>,6 x 10-26,,0.48,'-,0.044 unit decrease,NR,C11orf65,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,11:108377959
rs728739-<b>G</b>,4 x 10-18,,0.055,'-,0.081 unit increase,NR,TCL1A,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,14:95715725
rs12668837-<b>T</b>,2 x 10-9,,0.46,'-,0.026 unit decrease,NR,"ESYT2, NCAPG2",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,7:158708114
rs77874075-<b>G</b>,5 x 10-9,,0.22,'-,0.03 unit decrease,NR,"CENPN-AS1, CENPN",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,16:81032734
rs201753350-<b>T</b>,1 x 10-8,,0.0062,'-,0.15 unit decrease,NR,TP53,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,17:7676387
rs78997619-<b>T</b>,3 x 10-21,,0.06,'-,0.083 unit increase,NR,"FAM117A, SLC35B1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,17:49709799
rs2804301-<b>A</b>,4 x 10-8,,0.24,'-,0.027 unit decrease,NR,KANK1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,9:603916
rs9487023-<b>A</b>,4 x 10-8,,0.1,'-,0.04 unit increase,NR,CCDC162P,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,6:109268801
rs138423884-<b>G</b>,1 x 10-12,,0.038,'-,0.079 unit increase,NR,"RALGPS1, ANGPTL2",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,9:127093658
rs2646425-<b>T</b>,4 x 10-10,,0.31,'-,0.028 unit increase,NR,KRT8P37,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,10:8428424
rs12225799-<b>G</b>,1 x 10-8,,0.13,'-,0.036 unit decrease,NR,PSMD13,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,11:241124
rs2237896-<b>A</b>,2 x 10-22,,0.4,'-,0.043 unit increase,NR,KCNQ1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,11:2837210
rs74843651-<b>T</b>,2 x 10-8,,0.052,'-,0.055 unit increase,NR,SPON1-AS1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,11:14271441
rs10849448-<b>G</b>,2 x 10-18,,0.81,'-,0.05 unit decrease,NR,LTBR,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,12:6384185
rs34324-<b>A</b>,3 x 10-19,,0.43,'-,0.039 unit decrease,NR,"CDKN1B, APOLD1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,12:12724992
undefined,2 x 10-17,,NR,'-,'-,'-,TPX2,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,20:31767936
rs34468831-<b>G</b>,6 x 10-8,,0.09,'-,0.012 unit increase,'-,PRDM16,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,1:3180749
rs10687116-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,"MIR3168, RN7SL597P",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,13:41103946
rs115854006-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"SPINK8, FBXW12",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,3:48346680
rs17758695-<b>?</b>,1 x 10-33,,NR,'-,'-,'-,BCL2,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,18:63253621
rs17049722-<b>C</b>,8 x 10-8,,0.86,'-,0.009 unit increase,'-,LINC01122,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,2:58749728
rs34778241-<b>TG</b>,1 x 10-24,,0.62,'-,0.013 unit increase,'-,EIF4E3,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,3:71722065
rs2811487-<b>G</b>,3 x 10-12,,0.77,'-,0.01 unit increase,'-,"RPN1, LINC01565",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,3:128613036
rs871134-<b>T</b>,1 x 10-16,,0.57,'-,0.01 unit increase,'-,"TADA2B, CCDC96",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,4:7042653
rs2853677-<b>G</b>,8 x 10-6,,0.42,'-,0.005 unit increase,'-,TERT,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,5:1287079
rs10948011-<b>G</b>,9 x 10-36,,0.87,'-,0.022 unit increase,'-,TAF8,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,6:42056547
rs35355140-<b>C</b>,9 x 10-25,,0.93,'-,0.023 unit increase,'-,HOXA9,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,7:27165113
rs11769630-<b>A</b>,4 x 10-21,,0.07,'-,0.021 unit increase,'-,"SPATA48, IKZF1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,7:50218107
rs59543286-<b>A</b>,2 x 10-38,,0.84,'-,0.021 unit increase,'-,STMP1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,7:135666562
rs55727837-<b>G</b>,1 x 10-34,,0.89,'-,0.022 unit increase,'-,KRBA1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,7:149731512
rs12668837-<b>T</b>,1 x 10-6,,0.08,'-,0.011 unit increase,'-,"ESYT2, NCAPG2",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,7:158708114
rs2804301-<b>A</b>,2 x 10-6,,0.53,'-,0.006 unit increase,'-,KANK1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,9:603916
rs2237896-<b>G</b>,7 x 10-9,,0.96,'-,0.017 unit increase,'-,KCNQ1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,11:2837210
rs10849448-<b>G</b>,4 x 10-22,,0.75,'-,0.013 unit increase,'-,LTBR,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,12:6384185
rs34324-<b>A</b>,3 x 10-15,,0.4,'-,0.009 unit increase,'-,"CDKN1B, APOLD1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,12:12724992
rs9921295-<b>T</b>,8 x 10-7,,0.92,'-,0.01 unit increase,'-,"CNEP1R1, NCOA5LP",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,16:49993219
rs1859259-<b>T</b>,1 x 10-11,,0.3,'-,0.008 unit increase,'-,ADGRG5,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,16:57562640
rs2842873-<b>T</b>,3 x 10-88,,0.37,'-,0.024 unit increase,'-,"PMF1-BGLAP, PMF1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,1:156234862
rs4683900-<b>C</b>,6 x 10-44,,0.38,'-,0.016 unit increase,'-,SENP7,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,3:101415852
rs4681200-<b>C</b>,5 x 10-90,,0.21,'-,0.029 unit increase,'-,LINC01214,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,3:150284351
rs34468831-<b>G</b>,3 x 10-12,,0.37,'-,0.032 unit decrease,NR,PRDM16,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,1:3180749
rs9921295-<b>G</b>,4 x 10-12,,0.33,'-,0.031 unit increase,NR,"CNEP1R1, NCOA5LP",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,16:49993219
rs17049722-<b>T</b>,4 x 10-12,,0.17,'-,0.038 unit increase,NR,LINC01122,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,2:58749728
chr2:136879065-<b>?</b>,9 x 10-13,,0.32,'-,0.035 unit decrease,NR,'-,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,Mapping not available
rs34778241-<b>TG</b>,2 x 10-9,,0.71,'-,0.03 unit decrease,NR,EIF4E3,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,3:71722065
rs2811487-<b>A</b>,7 x 10-10,,0.36,'-,0.027 unit increase,NR,"RPN1, LINC01565",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,3:128613036
rs871134-<b>T</b>,1 x 10-14,,0.49,'-,0.032 unit decrease,NR,"TADA2B, CCDC96",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,4:7042653
rs4681200-<b>G</b>,4 x 10-19,,0.92,'-,0.072 unit increase,NR,LINC01214,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,3:150284351
rs10948011-<b>A</b>,4 x 10-12,,0.23,'-,0.035 unit increase,NR,TAF8,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,6:42056547
rs35355140-<b>A</b>,2 x 10-13,,0.14,'-,0.045 unit increase,NR,HOXA9,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,7:27165113
rs4721217-<b>T</b>,7 x 10-23,,0.42,'-,0.043 unit decrease,NR,MAD1L1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,7:1933943
rs59543286-<b>C</b>,8 x 10-32,,0.23,'-,0.059 unit increase,NR,STMP1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,7:135666562
rs55727837-<b>T</b>,1 x 10-19,,0.11,'-,0.061 unit increase,NR,KRBA1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,7:149731512
rs72698721-<b>A</b>,4 x 10-33,,0.32,'-,0.055 unit increase,NR,"DLK1, LINC00523",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,14:100714852
rs189309686-<b>T</b>,4 x 10-8,,0.25,'-,0.027 unit increase,NR,NSMAF,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,8:58596796
rs10692222-<b>CATT</b>,6 x 10-9,,0.43,'-,0.025 unit increase,NR,CCDC26,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,8:129585117
rs80277818-<b>G</b>,8 x 10-55,,0.26,'-,0.075 unit decrease,NR,LINC01478,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,18:44437936
rs9299129-<b>G</b>,2 x 10-9,,0.23,'-,0.03 unit increase,NR,ZNF462,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,9:106875886
rs4251697-<b>G</b>,2 x 10-10,,0.081,'-,0.059 unit increase,NR,CDKN1B,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,12:12721528
rs139012944-<b>C</b>,4 x 10-8,,0.071,'-,0.051 unit decrease,NR,TCL1A,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,14:95714368
rs8088824-<b>C</b>,3 x 10-23,,0.82,'-,0.056 unit decrease,NR,LINC01478,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,18:44571296
rs56116444-<b>G</b>,9 x 10-36,,0.07,'-,0.027 unit increase,'-,"NREP, STARD4-AS1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,5:111726150
rs11251-<b>G</b>,2 x 10-30,,0.61,'-,0.013 unit increase,'-,CD164,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,6:109368704
rs4709819-<b>G</b>,3 x 10-83,,0.59,'-,0.023 unit increase,'-,'-,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,6:164042323
rs4721217-<b>T</b>,3 x 10-55,,0.4,'-,0.019 unit increase,'-,MAD1L1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,7:1933943
rs2979469-<b>C</b>,3 x 10-30,,0.74,'-,0.015 unit increase,'-,RBPMS,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,8:30427575
rs227079-<b>A</b>,9 x 10-31,,0.55,'-,0.014 unit increase,'-,C11orf65,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,11:108377959
rs728739-<b>A</b>,2 x 10-106,,0.84,'-,0.035 unit increase,'-,TCL1A,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,14:95715725
rs72698721-<b>G</b>,1 x 10-52,,0.87,'-,0.026 unit increase,'-,"DLK1, LINC00523",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,14:100714852
rs77874075-<b>G</b>,5 x 10-25,,0.09,'-,0.021 unit increase,'-,"CENPN-AS1, CENPN",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,16:81032734
rs78997619-<b>C</b>,1 x 10-38,,0.96,'-,0.037 unit increase,'-,"FAM117A, SLC35B1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,17:49709799
rs80277818-<b>G</b>,3 x 10-80,,0.13,'-,0.033 unit increase,'-,LINC01478,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,18:44437936
rs17758695-<b>C</b>,1 x 10-33,,0.97,'-,0.01 unit decrease,NR,BCL2,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,18:63253621
rs1122138-<b>C</b>,6 x 10-31,,0.84,'-,0.005 unit decrease,NR,TCL1A,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,14:95713905
rs78378222-<b>G</b>,3 x 10-28,,0.01,'-,0.013 unit decrease,NR,TP53,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,17:7668434
rs59633341-<b>A</b>,4 x 10-28,,0.16,'-,0.004 unit decrease,NR,LINC01214,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,3:150301094
rs2736609-<b>T</b>,2 x 10-19,,0.36,'-,0.003 unit decrease,NR,"PMF1, PMF1-BGLAP",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,1:156232849
rs13191948-<b>C</b>,2 x 10-19,,0.54,'-,0.002 unit decrease,NR,CCDC162P,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,6:109313396
rs60084722-<b>CT</b>,2 x 10-17,,0.79,'-,0.003 unit decrease,NR,TPX2,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,20:31767936
rs381500-<b>C</b>,5 x 10-16,,0.55,'-,0.002 unit decrease,NR,'-,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,6:164057356
rs56084922-<b>G</b>,3 x 10-15,,0.08,'-,0.005 unit decrease,NR,"STARD4-AS1, NREP",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,5:111726186
rs137952017-<b>C</b>,4 x 10-15,,0.85,'-,0.003 unit decrease,NR,"LINC00523, DLK1",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,14:100709754
rs4721217-<b>T</b>,4 x 10-14,,0.4,'-,0.002 unit decrease,NR,MAD1L1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,7:1933943
rs35091702-<b>C</b>,1 x 10-11,,0.74,'-,0.002 unit decrease,NR,RBPMS,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,8:30421955
rs4754301-<b>A</b>,7 x 10-11,,0.55,'-,0.002 unit decrease,NR,NPAT,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,11:108177814
rs12448368-<b>C</b>,7 x 10-11,,0.13,'-,0.003 unit decrease,NR,"CMC2, CENPN",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,16:81011342
rs11082396-<b>C</b>,1 x 10-10,,0.13,'-,0.003 unit decrease,NR,LINC01478,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,18:44500755
rs13088318-<b>G</b>,3 x 10-10,,0.34,'-,0.002 unit decrease,NR,"FAM172BP, TRMT10C",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,3:101523907
rs77522818-<b>A</b>,9 x 10-10,,0.96,'-,0.005 unit decrease,NR,FAM117A,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,17:49740011
rs10687116-<b>AGATG</b>,9 x 10-10,,0.8,'-,0.002 unit decrease,NR,"MIR3168, RN7SL597P",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,13:41103946
rs115854006-<b>C</b>,5 x 10-8,,0.96,'-,0.006 unit decrease,NR,"SPINK8, FBXW12",Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009375,3:48346680
rs2887399-<b>G</b>,6 x 10-11,,0.77,1.57,'-,[1.36-1.80],TCL1A,Mosaic loss of chromosome Y,mosaic loss of chromosome Y measurement,GCST003421,14:95714358
rs2047898-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,FKBP1C,DNA methylation variation (age effect),DNA methylation,GCST006660,6:63148703
rs75293180-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MSRA,DNA methylation variation (age effect),DNA methylation,GCST006660,8:10368084
rs150007273-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RPL5P16,DNA methylation variation (age effect),DNA methylation,GCST006660,5:82722218
rs115840193-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"LINC02085, ZPLD1",DNA methylation variation (age effect),DNA methylation,GCST006660,3:102004038
rs73028974-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ATP2B2,DNA methylation variation (age effect),DNA methylation,GCST006660,3:10544960
rs149131629-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,IL34,DNA methylation variation (age effect),DNA methylation,GCST006660,16:70636753
rs182102769-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LINC00844,DNA methylation variation (age effect),DNA methylation,GCST006660,10:58983251
rs2147112-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,LRFN5,DNA methylation variation (age effect),DNA methylation,GCST006660,14:41871854
rs1780437-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LINC02629,DNA methylation variation (age effect),DNA methylation,GCST006660,10:33967875
rs61750222-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RUNX1,DNA methylation variation (age effect),DNA methylation,GCST006660,21:34792189
rs837890-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LINC01854,DNA methylation variation (age effect),DNA methylation,GCST006660,2:129346873
rs9364562-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LPA,DNA methylation variation (age effect),DNA methylation,GCST006660,6:160569425
rs189479531-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,RNU6-475P,DNA methylation variation (age effect),DNA methylation,GCST006660,6:114935838
rs184392414-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,RWDD1,DNA methylation variation (age effect),DNA methylation,GCST006660,6:116583268
rs72495198-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"ECEL1P1, DIS3L2P1",DNA methylation variation (age effect),DNA methylation,GCST006660,2:232420429
rs191982371-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,KRT18P24,DNA methylation variation (age effect),DNA methylation,GCST006660,9:79115425
rs62006538-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,MTND5P40,DNA methylation variation (age effect),DNA methylation,GCST006660,15:46404439
rs114458961-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CD5L,DNA methylation variation (age effect),DNA methylation,GCST006660,1:157869964
rs146690225-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,FNDC3B,DNA methylation variation (age effect),DNA methylation,GCST006660,3:172232611
rs146309381-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SMARCE1,DNA methylation variation (age effect),DNA methylation,GCST006660,17:40626609
rs141554673-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PPIAP74,DNA methylation variation (age effect),DNA methylation,GCST006660,3:167125281
rs71307987-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,3:144628193
rs113928546-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ZFAT,DNA methylation variation (age effect),DNA methylation,GCST006660,8:134538790
rs7648951-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MYRIP,DNA methylation variation (age effect),DNA methylation,GCST006660,3:39935725
rs112466685-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,8:134060970
rs16930542-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,SVIL,DNA methylation variation (age effect),DNA methylation,GCST006660,10:29740058
rs150144185-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,PCDH7,DNA methylation variation (age effect),DNA methylation,GCST006660,4:30849412
rs10434549-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC02118,DNA methylation variation (age effect),DNA methylation,GCST006660,5:52109622
rs181823181-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,"LINC02431, MIR6082",DNA methylation variation (age effect),DNA methylation,GCST006660,4:171116822
rs35277959-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,IPCEF1,DNA methylation variation (age effect),DNA methylation,GCST006660,6:154280820
rs341338-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,HMGB3P16,DNA methylation variation (age effect),DNA methylation,GCST006660,5:112486931
rs34414349-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LHX9,DNA methylation variation (age effect),DNA methylation,GCST006660,1:197988391
rs2265179-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,"OR6L2P, SCART1",DNA methylation variation (age effect),DNA methylation,GCST006660,10:133449883
rs62141280-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,C2orf16,DNA methylation variation (age effect),DNA methylation,GCST006660,2:27550188
rs183717966-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LRP1B,DNA methylation variation (age effect),DNA methylation,GCST006660,2:140666448
rs148655837-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RNU6-788P,DNA methylation variation (age effect),DNA methylation,GCST006660,3:23646851
rs191540449-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ACSL1,DNA methylation variation (age effect),DNA methylation,GCST006660,4:184781536
rs78287639-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,4:133701188
rs113147266-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"CXCL13, CNOT6L",DNA methylation variation (age effect),DNA methylation,GCST006660,4:77661587
rs183669222-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ATP6AP1L,DNA methylation variation (age effect),DNA methylation,GCST006660,5:82366640
rs189007515-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,SH3PXD2A,DNA methylation variation (age effect),DNA methylation,GCST006660,10:103816854
rs55895004-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,SEC61A2,DNA methylation variation (age effect),DNA methylation,GCST006660,10:12138808
rs72763380-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC02254, LINC02253",DNA methylation variation (age effect),DNA methylation,GCST006660,15:97409008
rs188284312-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ADAMTS18,DNA methylation variation (age effect),DNA methylation,GCST006660,16:77400691
rs11697151-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,BPIFB3,DNA methylation variation (age effect),DNA methylation,GCST006660,20:33059890
rs114870811-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,EPHA3,DNA methylation variation (age effect),DNA methylation,GCST006660,3:89401948
rs75250417-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,NALCN,DNA methylation variation (age effect),DNA methylation,GCST006660,13:82148594
rs12415920-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"TRAF6P1, PHYHIPL",DNA methylation variation (age effect),DNA methylation,GCST006660,10:59170536
rs11717844-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,GAP43,DNA methylation variation (age effect),DNA methylation,GCST006660,3:115616148
rs4380702-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,5:117084226
rs11768053-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MMD2,DNA methylation variation (age effect),DNA methylation,GCST006660,7:4958395
rs117321697-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC01252, ETV6",DNA methylation variation (age effect),DNA methylation,GCST006660,12:11640263
rs80170476-<b>?</b>,7 x 10-11,,NR,'-,'-,'-,ABCA1,DNA methylation variation (age effect),DNA methylation,GCST006660,9:104896803
rs7006988-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,EYA1,DNA methylation variation (age effect),DNA methylation,GCST006660,8:71631124
rs148586547-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,F13A1,DNA methylation variation (age effect),DNA methylation,GCST006660,6:6141025
rs28561649-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,ZNF839,DNA methylation variation (age effect),DNA methylation,GCST006660,14:102337226
rs7090078-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,Y_RNA,DNA methylation variation (age effect),DNA methylation,GCST006660,10:130582742
rs117511681-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"WNK2, NINJ1",DNA methylation variation (age effect),DNA methylation,GCST006660,9:93146310
rs140596460-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,CCDC26,DNA methylation variation (age effect),DNA methylation,GCST006660,8:128681202
rs76444204-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"CMKLR1, LINC01498",DNA methylation variation (age effect),DNA methylation,GCST006660,12:108369129
rs143277812-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,GNAL,DNA methylation variation (age effect),DNA methylation,GCST006660,18:11739527
rs138978821-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,PRDM5,DNA methylation variation (age effect),DNA methylation,GCST006660,4:120727011
rs142644146-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,HINT1,DNA methylation variation (age effect),DNA methylation,GCST006660,5:131136016
rs72961133-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,2:116263723
rs183669222-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,ATP6AP1L,DNA methylation variation (age effect),DNA methylation,GCST006660,5:82366640
rs140222672-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CNTNAP2,DNA methylation variation (age effect),DNA methylation,GCST006660,7:148034323
rs114437475-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,"EVA1A, EVA1A-AS",DNA methylation variation (age effect),DNA methylation,GCST006660,2:75534822
rs188284312-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ADAMTS18,DNA methylation variation (age effect),DNA methylation,GCST006660,16:77400691
rs112016995-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CDH13,DNA methylation variation (age effect),DNA methylation,GCST006660,16:83000572
rs13188817-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ARSB,DNA methylation variation (age effect),DNA methylation,GCST006660,5:78826293
rs759928-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,"GLULP5, LINC02459",DNA methylation variation (age effect),DNA methylation,GCST006660,12:114172706
rs79920190-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,ZNF124,DNA methylation variation (age effect),DNA methylation,GCST006660,1:247138568
rs180758259-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,TMEM135,DNA methylation variation (age effect),DNA methylation,GCST006660,11:87070490
rs6713406-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"GRHL1, KLF11",DNA methylation variation (age effect),DNA methylation,GCST006660,2:10019875
rs11930943-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"Metazoa_SRP, OR7E35P",DNA methylation variation (age effect),DNA methylation,GCST006660,4:9741099
rs117293193-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,14:45411093
rs141292672-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SUGP2,DNA methylation variation (age effect),DNA methylation,GCST006660,19:19020204
rs144241717-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CSMD1,DNA methylation variation (age effect),DNA methylation,GCST006660,8:3884864
rs1177847-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,10:130609249
rs2364754-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,"RPEP2, LINC00692",DNA methylation variation (age effect),DNA methylation,GCST006660,3:25966377
rs77254624-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PARD3B,DNA methylation variation (age effect),DNA methylation,GCST006660,2:204843049
rs1787864-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"MC5R, MC2R",DNA methylation variation (age effect),DNA methylation,GCST006660,18:13835002
rs80242667-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,PTPN20,DNA methylation variation (age effect),DNA methylation,GCST006660,10:47096536
rs12046867-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,ADGRL2,DNA methylation variation (age effect),DNA methylation,GCST006660,1:81413726
rs12610785-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"PTPRS, ZNRF4",DNA methylation variation (age effect),DNA methylation,GCST006660,19:5410094
rs185580150-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,GCKR,DNA methylation variation (age effect),DNA methylation,GCST006660,2:27507500
rs7170931-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,"LINC02253, LINC02254",DNA methylation variation (age effect),DNA methylation,GCST006660,15:97403736
rs72677209-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,4:104346227
rs77269753-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,PLXNA4,DNA methylation variation (age effect),DNA methylation,GCST006660,7:132221537
rs111623082-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC00560, LINC00433",DNA methylation variation (age effect),DNA methylation,GCST006660,13:88623281
rs4719463-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,CRPPA,DNA methylation variation (age effect),DNA methylation,GCST006660,7:16289463
rs115056352-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"NACA3P, FAM218BP",DNA methylation variation (age effect),DNA methylation,GCST006660,4:164943228
rs148788848-<b>?</b>,8 x 10-10,,NR,'-,'-,'-,MTATP6P21,DNA methylation variation (age effect),DNA methylation,GCST006660,7:67621302
rs34246082-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"ZBTB49, NSG1",DNA methylation variation (age effect),DNA methylation,GCST006660,4:4330102
rs16951805-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,18:7458207
rs117113357-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,RNU7-51P,DNA methylation variation (age effect),DNA methylation,GCST006660,14:83123519
rs16977635-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"GCOM1, MYZAP",DNA methylation variation (age effect),DNA methylation,GCST006660,15:57654988
rs141490781-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,CDH11,DNA methylation variation (age effect),DNA methylation,GCST006660,16:65080086
rs151120610-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,DCC,DNA methylation variation (age effect),DNA methylation,GCST006660,18:53347348
rs1110195-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC02074,DNA methylation variation (age effect),DNA methylation,GCST006660,17:73968767
rs11025640-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,"HMGB1P40, SLC6A5",DNA methylation variation (age effect),DNA methylation,GCST006660,11:20585932
rs6842071-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,TLR1,DNA methylation variation (age effect),DNA methylation,GCST006660,4:38818229
rs79266273-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,16:13731913
rs143691392-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"APP-DT, CYYR1-AS1",DNA methylation variation (age effect),DNA methylation,GCST006660,21:26316458
rs192098482-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,7:42546557
rs181179170-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RPL32P19, PPM1AP1",DNA methylation variation (age effect),DNA methylation,GCST006660,8:15894154
rs13193176-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,MTHFD1L,DNA methylation variation (age effect),DNA methylation,GCST006660,6:150945734
rs12240959-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"ENTPD1, ENTPD1-AS1",DNA methylation variation (age effect),DNA methylation,GCST006660,10:95809031
rs144001526-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MTRNR2L9,DNA methylation variation (age effect),DNA methylation,GCST006660,6:61503242
rs12675862-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,MSR1,DNA methylation variation (age effect),DNA methylation,GCST006660,8:16321658
rs67443441-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,BCL2,DNA methylation variation (age effect),DNA methylation,GCST006660,18:63207610
rs79396740-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,MAPRE1,DNA methylation variation (age effect),DNA methylation,GCST006660,20:32839143
rs181179170-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"RPL32P19, PPM1AP1",DNA methylation variation (age effect),DNA methylation,GCST006660,8:15894154
rs8077015-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,NLRP1,DNA methylation variation (age effect),DNA methylation,GCST006660,17:5665946
rs62379939-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"CIR1P1, HAND1",DNA methylation variation (age effect),DNA methylation,GCST006660,5:154490063
rs72726129-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LINC02055,DNA methylation variation (age effect),DNA methylation,GCST006660,8:136227219
rs113065892-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,2:129638160
rs60526088-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,CACNA1H,DNA methylation variation (age effect),DNA methylation,GCST006660,16:1218542
rs1437683-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,2:118541311
rs77944739-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,KAZN,DNA methylation variation (age effect),DNA methylation,GCST006660,1:14794049
rs142008161-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,"TSPOAP1-AS1, RNF43",DNA methylation variation (age effect),DNA methylation,GCST006660,17:58407183
rs4793062-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PYY,DNA methylation variation (age effect),DNA methylation,GCST006660,17:43981505
rs181361216-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"USH2A-AS2, USH2A",DNA methylation variation (age effect),DNA methylation,GCST006660,1:216074869
rs34339117-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,TENM4,DNA methylation variation (age effect),DNA methylation,GCST006660,11:79124369
rs79073424-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CREB5,DNA methylation variation (age effect),DNA methylation,GCST006660,7:28638559
rs35262746-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CACNA2D3,DNA methylation variation (age effect),DNA methylation,GCST006660,3:54720763
rs1281154-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RALGPS1,DNA methylation variation (age effect),DNA methylation,GCST006660,9:127129470
rs116399861-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,IKZF2,DNA methylation variation (age effect),DNA methylation,GCST006660,2:213064450
rs112568625-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC01470,DNA methylation variation (age effect),DNA methylation,GCST006660,5:153177696
rs148485005-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,TMEM260,DNA methylation variation (age effect),DNA methylation,GCST006660,14:56645567
rs10168452-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"RN7SL341P, SERTAD2",DNA methylation variation (age effect),DNA methylation,GCST006660,2:64798991
rs79560051-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,FAM169B,DNA methylation variation (age effect),DNA methylation,GCST006660,15:98501548
rs77009694-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"MPLKIP, Y_RNA",DNA methylation variation (age effect),DNA methylation,GCST006660,7:40128185
rs150939368-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,6:80821393
rs115658936-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:1614227
rs187319357-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RNMT,DNA methylation variation (age effect),DNA methylation,GCST006660,18:13742811
rs113835330-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,ATG5,DNA methylation variation (age effect),DNA methylation,GCST006660,6:106135349
rs11255043-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SFMBT2,DNA methylation variation (age effect),DNA methylation,GCST006660,10:7221247
rs192115356-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,18:40893474
rs74148699-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"SRP9, RNU6-1304P",DNA methylation variation (age effect),DNA methylation,GCST006660,1:225768963
rs6670083-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,LINC00970,DNA methylation variation (age effect),DNA methylation,GCST006660,1:168905115
rs74977054-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,GPATCH2L,DNA methylation variation (age effect),DNA methylation,GCST006660,14:76243564
rs4457620-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,1:82250535
rs145127301-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,7:126281817
rs149128771-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,OXR1,DNA methylation variation (age effect),DNA methylation,GCST006660,8:106491889
rs4915382-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,1:199749881
rs55689260-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC02765,DNA methylation variation (age effect),DNA methylation,GCST006660,1:225453114
rs73688764-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ADCYAP1R1,DNA methylation variation (age effect),DNA methylation,GCST006660,7:31100525
rs7636944-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,CNTN4,DNA methylation variation (age effect),DNA methylation,GCST006660,3:2488458
rs190853916-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,3:22628135
rs73943852-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,2:57204609
rs71597752-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,STK32B,DNA methylation variation (age effect),DNA methylation,GCST006660,4:5328583
rs188380356-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,KCNIP4,DNA methylation variation (age effect),DNA methylation,GCST006660,4:20858103
rs11696806-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,SUN5,DNA methylation variation (age effect),DNA methylation,GCST006660,20:32988840
rs1657408-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,WDR7,DNA methylation variation (age effect),DNA methylation,GCST006660,18:57001343
rs28952024-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,KNOP1P3,DNA methylation variation (age effect),DNA methylation,GCST006660,2:51448852
rs139634939-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,FAM184B,DNA methylation variation (age effect),DNA methylation,GCST006660,4:17730775
rs9542788-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RPS10P21,DNA methylation variation (age effect),DNA methylation,GCST006660,13:71947698
rs150220651-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"RBFOX2, APOL3",DNA methylation variation (age effect),DNA methylation,GCST006660,22:36107092
rs183736659-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,TSPAN9,DNA methylation variation (age effect),DNA methylation,GCST006660,12:3088513
rs77488208-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,COL28A1,DNA methylation variation (age effect),DNA methylation,GCST006660,7:7387157
rs114581300-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"RNU6-612P, ATP1B3P1",DNA methylation variation (age effect),DNA methylation,GCST006660,2:60726465
rs74967706-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,1:195497020
rs3758079-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LNCOC1,DNA methylation variation (age effect),DNA methylation,GCST006660,8:142726233
rs62049757-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"CDH8, RNU6-21P",DNA methylation variation (age effect),DNA methylation,GCST006660,16:62133113
rs143233814-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"PDE8A, NIFKP8",DNA methylation variation (age effect),DNA methylation,GCST006660,15:85151596
rs75433790-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,5:165342291
rs113146055-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"SLMAP, DENND6A-DT",DNA methylation variation (age effect),DNA methylation,GCST006660,3:57704408
rs191060451-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"AGR3, AHR",DNA methylation variation (age effect),DNA methylation,GCST006660,7:16894680
rs9302592-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"CHD9, PHBP21",DNA methylation variation (age effect),DNA methylation,GCST006660,16:53010083
rs36084697-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,PITPNC1,DNA methylation variation (age effect),DNA methylation,GCST006660,17:67517672
rs113975478-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ZNF467,DNA methylation variation (age effect),DNA methylation,GCST006660,7:149768330
rs11997721-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,GFRA2,DNA methylation variation (age effect),DNA methylation,GCST006660,8:21708111
rs11017740-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,TCERG1L,DNA methylation variation (age effect),DNA methylation,GCST006660,10:131128145
rs79418323-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:11635410
rs3796839-<b>?</b>,3 x 10-42,,NR,'-,0.095 unit decrease,[0.082-0.108],"SLC2A9-AS1, SLC2A9",DNA methylation variation (age effect),DNA methylation,GCST006660,4:10008293
rs10948674-<b>?</b>,3 x 10-31,,NR,'-,0.081 unit increase,[0.068-0.094],"MIR206, PKHD1",DNA methylation variation (age effect),DNA methylation,GCST006660,6:52113347
rs190148485-<b>?</b>,2 x 10-11,,NR,'-,0.089 unit increase,[0.064-0.114],RASSF2,DNA methylation variation (age effect),DNA methylation,GCST006660,20:4795437
rs8015861-<b>?</b>,5 x 10-18,,NR,'-,0.046 unit increase,[0.036-0.056],TRAV8-5,DNA methylation variation (age effect),DNA methylation,GCST006660,14:21904124
rs58906513-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,JHY,DNA methylation variation (age effect),DNA methylation,GCST006660,11:122919389
rs182668686-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SCFD2,DNA methylation variation (age effect),DNA methylation,GCST006660,4:52967776
rs148580205-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,DELEC1,DNA methylation variation (age effect),DNA methylation,GCST006660,9:115277708
rs114732119-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,PPIAP63,DNA methylation variation (age effect),DNA methylation,GCST006660,2:56677094
rs150226882-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,MIR3681HG,DNA methylation variation (age effect),DNA methylation,GCST006660,2:12621197
rs73759508-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,RAB3C,DNA methylation variation (age effect),DNA methylation,GCST006660,5:58616936
rs72795008-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,RPSAP37,DNA methylation variation (age effect),DNA methylation,GCST006660,5:125929364
rs112164679-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,HMGA1P6,DNA methylation variation (age effect),DNA methylation,GCST006660,13:23082932
rs114322830-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"DDAH1, LINC01648",DNA methylation variation (age effect),DNA methylation,GCST006660,1:30097700
rs77853392-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,AP3B1,DNA methylation variation (age effect),DNA methylation,GCST006660,5:78223235
rs182795071-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,TRIO,DNA methylation variation (age effect),DNA methylation,GCST006660,5:14317779
rs118053310-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,"RNY1P5, RPL21P108",DNA methylation variation (age effect),DNA methylation,GCST006660,13:74294570
rs117734071-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"OR5BQ1P, OR5AK1P",DNA methylation variation (age effect),DNA methylation,GCST006660,11:57022711
rs12907605-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"NPM1P47, C2CD4B",DNA methylation variation (age effect),DNA methylation,GCST006660,15:62092143
rs116889104-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MCHR2-AS1,DNA methylation variation (age effect),DNA methylation,GCST006660,6:100024016
rs9521357-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LINC00399,DNA methylation variation (age effect),DNA methylation,GCST006660,13:109417390
rs12527429-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,WDR27,DNA methylation variation (age effect),DNA methylation,GCST006660,6:169652762
rs189007515-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,SH3PXD2A,DNA methylation variation (age effect),DNA methylation,GCST006660,10:103816854
rs59050332-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ACVR1B,DNA methylation variation (age effect),DNA methylation,GCST006660,12:51963531
rs1551720-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"SCARA5, PBK",DNA methylation variation (age effect),DNA methylation,GCST006660,8:27840720
rs12444040-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"RPL34P29, ZNF423",DNA methylation variation (age effect),DNA methylation,GCST006660,16:49864174
rs113679437-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,"Metazoa_SRP, Y_RNA",DNA methylation variation (age effect),DNA methylation,GCST006660,10:21476302
rs112779669-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,RBMS3,DNA methylation variation (age effect),DNA methylation,GCST006660,3:28591921
rs72810550-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"MRPL33, RBKS",DNA methylation variation (age effect),DNA methylation,GCST006660,2:27860513
rs58426008-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CCDC71L,DNA methylation variation (age effect),DNA methylation,GCST006660,7:106608079
rs13433330-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PLCB1,DNA methylation variation (age effect),DNA methylation,GCST006660,20:8514398
rs139978857-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"STPG2, STPG2-AS1",DNA methylation variation (age effect),DNA methylation,GCST006660,4:97367541
rs147735245-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"ANXA13, FAM91A1",DNA methylation variation (age effect),DNA methylation,GCST006660,8:123766220
rs149386674-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,LINC01588,DNA methylation variation (age effect),DNA methylation,GCST006660,14:50056489
rs115135226-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"LINC01866, RN7SKP168",DNA methylation variation (age effect),DNA methylation,GCST006660,2:17047249
rs111484648-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,BICD1,DNA methylation variation (age effect),DNA methylation,GCST006660,12:32096525
rs141977720-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC01399,DNA methylation variation (age effect),DNA methylation,GCST006660,22:35209033
rs117551578-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ANO3,DNA methylation variation (age effect),DNA methylation,GCST006660,11:26374622
rs61750467-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC01572, PMFBP1",DNA methylation variation (age effect),DNA methylation,GCST006660,16:72224753
rs147809295-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"TEX261, OR7E91P",DNA methylation variation (age effect),DNA methylation,GCST006660,2:71016091
rs75205693-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"ACTBP8, CNR1",DNA methylation variation (age effect),DNA methylation,GCST006660,6:88178685
rs11697151-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,BPIFB3,DNA methylation variation (age effect),DNA methylation,GCST006660,20:33059890
rs147751337-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LINC02720,DNA methylation variation (age effect),DNA methylation,GCST006660,11:80848277
rs189479531-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RNU6-475P,DNA methylation variation (age effect),DNA methylation,GCST006660,6:114935838
rs34875023-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC01801,DNA methylation variation (age effect),DNA methylation,GCST006660,19:34818418
rs148286224-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,DTD1,DNA methylation variation (age effect),DNA methylation,GCST006660,20:18659884
rs139703972-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,RN7SL643P,DNA methylation variation (age effect),DNA methylation,GCST006660,6:86495853
rs142992315-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"KRT125P, BTBD10P1",DNA methylation variation (age effect),DNA methylation,GCST006660,12:52741048
rs9485244-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,6:148088385
rs113677319-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,OVOL2,DNA methylation variation (age effect),DNA methylation,GCST006660,20:18028199
rs138696382-<b>?</b>,6 x 10-11,,NR,'-,'-,'-,AP1G1,DNA methylation variation (age effect),DNA methylation,GCST006660,16:71800658
rs144042126-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LRRTM4,DNA methylation variation (age effect),DNA methylation,GCST006660,2:77251425
rs76443714-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,10:130780235
rs149142052-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,EXOC4,DNA methylation variation (age effect),DNA methylation,GCST006660,7:133610309
rs10758619-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"SLC1A1, RNU6-694P",DNA methylation variation (age effect),DNA methylation,GCST006660,9:4394612
rs144870397-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ZHX3,DNA methylation variation (age effect),DNA methylation,GCST006660,20:41247223
rs609990-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"RGS16, LINC01686",DNA methylation variation (age effect),DNA methylation,GCST006660,1:182610793
rs17559144-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,PLEKHG4B,DNA methylation variation (age effect),DNA methylation,GCST006660,5:188604
rs78025620-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,TNR,DNA methylation variation (age effect),DNA methylation,GCST006660,1:175474362
rs2082278-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,PXDNL,DNA methylation variation (age effect),DNA methylation,GCST006660,8:51403837
rs132275-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,KREMEN1,DNA methylation variation (age effect),DNA methylation,GCST006660,22:29130209
rs184472829-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ANKRD50,DNA methylation variation (age effect),DNA methylation,GCST006660,4:124761267
rs77259676-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CMC1,DNA methylation variation (age effect),DNA methylation,GCST006660,3:28245187
rs12742393-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NOS1AP,DNA methylation variation (age effect),DNA methylation,GCST006660,1:162254796
rs114605388-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LNC-LBCS,DNA methylation variation (age effect),DNA methylation,GCST006660,6:19835400
rs138832179-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,MROH2B,DNA methylation variation (age effect),DNA methylation,GCST006660,5:41051366
rs76969352-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,HDAC9,DNA methylation variation (age effect),DNA methylation,GCST006660,7:18387678
rs79719606-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"Y_RNA, PRDM13",DNA methylation variation (age effect),DNA methylation,GCST006660,6:99620611
rs140224167-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,ALMS1,DNA methylation variation (age effect),DNA methylation,GCST006660,2:73538779
rs186178198-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,PARD3B,DNA methylation variation (age effect),DNA methylation,GCST006660,2:205268477
rs149948521-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,HLA-C,DNA methylation variation (age effect),DNA methylation,GCST006660,6:31269460
rs116486761-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,MIR548AD,DNA methylation variation (age effect),DNA methylation,GCST006660,2:35467169
rs73024730-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ATP2B2,DNA methylation variation (age effect),DNA methylation,GCST006660,3:10487717
rs192339095-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,RPL23AP38,DNA methylation variation (age effect),DNA methylation,GCST006660,3:1526228
rs140596460-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,CCDC26,DNA methylation variation (age effect),DNA methylation,GCST006660,8:128681202
rs140546855-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,FRA10AC1,DNA methylation variation (age effect),DNA methylation,GCST006660,10:93676847
rs6916624-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,ILRUN,DNA methylation variation (age effect),DNA methylation,GCST006660,6:34671328
rs11224476-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,ARHGAP42,DNA methylation variation (age effect),DNA methylation,GCST006660,11:100827501
rs117272108-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:108610864
rs62372132-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"PRELID3BP7, PRELID3BP6",DNA methylation variation (age effect),DNA methylation,GCST006660,5:42955886
rs116987964-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,EEA1,DNA methylation variation (age effect),DNA methylation,GCST006660,12:92892438
rs61878546-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ART1,DNA methylation variation (age effect),DNA methylation,GCST006660,11:3653650
rs182924987-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MON1B,DNA methylation variation (age effect),DNA methylation,GCST006660,16:77123090
rs11953990-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LINC01018,DNA methylation variation (age effect),DNA methylation,GCST006660,5:6593346
rs78683083-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"LINC02228, NDUFS6",DNA methylation variation (age effect),DNA methylation,GCST006660,5:25036722
rs117955096-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ACTBP8,DNA methylation variation (age effect),DNA methylation,GCST006660,6:88282167
rs115881877-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,3:43891240
rs150216791-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,ARMC2,DNA methylation variation (age effect),DNA methylation,GCST006660,6:108942260
rs11762096-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,DPP6,DNA methylation variation (age effect),DNA methylation,GCST006660,7:154566308
rs117992102-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,BMP7,DNA methylation variation (age effect),DNA methylation,GCST006660,20:57087817
rs148845971-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,SMTNL2,DNA methylation variation (age effect),DNA methylation,GCST006660,17:4591446
rs7639060-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,3:154798236
rs189988997-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:23074740
rs56326811-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"NAA11, GK2",DNA methylation variation (age effect),DNA methylation,GCST006660,4:79334851
rs191175118-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,12:91567840
rs150007273-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,RPL5P16,DNA methylation variation (age effect),DNA methylation,GCST006660,5:82722218
rs76522264-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,8:112020580
rs114894862-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"SSBP3, LINC02784",DNA methylation variation (age effect),DNA methylation,GCST006660,1:54483374
rs333891-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,2:117252376
rs149564412-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PARD3B,DNA methylation variation (age effect),DNA methylation,GCST006660,2:205148674
rs874060-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,"OR6B2, OR6B3",DNA methylation variation (age effect),DNA methylation,GCST006660,2:240032033
rs11595127-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"RNMTL1P1, Metazoa_SRP",DNA methylation variation (age effect),DNA methylation,GCST006660,10:21412806
rs28516534-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,CNTNAP2,DNA methylation variation (age effect),DNA methylation,GCST006660,7:147064215
rs114313448-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"DMRTB1, GLIS1",DNA methylation variation (age effect),DNA methylation,GCST006660,1:53492514
rs183717966-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,LRP1B,DNA methylation variation (age effect),DNA methylation,GCST006660,2:140666448
rs192224341-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"PPP1R21-DT, FOXN2",DNA methylation variation (age effect),DNA methylation,GCST006660,2:48419429
rs1247769-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,KCNMA1,DNA methylation variation (age effect),DNA methylation,GCST006660,10:77048422
rs117578199-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,TEAD1,DNA methylation variation (age effect),DNA methylation,GCST006660,11:12804647
rs34356419-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"ADAMTS6, CENPK",DNA methylation variation (age effect),DNA methylation,GCST006660,5:65483430
rs1523707-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LRP1B,DNA methylation variation (age effect),DNA methylation,GCST006660,2:142190133
rs76982571-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,KCNC2,DNA methylation variation (age effect),DNA methylation,GCST006660,12:74966902
rs62277117-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,3:147965857
rs78847175-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RMI2, LITAF",DNA methylation variation (age effect),DNA methylation,GCST006660,16:11458046
rs113316507-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CD82,DNA methylation variation (age effect),DNA methylation,GCST006660,11:44591260
rs185374745-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SLC8A1,DNA methylation variation (age effect),DNA methylation,GCST006660,2:40565967
rs79714767-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SEMA3A,DNA methylation variation (age effect),DNA methylation,GCST006660,7:84275186
rs74762505-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,NFIA,DNA methylation variation (age effect),DNA methylation,GCST006660,1:61193014
rs144994126-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PIK3CG,DNA methylation variation (age effect),DNA methylation,GCST006660,7:106919946
rs11697151-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,BPIFB3,DNA methylation variation (age effect),DNA methylation,GCST006660,20:33059890
rs79897941-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC01960, SP3",DNA methylation variation (age effect),DNA methylation,GCST006660,2:174007264
rs145658364-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PRDM10,DNA methylation variation (age effect),DNA methylation,GCST006660,11:129988672
rs142469837-<b>?</b>,7 x 10-10,,NR,'-,'-,'-,LINC02599,DNA methylation variation (age effect),DNA methylation,GCST006660,8:48589026
rs75607637-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC02438,DNA methylation variation (age effect),DNA methylation,GCST006660,4:19239202
rs35082390-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,4:35727157
rs60936317-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,CTNND2,DNA methylation variation (age effect),DNA methylation,GCST006660,5:11544845
rs77834246-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CDK14,DNA methylation variation (age effect),DNA methylation,GCST006660,7:91140036
rs79562083-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"KCNG4, RNA5SP433",DNA methylation variation (age effect),DNA methylation,GCST006660,16:84257235
rs2227492-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,IL22,DNA methylation variation (age effect),DNA methylation,GCST006660,12:68252357
rs73547611-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"HMGB1P13, LINC00326",DNA methylation variation (age effect),DNA methylation,GCST006660,6:132897832
rs425903-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CDH18,DNA methylation variation (age effect),DNA methylation,GCST006660,5:19466211
rs12357875-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CELF2, USP6NL",DNA methylation variation (age effect),DNA methylation,GCST006660,10:11382596
rs4768451-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,12:42838581
rs182981601-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,LINC02328,DNA methylation variation (age effect),DNA methylation,GCST006660,14:85849237
rs115427296-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LRRIQ3,DNA methylation variation (age effect),DNA methylation,GCST006660,1:74158289
rs192879075-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PLCE1,DNA methylation variation (age effect),DNA methylation,GCST006660,10:94257517
rs12813347-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LINC02414,DNA methylation variation (age effect),DNA methylation,GCST006660,12:131603856
rs62141280-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,C2orf16,DNA methylation variation (age effect),DNA methylation,GCST006660,2:27550188
rs183717966-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LRP1B,DNA methylation variation (age effect),DNA methylation,GCST006660,2:140666448
rs114437475-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"EVA1A, EVA1A-AS",DNA methylation variation (age effect),DNA methylation,GCST006660,2:75534822
rs147755126-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,3:118529701
rs72687745-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,TENM3-AS1,DNA methylation variation (age effect),DNA methylation,GCST006660,4:181875035
rs56333853-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"YAE1, POU6F2",DNA methylation variation (age effect),DNA methylation,GCST006660,7:39544785
rs187723957-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:108446696
rs4706938-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,IBTK,DNA methylation variation (age effect),DNA methylation,GCST006660,6:82200530
rs180936053-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"TUSC3, SGCZ",DNA methylation variation (age effect),DNA methylation,GCST006660,8:15330022
rs191060451-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"AGR3, AHR",DNA methylation variation (age effect),DNA methylation,GCST006660,7:16894680
rs117183447-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,SCP2D1-AS1,DNA methylation variation (age effect),DNA methylation,GCST006660,20:18898320
rs948708-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,"GALR1, BDP1P",DNA methylation variation (age effect),DNA methylation,GCST006660,18:77342826
rs187857589-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,SCFD2,DNA methylation variation (age effect),DNA methylation,GCST006660,4:53229847
rs1961952-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,"GKAP1, UBQLN1",DNA methylation variation (age effect),DNA methylation,GCST006660,9:83710891
rs9515642-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RPL7L1P1,DNA methylation variation (age effect),DNA methylation,GCST006660,13:89852886
rs57721847-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,STC1,DNA methylation variation (age effect),DNA methylation,GCST006660,8:23837432
rs189007515-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SH3PXD2A,DNA methylation variation (age effect),DNA methylation,GCST006660,10:103816854
rs148992522-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,MMP26,DNA methylation variation (age effect),DNA methylation,GCST006660,11:4959216
rs112164679-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,HMGA1P6,DNA methylation variation (age effect),DNA methylation,GCST006660,13:23082932
rs143699509-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,RPL7L1P1,DNA methylation variation (age effect),DNA methylation,GCST006660,13:89868224
rs62339710-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RPS23P5,DNA methylation variation (age effect),DNA methylation,GCST006660,5:13343708
rs753341-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,BMP7,DNA methylation variation (age effect),DNA methylation,GCST006660,20:57082588
rs3890907-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,H19,DNA methylation variation (age effect),DNA methylation,GCST006660,11:2006913
rs150845610-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"BAK1P1, C20orf203",DNA methylation variation (age effect),DNA methylation,GCST006660,20:32674821
rs61458527-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"RBM38, HMGB1P1",DNA methylation variation (age effect),DNA methylation,GCST006660,20:57482037
rs138837919-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:108519414
rs187996666-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,16:82489520
rs138493184-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,6:86734852
rs2253204-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,TIAM1,DNA methylation variation (age effect),DNA methylation,GCST006660,21:31255676
rs62302171-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,LINC02265,DNA methylation variation (age effect),DNA methylation,GCST006660,4:40328557
rs930055-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,COL23A1,DNA methylation variation (age effect),DNA methylation,GCST006660,5:178328174
rs80101936-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CDH13,DNA methylation variation (age effect),DNA methylation,GCST006660,16:82548005
rs76610913-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,CCSER1,DNA methylation variation (age effect),DNA methylation,GCST006660,4:91166612
rs242942-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,"LINC02210-CRHR1, MAPT-AS1, CRHR1",DNA methylation variation (age effect),DNA methylation,GCST006660,17:45814267
rs60113019-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,FREM1,DNA methylation variation (age effect),DNA methylation,GCST006660,9:14790669
rs6875834-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,U4,DNA methylation variation (age effect),DNA methylation,GCST006660,5:179487710
rs118150334-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,HIP1,DNA methylation variation (age effect),DNA methylation,GCST006660,7:75665539
rs146421862-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,AKR1D1,DNA methylation variation (age effect),DNA methylation,GCST006660,7:138037820
rs142163225-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,LINC00560,DNA methylation variation (age effect),DNA methylation,GCST006660,13:88696103
rs61783053-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,DDAH1,DNA methylation variation (age effect),DNA methylation,GCST006660,1:85445017
rs140817157-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,SLC35F4,DNA methylation variation (age effect),DNA methylation,GCST006660,14:57593766
rs111281351-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,HNRNPA1P58,DNA methylation variation (age effect),DNA methylation,GCST006660,6:23977858
rs188810024-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,HYAL1,DNA methylation variation (age effect),DNA methylation,GCST006660,3:50311701
rs2748297-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MDN1,DNA methylation variation (age effect),DNA methylation,GCST006660,6:89716105
rs148979203-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,GRIN2B,DNA methylation variation (age effect),DNA methylation,GCST006660,12:13764506
rs61846062-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"LINC02629, LINC02658",DNA methylation variation (age effect),DNA methylation,GCST006660,10:33971707
rs118137874-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"IMPA1P1, FABP12",DNA methylation variation (age effect),DNA methylation,GCST006660,8:81570795
rs145215398-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"NEBL, NEBL-AS1",DNA methylation variation (age effect),DNA methylation,GCST006660,10:21174811
rs6912975-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,FYN,DNA methylation variation (age effect),DNA methylation,GCST006660,6:111773135
rs13201459-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,STMND1,DNA methylation variation (age effect),DNA methylation,GCST006660,6:17164577
rs61747002-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,RRH,DNA methylation variation (age effect),DNA methylation,GCST006660,4:109836068
rs72694622-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,KCND3,DNA methylation variation (age effect),DNA methylation,GCST006660,1:111939045
rs693680-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"DPYD-AS1, DPYD",DNA methylation variation (age effect),DNA methylation,GCST006660,1:97261527
rs4325093-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,PDC-AS1,DNA methylation variation (age effect),DNA methylation,GCST006660,1:186546936
rs146331657-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,"SUCLG1, DNAH6",DNA methylation variation (age effect),DNA methylation,GCST006660,2:84487632
rs114758110-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,"MYO3B-AS1, MYO3B",DNA methylation variation (age effect),DNA methylation,GCST006660,2:170377139
rs185580150-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,GCKR,DNA methylation variation (age effect),DNA methylation,GCST006660,2:27507500
rs143461983-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,EPHB1,DNA methylation variation (age effect),DNA methylation,GCST006660,3:135174099
rs73200114-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,EVC2,DNA methylation variation (age effect),DNA methylation,GCST006660,4:5677694
rs183669222-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,ATP6AP1L,DNA methylation variation (age effect),DNA methylation,GCST006660,5:82366640
rs140713122-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,"HNRNPA1P12, RBMX2P5",DNA methylation variation (age effect),DNA methylation,GCST006660,5:80342854
rs76969957-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"CDH10, BTG4P1",DNA methylation variation (age effect),DNA methylation,GCST006660,5:24738669
rs115863756-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,HSD17B4,DNA methylation variation (age effect),DNA methylation,GCST006660,5:119512455
rs138870727-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC01331, LINC01333, LINC01332",DNA methylation variation (age effect),DNA methylation,GCST006660,5:74330037
rs150007273-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RPL5P16,DNA methylation variation (age effect),DNA methylation,GCST006660,5:82722218
rs1368652-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,ABCA13,DNA methylation variation (age effect),DNA methylation,GCST006660,7:48404652
rs11858071-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,GABRG3,DNA methylation variation (age effect),DNA methylation,GCST006660,15:27601902
rs138498518-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,AKR1B1P2,DNA methylation variation (age effect),DNA methylation,GCST006660,3:74133329
rs5017416-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"RNF144B, MIR548A1HG",DNA methylation variation (age effect),DNA methylation,GCST006660,6:18492119
rs138701026-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CCDC30,DNA methylation variation (age effect),DNA methylation,GCST006660,1:42480029
rs113809996-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"STIP1, MACROD1",DNA methylation variation (age effect),DNA methylation,GCST006660,11:64176135
rs143599985-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,LINC01741,DNA methylation variation (age effect),DNA methylation,GCST006660,1:177774168
rs113817060-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,LINC02884,DNA methylation variation (age effect),DNA methylation,GCST006660,1:112272324
rs1247769-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,KCNMA1,DNA methylation variation (age effect),DNA methylation,GCST006660,10:77048422
rs11172247-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,KIF5A,DNA methylation variation (age effect),DNA methylation,GCST006660,12:57552727
rs76735429-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,DCST1,DNA methylation variation (age effect),DNA methylation,GCST006660,1:155043651
rs80234081-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"ATP5MGP3, DHX15",DNA methylation variation (age effect),DNA methylation,GCST006660,4:24639073
rs203425-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,FRY,DNA methylation variation (age effect),DNA methylation,GCST006660,13:31893950
rs9925497-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,16:51380507
rs150980669-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,MTATP6P30,DNA methylation variation (age effect),DNA methylation,GCST006660,9:31488488
rs180682174-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LRRC4C,DNA methylation variation (age effect),DNA methylation,GCST006660,11:40203478
rs34623288-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,RABGAP1L,DNA methylation variation (age effect),DNA methylation,GCST006660,1:174161875
rs74778687-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MRPL42P4,DNA methylation variation (age effect),DNA methylation,GCST006660,7:47086746
rs4720550-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,EPS15P1,DNA methylation variation (age effect),DNA methylation,GCST006660,7:46805657
rs75649790-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,18:66399962
rs111485759-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"PLEKHA2, TACC1",DNA methylation variation (age effect),DNA methylation,GCST006660,8:38894755
rs61945108-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,MIPEP,DNA methylation variation (age effect),DNA methylation,GCST006660,13:23848922
rs8124080-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ATP9A,DNA methylation variation (age effect),DNA methylation,GCST006660,20:51726271
rs190726239-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,RGMA,DNA methylation variation (age effect),DNA methylation,GCST006660,15:93175272
rs11216614-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,TMPRSS13,DNA methylation variation (age effect),DNA methylation,GCST006660,11:117907214
rs146161311-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:23032468
rs78058068-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ERO1A,DNA methylation variation (age effect),DNA methylation,GCST006660,14:52695331
rs113796581-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC02382, HSP90AA6P",DNA methylation variation (age effect),DNA methylation,GCST006660,4:170668059
rs149211860-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,TENM3,DNA methylation variation (age effect),DNA methylation,GCST006660,4:182544158
rs149029090-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,LINC02502,DNA methylation variation (age effect),DNA methylation,GCST006660,4:119957380
rs141515844-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,CA6,DNA methylation variation (age effect),DNA methylation,GCST006660,1:8965939
rs192079295-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"LINC01033, HSPB3",DNA methylation variation (age effect),DNA methylation,GCST006660,5:54455171
rs75218770-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LINC02532,DNA methylation variation (age effect),DNA methylation,GCST006660,6:106731956
rs186781917-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"FAM87A, ZNF596",DNA methylation variation (age effect),DNA methylation,GCST006660,8:315710
rs189007515-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,SH3PXD2A,DNA methylation variation (age effect),DNA methylation,GCST006660,10:103816854
rs143077495-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,MRPS11P1,DNA methylation variation (age effect),DNA methylation,GCST006660,20:20871030
rs148791220-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"THBD, CD93",DNA methylation variation (age effect),DNA methylation,GCST006660,20:23057437
rs763236-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,BRD1,DNA methylation variation (age effect),DNA methylation,GCST006660,22:49785992
rs74735086-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,GPRIN3,DNA methylation variation (age effect),DNA methylation,GCST006660,4:89350357
rs111355438-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,LINC02248,DNA methylation variation (age effect),DNA methylation,GCST006660,15:26438152
rs7563627-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PRKCE,DNA methylation variation (age effect),DNA methylation,GCST006660,2:45659841
rs663497-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,MTUS2,DNA methylation variation (age effect),DNA methylation,GCST006660,13:28955240
rs151060196-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,KLRB1,DNA methylation variation (age effect),DNA methylation,GCST006660,12:9593320
rs7032102-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"SH3GL2, STK33P1",DNA methylation variation (age effect),DNA methylation,GCST006660,9:17800124
rs148822459-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,LINC02629,DNA methylation variation (age effect),DNA methylation,GCST006660,10:33973918
rs112787780-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"NDFIP1, GNPDA1",DNA methylation variation (age effect),DNA methylation,GCST006660,5:142049585
rs118123545-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"SLC16A10, RIMS1",DNA methylation variation (age effect),DNA methylation,GCST006660,6:72484068
rs186513784-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"NR1D2, LINC00691",DNA methylation variation (age effect),DNA methylation,GCST006660,3:24010915
rs112644024-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"POLR1D, GSX1",DNA methylation variation (age effect),DNA methylation,GCST006660,13:27787334
rs73096474-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"ABCA13, LINC02838",DNA methylation variation (age effect),DNA methylation,GCST006660,7:48693797
rs1060348-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,HMGB1,DNA methylation variation (age effect),DNA methylation,GCST006660,13:30462700
rs12493585-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,FHIT,DNA methylation variation (age effect),DNA methylation,GCST006660,3:60180162
rs12501358-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,4:138776220
rs62430436-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,UBE3D,DNA methylation variation (age effect),DNA methylation,GCST006660,6:82836527
rs9506281-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,KATNAL1,DNA methylation variation (age effect),DNA methylation,GCST006660,13:30292907
rs117561879-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,9:80896650
rs62445864-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,DNAH11,DNA methylation variation (age effect),DNA methylation,GCST006660,7:21854755
rs4309187-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,DRD2,DNA methylation variation (age effect),DNA methylation,GCST006660,11:113541721
rs62141280-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,C2orf16,DNA methylation variation (age effect),DNA methylation,GCST006660,2:27550188
rs10000513-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,DNA methylation variation (age effect),DNA methylation,GCST006660,4:160334994
rs183669222-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,ATP6AP1L,DNA methylation variation (age effect),DNA methylation,GCST006660,5:82366640
rs4930103-<b>A</b>,5 x 10-16,(H19-ICR-CpG02),0.49,'-,'-,'-,H19,DNA methylation (parent-of-origin),DNA methylation,GCST002057,11:2003314
rs7931462-<b>G</b>,2 x 10-9,(KvDMR 10-11-12),0.02,'-,'-,'-,"MTNR1B, RPL26P31",DNA methylation (parent-of-origin),DNA methylation,GCST002057,11:93051037
rs10497324-<b>A</b>,2 x 10-9,(KvDMR 21),0.04,'-,'-,'-,XIRP2,DNA methylation (parent-of-origin),DNA methylation,GCST002057,2:167302841
rs10934011-<b>G</b>,1 x 10-9,(NESPAS CpG08_09),0.21,'-,'-,'-,'-,DNA methylation (parent-of-origin),DNA methylation,GCST002057,3:110070723
rs10012307-<b>T</b>,2 x 10-8,(H19-ICR CpG 09-10),0.06,'-,'-,'-,'-,DNA methylation (parent-of-origin),DNA methylation,GCST002057,4:136605429
rs4819833-<b>C</b>,6 x 10-8,(IGF2-DMR CpG01),0.34,'-,'-,'-,SEPTIN5,DNA methylation (parent-of-origin),DNA methylation,GCST002057,22:19703979
rs13135284-<b>C</b>,5 x 10-8,(NESPAS CpG02),0.26,'-,'-,'-,GPAT3,DNA methylation (parent-of-origin),DNA methylation,GCST002057,4:153943598
rs10769945-<b>T</b>,5 x 10-7,(H19-ICR),0.48,'-,'-,'-,MRPL23,DNA methylation (variation),DNA methylation,GCST002058,11:1963897
rs4930103-<b>G</b>,1 x 10-14,(H19-ICR),0.397,'-,'-,'-,H19,DNA methylation (variation),DNA methylation,GCST002058,11:2003314
rs2555155-<b>G</b>,5 x 10-6,(H19-ICR),0.117,'-,'-,'-,DNHD1,DNA methylation (variation),DNA methylation,GCST002058,11:6501574
rs10462794-<b>C</b>,5 x 10-6,(IGF2-DMR),0.24,'-,'-,'-,'-,DNA methylation (variation),DNA methylation,GCST002058,5:4488132
rs11227306-<b>A</b>,2 x 10-7,(IGF2-DMR),0.38,'-,'-,'-,"OVOL1, CFL1",DNA methylation (variation),DNA methylation,GCST002058,11:65811201
rs9596905-<b>A</b>,2 x 10-6,(IGF2-DMR),0.06,'-,'-,'-,LINC00458,DNA methylation (variation),DNA methylation,GCST002058,13:54059238
rs4304977-<b>A</b>,5 x 10-6,(IGF2-DMR),0.46,'-,'-,'-,"DUXAP6, SLCO3A1",DNA methylation (variation),DNA methylation,GCST002058,15:92263061
rs1004689-<b>G</b>,2 x 10-6,(IGF2-DMR),0.467,'-,'-,'-,MIR3201,DNA methylation (variation),DNA methylation,GCST002058,22:48256185
rs11933531-<b>A</b>,3 x 10-8,(KvDMR),0.04,'-,'-,'-,CCSER1,DNA methylation (variation),DNA methylation,GCST002058,4:91494378
rs3858526-<b>C</b>,3 x 10-6,(KvDMR),0.27,'-,'-,'-,TRIM5,DNA methylation (variation),DNA methylation,GCST002058,11:5938527
rs965808-<b>G</b>,5 x 10-9,(NESPAS-ICR),0.22,'-,'-,'-,GNAS-AS1,DNA methylation (variation),DNA methylation,GCST002058,20:58833371
rs3763558-<b>A</b>,1 x 10-6,(NESPAS-ICR),0.11,'-,'-,'-,CPQ,DNA methylation (variation),DNA methylation,GCST002058,8:96784503
rs1007190-<b>T</b>,2 x 10-6,(IGF2-DMR),0.13,'-,'-,'-,"C1QL1, NMT1",DNA methylation (variation),DNA methylation,GCST002058,17:44960841
rs7644516-<b>G</b>,4 x 10-6,(KvDMR),0.12,'-,'-,'-,LINC00692,DNA methylation (variation),DNA methylation,GCST002058,3:25880794
rs7027203-<b>C</b>,6 x 10-6,(KvDMR),0.35,'-,'-,'-,MIR4291,DNA methylation (variation),DNA methylation,GCST002058,9:93800281
rs17261688-<b>G</b>,3 x 10-6,(NESPAS-ICR),0.12,'-,'-,'-,'-,DNA methylation (variation),DNA methylation,GCST002058,4:160107665
rs724210-<b>C</b>,8 x 10-7,(NESPAS-ICR),0.33,'-,'-,'-,LINC02304,DNA methylation (variation),DNA methylation,GCST002058,14:97057408
rs11897432-<b>A</b>,8 x 10-7,(H19-ICR),0.22,'-,'-,'-,THADA,DNA methylation (variation),DNA methylation,GCST002058,2:43590366
rs2412488-<b>A</b>,9 x 10-7,(H19-ICR),0.29,'-,'-,'-,LNX1,DNA methylation (variation),DNA methylation,GCST002058,4:53464700
rs10488631-<b>?</b>,9 x 10-7,(EA),'-,'-,'-,'-,"IRF5, TNPO3",Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005333,7:128954129
rs11642873-<b>?</b>,4 x 10-6,(EA),'-,'-,'-,'-,LINC02132,Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005333,16:85958099
rs4554699-<b>?</b>,6 x 10-14,(EA),NR,'-,'-,'-,"FCGR2B, FCGR3B",Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005552,1:161638578
rs10174238-<b>?</b>,2 x 10-9,(EA),NR,'-,'-,'-,STAT4,Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005552,2:191108308
rs16991498-<b>?</b>,8 x 10-7,(EA),NR,'-,'-,'-,PARVB,Systemic sclerosis (anti-centromere-positive),anti-centromere-antibody-positive systemic scleroderma,GCST005552,22:44107052
rs3960554-<b>G</b>,2 x 10-6,,NR,'-,0.0798 SD units decrease,[0.047-0.113],SRRM3,Eotaxin levels,eotaxin measurement,GCST004460,7:76216279
rs12386893-<b>G</b>,9 x 10-6,,NR,'-,0.0788 SD units decrease,[0.044-0.114],'-,Eotaxin levels,eotaxin measurement,GCST004460,8:139268547
rs2210755-<b>C</b>,5 x 10-6,,NR,'-,0.1104 SD units increase,[0.063-0.158],GNA14,Eotaxin levels,eotaxin measurement,GCST004460,9:77608907
rs2211994-<b>C</b>,6 x 10-7,,NR,'-,0.0885 SD units decrease,[0.054-0.123],"RNU1-98P, MIR99AHG",Eotaxin levels,eotaxin measurement,GCST004460,21:16675274
rs11087905-<b>C</b>,5 x 10-7,,NR,'-,0.0941 SD units decrease,[0.057-0.131],'-,Eotaxin levels,eotaxin measurement,GCST004460,21:24133015
rs9975149-<b>T</b>,3 x 10-6,,NR,'-,0.076 SD units decrease,[0.044-0.108],LINC01692,Eotaxin levels,eotaxin measurement,GCST004460,21:24833387
rs11253668-<b>G</b>,9 x 10-6,,NR,'-,0.0797 SD units decrease,[0.044-0.115],MINDY3,Eotaxin levels,eotaxin measurement,GCST004460,10:15883967
rs2419841-<b>C</b>,5 x 10-6,,NR,'-,0.1277 SD units increase,[0.073-0.182],HABP2,Eotaxin levels,eotaxin measurement,GCST004460,10:113576224
rs5746492-<b>G</b>,4 x 10-6,,NR,'-,0.0954 SD units decrease,[0.055-0.136],MICAL3,Eotaxin levels,eotaxin measurement,GCST004460,22:17911167
rs5754733-<b>C</b>,1 x 10-6,,NR,'-,0.1042 SD units increase,[0.062-0.146],LARGE1,Eotaxin levels,eotaxin measurement,GCST004460,22:33873606
rs2027855-<b>C</b>,5 x 10-6,,NR,'-,0.0736 SD units decrease,[0.042-0.105],LINC01644,Eotaxin levels,eotaxin measurement,GCST004460,22:47441763
rs17116545-<b>G</b>,5 x 10-6,,NR,'-,0.2246 SD units increase,[0.13-0.32],ZBTB16,Eotaxin levels,eotaxin measurement,GCST004460,11:114156555
rs9317045-<b>C</b>,6 x 10-7,,NR,'-,0.1182 SD units decrease,[0.072-0.165],"HMGN2P39, POLR3KP1",Eotaxin levels,eotaxin measurement,GCST004460,13:59055904
rs76827035-<b>G</b>,7 x 10-6,,NR,'-,0.1776 SD units increase,[0.1-0.255],EGLN3,Eotaxin levels,eotaxin measurement,GCST004460,14:34324633
rs75426604-<b>C</b>,3 x 10-6,,NR,'-,0.1366 SD units increase,[0.08-0.194],"NFKBIA, PSMA6",Eotaxin levels,eotaxin measurement,GCST004460,14:35388508
rs144029336-<b>G</b>,9 x 10-6,,NR,'-,0.4551 SD units decrease,[0.25-0.66],"PPP2R5C, LINC00239",Eotaxin levels,eotaxin measurement,GCST004460,14:101743226
rs745331-<b>G</b>,7 x 10-6,,NR,'-,0.0792 SD units increase,[0.045-0.114],OCA2,Eotaxin levels,eotaxin measurement,GCST004460,15:27684001
rs79722574-<b>C</b>,1 x 10-6,,NR,'-,0.1113 SD units increase,[0.067-0.156],"CCL11, CCL8",Eotaxin levels,eotaxin measurement,GCST004460,17:34292033
rs80341932-<b>G</b>,7 x 10-7,,NR,'-,0.1016 SD units decrease,[0.061-0.142],"GRP, RAX",Eotaxin levels,eotaxin measurement,GCST004460,18:59248696
rs199597369-<b>AC</b>,7 x 10-6,,NR,'-,0.3621 SD units increase,[0.2-0.52],"IFNL2, IFNL1",Eotaxin levels,eotaxin measurement,GCST004460,19:39294154
rs3746082-<b>G</b>,5 x 10-7,,NR,'-,0.322 SD units increase,[0.2-0.45],MED29,Eotaxin levels,eotaxin measurement,GCST004460,19:39397871
rs1476670-<b>C</b>,4 x 10-6,,NR,'-,0.1007 SD units increase,[0.058-0.143],"SLC6A9, KRT8P47",Eotaxin levels,eotaxin measurement,GCST004460,1:44042523
rs946077-<b>C</b>,6 x 10-7,,NR,'-,0.1246 SD units increase,[0.076-0.174],"LINC01763, PHKA1P1",Eotaxin levels,eotaxin measurement,GCST004460,1:90881235
rs187131-<b>G</b>,4 x 10-7,,NR,'-,0.1291 SD units decrease,[0.079-0.179],RPL5P6,Eotaxin levels,eotaxin measurement,GCST004460,1:91038780
rs12075-<b>G</b>,1 x 10-26,,NR,'-,0.1671 SD units decrease,[0.14-0.2],"ACKR1, CADM3-AS1",Eotaxin levels,eotaxin measurement,GCST004460,1:159205564
rs12045356-<b>G</b>,2 x 10-9,,NR,'-,0.1294 SD units decrease,[0.087-0.172],"OR10J8P, OR10J7P",Eotaxin levels,eotaxin measurement,GCST004460,1:159365486
rs10908733-<b>T</b>,2 x 10-9,,NR,'-,0.1387 SD units increase,[0.093-0.184],"OR10J5, LINC02819",Eotaxin levels,eotaxin measurement,GCST004460,1:159534264
rs148540034-<b>C</b>,2 x 10-6,,NR,'-,0.4107 SD units increase,[0.24-0.58],LINC01810,Eotaxin levels,eotaxin measurement,GCST004460,2:5827160
rs114202043-<b>C</b>,2 x 10-18,,NR,'-,0.3392 SD units decrease,[0.26-0.41],SEC22C,Eotaxin levels,eotaxin measurement,GCST004460,3:42550362
rs115333627-<b>G</b>,8 x 10-25,,NR,'-,0.4251 SD units decrease,[0.34-0.51],CCDC13,Eotaxin levels,eotaxin measurement,GCST004460,3:42747590
rs2228467-<b>C</b>,2 x 10-46,,NR,'-,0.4163 SD units increase,[0.36-0.47],"ACKR2, KRBOX1, CYP8B1",Eotaxin levels,eotaxin measurement,GCST004460,3:42864624
rs116826172-<b>C</b>,4 x 10-27,,NR,'-,0.4338 SD units increase,[0.35-0.51],"KRBOX1, GASK1A",Eotaxin levels,eotaxin measurement,GCST004460,3:42979009
rs190198015-<b>C</b>,6 x 10-8,,NR,'-,0.4281 SD units decrease,[0.27-0.58],POMGNT2,Eotaxin levels,eotaxin measurement,GCST004460,3:43090280
rs73072941-<b>T</b>,7 x 10-7,,NR,'-,0.1309 SD units increase,[0.079-0.183],SNRK,Eotaxin levels,eotaxin measurement,GCST004460,3:43266043
rs59290516-<b>AG</b>,5 x 10-7,,NR,'-,0.0907 SD units increase,[0.055-0.126],"SNRK, ANO10",Eotaxin levels,eotaxin measurement,GCST004460,3:43375803
rs7648466-<b>G</b>,9 x 10-9,,NR,'-,0.1056 SD units decrease,[0.07-0.141],CCR3,Eotaxin levels,eotaxin measurement,GCST004460,3:46146030
rs3091309-<b>G</b>,4 x 10-10,,NR,'-,0.1283 SD units decrease,[0.089-0.168],CCR3,Eotaxin levels,eotaxin measurement,GCST004460,3:46261693
rs112347425-<b>C</b>,9 x 10-9,,NR,'-,0.158 SD units decrease,[0.1-0.21],LINC02009,Eotaxin levels,eotaxin measurement,GCST004460,3:46419397
rs12639258-<b>G</b>,5 x 10-6,,NR,'-,0.09 SD units increase,[0.051-0.129],LRRC2,Eotaxin levels,eotaxin measurement,GCST004460,3:46524259
rs189587938-<b>G</b>,2 x 10-7,,NR,'-,0.3374 SD units decrease,[0.21-0.47],CCDC12,Eotaxin levels,eotaxin measurement,GCST004460,3:46943013
rs1402031-<b>C</b>,9 x 10-6,,NR,'-,0.113 SD units increase,[0.063-0.163],RNU7-126P,Eotaxin levels,eotaxin measurement,GCST004460,4:25593908
rs59808887-<b>C</b>,3 x 10-6,,NR,'-,0.1673 SD units increase,[0.097-0.237],PDZD2,Eotaxin levels,eotaxin measurement,GCST004460,5:31846414
rs147287945-<b>G</b>,5 x 10-6,,NR,'-,0.1428 SD units increase,[0.081-0.204],RREB1,Eotaxin levels,eotaxin measurement,GCST004460,6:7223333
rs2024050-<b>G</b>,1 x 10-8,,NR,'-,0.1728 SD units decrease,[0.11-0.23],"RHBDD2, CCL24",Eotaxin levels,eotaxin measurement,GCST004460,7:75831075
rs239951-<b>G</b>,7 x 10-7,,NR,'-,0.0927 SD units increase,[0.056-0.129],POR,Eotaxin levels,eotaxin measurement,GCST004460,7:75952023
rs200130196-<b>GAAGA</b>,6 x 10-6,,NR,'-,0.0726 SD units decrease,[0.041-0.104],"RNU6-863P, MDH2",Eotaxin levels,eotaxin measurement,GCST004460,7:76078202
rs10797037-<b>?</b>,2 x 10-6,,NR,'-,0.19 unit increase,[0.11-0.26],"LINC02819, OR10J5",Chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008940,1:159488581
rs9647884-<b>?</b>,7 x 10-6,,NR,'-,0.1 unit increase,[0.06-0.15],STAG3L4,Chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008940,7:67303453
rs2293982-<b>?</b>,1 x 10-6,,NR,'-,0.15 unit increase,[0.09-0.21],UBR5,Chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008940,8:102285479
rs10799227-<b>?</b>,5 x 10-6,,NR,'-,0.15 unit increase,[0.09-0.22],"LINC01346, LINC02780",Chromosomal aberration frequency (total) in genotoxic compound exposure,"genotoxic compound exposure measurement, chromosomal aberration frequency",GCST008946,1:3975613
rs144758183-<b>?</b>,3 x 10-6,,NR,1.923077,'-,[NR],LINC02477,High chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008950,4:160653731
rs17355669-<b>?</b>,8 x 10-6,,NR,1.8181818,'-,[NR],LINC02477,High chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008950,4:160551757
rs735912-<b>?</b>,8 x 10-6,,NR,1.5625,'-,[NR],"SEPHS1P2, CYP11A1",High chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008950,15:93357709
rs11792561-<b>?</b>,2 x 10-7,,NR,'-,0.15 unit decrease,[NR],SYK,Chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008951,9:90818901
rs7078885-<b>?</b>,3 x 10-6,,NR,'-,0.1 unit increase,[NR],RNA5SP318,Chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008951,10:53437111
rs418355-<b>?</b>,2 x 10-6,,NR,1.95,'-,[1.48-2.56],'-,High chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008956,7:9162211
rs10585869-<b>?</b>,1 x 10-6,,NR,2.09,'-,[1.55-2.81],"COPB1, RRAS2",High chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008956,11:14416869
rs2191100-<b>?</b>,7 x 10-6,,NR,2.11,'-,[1.52-2.92],RBFOX1,High chromosomal aberration frequency (total),chromosomal aberration frequency,GCST008956,16:5676071
rs518427-<b>?</b>,7 x 10-6,,NR,1.59,'-,[1.30-1.94],STX3,High chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008943,11:59716220
rs4447484-<b>?</b>,7 x 10-6,,NR,1.7,'-,[1.35-2.14],LINC01482,High chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008943,17:68725298
rs13121139-<b>?</b>,8 x 10-6,,NR,'-,0.1 unit increase,[0.06-0.15],"RN7SL205P, LINC02377",Chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008944,4:131649836
rs13244247-<b>?</b>,4 x 10-6,,NR,'-,0.08 unit increase,[0.05-0.12],STAG3L4,Chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008944,7:67304786
rs12827634-<b>?</b>,4 x 10-6,,NR,'-,0.09 unit increase,[0.05-0.12],NR2C1,Chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008944,12:95026751
rs11697697-<b>?</b>,2 x 10-6,,NR,'-,0.09 unit increase,[0.05-0.12],LINC01721,Chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008944,20:24182966
rs12763672-<b>?</b>,3 x 10-6,,NR,1.923077,'-,[1.47-2.56],GUCY2GP,High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure,"chromosome-type aberration frequency, genotoxic compound exposure measurement",GCST008949,10:112352291
rs7210082-<b>?</b>,8 x 10-6,,NR,2.2727273,'-,[1.59-3.33],UTP6,High chromosomal aberration frequency (chromosome type) in genotoxic compound exposure,"chromosome-type aberration frequency, genotoxic compound exposure measurement",GCST008949,17:31871225
rs17673474-<b>?</b>,3 x 10-6,,NR,'-,0.22 unit increase,[0.13-0.30],MEGF10,Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure,"chromosome-type aberration frequency, genotoxic compound exposure measurement",GCST008939,5:127409296
rs10514928-<b>?</b>,8 x 10-6,,NR,'-,0.29 unit decrease,[0.16-0.41],EFCAB13,Chromosomal aberration frequency (chromosome type) in genotoxic compound exposure,"chromosome-type aberration frequency, genotoxic compound exposure measurement",GCST008939,17:47426173
rs2254235-<b>?</b>,2 x 10-6,,NR,1.45,'-,[NR],SLC2A12,High chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008954,6:134043905
rs8054859-<b>?</b>,7 x 10-7,,NR,1.55,'-,[NR],FTO,High chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008954,16:53820776
rs112076008-<b>?</b>,5 x 10-6,,NR,1.6393442,'-,[NR],"SUZ12, UTP6",High chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008954,17:31930146
rs72825681-<b>?</b>,3 x 10-6,,NR,2.0408163,'-,[NR],EFCAB13,High chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008954,17:47391821
rs13121139-<b>?</b>,4 x 10-6,,NR,'-,0.09 unit increase,[NR],"RN7SL205P, LINC02377",Chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008955,4:131649836
rs8054859-<b>?</b>,4 x 10-6,,NR,'-,0.08 unit increase,[NR],FTO,Chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008955,16:53820776
rs11697697-<b>?</b>,7 x 10-7,,NR,'-,0.08 unit increase,[NR],LINC01721,Chromosomal aberration frequency (chromosome type),chromosome-type aberration frequency,GCST008955,20:24182966
rs6928832-<b>?</b>,3 x 10-7,,NR,1.69,'-,[1.39-2.07],BLOC1S5-TXNDC5,High chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008941,6:7973684
rs2408086-<b>?</b>,8 x 10-6,,NR,1.5625,'-,[1.28-1.89],'-,High chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008941,8:5640738
rs6693671-<b>?</b>,3 x 10-6,,NR,'-,0.1 unit increase,[0.06-0.14],'-,Chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008942,1:105173718
rs258859-<b>?</b>,6 x 10-6,,NR,'-,0.16 unit increase,[0.09-0.23],BOD1,Chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008942,5:173608115
rs7816388-<b>?</b>,2 x 10-6,,NR,'-,0.12 unit increase,[0.07-0.16],"KLF10, POU5F1P2",Chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008942,8:102629440
rs1030415-<b>?</b>,1 x 10-6,,NR,'-,0.1 unit increase,[0.06-0.15],LINC02882,Chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008942,12:74367872
rs67448492-<b>?</b>,1 x 10-6,,NR,2.564103,'-,[1.75-3.7],DPP10,High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure,"chromatid-type aberration frequency, genotoxic compound exposure measurement",GCST008947,2:115119732
rs10040952-<b>?</b>,6 x 10-7,,NR,2.4,'-,[1.71-3.39],SEMA5A,High chromosomal aberration frequency (chromatid type) in genotoxic compound exposure,"chromatid-type aberration frequency, genotoxic compound exposure measurement",GCST008947,5:9317254
rs56217929-<b>?</b>,9 x 10-8,,NR,'-,0.31 unit increase,[0.20-0.42],KLF7,Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure,"chromatid-type aberration frequency, genotoxic compound exposure measurement",GCST008948,2:207071685
rs13118804-<b>?</b>,4 x 10-6,,NR,'-,0.17 unit decrease,[0.1-0.25],LINC02619,Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure,"chromatid-type aberration frequency, genotoxic compound exposure measurement",GCST008948,4:58934625
rs3783170-<b>?</b>,5 x 10-6,,NR,'-,0.18 unit increase,[0.10-0.25],PCCA,Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure,"chromatid-type aberration frequency, genotoxic compound exposure measurement",GCST008948,13:100463366
rs4481060-<b>?</b>,8 x 10-6,,NR,'-,0.16 unit decrease,[0.09-0.23],GNAS,Chromosomal aberration frequency (chromatid type) in genotoxic compound exposure,"chromatid-type aberration frequency, genotoxic compound exposure measurement",GCST008948,20:58882714
rs2933639-<b>?</b>,3 x 10-7,,NR,1.53,'-,[NR],LINC02214,High chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008952,5:116762308
rs6478789-<b>?</b>,2 x 10-6,,NR,1.6666665,'-,[NR],GABBR2,High chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008952,9:98633893
rs12811924-<b>?</b>,5 x 10-6,,NR,1.74,'-,[NR],TMEM132C,High chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008952,12:128670396
rs7607212-<b>?</b>,2 x 10-6,,NR,'-,0.11 unit decrease,[NR],Y_RNA,Chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008953,2:52293783
rs57068542-<b>?</b>,4 x 10-7,,NR,'-,0.09 unit decrease,[NR],RNA5SP172,Chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008953,4:177492144
rs34704083-<b>?</b>,6 x 10-6,,NR,'-,0.08 unit increase,[NR],"CARTPT, MCCC2",Chromosomal aberration frequency (chromatid type),chromatid-type aberration frequency,GCST008953,5:71664307
rs1855111-<b>?</b>,2 x 10-6,,'-,2.57,'-,[NR],TMEM72-AS1,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,10:44857795
rs76740710-<b>?</b>,4 x 10-6,,'-,3.45,'-,[NR],FZD3,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,8:28497337
rs12981234-<b>?</b>,4 x 10-6,,'-,2.33,'-,[NR],FCER2,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,19:7698992
rs200216460-<b>?</b>,5 x 10-6,,'-,3.62,'-,[NR],ODAD2,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,10:27958512
rs11668205-<b>?</b>,5 x 10-6,,'-,2.14,'-,[NR],IZUMO4,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,19:2099251
rs146838878-<b>?</b>,6 x 10-6,,'-,5.08,'-,[NR],HS6ST3,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,13:96362313
rs115281615-<b>?</b>,6 x 10-6,,'-,4.54,'-,[NR],C1QTNF7-AS1,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,4:15263521
rs62359711-<b>?</b>,7 x 10-6,,'-,5.22,'-,[NR],INTS6P1,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,5:39697181
rs73178888-<b>?</b>,7 x 10-6,,'-,3.83,'-,[NR],ERICH1,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,8:733209
rs9966603-<b>?</b>,7 x 10-6,,'-,2.97,'-,[NR],PSTPIP2,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,18:46057277
rs13020106-<b>?</b>,7 x 10-6,,'-,2.57,'-,[NR],SNTG2,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,2:1075096
rs2560850-<b>?</b>,8 x 10-6,,'-,1.86,'-,[NR],MYO10,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,5:16893775
rs115281615-<b>?</b>,7 x 10-7,,'-,6.79,'-,[NR],C1QTNF7-AS1,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,4:15263521
rs6440985-<b>?</b>,1 x 10-6,,'-,1.91,'-,[NR],PLCH1,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,3:155427563
rs2806747-<b>?</b>,1 x 10-6,,'-,1.97,'-,[NR],'-,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,13:104025589
rs9319652-<b>?</b>,4 x 10-6,,'-,2.29,'-,[NR],"CCND3P2, ZNF236-DT",Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,18:76792879
rs11977478-<b>?</b>,4 x 10-6,,'-,2.1276596,'-,[NR],'-,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,7:12095565
rs11034351-<b>?</b>,4 x 10-6,,'-,1.92,'-,[NR],RPL7AP56,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,11:37658889
rs7685548-<b>?</b>,5 x 10-6,,'-,2.31,'-,[NR],LINC02505,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,4:36538961
rs71967233-<b>?</b>,5 x 10-6,,'-,1.95,'-,[NR],ARHGAP44,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,17:12978554
rs34282937-<b>?</b>,5 x 10-6,,'-,2.74,'-,[NR],LINC00511,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,17:72470852
rs77525287-<b>?</b>,6 x 10-6,,'-,5.94,'-,[NR],LINC01741,Maternal nondisjunction of chromosome 21 (MI error vs MII error),Abnormality of chromosome segregation,GCST009705,1:177604309
rs10948101-<b>?</b>,8 x 10-7,,'-,1.4925373,'-,[NR],LINC02537,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,6:43887745
rs35141718-<b>?</b>,2 x 10-6,,'-,2.0833335,'-,[NR],PTP4A1,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,6:63543717
rs11535058-<b>?</b>,2 x 10-6,,'-,1.95,'-,[NR],"LINC01825, RNU6-169P",Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,2:195525011
rs62086686-<b>?</b>,4 x 10-6,,'-,2.173913,'-,[NR],"RNMT, MC5R",Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,18:13805143
rs75733466-<b>?</b>,5 x 10-6,,'-,1.89,'-,[NR],RN7SKP224,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,2:48125204
rs117746305-<b>?</b>,5 x 10-6,,'-,2.53,'-,[NR],FZD3,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,8:28557066
rs12947774-<b>?</b>,6 x 10-6,,'-,1.6129031,'-,[NR],"SCPEP1, RNF126P1",Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,17:57017346
rs1612273-<b>?</b>,6 x 10-6,,'-,1.51,'-,[NR],"TDRP, ERICH1",Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,8:593250
rs12652455-<b>?</b>,6 x 10-6,,'-,2.51,'-,'-,FYB1,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,5:39174201
rs148846406-<b>?</b>,7 x 10-6,,'-,1.8181818,'-,[NR],"ZBTB14, EPB41L3",Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,18:5372695
rs11026040-<b>?</b>,8 x 10-6,,'-,1.71,'-,[NR],MRGPRE,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,11:3228599
rs7010571-<b>?</b>,8 x 10-6,,'-,1.6393442,'-,[NR],'-,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,8:77957525
rs10948100-<b>?</b>,8 x 10-7,,'-,1.4925373,'-,[NR],LINC02537,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,6:43887714
rs76740710-<b>?</b>,7 x 10-6,,'-,2.48,'-,[NR],FZD3,Maternal nondisjunction of chromosome 21 (mothers vs fathers),Abnormality of chromosome segregation,GCST009704,8:28497337
rs10948101-<b>?</b>,2 x 10-6,,'-,1.58,'-,[NR],LINC02537,Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,6:43887745
rs10948100-<b>?</b>,2 x 10-6,,'-,1.58,'-,[NR],LINC02537,Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,6:43887714
rs35288347-<b>?</b>,3 x 10-6,,'-,2.15,'-,[NR],"RPL7AP69, USP29",Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,19:57070815
rs4649043-<b>?</b>,3 x 10-6,,'-,2.173913,'-,[NR],"MIR4425, RUNX3",Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,1:25015765
rs437933-<b>?</b>,3 x 10-6,,'-,1.5625,'-,[NR],"RNU6-967P, RNA5SP471",Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,19:31724603
rs16847735-<b>?</b>,4 x 10-6,,'-,1.58,'-,[NR],CLDN18,Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,3:138000428
rs2467011-<b>?</b>,4 x 10-6,,'-,1.49,'-,[NR],SCAF11,Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,12:46061024
rs9442389-<b>?</b>,5 x 10-6,,'-,1.5151515,'-,[NR],AGRN,Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,1:1027633
rs731245-<b>?</b>,7 x 10-6,,'-,1.46,'-,[NR],HTR2A,Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,13:46898131
rs984968-<b>?</b>,7 x 10-6,,'-,1.52,'-,[NR],MACROD2,Maternal nondisjunction of chromosome 21 (MI error vs fathers),Abnormality of chromosome segregation,GCST009707,20:14883012
rs117746305-<b>?</b>,4 x 10-6,,'-,3.45,'-,[NR],FZD3,Maternal nondisjunction of chromosome 21 (MII error vs fathers),Abnormality of chromosome segregation,GCST009706,8:28557066
rs722178-<b>C</b>,6 x 10-6,,'-,'-,0.126 SD units decrease,[0.071-0.181],"GPC5-IT1, GPC5",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,13:92490109
rs62024303-<b>G</b>,4 x 10-6,,'-,'-,0.3053 SD units increase,[0.17-0.44],NTRK3-AS1,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,15:88327931
rs1113500-<b>G</b>,2 x 10-6,,'-,'-,0.1174 SD units decrease,[0.07-0.165],LINC02785,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,1:108052820
rs12075-<b>G</b>,1 x 10-55,,'-,'-,0.3751 SD units decrease,[0.33-0.42],"ACKR1, CADM3-AS1",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,1:159205564
rs36080575-<b>TA</b>,5 x 10-29,,'-,'-,0.3012 SD units increase,[0.25-0.35],"OR10J7P, OR10J3",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,1:159317554
rs4656236-<b>G</b>,3 x 10-21,,'-,'-,0.2593 SD units decrease,[0.21-0.31],OR10J1,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,1:159441185
rs9662662-<b>C</b>,2 x 10-9,,'-,'-,0.1548 SD units decrease,[0.1-0.21],"OR10J5, OR10AE1P",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,1:159549353
rs34197548-<b>C</b>,9 x 10-6,,'-,'-,0.2938 SD units decrease,[0.17-0.42],"CRPP1, OR10J6P",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,1:159672969
rs76390238-<b>G</b>,6 x 10-6,,'-,'-,0.6031 SD units decrease,[0.34-0.87],ST6GAL2,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,2:106885458
rs114262236-<b>G</b>,5 x 10-6,,'-,'-,0.4187 SD units increase,[0.24-0.6],SNED1,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,2:241070501
rs11715515-<b>C</b>,7 x 10-6,,'-,'-,0.1717 SD units increase,[0.097-0.247],CFAP44,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,3:113358489
rs508977-<b>G</b>,8 x 10-42,,'-,'-,0.3802 SD units increase,[0.33-0.44],"HNRNPA1P55, CXCL1",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,4:73896666
rs193055909-<b>G</b>,9 x 10-6,,'-,'-,0.2716 SD units increase,[0.15-0.39],"CXCL5, RN7SL218P",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,4:74002748
rs75078633-<b>C</b>,7 x 10-7,,'-,'-,0.9114 SD units decrease,[0.55-1.27],MTHFD2L,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,4:74167233
rs17137580-<b>G</b>,8 x 10-6,,'-,'-,0.3465 SD units increase,[0.19-0.5],PGGT1B,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,5:115252936
rs185768063-<b>G</b>,1 x 10-7,,'-,'-,0.3998 SD units decrease,[0.25-0.55],ATXN1,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,6:16494752
rs114991247-<b>C</b>,8 x 10-6,,'-,'-,0.2092 SD units increase,[0.12-0.3],"HLA-DRB1, HLA-DQA1",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,6:32615727
rs118158560-<b>G</b>,3 x 10-6,,'-,'-,0.2703 SD units decrease,[0.15-0.39],"STARD3NL, SFRP4",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,7:38107008
rs113692724-<b>G</b>,4 x 10-6,,'-,'-,0.7235 SD units decrease,[0.42-1.03],CDK14,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,7:90621328
rs188345231-<b>C</b>,4 x 10-6,,'-,'-,0.623 SD units decrease,[0.36-0.88],GPAT4,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,8:41579831
rs185085487-<b>C</b>,3 x 10-6,,'-,'-,0.4988 SD units decrease,[0.29-0.71],"MTCO2P4, LINC01181",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,8:103117425
rs2422841-<b>G</b>,5 x 10-6,,'-,'-,0.1657 SD units increase,[0.095-0.236],"RN7SL555P, UBOX5-AS1",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,20:3099706
rs78653452-<b>G</b>,1 x 10-6,,'-,'-,0.7362 SD units increase,[0.43-1.04],PAK5,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,20:9781407
rs2836049-<b>C</b>,7 x 10-6,,'-,'-,0.1896 SD units decrease,[0.11-0.27],KCNJ6,Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,21:37912334
rs140734053-<b>G</b>,4 x 10-6,,'-,'-,0.7257 SD units decrease,[0.42-1.03],"RPL26P28, UCN3",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,10:5359496
rs74544699-<b>G</b>,4 x 10-11,(Conditioned on rs508977),'-,'-,0.563 SD units increase,'-,"PF4V1, CXCL1",Growth-regulated protein alpha levels,growth-regulated alpha protein measurement,GCST004457,4:73868964
rs3117600-<b>G</b>,3 x 10-120,(Growth-regulated alpha protein),0.2966867,'-,1.013 unit increase,[0.94-1.09],"PF4V1, CXCL1",Blood protein levels,growth-regulated alpha protein measurement,GCST004365,4:73866095
rs16845091-<b>T</b>,2 x 10-39,(Growth-regulated alpha protein),0.05466399,'-,1.237 unit increase,[1.06-1.41],"CXCL1, HNRNPA1P55",Blood protein levels,growth-regulated alpha protein measurement,GCST004365,4:73893084
rs74544699-<b>A</b>,1 x 10-30,,0.95,'-,0.45 unit decrease,'-,"PF4V1, CXCL1",Blood protein levels in cardiovascular risk,growth-regulated alpha protein measurement,GCST009731,4:73868964
rs11710456-<b>A</b>,7 x 10-42,,0.29,'-,'-,'-,ST6GAL1,IgG monosialylation phenotypes (multivariate analysis),IgG monosialylation measurement,GCST004932,3:187008099
rs11847263-<b>G</b>,6 x 10-15,,0.35,'-,'-,'-,"PTBP1P, MIR4708",IgG monosialylation phenotypes (multivariate analysis),IgG monosialylation measurement,GCST004932,14:65308977
rs35590487-<b>T</b>,1 x 10-12,,0.23,'-,'-,'-,"TMEM121, TEDC1",IgG monosialylation phenotypes (multivariate analysis),IgG monosialylation measurement,GCST004932,14:105523262
rs11710456-<b>A</b>,2 x 10-13,,0.29,'-,'-,'-,ST6GAL1,IgG disialylation phenotypes (multivariate analysis),IgG disialylation measurement,GCST004931,3:187008099
rs2186369-<b>G</b>,1 x 10-7,,0.13,'-,'-,'-,SMARCB1,IgG disialylation phenotypes (multivariate analysis),IgG disialylation measurement,GCST004931,22:23828809
rs909674-<b>A</b>,4 x 10-14,,0.78,'-,'-,'-,MGAT3,IgG disialylation phenotypes (multivariate analysis),IgG disialylation measurement,GCST004931,22:39463164
rs6421315-<b>C</b>,3 x 10-7,,0.39,'-,'-,'-,IKZF1,IgG disialylation phenotypes (multivariate analysis),IgG disialylation measurement,GCST004931,7:50315611
rs8013055-<b>A</b>,1 x 10-12,,0.22,'-,'-,'-,"TMEM121, TEDC1",IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),IgG bisecting N-acetyl glucosamine measurement,GCST004928,14:105524283
rs11710456-<b>A</b>,2 x 10-24,,0.29,'-,'-,'-,ST6GAL1,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),IgG bisecting N-acetyl glucosamine measurement,GCST004928,3:187008099
rs909674-<b>A</b>,4 x 10-10,,0.78,'-,'-,'-,MGAT3,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),IgG bisecting N-acetyl glucosamine measurement,GCST004928,22:39463164
rs2186369-<b>G</b>,4 x 10-11,,0.13,'-,'-,'-,SMARCB1,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),IgG bisecting N-acetyl glucosamine measurement,GCST004928,22:23828809
rs6421315-<b>C</b>,3 x 10-6,,0.39,'-,'-,'-,IKZF1,IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis),IgG bisecting N-acetyl glucosamine measurement,GCST004928,7:50315611
rs11847263-<b>G</b>,1 x 10-17,,0.35,'-,'-,'-,"PTBP1P, MIR4708",IgG monogalactosylation phenotypes (multivariate analysis),IgG monogalactosylation measurement,GCST004924,14:65308977
rs2186369-<b>G</b>,1 x 10-12,,0.13,'-,'-,'-,SMARCB1,IgG monogalactosylation phenotypes (multivariate analysis),IgG monogalactosylation measurement,GCST004924,22:23828809
rs909674-<b>A</b>,1 x 10-6,,0.78,'-,'-,'-,MGAT3,IgG monogalactosylation phenotypes (multivariate analysis),IgG monogalactosylation measurement,GCST004924,22:39463164
rs35590487-<b>T</b>,4 x 10-17,,0.23,'-,'-,'-,"TMEM121, TEDC1",IgG monogalactosylation phenotypes (multivariate analysis),IgG monogalactosylation measurement,GCST004924,14:105523262
rs909674-<b>A</b>,3 x 10-13,,0.78,'-,'-,'-,MGAT3,IgG digalactosylation phenotypes (multivariate analysis),IgG digalactosylation measurement,GCST004926,22:39463164
rs11135441-<b>T</b>,2 x 10-9,,0.32,'-,'-,'-,ELL2,IgG digalactosylation phenotypes (multivariate analysis),IgG digalactosylation measurement,GCST004926,5:95886573
rs11710456-<b>A</b>,3 x 10-69,,0.29,'-,'-,'-,ST6GAL1,IgG monogalactosylation phenotypes (multivariate analysis),IgG monogalactosylation measurement,GCST004924,3:187008099
rs6421315-<b>C</b>,3 x 10-6,,0.39,'-,'-,'-,IKZF1,IgG monogalactosylation phenotypes (multivariate analysis),IgG monogalactosylation measurement,GCST004924,7:50315611
rs11710456-<b>A</b>,5 x 10-79,,0.29,'-,'-,'-,ST6GAL1,IgG digalactosylation phenotypes (multivariate analysis),IgG digalactosylation measurement,GCST004926,3:187008099
rs11847263-<b>G</b>,3 x 10-16,,0.35,'-,'-,'-,"PTBP1P, MIR4708",IgG digalactosylation phenotypes (multivariate analysis),IgG digalactosylation measurement,GCST004926,14:65308977
rs2186369-<b>G</b>,4 x 10-10,,0.13,'-,'-,'-,SMARCB1,IgG digalactosylation phenotypes (multivariate analysis),IgG digalactosylation measurement,GCST004926,22:23828809
rs6421315-<b>C</b>,2 x 10-7,,0.39,'-,'-,'-,IKZF1,IgG digalactosylation phenotypes (multivariate analysis),IgG digalactosylation measurement,GCST004926,7:50315611
rs11847263-<b>G</b>,5 x 10-15,,0.35,'-,'-,'-,"PTBP1P, MIR4708",IgG sialylation phenotypes (multivariate analysis),IgG sialylation measurement,GCST004930,14:65308977
rs2186369-<b>G</b>,1 x 10-6,,0.13,'-,'-,'-,SMARCB1,IgG sialylation phenotypes (multivariate analysis),IgG sialylation measurement,GCST004930,22:23828809
rs6421315-<b>C</b>,2 x 10-8,,0.39,'-,'-,'-,IKZF1,IgG sialylation phenotypes (multivariate analysis),IgG sialylation measurement,GCST004930,7:50315611
rs35590487-<b>T</b>,2 x 10-12,,0.23,'-,'-,'-,"TMEM121, TEDC1",IgG sialylation phenotypes (multivariate analysis),IgG sialylation measurement,GCST004930,14:105523262
rs11847263-<b>G</b>,6 x 10-10,,0.35,'-,'-,'-,"PTBP1P, MIR4708",IgG fucosylation phenotypes (multivariate analysis),IgG fucosylation measurement,GCST004929,14:65308977
rs909674-<b>A</b>,1 x 10-20,,0.78,'-,'-,'-,MGAT3,IgG fucosylation phenotypes (multivariate analysis),IgG fucosylation measurement,GCST004929,22:39463164
rs2659009-<b>A</b>,4 x 10-11,,0.5,'-,'-,'-,NDUFAF8,IgG fucosylation phenotypes (multivariate analysis),IgG fucosylation measurement,GCST004929,17:81239505
rs58087925-<b>T</b>,4 x 10-19,,0.22,'-,'-,'-,"TMEM121, TEDC1",IgG fucosylation phenotypes (multivariate analysis),IgG fucosylation measurement,GCST004929,14:105516759
rs11710456-<b>A</b>,2 x 10-51,,0.29,'-,'-,'-,ST6GAL1,IgG sialylation phenotypes (multivariate analysis),IgG sialylation measurement,GCST004930,3:187008099
rs909674-<b>A</b>,1 x 10-13,,0.78,'-,'-,'-,MGAT3,IgG sialylation phenotypes (multivariate analysis),IgG sialylation measurement,GCST004930,22:39463164
rs11135441-<b>T</b>,5 x 10-10,,0.32,'-,'-,'-,ELL2,IgG sialylation phenotypes (multivariate analysis),IgG sialylation measurement,GCST004930,5:95886573
rs11710456-<b>A</b>,1 x 10-88,,0.29,'-,'-,'-,ST6GAL1,IgG fucosylation phenotypes (multivariate analysis),IgG fucosylation measurement,GCST004929,3:187008099
rs12342831-<b>C</b>,5 x 10-13,,0.29,'-,'-,'-,B4GALT1,IgG fucosylation phenotypes (multivariate analysis),IgG fucosylation measurement,GCST004929,9:33124874
rs2186369-<b>G</b>,3 x 10-11,,0.13,'-,'-,'-,SMARCB1,IgG fucosylation phenotypes (multivariate analysis),IgG fucosylation measurement,GCST004929,22:23828809
rs11847263-<b>G</b>,1 x 10-15,,0.35,'-,'-,'-,"PTBP1P, MIR4708",IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,14:65308977
rs909674-<b>A</b>,2 x 10-14,,0.78,'-,'-,'-,MGAT3,IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,22:39463164
rs35590487-<b>T</b>,3 x 10-18,,0.23,'-,'-,'-,"TMEM121, TEDC1",IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,14:105523262
rs9319617-<b>C</b>,3 x 10-9,,0.52,'-,'-,'-,CEP131,IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,17:81218646
rs11710456-<b>A</b>,2 x 10-90,,0.29,'-,'-,'-,ST6GAL1,IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,3:187008099
rs12342831-<b>C</b>,7 x 10-8,,0.29,'-,'-,'-,B4GALT1,IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,9:33124874
rs2186369-<b>G</b>,3 x 10-10,,0.13,'-,'-,'-,SMARCB1,IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,22:23828809
rs6421315-<b>C</b>,1 x 10-8,,0.39,'-,'-,'-,IKZF1,IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,7:50315611
rs116108880-<b>G</b>,8 x 10-10,,0.6,'-,'-,'-,HLA-C,IgG galactosylation phenotypes (multivariate analysis),IgG galactosylation measurement,GCST004927,6:31272025
rs11710456-<b>A</b>,6 x 10-87,,0.29,'-,'-,'-,ST6GAL1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,3:187008099
rs12342831-<b>C</b>,1 x 10-10,,0.29,'-,'-,'-,B4GALT1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,9:33124874
rs11847263-<b>G</b>,3 x 10-15,,0.35,'-,'-,'-,"PTBP1P, MIR4708",IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,14:65308977
rs2186369-<b>G</b>,3 x 10-11,,0.13,'-,'-,'-,SMARCB1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,22:23828809
rs909674-<b>A</b>,3 x 10-19,,0.78,'-,'-,'-,MGAT3,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,22:39463164
rs6421315-<b>C</b>,2 x 10-7,,0.39,'-,'-,'-,IKZF1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,7:50315611
rs12019136-<b>A</b>,2 x 10-13,,0.05,'-,'-,'-,FUT6,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,19:5835666
rs35590487-<b>T</b>,6 x 10-17,,0.23,'-,'-,'-,"TMEM121, TEDC1",IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,14:105523262
rs9319617-<b>C</b>,3 x 10-9,,0.52,'-,'-,'-,CEP131,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST004925,17:81218646
rs67662065-<b>T</b>,8 x 10-12,(IgG1 Fn/Bn),0.2339,'-,0.3079 unit decrease,[0.22-0.4],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs867972-<b>C</b>,2 x 10-11,(IgG1 Fn/Bn),0.4875,'-,0.2506 unit increase,[0.18-0.32],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs5750828-<b>C</b>,1 x 10-18,(IgG1 Fn/Bn total),0.697,'-,0.3787 unit increase,[0.29-0.46],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,1 x 10-8,(IgG1 Fn/Bn total),0.1974,'-,0.2661 unit increase,[0.17-0.36],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs11847263-<b>G</b>,2 x 10-20,(IgG1 Fucosylation),0.3303,'-,0.3718 unit decrease,[0.29-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,4 x 10-14,(IgG1 Fucosylation),0.4875,'-,0.2849 unit increase,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs67662065-<b>T</b>,6 x 10-14,(IgG1 Fucosylation),0.2339,'-,0.3405 unit decrease,[0.25-0.43],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs7153297-<b>A</b>,1 x 10-13,(IgG1 Fucosylation),0.4825,'-,0.2838 unit increase,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs1328899-<b>T</b>,1 x 10-9,(IgG1 G0n),0.0176,'-,0.8198 unit decrease,[0.55-1.09],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33151417
rs1328899-<b>T</b>,1 x 10-7,(IgG1 G1n),0.0176,'-,0.7322 unit increase,[0.46-1],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33151417
rs11158592-<b>T</b>,2 x 10-13,(IgG1 G1S1/(G1+G1S1)),0.531,'-,0.2704 unit increase,[0.2-0.34],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs11158602-<b>G</b>,9 x 10-11,(IgG1 G1S1/(G1+G1S1)),0.5061,'-,0.2384 unit increase,[0.17-0.31],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65605015
rs6573626-<b>C</b>,3 x 10-10,(IgG1 G1S1/(G1+G1S1)),0.542,'-,0.2343 unit increase,[0.16-0.31],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65773977
rs3824459-<b>T</b>,3 x 10-7,(IgG1 G2n),0.0204,'-,0.6286 unit increase,[0.39-0.87],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs62292620-<b>G</b>,8 x 10-11,(IgG1 G2S1/(G2+G2S1)),0.2798,'-,0.2858 unit decrease,[0.2-0.37],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:186995501
rs3824459-<b>T</b>,3 x 10-8,(IgG1 Galactosylation),0.0204,'-,0.6793 unit increase,[0.44-0.92],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs11158592-<b>T</b>,1 x 10-11,(IgG1 GS1/(G+GS1)),0.531,'-,0.2543 unit increase,[0.18-0.33],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs7153297-<b>A</b>,3 x 10-10,(IgG1 GS1/(G+GS1)),0.4825,'-,0.2368 unit increase,[0.16-0.31],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs11158592-<b>T</b>,2 x 10-10,(IgG1 GS1/(G0+G+GS1)),0.531,'-,0.237 unit increase,[0.16-0.31],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs7153297-<b>A</b>,8 x 10-9,(IgG1 GS1/(G0+G+GS1)),0.4825,'-,0.2146 unit increase,[0.14-0.29],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs10483785-<b>A</b>,1 x 10-8,(IgG1 GS1/(G0+G+GS1)),0.5094,'-,0.2093 unit increase,[0.14-0.28],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65752799
rs6764279-<b>A</b>,9 x 10-30,(IgG1 SA per Gal),0.2934,'-,0.452 unit decrease,[0.37-0.53],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11847263-<b>G</b>,5 x 10-20,(IgG1_G0),0.3303,'-,0.366 unit increase,[0.29-0.44],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,2 x 10-15,(IgG1_G0),0.4875,'-,0.2989 unit decrease,[0.23-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs6573626-<b>C</b>,5 x 10-15,(IgG1_G0),0.542,'-,0.3026 unit decrease,[0.23-0.38],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65773977
rs67662065-<b>T</b>,5 x 10-13,(IgG1 FG0n total/G0n),0.2339,'-,0.3282 unit decrease,[0.24-0.42],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs7153297-<b>A</b>,9 x 10-13,(IgG1 FG0n total/G0n),0.4825,'-,0.2733 unit increase,[0.2-0.35],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs5750828-<b>C</b>,6 x 10-16,(IgG1 FG0n/G0n),0.697,'-,0.3474 unit increase,[0.26-0.43],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs11847263-<b>G</b>,9 x 10-21,(IgG1 FG1n total/G1n),0.3303,'-,0.3754 unit decrease,[0.3-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,1 x 10-15,(IgG1 FG1n total/G1n),0.4875,'-,0.3009 unit increase,[0.23-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7153297-<b>A</b>,3 x 10-15,(IgG1 FG1n total/G1n),0.4825,'-,0.3009 unit increase,[0.23-0.38],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs8018379-<b>G</b>,1 x 10-12,(IgG1 FG1n total/G1n),0.4055,'-,0.2727 unit decrease,[0.2-0.35],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs6764279-<b>A</b>,9 x 10-63,(IgG1 FG1S1/(FG1+FG1S1)),0.293,'-,0.698 unit decrease,[0.62-0.78],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11847263-<b>G</b>,2 x 10-20,(IgG1 FG2n total/G2n),0.3303,'-,0.3708 unit decrease,[0.29-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs12894902-<b>T</b>,6 x 10-16,(IgG1 FG2n total/G2n),0.4923,'-,0.3019 unit increase,[0.23-0.38],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs7153297-<b>A</b>,6 x 10-16,(IgG1 FG2n total/G2n),0.4825,'-,0.3071 unit increase,[0.23-0.38],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs8018379-<b>G</b>,8 x 10-14,(IgG1 FG2n total/G2n),0.4055,'-,0.2859 unit decrease,[0.21-0.36],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs67662065-<b>T</b>,1 x 10-9,(IgG1 FG2n/G2n),0.2339,'-,0.2734 unit decrease,[0.19-0.36],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs11621680-<b>G</b>,2 x 10-9,(IgG1 FG2n/G2n),0.5087,'-,0.2295 unit increase,[0.16-0.3],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65547963
rs867972-<b>C</b>,6 x 10-9,(IgG1 FG2n/G2n),0.4875,'-,0.2175 unit increase,[0.14-0.29],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs11710456-<b>A</b>,1 x 10-8,(IgG1 FGS1/(F+FG+FGS1)),0.2939,'-,0.2236 unit decrease,[0.15-0.3],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs11710456-<b>A</b>,2 x 10-19,(IgG1 FGS1/(FG+FGS1)),0.2939,'-,0.3586 unit decrease,[0.28-0.44],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs11158592-<b>T</b>,1 x 10-6,(IgG1 Fn),0.531,'-,0.1817 unit increase,[0.11-0.26],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs11847263-<b>G</b>,3 x 10-20,(IgG1 Fn total),0.3303,'-,0.3703 unit decrease,[0.29-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,3 x 10-15,(IgG1 Fn total),0.4875,'-,0.297 unit increase,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7153297-<b>A</b>,9 x 10-15,(IgG1 Fn total),0.4825,'-,0.2966 unit increase,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs12894902-<b>T</b>,1 x 10-14,(IgG1 Fn total),0.4923,'-,0.2908 unit increase,[0.22-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs8018379-<b>G</b>,3 x 10-12,(IgG1 Fn total),0.4055,'-,0.2681 unit decrease,[0.19-0.34],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs7782210-<b>G</b>,8 x 10-13,(IgG1 Fn/Bn),0.4071,'-,0.2789 unit increase,[0.2-0.36],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs11847263-<b>G</b>,3 x 10-15,(IgG1 Fn/Bn),0.3303,'-,0.3144 unit decrease,[0.24-0.39],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs7153297-<b>A</b>,2 x 10-14,(IgG1_G1),0.4825,'-,0.292 unit decrease,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs12894902-<b>T</b>,3 x 10-14,(IgG1_G1),0.4923,'-,0.2853 unit decrease,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs8018379-<b>G</b>,2 x 10-11,(IgG1_G1),0.4055,'-,0.2591 unit increase,[0.18-0.33],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs1328899-<b>T</b>,3 x 10-9,(IgG1_G1F/IgG1_G0F),0.0176,'-,0.8052 unit increase,[0.54-1.07],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33151417
rs11847263-<b>G</b>,2 x 10-19,(IgG1_G1F/IgG1_G1),0.3303,'-,0.362 unit decrease,[0.28-0.44],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,1 x 10-14,(IgG1_G1F/IgG1_G1),0.4875,'-,0.2896 unit increase,[0.22-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs12894902-<b>T</b>,4 x 10-14,(IgG1_G1F/IgG1_G1),0.4923,'-,0.2837 unit increase,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs8018379-<b>G</b>,1 x 10-11,(IgG1_G1F/IgG1_G1),0.4055,'-,0.2597 unit decrease,[0.18-0.33],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs11158593-<b>A</b>,2 x 10-6,(IgG1_G1Fn),0.532,'-,0.1729 unit increase,[0.1-0.24],"FUT8, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393266
rs9624326-<b>T</b>,3 x 10-8,(IgG1_G1FN),0.1728,'-,0.2756 unit decrease,[0.18-0.37],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23792856
rs9306335-<b>C</b>,1 x 10-8,(IgG1_G1FN(10)/IgG4_G1FN),0.7209,'-,0.2451 unit increase,[0.16-0.33],"MGAT3, TAB1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39447532
rs1328899-<b>T</b>,3 x 10-10,(IgG1_G1FN/IgG1_G0FN),0.0176,'-,0.8511 unit increase,[0.59-1.12],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33151417
rs12167679-<b>G</b>,5 x 10-8,(IgG1_G1FN/IgG1_G1F),0.1974,'-,0.253 unit decrease,[0.16-0.34],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs11847263-<b>G</b>,2 x 10-24,(IgG1_G1FN/IgG1_G1N),0.3303,'-,0.4091 unit decrease,[0.33-0.49],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,1 x 10-18,(IgG1_G1FN/IgG1_G1N),0.4875,'-,0.3324 unit increase,[0.26-0.41],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs12894902-<b>T</b>,4 x 10-18,(IgG1_G1FN/IgG1_G1N),0.4923,'-,0.3258 unit increase,[0.25-0.4],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs8018379-<b>G</b>,5 x 10-16,(IgG1_G1FN/IgG1_G1N),0.4055,'-,0.3131 unit decrease,[0.24-0.39],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs72712459-<b>A</b>,1 x 10-9,(IgG1_G1FN/IgG1_G1N),0.3201,'-,0.2567 unit decrease,[0.17-0.34],"PTBP1P, RPL21P7",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65267882
rs9624326-<b>T</b>,7 x 10-8,(IgG1_G1FNn),0.1728,'-,0.2666 unit decrease,[0.17-0.36],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23792856
rs6764279-<b>A</b>,8 x 10-44,(IgG1_G1FS1),0.293,'-,0.5748 unit decrease,[0.49-0.66],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs6764279-<b>A</b>,1 x 10-62,(IgG1_G1FS1/IgG1_G1F),0.293,'-,0.6986 unit decrease,[0.62-0.78],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11847263-<b>G</b>,1 x 10-19,(IgG1_G1n),0.3303,'-,0.3647 unit increase,[0.29-0.44],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs11847263-<b>G</b>,9 x 10-16,(IgG1_G1N),0.3303,'-,0.3208 unit increase,[0.24-0.4],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,2 x 10-14,(IgG1_G1n),0.4875,'-,0.2879 unit decrease,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs12894902-<b>T</b>,5 x 10-14,(IgG1_G1n),0.4923,'-,0.2824 unit decrease,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs7153297-<b>A</b>,6 x 10-15,(IgG1_G0),0.4825,'-,0.2966 unit decrease,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs11847263-<b>G</b>,1 x 10-17,(IgG1_G0F/IgG1_G0),0.3303,'-,0.3434 unit decrease,[0.26-0.42],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,9 x 10-13,(IgG1_G0F/IgG1_G0),0.4875,'-,0.2687 unit increase,[0.2-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs12894902-<b>T</b>,2 x 10-12,(IgG1_G0F/IgG1_G0),0.4923,'-,0.2634 unit increase,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs7153297-<b>A</b>,2 x 10-12,(IgG1_G0F/IgG1_G0),0.4825,'-,0.2678 unit increase,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs8018379-<b>G</b>,1 x 10-9,(IgG1_G0F/IgG1_G0),0.4055,'-,0.2334 unit decrease,[0.16-0.31],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs1328899-<b>T</b>,5 x 10-9,(IgG1_G0FN),0.0176,'-,0.7875 unit decrease,[0.52-1.05],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33151417
rs5750828-<b>C</b>,7 x 10-26,(IgG1_G0FN/IgG1_G0F),0.697,'-,0.4527 unit decrease,[0.37-0.54],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,1 x 10-9,(IgG1_G0FN/IgG1_G0F),0.1974,'-,0.2827 unit decrease,[0.19-0.37],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs11847263-<b>G</b>,1 x 10-20,(IgG1_G0FN/IgG1_G0N),0.3303,'-,0.375 unit decrease,[0.3-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,4 x 10-14,(IgG1_G0FN/IgG1_G0N),0.4875,'-,0.2867 unit increase,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7153297-<b>A</b>,1 x 10-13,(IgG1_G0FN/IgG1_G0N),0.4825,'-,0.2842 unit increase,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs1328899-<b>T</b>,8 x 10-9,(IgG1_G0FNn),0.0176,'-,0.7825 unit decrease,[0.52-1.05],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33151417
rs7782210-<b>G</b>,4 x 10-10,(IgG1_G0N),0.4071,'-,0.2433 unit decrease,[0.17-0.32],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs11847263-<b>G</b>,3 x 10-20,(IgG1_G0n),0.3303,'-,0.3697 unit increase,[0.29-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs10134589-<b>T</b>,1 x 10-17,(IgG1_G0N),0.1676,'-,0.4224 unit increase,[0.33-0.52],"MIR4708, PTBP1P",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65314516
rs6573626-<b>C</b>,4 x 10-15,(IgG1_G0n),0.542,'-,0.3042 unit decrease,[0.23-0.38],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65773977
rs7153297-<b>A</b>,5 x 10-15,(IgG1_G0n),0.4825,'-,0.2974 unit decrease,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs28470717-<b>C</b>,9 x 10-13,(IgG1_G0N),0.3984,'-,0.2918 unit increase,[0.21-0.37],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784332
rs2149841-<b>T</b>,2 x 10-11,(IgG1_G0N),0.492,'-,0.2516 unit decrease,[0.18-0.32],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65543601
rs7782210-<b>G</b>,1 x 10-10,(IgG1_G0Nn),0.4071,'-,0.2507 unit decrease,[0.17-0.33],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs10134589-<b>T</b>,5 x 10-18,(IgG1_G0Nn),0.1676,'-,0.4289 unit increase,[0.33-0.53],"MIR4708, PTBP1P",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65314516
rs867972-<b>C</b>,8 x 10-12,(IgG1_G0Nn),0.4875,'-,0.256 unit decrease,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs2149841-<b>T</b>,2 x 10-11,(IgG1_G0Nn),0.492,'-,0.2516 unit decrease,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65543601
rs11847263-<b>G</b>,6 x 10-20,(IgG1_G1),0.3303,'-,0.3671 unit increase,[0.29-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,3 x 10-12,(IgG1 Bn),0.4875,'-,0.2619 unit decrease,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7153297-<b>A</b>,7 x 10-12,(IgG1 Bn),0.4825,'-,0.2612 unit decrease,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs5750828-<b>C</b>,7 x 10-19,(IgG1 Bn total),0.697,'-,0.384 unit decrease,[0.3-0.47],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,2 x 10-9,(IgG1 Bn total),0.1974,'-,0.2817 unit decrease,[0.19-0.37],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs7782210-<b>G</b>,4 x 10-12,(IgG1 Bn/Fn total),0.4071,'-,0.2713 unit decrease,[0.19-0.35],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs11847263-<b>G</b>,3 x 10-17,(IgG1 Bn/Fn total),0.3303,'-,0.3382 unit increase,[0.26-0.42],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs67662065-<b>T</b>,1 x 10-12,(IgG1 Bn/Fn total),0.2339,'-,0.3204 unit increase,[0.23-0.41],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs867972-<b>C</b>,2 x 10-12,(IgG1 Bn/Fn total),0.4875,'-,0.2653 unit decrease,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7153297-<b>A</b>,4 x 10-12,(IgG1 Bn/Fn total),0.4825,'-,0.2645 unit decrease,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs5750828-<b>C</b>,2 x 10-24,(IgG1 FBG0n/G0n),0.697,'-,0.4425 unit decrease,[0.36-0.53],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,7 x 10-10,(IgG1 FBG0n/G0n),0.1974,'-,0.2905 unit decrease,[0.2-0.38],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs5750828-<b>C</b>,4 x 10-14,(IgG1 FBG1n/G1n),0.697,'-,0.3266 unit decrease,[0.24-0.41],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,3 x 10-8,(IgG1 FBG1n/G1n),0.1974,'-,0.259 unit decrease,[0.17-0.35],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs5750828-<b>C</b>,2 x 10-11,(IgG1 FBG2n/G2n),0.697,'-,0.293 unit decrease,[0.21-0.38],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs9624326-<b>T</b>,2 x 10-6,(IgG1 FBG2n/G2n),0.1728,'-,0.2378 unit decrease,[0.14-0.34],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23792856
rs5750828-<b>C</b>,3 x 10-18,(IgG1 FBn),0.697,'-,0.3784 unit decrease,[0.29-0.46],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs7804185-<b>C</b>,2 x 10-9,(IgG1 FBn/Bn total),0.4049,'-,0.2374 unit increase,[0.16-0.31],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50313548
rs11847263-<b>G</b>,4 x 10-23,(IgG1 FBn/Bn total),0.3303,'-,0.3998 unit decrease,[0.32-0.48],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,2 x 10-17,(IgG1 FBn/Bn total),0.4875,'-,0.322 unit increase,[0.25-0.4],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs12894902-<b>T</b>,8 x 10-17,(IgG1 FBn/Bn total),0.4923,'-,0.3145 unit increase,[0.24-0.39],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs8018379-<b>G</b>,2 x 10-14,(IgG1 FBn/Bn total),0.4055,'-,0.297 unit decrease,[0.22-0.37],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs5750828-<b>C</b>,7 x 10-20,(IgG1 FBn/Fn),0.697,'-,0.3937 unit decrease,[0.31-0.48],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs5750828-<b>C</b>,7 x 10-20,(IgG1 FBn/Fn total),0.697,'-,0.3934 unit decrease,[0.31-0.48],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,2 x 10-9,(IgG1 FBn/Fn total),0.1974,'-,0.2791 unit decrease,[0.19-0.37],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs11847263-<b>G</b>,1 x 10-18,(IgG1 FG0n total/G0n),0.3303,'-,0.3541 unit decrease,[0.28-0.43],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs5750828-<b>C</b>,2 x 10-24,(IgG1 BG0n total/G0n),0.697,'-,0.4406 unit decrease,[0.36-0.53],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,1 x 10-9,(IgG1 BG0n total/G0n),0.1974,'-,0.2855 unit decrease,[0.19-0.38],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs7782210-<b>G</b>,1 x 10-12,(IgG1 BG0n/G0n),0.4071,'-,0.2786 unit decrease,[0.2-0.36],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs10134589-<b>T</b>,2 x 10-16,(IgG1 BG0n/G0n),0.1676,'-,0.4089 unit increase,[0.31-0.51],"MIR4708, PTBP1P",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65314516
rs67662065-<b>T</b>,3 x 10-11,(IgG1 BG0n/G0n),0.2339,'-,0.3001 unit increase,[0.21-0.39],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs867972-<b>C</b>,2 x 10-10,(IgG1 BG0n/G0n),0.4875,'-,0.2381 unit decrease,[0.16-0.31],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs2149841-<b>T</b>,4 x 10-10,(IgG1 BG0n/G0n),0.492,'-,0.2349 unit decrease,[0.16-0.31],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65543601
rs5750828-<b>C</b>,2 x 10-14,(IgG1 BG1n total/G1n),0.697,'-,0.3307 unit decrease,[0.25-0.42],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,3 x 10-8,(IgG1 BG1n total/G1n),0.1974,'-,0.2576 unit decrease,[0.17-0.35],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs7782210-<b>G</b>,1 x 10-12,(IgG1 BG1n/G1n),0.4071,'-,0.2777 unit decrease,[0.2-0.35],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs11847263-<b>G</b>,7 x 10-17,(IgG1 BG1n/G1n),0.3303,'-,0.3328 unit increase,[0.25-0.41],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,1 x 10-12,(IgG1 BG1n/G1n),0.4875,'-,0.2657 unit decrease,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs67662065-<b>T</b>,2 x 10-12,(IgG1 BG1n/G1n),0.2339,'-,0.3184 unit increase,[0.23-0.41],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs7153297-<b>A</b>,2 x 10-12,(IgG1 BG1n/G1n),0.4825,'-,0.2657 unit decrease,[0.19-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs11158592-<b>T</b>,3 x 10-14,(IgG1 BG1S1/(BG1+BG1S1)),0.531,'-,0.2837 unit increase,[0.21-0.36],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs12894902-<b>T</b>,1 x 10-12,(IgG1 BG1S1/(BG1+BG1S1)),0.4923,'-,0.2597 unit increase,[0.19-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs2149841-<b>T</b>,2 x 10-12,(IgG1 BG1S1/(BG1+BG1S1)),0.492,'-,0.2593 unit increase,[0.19-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65543601
rs1005522-<b>A</b>,3 x 10-12,(IgG1 BG2n total/G2n),0.7434,'-,0.3108 unit decrease,[0.22-0.4],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39449893
rs11158592-<b>T</b>,4 x 10-15,(IgG1 BGS1/(BG0+BG+BGS1)),0.5308,'-,0.2968 unit increase,[0.22-0.37],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs2149841-<b>T</b>,4 x 10-12,(IgG1 BGS1/(BG0+BG+BGS1)),0.492,'-,0.2577 unit increase,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65543601
rs5750828-<b>C</b>,3 x 10-18,(IgG1 Bisecting_GlcNAc),0.6973,'-,0.3755 unit decrease,[0.29-0.46],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12167679-<b>G</b>,2 x 10-9,(IgG1 Bisecting_GlcNAc),0.1976,'-,0.2795 unit decrease,[0.19-0.37],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs7782210-<b>G</b>,1 x 10-12,(IgG1 Bn),0.4071,'-,0.2789 unit decrease,[0.2-0.36],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs11847263-<b>G</b>,2 x 10-16,(IgG1 Bn),0.3303,'-,0.3305 unit increase,[0.25-0.41],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs67662065-<b>T</b>,2 x 10-12,(IgG1 Bn),0.2339,'-,0.3166 unit increase,[0.23-0.41],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs1005522-<b>A</b>,5 x 10-12,(IgG1_G2FN/IgG1_G2F),0.7434,'-,0.3059 unit decrease,[0.22-0.39],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39449893
rs12342831-<b>C</b>,9 x 10-10,(IgG1_G2FS1/IgG1_G1FS1),0.2631,'-,0.2505 unit decrease,[0.17-0.33],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33124874
rs6764279-<b>A</b>,2 x 10-39,(IgG1_G2FS1/IgG1_G2F),0.293,'-,0.5325 unit decrease,[0.45-0.61],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11158592-<b>T</b>,1 x 10-17,(IgG1_G2FS1/IgG1_G2S1),0.531,'-,0.3233 unit increase,[0.25-0.4],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs11621680-<b>G</b>,8 x 10-14,(IgG1_G2FS1/IgG1_G2S1),0.5087,'-,0.284 unit increase,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65547963
rs12894902-<b>T</b>,2 x 10-13,(IgG1_G2FS1/IgG1_G2S1),0.4923,'-,0.2724 unit increase,[0.2-0.35],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs11847263-<b>G</b>,3 x 10-14,(IgG1_G2n),0.3303,'-,0.2997 unit increase,[0.22-0.38],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs11158592-<b>T</b>,5 x 10-12,(IgG1_G2N/IgG1_G1N),0.531,'-,0.2572 unit increase,[0.18-0.33],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs8022764-<b>G</b>,2 x 10-10,(IgG1_G2N/IgG1_G1N),0.5214,'-,0.244 unit increase,[0.17-0.32],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65777937
rs4902407-<b>G</b>,5 x 10-9,(IgG1_G2N/IgG1_G1N),0.5018,'-,0.2193 unit increase,[0.15-0.29],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65607917
rs62292620-<b>G</b>,8 x 10-11,(IgG1_G2S1/IgG1_G2),0.2798,'-,0.2858 unit decrease,[0.2-0.37],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:186995501
rs9624327-<b>T</b>,9 x 10-13,(IgG2 BG0n total/G0n),0.1925,'-,0.3491 unit decrease,[0.25-0.44],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23797087
rs5750828-<b>C</b>,4 x 10-8,(IgG2 BG0n total/G0n),0.6968,'-,0.2415 unit decrease,[0.16-0.33],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs2186369-<b>G</b>,2 x 10-10,(IgG2 BG1n total/G1n),0.1608,'-,0.3293 unit decrease,[0.23-0.43],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs73396548-<b>A</b>,7 x 10-10,(IgG2 BG2n total/G2n),0.1662,'-,0.3291 unit decrease,[0.22-0.43],CHCHD10,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23767098
rs2186369-<b>G</b>,3 x 10-13,(IgG2 Bisecting_GlcNAc),0.1599,'-,0.3778 unit decrease,[0.28-0.48],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs2186369-<b>G</b>,6 x 10-13,(IgG2 Bn total),0.1608,'-,0.371 unit decrease,[0.27-0.47],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs9624327-<b>T</b>,5 x 10-13,(IgG2 FBG0n/G0n),0.1925,'-,0.3534 unit decrease,[0.26-0.45],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23797087
rs5750828-<b>C</b>,3 x 10-8,(IgG2 FBG0n/G0n),0.6968,'-,0.2439 unit decrease,[0.16-0.33],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs2186369-<b>G</b>,2 x 10-10,(IgG2 FBG1n/G1n),0.1608,'-,0.3292 unit decrease,[0.23-0.43],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs9624327-<b>T</b>,1 x 10-9,(IgG2 FBG2n/G2n),0.1925,'-,0.3005 unit decrease,[0.2-0.4],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23797087
rs2186369-<b>G</b>,3 x 10-13,(IgG2 FBn),0.1608,'-,0.3754 unit decrease,[0.27-0.48],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs2186369-<b>G</b>,6 x 10-13,(IgG2 FBn/Fn),0.1608,'-,0.3709 unit decrease,[0.27-0.47],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs2186369-<b>G</b>,6 x 10-13,(IgG2 FBn/Fn total),0.1608,'-,0.3709 unit decrease,[0.27-0.47],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs11158592-<b>T</b>,7 x 10-15,(IgG2 FG0n total/G0n),0.531,'-,0.2952 unit increase,[0.22-0.37],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs67662065-<b>T</b>,4 x 10-12,(IgG1_G1N),0.2339,'-,0.3118 unit increase,[0.22-0.4],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs8018379-<b>G</b>,2 x 10-11,(IgG1_G1n),0.4055,'-,0.2574 unit increase,[0.18-0.33],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs7153297-<b>A</b>,3 x 10-11,(IgG1_G1N),0.4825,'-,0.2524 unit decrease,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs10134589-<b>T</b>,4 x 10-10,(IgG1_G1N(20)/IgG2_G1N(20)),0.1676,'-,0.2982 unit increase,[0.21-0.39],"MIR4708, PTBP1P",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65314516
rs7782210-<b>G</b>,2 x 10-13,(IgG1_G1Nn),0.4071,'-,0.2853 unit decrease,[0.21-0.36],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs11847263-<b>G</b>,2 x 10-15,(IgG1_G1Nn),0.3303,'-,0.3155 unit increase,[0.24-0.39],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs67662065-<b>T</b>,1 x 10-11,(IgG1_G1Nn),0.2339,'-,0.3049 unit increase,[0.22-0.39],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs11621680-<b>G</b>,6 x 10-11,(IgG1_G1Nn),0.5087,'-,0.2489 unit decrease,[0.17-0.32],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65547963
rs11158592-<b>T</b>,4 x 10-14,(IgG1_G1NS1/IgG1_G1N),0.531,'-,0.2833 unit increase,[0.21-0.36],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs12894902-<b>T</b>,1 x 10-12,(IgG1_G1NS1/IgG1_G1N),0.4923,'-,0.2591 unit increase,[0.19-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs2149841-<b>T</b>,2 x 10-12,(IgG1_G1NS1/IgG1_G1N),0.492,'-,0.2588 unit increase,[0.19-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65543601
rs11158592-<b>T</b>,3 x 10-13,(IgG1_G1S1/IgG1_G1),0.531,'-,0.269 unit increase,[0.2-0.34],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs11158602-<b>G</b>,1 x 10-10,(IgG1_G1S1/IgG1_G1),0.5061,'-,0.236 unit increase,[0.16-0.31],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65605015
rs6573626-<b>C</b>,5 x 10-10,(IgG1_G1S1/IgG1_G1),0.542,'-,0.2324 unit increase,[0.16-0.31],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65773977
rs11847263-<b>G</b>,7 x 10-15,(IgG1_G2),0.3303,'-,0.3079 unit increase,[0.23-0.39],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs11158602-<b>G</b>,3 x 10-11,(IgG1_G2,0.5061,'-,0.252 unit decrease,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65605015
rs11158591-<b>T</b>,9 x 10-7,(IgG1_G2(20)/IgG2_G2(20)),0.5986,'-,0.1839 unit decrease,[0.11-0.26],"FUT8, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65389044
rs3824459-<b>T</b>,3 x 10-8,(IgG1_G2F),0.0204,'-,0.6865 unit increase,[0.44-0.93],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs12342831-<b>C</b>,2 x 10-7,(IgG1_G2F/IgG1_G1F),0.2631,'-,0.2134 unit decrease,[0.13-0.29],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33124874
rs11847263-<b>G</b>,2 x 10-20,(IgG1_G2F/IgG1_G2),0.3303,'-,0.3686 unit decrease,[0.29-0.45],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs867972-<b>C</b>,8 x 10-16,(IgG1_G2F/IgG1_G2),0.4875,'-,0.3013 unit increase,[0.23-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7153297-<b>A</b>,2 x 10-15,(IgG1_G2F/IgG1_G2),0.4825,'-,0.301 unit increase,[0.23-0.38],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs12894902-<b>T</b>,2 x 10-15,(IgG1_G2F/IgG1_G2),0.4923,'-,0.2956 unit increase,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs8018379-<b>G</b>,2 x 10-13,(IgG1_G2F/IgG1_G2),0.4055,'-,0.2808 unit decrease,[0.21-0.36],"NCOA4P1, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65795219
rs3824459-<b>T</b>,3 x 10-8,(IgG1_G2Fn),0.0204,'-,0.6786 unit increase,[0.44-0.92],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs867972-<b>C</b>,2 x 10-16,(IgG1 FG2n total/G2n),0.4875,'-,0.3075 unit increase,[0.23-0.38],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs11847263-<b>G</b>,2 x 10-12,(IgG1 FG2n/G2n),0.3303,'-,0.2798 unit decrease,[0.2-0.36],"PTBP1P, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65308977
rs6764279-<b>A</b>,2 x 10-39,(IgG1 FG2S1/(FG2+FG2S1)),0.293,'-,0.5323 unit decrease,[0.45-0.61],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs1005522-<b>A</b>,4 x 10-9,(IgG1_G0FN),0.7434,'-,0.254 unit decrease,[0.17-0.34],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39449893
rs67662065-<b>T</b>,1 x 10-14,(IgG1_G0FN/IgG1_G0N),0.2339,'-,0.3521 unit decrease,[0.26-0.44],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784281
rs1005522-<b>A</b>,3 x 10-10,(IgG1_G0FNn),0.7434,'-,0.2729 unit decrease,[0.19-0.36],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39449893
rs867972-<b>C</b>,2 x 10-15,(IgG1_G0n),0.4875,'-,0.2993 unit decrease,[0.23-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs867972-<b>C</b>,7 x 10-12,(IgG1_G0N),0.4875,'-,0.2566 unit decrease,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs28470717-<b>C</b>,8 x 10-13,(IgG1_G0Nn),0.3984,'-,0.2929 unit increase,[0.21-0.37],"FUT8, NCOA4P1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65784332
rs867972-<b>C</b>,9 x 10-15,(IgG1_G1),0.4875,'-,0.2918 unit decrease,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs3824459-<b>T</b>,4 x 10-7,(IgG1_G1/IgG1_G0),0.0204,'-,0.6225 unit increase,[0.38-0.86],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs7153297-<b>A</b>,3 x 10-14,(IgG1_G1F/IgG1_G1),0.4825,'-,0.2898 unit increase,[0.22-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs5750828-<b>C</b>,3 x 10-15,(IgG1_G1FN),0.697,'-,0.3418 unit decrease,[0.26-0.43],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs5750828-<b>C</b>,6 x 10-15,(IgG1_G1FN/IgG1_G1F),0.697,'-,0.3351 unit decrease,[0.25-0.42],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs7153297-<b>A</b>,4 x 10-18,(IgG1_G1FN/IgG1_G1N),0.4825,'-,0.3317 unit increase,[0.26-0.41],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs5750828-<b>C</b>,1 x 10-14,(IgG1_G1FNn),0.697,'-,0.3356 unit decrease,[0.25-0.42],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs7782210-<b>G</b>,4 x 10-13,(IgG1_G1N),0.4071,'-,0.2826 unit decrease,[0.21-0.36],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50309149
rs7153297-<b>A</b>,4 x 10-14,(IgG1_G1n),0.4825,'-,0.2885 unit decrease,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs867972-<b>C</b>,2 x 10-11,(IgG1_G1N),0.4875,'-,0.2521 unit decrease,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7797255-<b>G</b>,1 x 10-8,(IgG1_G1N/IgG1_G1),0.4016,'-,0.2227 unit decrease,[0.15-0.3],IKZF1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,7:50312008
rs867972-<b>C</b>,4 x 10-11,(IgG1_G1Nn),0.4875,'-,0.2467 unit decrease,[0.17-0.32],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs16830188-<b>T</b>,4 x 10-10,(IgG2_G1F),0.0212,'-,0.9129 unit decrease,[0.63-1.2],"RUNX3, MIR4425",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,1:24972350
rs1328899-<b>T</b>,4 x 10-14,(IgG2_G1Fn),0.0176,'-,1.0023 unit increase,[0.74-1.26],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33151417
rs3824459-<b>T</b>,4 x 10-14,(IgG2_G1FN/IgG2_G0FN),0.0204,'-,0.9243 unit increase,[0.69-1.16],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs11710456-<b>A</b>,2 x 10-24,(IgG4 FGS1/(FG+FGS1)),0.2939,'-,0.4054 unit decrease,[0.33-0.48],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs10971420-<b>C</b>,2 x 10-12,(IgG4 FGS1/(FG+FGS1)),0.3271,'-,0.2689 unit decrease,[0.19-0.34],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33125002
rs11710456-<b>A</b>,2 x 10-39,(IgG4 SA per Gal),0.2936,'-,0.5365 unit decrease,[0.46-0.62],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs1005522-<b>A</b>,8 x 10-19,(IgG4_G0FN),0.7434,'-,0.3874 unit decrease,[0.3-0.47],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39449893
rs5750828-<b>C</b>,7 x 10-11,(IgG4_G0Fn),0.697,'-,0.2786 unit increase,[0.19-0.36],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs73167342-<b>G</b>,3 x 10-38,(IgG4_G0FN/IgG4_G0F),0.6853,'-,0.5559 unit decrease,[0.47-0.64],"MGAT3, TAB1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39438097
rs10644269-<b>CTT</b>,3 x 10-30,(IgG4_G1FN),0.7136,'-,0.4895 unit decrease,[0.41-0.57],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39440968
rs9306335-<b>C</b>,3 x 10-19,(IgG4_G1FN(10)/(IgG1_G1FN(10) + IgG2_G1FN(10) +IgG4_G1FN(10)),0.7218,'-,0.3854 unit decrease,[0.3-0.47],"MGAT3, TAB1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39447532
rs5750828-<b>C</b>,4 x 10-27,(IgG4_G1FN/IgG4_G1F),0.697,'-,0.4678 unit decrease,[0.38-0.55],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs6764279-<b>A</b>,8 x 10-34,(IgG4_G1FS1),0.293,'-,0.4918 unit decrease,[0.41-0.57],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs6764279-<b>A</b>,1 x 10-51,(IgG4_G1FS1/IgG4_G1F),0.293,'-,0.6152 unit decrease,[0.54-0.69],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs16830188-<b>T</b>,2 x 10-7,(IgG4_G2F),0.0212,'-,0.9452 unit decrease,[0.59-1.3],"RUNX3, MIR4425",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,1:24972350
rs12342831-<b>C</b>,1 x 10-14,(IgG4_G2F/IgG4_G1F),0.2631,'-,0.3203 unit decrease,[0.24-0.4],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33124874
rs10971434-<b>A</b>,8 x 10-10,(IgG4_G2Fn),0.2682,'-,0.2631 unit decrease,[0.18-0.35],B4GALT1-AS1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33168893
rs4821898-<b>T</b>,1 x 10-7,(IgG4_G2FN(10)/(IgG1_G2FN(10) + IgG2_G2FN(10) +IgG4_G2FN(10)),0.7209,'-,0.2197 unit decrease,[0.14-0.3],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39442347
rs5750828-<b>C</b>,3 x 10-19,(IgG4_G2FN/IgG4_G2F),0.697,'-,0.3804 unit decrease,[0.3-0.46],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs5750828-<b>C</b>,4 x 10-10,(IgG4_G2FNn),0.697,'-,0.2636 unit decrease,[0.18-0.35],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12342831-<b>C</b>,3 x 10-20,(IgG4_G2FS1/IgG4_G1FS1),0.2631,'-,0.3813 unit decrease,[0.3-0.46],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33124874
rs11710456-<b>A</b>,5 x 10-45,(IgG4_G2FS1/IgG4_G2F),0.2939,'-,0.576 unit decrease,[0.5-0.66],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs10971434-<b>A</b>,1 x 10-9,(IgG4_G2n),0.2682,'-,0.2585 unit decrease,[0.17-0.34],B4GALT1-AS1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33168893
rs7153297-<b>A</b>,7 x 10-17,(IgG1 FBn/Bn total),0.4825,'-,0.3206 unit increase,[0.25-0.4],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65536748
rs12167679-<b>G</b>,2 x 10-9,(IgG1 FBn/Fn),0.1974,'-,0.28 unit decrease,[0.19-0.37],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs12167679-<b>G</b>,2 x 10-9,(IgG1 FBn),0.1974,'-,0.2819 unit decrease,[0.19-0.37],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23799503
rs867972-<b>C</b>,3 x 10-13,(IgG1 FG0n total/G0n),0.4875,'-,0.2747 unit increase,[0.2-0.35],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65429043
rs7286917-<b>G</b>,6 x 10-14,(IgG1 FG0n/G0n),0.7161,'-,0.3434 unit increase,[0.25-0.43],MGAT3,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39464863
rs2411822-<b>G</b>,2 x 10-13,(IgG2_G2/IgG2_G1),0.4875,'-,0.2698 unit increase,[0.2-0.34],"FUT8, FUT8-AS1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65411677
chr9:33152337:D-<b>C</b>,8 x 10-7,(IgG2_G2F/IgG2_G1F),0.2654,'-,0.2059 unit decrease,[0.12-0.29],'-,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,Mapping not available
rs12342831-<b>C</b>,1 x 10-9,(IgG2_G2FS1/IgG2_G1FS1),0.2631,'-,0.2483 unit decrease,[0.17-0.33],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33124874
rs11710456-<b>A</b>,5 x 10-45,(IgG4 FG2S1/(FG2+FG2S1)),0.2939,'-,0.576 unit decrease,[0.5-0.66],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs5750828-<b>C</b>,7 x 10-8,(IgG4_G0F),0.697,'-,0.2285 unit increase,[0.15-0.31],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs1005522-<b>A</b>,6 x 10-21,(IgG4_G0FNn),0.7434,'-,0.4111 unit decrease,[0.33-0.5],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39449893
rs10644269-<b>CTT</b>,1 x 10-27,(IgG4_G1FNn),0.7136,'-,0.4634 unit decrease,[0.38-0.55],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39440968
rs12342831-<b>C</b>,3 x 10-8,(IgG4_G2F),0.2631,'-,0.2336 unit decrease,[0.15-0.32],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33124874
rs5750828-<b>C</b>,6 x 10-12,(IgG4_G2FN),0.697,'-,0.2906 unit decrease,[0.21-0.37],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs12342831-<b>C</b>,4 x 10-16,(IgG4_G2FS1),0.2631,'-,0.3346 unit decrease,[0.25-0.42],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33124874
rs12894902-<b>T</b>,4 x 10-15,(IgG1 FG1n total/G1n),0.4923,'-,0.2948 unit increase,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65695081
rs10903120-<b>A</b>,3 x 10-9,(IgG2_G0FNn),0.0293,'-,0.8392 unit increase,[0.56-1.12],"MIR4425, RUNX3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,1:24971793
rs9624334-<b>C</b>,8 x 10-12,(IgG2_G0FNn),0.1601,'-,0.3414 unit decrease,[0.24-0.44],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23824069
rs6001600-<b>T</b>,7 x 10-7,(IgG2_G0FNn),0.7242,'-,0.2175 unit decrease,[0.13-0.3],"MGAT3, TAB1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39456916
rs7157006-<b>T</b>,3 x 10-16,(IgG2_G0n),0.6053,'-,0.3121 unit decrease,[0.24-0.39],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65361489
rs11158602-<b>G</b>,1 x 10-14,(IgG2_G0n),0.506,'-,0.294 unit decrease,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65605015
rs6573626-<b>C</b>,1 x 10-13,(IgG2_G0n),0.5422,'-,0.287 unit decrease,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65773977
rs113197944-<b>A</b>,1 x 10-10,(IgG2_G1F),0.0171,'-,0.8764 unit increase,[0.61-1.14],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33149342
rs3824459-<b>T</b>,8 x 10-14,(IgG2_G1F/IgG2_G0F),0.0204,'-,0.9179 unit increase,[0.68-1.16],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs10903120-<b>A</b>,7 x 10-11,(IgG2_G1Fn),0.0293,'-,0.8725 unit decrease,[0.61-1.13],"MIR4425, RUNX3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,1:24971793
rs34556611-<b>T</b>,3 x 10-8,(IgG2_G1FN),0.1727,'-,0.2816 unit decrease,[0.18-0.38],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23807363
rs5750829-<b>G</b>,4 x 10-21,(IgG2_G1FN(10)/(IgG1_G1FN(10) + IgG2_G1FN(10) +IgG4_G1FN(10)),0.6816,'-,0.4048 unit increase,[0.32-0.49],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39442013
rs9306335-<b>C</b>,1 x 10-27,(IgG2_G1FN(10)/IgG4_G1FN),0.721,'-,0.4683 unit increase,[0.38-0.55],"MGAT3, TAB1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39447532
rs2186369-<b>G</b>,3 x 10-10,(IgG2_G1FN/IgG2_G1F),0.1606,'-,0.327 unit decrease,[0.23-0.43],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs6764279-<b>A</b>,9 x 10-48,(IgG2_G1FS1),0.293,'-,0.5881 unit decrease,[0.51-0.67],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11710456-<b>A</b>,6 x 10-73,(IgG2_G1FS1/IgG2_G1F),0.2939,'-,0.7558 unit decrease,[0.67-0.84],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs4902407-<b>G</b>,4 x 10-13,(IgG2_G2/IgG2_G1),0.5018,'-,0.2713 unit increase,[0.2-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65607917
rs11622829-<b>A</b>,3 x 10-12,(IgG2_G2/IgG2_G1),0.5031,'-,0.2561 unit increase,[0.18-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65725064
rs12337458-<b>C</b>,6 x 10-10,(IgG2_G2F),0.0132,'-,0.9829 unit increase,[0.67-1.29],B4GALT1-AS1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33180568
rs12337458-<b>C</b>,1 x 10-9,(IgG2_G2Fn),0.0132,'-,0.9584 unit increase,[0.65-1.27],B4GALT1-AS1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33180568
rs5750828-<b>C</b>,4 x 10-11,(IgG2_G2FN(10)/(IgG1_G2FN(10) + IgG2_G2FN(10) +IgG4_G2FN(10)),0.697,'-,0.2751 unit increase,[0.19-0.36],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs5750828-<b>C</b>,6 x 10-12,(IgG2_G2FN(10)/IgG4_G2FN),0.6964,'-,0.2832 unit increase,[0.2-0.36],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs73396548-<b>A</b>,1 x 10-9,(IgG2_G2FN/IgG2_G2F),0.1659,'-,0.3269 unit decrease,[0.22-0.43],CHCHD10,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23767098
rs6764279-<b>A</b>,3 x 10-59,(IgG2_G2FS1/IgG2_G2F),0.293,'-,0.6717 unit decrease,[0.59-0.75],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs73167342-<b>G</b>,5 x 10-31,(IgG4 Bisecting_GlcNAc),0.6846,'-,0.5006 unit decrease,[0.42-0.59],"MGAT3, TAB1",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39438097
rs6764279-<b>A</b>,1 x 10-51,(IgG4 FG1S1/(FG1+FG1S1)),0.293,'-,0.6151 unit decrease,[0.54-0.69],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11158602-<b>G</b>,2 x 10-14,(IgG2 FG0n total/G0n),0.506,'-,0.2914 unit increase,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65605015
rs8018278-<b>G</b>,3 x 10-13,(IgG2 FG0n total/G0n),0.5025,'-,0.2708 unit increase,[0.2-0.34],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65713370
rs11710456-<b>A</b>,7 x 10-73,(IgG2 FG1S1/(FG1+FG1S1)),0.2939,'-,0.7558 unit decrease,[0.67-0.84],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs6764279-<b>A</b>,4 x 10-59,(IgG2 FG2S1/(FG2+FG2S1)),0.293,'-,0.6716 unit decrease,[0.59-0.75],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11710456-<b>A</b>,9 x 10-17,(IgG2 FGS1/(F+FG+FGS1)),0.2939,'-,0.3321 unit decrease,[0.25-0.41],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs11710456-<b>A</b>,1 x 10-46,(IgG2 FGS1/(FG+FGS1)),0.2939,'-,0.5886 unit decrease,[0.51-0.67],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs2186369-<b>G</b>,1 x 10-12,(IgG2 Fn/Bn total),0.1608,'-,0.3653 unit increase,[0.26-0.47],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23828809
rs16830188-<b>T</b>,1 x 10-6,(IgG2 G0n),0.0212,'-,0.777 unit increase,[0.46-1.09],"RUNX3, MIR4425",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,1:24972350
rs3824459-<b>T</b>,5 x 10-14,(IgG2 G0n),0.0205,'-,0.924 unit decrease,[0.68-1.16],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33134619
rs16830188-<b>T</b>,3 x 10-7,(IgG2 G1n),0.0212,'-,0.7958 unit decrease,[0.49-1.1],"RUNX3, MIR4425",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,1:24972350
rs113197944-<b>A</b>,8 x 10-15,(IgG2 G1n),0.0172,'-,1.0251 unit increase,[0.77-1.28],B4GALT1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33149342
rs12337458-<b>C</b>,2 x 10-10,(IgG2 Galactosylation),0.0133,'-,0.9873 unit increase,[0.68-1.29],B4GALT1-AS1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,9:33180568
rs6764279-<b>A</b>,8 x 10-60,(IgG2 SA per Gal),0.2934,'-,0.6762 unit decrease,[0.59-0.76],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187006187
rs11710456-<b>A</b>,8 x 10-16,(IgG2 Sialylation),0.2944,'-,0.3211 unit decrease,[0.24-0.4],ST6GAL1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,3:187008099
rs11621604-<b>G</b>,9 x 10-16,(IgG2_G0),0.593,'-,0.3085 unit decrease,[0.23-0.38],"FUT8, MIR4708",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65374056
rs11158602-<b>G</b>,2 x 10-14,(IgG2_G0),0.5061,'-,0.2911 unit decrease,[0.22-0.37],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65605015
rs8018278-<b>G</b>,2 x 10-13,(IgG2_G0),0.5025,'-,0.2747 unit decrease,[0.2-0.35],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65713370
rs5750829-<b>G</b>,5 x 10-7,(IgG2_G0F(10)/IgG4_G0F),0.681,'-,0.2101 unit decrease,[0.13-0.29],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39442013
rs11158592-<b>T</b>,2 x 10-14,(IgG2_G0F/IgG2_G0),0.531,'-,0.288 unit increase,[0.21-0.36],"MIR4708, FUT8",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65393250
rs11158602-<b>G</b>,7 x 10-14,(IgG2_G0F/IgG2_G0),0.5061,'-,0.2834 unit increase,[0.21-0.36],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65605015
rs8018278-<b>G</b>,1 x 10-12,(IgG2_G0F/IgG2_G0),0.5025,'-,0.2621 unit increase,[0.19-0.33],FUT8,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,14:65713370
rs10903120-<b>A</b>,2 x 10-9,(IgG2_G0FN),0.0293,'-,0.8383 unit increase,[0.56-1.11],"MIR4425, RUNX3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,1:24971793
rs1005522-<b>A</b>,1 x 10-10,(IgG2_G0FN(10)/(IgG1_G0FN(10) + IgG2_G0FN(10) +IgG4_G0FN(10)),0.7434,'-,0.2747 unit increase,[0.19-0.36],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39449893
rs9624327-<b>T</b>,9 x 10-13,(IgG2_G0FN/IgG2_G0F),0.1922,'-,0.3495 unit decrease,[0.25-0.45],SMARCB1,IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:23797087
rs5750828-<b>C</b>,3 x 10-8,(IgG2_G0FN/IgG2_G0F),0.697,'-,0.2429 unit decrease,[0.16-0.33],"TAB1, MGAT3",IgG glycosylation patterns,serum IgG glycosylation measurement,GCST005656,22:39439078
rs11619878-<b>G</b>,1 x 10-7,(IGP15),0.510985562,'-,0.1632 unit decrease,[0.1-0.22],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:65637888
rs4878639-<b>C</b>,4 x 10-8,(IGP17),0.263725273,'-,0.1959 unit decrease,[0.13-0.27],RECK,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:36099402
rs11710456-<b>G</b>,2 x 10-45,(IGP15),0.699014551,'-,0.4981 unit increase,[0.43-0.57],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs1467979-<b>C</b>,2 x 10-6,(IGP15),0.823132285,'-,0.1923 unit decrease,[0.11-0.27],CCDC40,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:80086944
rs16952065-<b>C</b>,6 x 10-6,(IGP15),0.937468575,'-,0.4117 unit decrease,[0.23-0.59],ITGA11,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:68426648
rs2200578-<b>C</b>,4 x 10-7,(IGP15),0.788386317,'-,0.1902 unit decrease,[0.12-0.26],"LYG2, LYG1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:99259781
rs6908917-<b>C</b>,2 x 10-6,(IGP15),0.751956642,'-,0.1674 unit increase,[0.098-0.236],EPB41L2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:131034724
rs2094962-<b>C</b>,5 x 10-6,(IGP54),0.901323053,'-,0.2366 unit decrease,[0.14-0.34],FCN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:134924613
rs2186369-<b>G</b>,2 x 10-7,(IGP54),0.189496821,'-,0.2177 unit decrease,[0.14-0.3],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs278541-<b>C</b>,4 x 10-8,(IGP54),0.979063006,'-,0.8053 unit decrease,[0.52-1.09],"C8orf87, LINC00535",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:93210716
rs7978454-<b>G</b>,7 x 10-6,(IGP15),0.409630411,'-,0.1473 unit increase,[0.083-0.212],DNAH10,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:123832329
rs17348299-<b>C</b>,1 x 10-10,(IGP55),0.836731981,'-,0.2864 unit decrease,[0.2-0.37],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs1439523-<b>C</b>,4 x 10-6,(IGP16),0.983777045,'-,0.6089 unit increase,[0.35-0.87],PLD5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:242368352
rs9886428-<b>G</b>,2 x 10-6,(IGP55),0.455051607,'-,0.1472 unit decrease,[0.087-0.207],SGCZ,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:14256307
rs1058065-<b>G</b>,4 x 10-6,(IGP56),0.975527393,'-,0.54 unit increase,[0.31-0.77],EIF2B4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:27364857
rs4376071-<b>C</b>,8 x 10-6,(IGP16),0.313983693,'-,0.1605 unit decrease,[0.09-0.231],"RPSAP11, CMTM8",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:32223499
rs13272623-<b>G</b>,4 x 10-6,(IGP56),0.155110978,'-,0.2093 unit increase,[0.12-0.3],LACTB2-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:70632513
rs13295552-<b>C</b>,5 x 10-6,(IGP56),0.029172681,'-,0.9104 unit increase,[0.52-1.3],"SPATA31D5P, RNA5SP287",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:81907834
rs17348299-<b>C</b>,8 x 10-6,(IGP56),0.83666024,'-,0.2001 unit increase,[0.11-0.29],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs11710456-<b>G</b>,1 x 10-8,(IGP17),0.698919993,'-,0.1999 unit increase,[0.13-0.27],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs2106139-<b>G</b>,6 x 10-6,(IGP56),0.96677402,'-,0.4353 unit decrease,[0.25-0.62],LINC00895,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:19577734
rs2538958-<b>C</b>,8 x 10-6,(IGP56),0.436017399,'-,0.1388 unit increase,[0.078-0.2],CNTNAP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:147918548
rs1364477-<b>G</b>,6 x 10-6,(IGP17),0.178595763,'-,0.1816 unit increase,[0.1-0.26],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:185319303
rs17161553-<b>C</b>,6 x 10-6,(IGP17),0.00759162,'-,1.5958 unit increase,[0.9-2.29],ST8SIA4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:100966102
rs17719439-<b>G</b>,1 x 10-6,(IGP17),0.962346685,'-,0.4037 unit decrease,[0.24-0.57],"LINC02463, RN7SL865P",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:115774058
rs2381628-<b>C</b>,6 x 10-6,(IGP17),0.816537394,'-,0.1783 unit increase,[0.1-0.26],"PPIAP33, RPL4P5",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:7518656
rs2530544-<b>G</b>,8 x 10-7,(IGP17),0.768357767,'-,0.1982 unit increase,[0.12-0.28],NPSR1-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:34657448
rs10813957-<b>G</b>,3 x 10-9,(IGP57),0.738414639,'-,0.2125 unit increase,[0.14-0.28],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33153529
rs13174348-<b>G</b>,3 x 10-6,(IGP54),0.784686077,'-,0.1823 unit increase,[0.11-0.26],"CDO1, RNU2-49P",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:115803051
rs17776120-<b>C</b>,2 x 10-6,(IGP54),0.636448318,'-,0.1654 unit decrease,[0.097-0.234],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187014891
rs7361168-<b>C</b>,3 x 10-6,(IGP15),0.758153525,'-,0.3571 unit increase,[0.21-0.51],"WFDC12, PI3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:45145096
rs7652995-<b>G</b>,5 x 10-19,(IGP15),0.176763001,'-,0.3911 unit increase,[0.31-0.48],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs7691216-<b>G</b>,7 x 10-6,(IGP15),0.155663415,'-,0.1881 unit decrease,[0.11-0.27],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:85208463
rs6466479-<b>G</b>,7 x 10-6,(IGP54),0.122643248,'-,0.2166 unit increase,[0.12-0.31],FOXP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:114101050
rs16949825-<b>C</b>,7 x 10-6,(IGP55),0.902274751,'-,0.2457 unit increase,[0.14-0.35],CTIF,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:48701073
rs918629-<b>G</b>,1 x 10-6,(IGP15),0.745524386,'-,0.1737 unit increase,[0.1-0.24],"ELL2, FABP5P5",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:95965759
rs10971170-<b>G</b>,9 x 10-6,(IGP16),0.969529949,'-,0.4143 unit increase,[0.23-0.6],"APTX, Y_RNA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:32870070
rs626657-<b>C</b>,2 x 10-6,(IGP55),0.861032879,'-,0.2321 unit decrease,[0.14-0.33],CACNB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:39176710
rs3097645-<b>C</b>,6 x 10-6,(IGP16),0.873857556,'-,0.2057 unit decrease,[0.12-0.29],"BRD2, HLA-DOA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32985503
rs12045693-<b>C</b>,3 x 10-6,(IGP56),0.573032701,'-,0.1539 unit decrease,[0.089-0.219],SKI,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:2274142
rs7529251-<b>C</b>,3 x 10-7,(IGP16),0.907539243,'-,0.2765 unit decrease,[0.17-0.38],RYR2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:237435116
rs11212260-<b>C</b>,5 x 10-6,(IGP17),0.028142852,'-,0.455 unit increase,[0.26-0.65],"ALKBH8, CWF19L2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:107476551
rs17783561-<b>T</b>,6 x 10-6,(IGP56),0.135585938,'-,0.2748 unit decrease,[0.16-0.39],"RNU5B-6P, RNU6-839P",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:109211677
rs12342831-<b>C</b>,3 x 10-11,(IGP17),0.262623398,'-,0.2366 unit decrease,[0.17-0.31],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33124874
rs523516-<b>T</b>,4 x 10-6,(IGP56),0.176237627,'-,0.1916 unit decrease,[0.11-0.27],CACNB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:39175092
rs604708-<b>C</b>,8 x 10-6,(IGP56),0.970210568,'-,0.4114 unit decrease,[0.23-0.59],DNASE2B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:84403278
rs4866334-<b>C</b>,4 x 10-6,(IGP17),0.088395507,'-,0.2533 unit decrease,[0.15-0.36],RN7SL58P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:18483542
rs12367448-<b>C</b>,6 x 10-6,(IGP57),0.83167148,'-,0.2468 unit increase,[0.14-0.35],CPSF6,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:69187442
rs13021885-<b>C</b>,8 x 10-6,(IGP57),0.932509118,'-,0.3904 unit decrease,[0.22-0.56],CNTNAP5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:124534260
rs17348299-<b>C</b>,1 x 10-10,(IGP57),0.836731981,'-,0.2872 unit increase,[0.2-0.37],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs1794265-<b>C</b>,1 x 10-6,(IGP19),0.945736455,'-,0.3272 unit decrease,[0.2-0.46],"HLA-DQB3, MTCO3P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32706960
rs322668-<b>G</b>,4 x 10-6,(IGP19),0.285734488,'-,0.159 unit decrease,[0.092-0.226],RARB,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:25302124
rs3763048-<b>C</b>,9 x 10-6,(IGP19),0.672342024,'-,0.1425 unit decrease,[0.08-0.205],DOCK2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:170034543
rs4711279-<b>C</b>,3 x 10-7,(IGP19),0.823257144,'-,0.1964 unit decrease,[0.12-0.27],SNHG32,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31834688
rs4852708-<b>C</b>,9 x 10-6,(IGP19),0.875251657,'-,0.2055 unit decrease,[0.11-0.3],"LINC01143, CD207",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:70836812
rs7734985-<b>G</b>,2 x 10-6,(IGP19),0.336041272,'-,0.1571 unit decrease,[0.093-0.221],MIR583HG,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:96092980
rs9468811-<b>C</b>,6 x 10-7,(IGP19),0.937946819,'-,0.3471 unit decrease,[0.21-0.48],"RPL7P4, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30698892
rs1049110-<b>C</b>,4 x 10-8,(IGP2),0.34601888,'-,0.1853 unit increase,[0.12-0.25],HLA-DQB2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32759026
rs9308433-<b>C</b>,4 x 10-6,(IGP2),0.408224477,'-,0.1457 unit decrease,[0.084-0.207],SMYD2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:214283666
rs10519937-<b>C</b>,9 x 10-6,(IGP2),0.831854334,'-,0.188 unit decrease,[0.11-0.27],MEGF10,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:127386161
rs1122979-<b>G</b>,2 x 10-10,(IGP2),0.875182809,'-,0.3134 unit increase,[0.22-0.41],"ABCF2-H2BE1, ABCF2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:151217985
rs11774682-<b>C</b>,1 x 10-6,(IGP2),0.966153683,'-,0.8276 unit decrease,[0.49-1.16],"KCTD9P6, WRN",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:31176759
rs11847263-<b>G</b>,8 x 10-20,(IGP2),0.390847885,'-,0.2915 unit increase,[0.23-0.35],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs1334809-<b>G</b>,8 x 10-6,(IGP2),0.884652632,'-,0.2206 unit increase,[0.12-0.32],TEK,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:27126417
rs3094093-<b>T</b>,8 x 10-6,(IGP2),0.10741842,'-,0.2231 unit increase,[0.13-0.32],"MDC1-AS1, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30711851
rs3097645-<b>C</b>,5 x 10-6,(IGP2),0.874157767,'-,0.2092 unit decrease,[0.12-0.3],"BRD2, HLA-DOA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32985503
rs592229-<b>G</b>,9 x 10-6,(IGP2),0.37028313,'-,0.1479 unit increase,[0.083-0.213],SKIV2L,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31962664
rs6583437-<b>G</b>,2 x 10-9,(IGP2),0.63670096,'-,0.1929 unit increase,[0.13-0.26],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs7731390-<b>C</b>,3 x 10-6,(IGP2),0.947724238,'-,0.3771 unit increase,[0.22-0.53],SLC22A5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:132386057
rs7953959-<b>C</b>,8 x 10-6,(IGP2),0.490438445,'-,0.1389 unit increase,[0.078-0.2],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:97134362
rs10937705-<b>G</b>,4 x 10-6,(IGP20),0.779354751,'-,0.1717 unit decrease,[0.099-0.244],"JAKMIP1, C4orf50",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:6181457
rs1386809-<b>C</b>,7 x 10-6,(IGP20),0.284827378,'-,0.1576 unit increase,[0.089-0.226],"NEUROD4, OR9K1P",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:55031132
rs1598106-<b>C</b>,2 x 10-7,(IGP20),0.408824844,'-,0.1642 unit decrease,[0.1-0.23],LINC00276,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:13889623
rs7160685-<b>C</b>,8 x 10-6,(IGP20),0.700909355,'-,0.1565 unit increase,[0.088-0.225],"GOLGA5, LGMN",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:92757645
rs11847263-<b>G</b>,2 x 10-6,(IGP21),0.393609222,'-,0.1501 unit increase,[0.089-0.211],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs17515642-<b>C</b>,2 x 10-6,(IGP21),0.85511842,'-,0.2258 unit decrease,[0.13-0.32],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:9526947
rs2126200-<b>C</b>,7 x 10-6,(IGP21),0.541753456,'-,0.1392 unit decrease,[0.078-0.2],"RPL34P23, BSX",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:123002368
rs11847263-<b>G</b>,1 x 10-22,(IGP59),0.393000049,'-,0.3124 unit decrease,[0.25-0.37],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs12950390-<b>C</b>,3 x 10-6,(IGP59),0.252525315,'-,0.1687 unit decrease,[0.098-0.239],"TBX21, OSBPL7",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:47753582
rs2270788-<b>C</b>,7 x 10-6,(IGP59),0.099155495,'-,0.2364 unit increase,[0.13-0.34],ABCB9,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:122929802
rs2859113-<b>C</b>,6 x 10-8,(IGP59),0.378328302,'-,0.1817 unit decrease,[0.12-0.25],"MTCO3P1, HLA-DQB3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32730008
rs3097645-<b>C</b>,7 x 10-6,(IGP59),0.874383288,'-,0.2057 unit increase,[0.12-0.3],"BRD2, HLA-DOA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32985503
rs6583437-<b>G</b>,1 x 10-9,(IGP59),0.636650594,'-,0.1949 unit decrease,[0.13-0.26],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs7209700-<b>G</b>,4 x 10-7,(IGP59),0.308782806,'-,0.1681 unit decrease,[0.1-0.23],ITGB3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:47273752
rs7951911-<b>G</b>,8 x 10-6,(IGP59),0.083803987,'-,0.2689 unit decrease,[0.15-0.39],"LINC02685, PRDM11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:45062980
rs9329350-<b>G</b>,8 x 10-6,(IGP59),0.94138927,'-,0.3006 unit decrease,[0.17-0.43],TMEM255B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:113804266
rs10236237-<b>T</b>,7 x 10-6,(IGP6),0.267901504,'-,0.1584 unit decrease,[0.089-0.228],ZNF804B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:89065756
rs11847263-<b>G</b>,5 x 10-15,(IGP6),0.394040136,'-,0.2482 unit increase,[0.19-0.31],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs2844479-<b>C</b>,4 x 10-6,(IGP6),0.39363138,'-,0.1506 unit decrease,[0.086-0.215],"NCR3, UQCRHP1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31605179
rs2887004-<b>G</b>,6 x 10-6,(IGP6),0.18082608,'-,0.1862 unit increase,[0.11-0.27],LINC01899,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:71712154
rs6583437-<b>G</b>,1 x 10-8,(IGP6),0.637609347,'-,0.1817 unit increase,[0.12-0.24],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs10236237-<b>T</b>,6 x 10-6,(IGP60),0.26751565,'-,0.16 unit increase,[0.091-0.229],ZNF804B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:89065756
rs11847263-<b>G</b>,3 x 10-14,(IGP60),0.393211372,'-,0.2402 unit decrease,[0.18-0.3],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs2389339-<b>G</b>,3 x 10-6,(IGP60),0.790576647,'-,0.18 unit increase,[0.1-0.26],RNU6-119P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:116928293
rs2844479-<b>C</b>,4 x 10-6,(IGP60),0.393698651,'-,0.151 unit increase,[0.087-0.215],"NCR3, UQCRHP1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31605179
rs6583437-<b>G</b>,5 x 10-9,(IGP60),0.637881568,'-,0.1862 unit decrease,[0.12-0.25],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs10069748-<b>C</b>,5 x 10-6,(IGP61),0.274419213,'-,0.1539 unit decrease,[0.088-0.22],ELL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:95905518
rs11665307-<b>C</b>,3 x 10-7,(IGP61),0.173309217,'-,0.2071 unit decrease,[0.13-0.29],LINC01899,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:71698064
rs11847263-<b>G</b>,3 x 10-17,(IGP61),0.393162372,'-,0.2676 unit decrease,[0.21-0.33],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs11880637-<b>T</b>,6 x 10-6,(IGP61),0.011251,'-,3.9379 unit decrease,[2.24-5.64],CNN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,19:11544195
rs1953652-<b>C</b>,9 x 10-6,(IGP57),0.653295152,'-,0.1426 unit increase,[0.08-0.206],CLCA4-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:86585518
rs6466479-<b>G</b>,2 x 10-6,(IGP57),0.122643248,'-,0.2271 unit increase,[0.13-0.32],FOXP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:114101050
rs7649739-<b>G</b>,6 x 10-6,(IGP57),0.35883683,'-,0.1501 unit decrease,[0.085-0.215],MAGI1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:65413223
rs9886428-<b>G</b>,2 x 10-6,(IGP57),0.455051607,'-,0.1476 unit increase,[0.087-0.208],SGCZ,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:14256307
rs16844846-<b>G</b>,6 x 10-6,(IGP58),0.058331544,'-,0.311 unit decrease,[0.18-0.45],LBR,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:225405225
rs2140930-<b>G</b>,5 x 10-6,(IGP58),0.348471261,'-,0.1678 unit increase,[0.095-0.24],"ARL6IP1P3, RNU6-544P",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:80600627
rs2844479-<b>C</b>,7 x 10-6,(IGP58),0.393054781,'-,0.1476 unit increase,[0.083-0.212],"NCR3, UQCRHP1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31605179
rs3097645-<b>C</b>,3 x 10-6,(IGP58),0.873514574,'-,0.2131 unit increase,[0.12-0.3],"BRD2, HLA-DOA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32985503
rs6583437-<b>G</b>,3 x 10-8,(IGP58),0.63691516,'-,0.1772 unit decrease,[0.11-0.24],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs1122979-<b>G</b>,7 x 10-6,(IGP59),0.874968859,'-,0.2213 unit decrease,[0.12-0.32],"ABCF2-H2BE1, ABCF2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:151217985
rs12664111-<b>G</b>,6 x 10-6,(IGP68),0.091961541,'-,0.2425 unit decrease,[0.14-0.35],FILNC1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:139818678
rs17403780-<b>T</b>,7 x 10-6,(IGP68),0.910564154,'-,0.3113 unit decrease,[0.18-0.45],LINC02770,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:191970658
rs1747683-<b>G</b>,1 x 10-7,(IGP68),0.414510835,'-,0.1694 unit increase,[0.11-0.23],SEPHS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13319976
rs2292298-<b>G</b>,4 x 10-6,(IGP68),0.360936488,'-,0.1504 unit decrease,[0.086-0.215],RELL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:37649533
rs2745851-<b>G</b>,6 x 10-7,(IGP68),0.639234834,'-,0.1618 unit increase,[0.098-0.225],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17848636
rs4862046-<b>G</b>,9 x 10-6,(IGP68),0.907650658,'-,0.2467 unit increase,[0.14-0.36],TENM3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:182379461
rs10751776-<b>C</b>,7 x 10-6,(IGP69),0.541128985,'-,0.1484 unit increase,[0.084-0.213],"MIR4425, RUNX3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:24970252
rs10813951-<b>G</b>,7 x 10-8,(IGP69),0.262989649,'-,0.1926 unit increase,[0.12-0.26],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33128023
rs10817408-<b>C</b>,6 x 10-6,(IGP69),0.149316171,'-,0.2277 unit increase,[0.13-0.33],"SLC46A2, ZNF883",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:112925455
rs11779594-<b>C</b>,9 x 10-6,(IGP69),0.930937854,'-,0.2652 unit increase,[0.15-0.38],PNOC,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:28324238
rs2072209-<b>G</b>,1 x 10-8,(IGP69),0.058275921,'-,0.3742 unit decrease,[0.25-0.5],LAMB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:107951753
rs2186369-<b>G</b>,2 x 10-8,(IGP69),0.189823637,'-,0.2336 unit decrease,[0.15-0.32],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs2933343-<b>G</b>,8 x 10-6,(IGP69),0.759492835,'-,0.1615 unit decrease,[0.091-0.232],CFAP92,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:128939649
rs909674-<b>C</b>,9 x 10-6,(IGP69),0.299323467,'-,0.151 unit increase,[0.084-0.218],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs9468811-<b>C</b>,3 x 10-6,(IGP69),0.937418951,'-,0.3228 unit decrease,[0.19-0.46],"RPL7P4, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30698892
rs12455580-<b>C</b>,7 x 10-6,(IGP61),0.662638724,'-,0.1605 unit increase,[0.091-0.23],"LINC01029, RNA5SP461",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:77926067
rs1470506-<b>C</b>,6 x 10-6,(IGP61),0.594972305,'-,0.1425 unit increase,[0.081-0.204],"LRRTM4, LRRTM4-AS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:76996812
rs1577330-<b>G</b>,4 x 10-6,(IGP61),0.245380582,'-,0.1746 unit increase,[0.1-0.25],"TEK, IFT74",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:27075717
rs16844846-<b>G</b>,4 x 10-6,(IGP61),0.058460111,'-,0.3154 unit decrease,[0.18-0.45],LBR,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:225405225
rs2844479-<b>C</b>,9 x 10-6,(IGP61),0.393516128,'-,0.1445 unit increase,[0.081-0.208],"NCR3, UQCRHP1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31605179
rs4917017-<b>G</b>,1 x 10-8,(IGP70),0.705765807,'-,0.1974 unit increase,[0.13-0.27],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50295636
rs6059594-<b>G</b>,5 x 10-6,(IGP70),0.962797339,'-,0.4906 unit increase,[0.28-0.7],"PIGPP3, RALY-AS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:33968971
rs909674-<b>C</b>,4 x 10-16,(IGP70),0.29901312,'-,0.2754 unit increase,[0.21-0.34],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs11675841-<b>C</b>,6 x 10-6,(IGP71),0.607345677,'-,0.1448 unit decrease,[0.082-0.208],FMNL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:152580056
rs1747683-<b>G</b>,4 x 10-7,(IGP71),0.414548764,'-,0.1618 unit increase,[0.099-0.224],SEPHS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13319976
rs2186369-<b>G</b>,9 x 10-17,(IGP71),0.189496821,'-,0.347 unit decrease,[0.27-0.43],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs2745851-<b>G</b>,9 x 10-6,(IGP71),0.63917289,'-,0.1435 unit increase,[0.08-0.207],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17848636
rs435066-<b>C</b>,7 x 10-6,(IGP71),0.196103508,'-,0.1774 unit decrease,[0.1-0.255],"DEPDC1, RPE65",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:68461830
rs6059594-<b>G</b>,4 x 10-6,(IGP71),0.962797339,'-,0.4964 unit increase,[0.29-0.71],"PIGPP3, RALY-AS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:33968971
rs6421315-<b>C</b>,1 x 10-8,(IGP71),0.368179075,'-,0.1829 unit decrease,[0.12-0.25],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs909674-<b>C</b>,6 x 10-16,(IGP71),0.29901312,'-,0.2737 unit increase,[0.21-0.34],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs1747683-<b>G</b>,4 x 10-7,(IGP72),0.414510835,'-,0.1616 unit decrease,[0.099-0.224],SEPHS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13319976
rs2186369-<b>G</b>,9 x 10-17,(IGP72),0.189358691,'-,0.3471 unit increase,[0.27-0.43],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs435066-<b>C</b>,8 x 10-6,(IGP72),0.195968165,'-,0.1763 unit increase,[0.099-0.254],"DEPDC1, RPE65",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:68461830
rs6059594-<b>G</b>,7 x 10-6,(IGP72),0.962818624,'-,0.4826 unit decrease,[0.27-0.69],"PIGPP3, RALY-AS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:33968971
rs6421315-<b>C</b>,8 x 10-9,(IGP72),0.368120581,'-,0.1863 unit increase,[0.12-0.25],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs10049992-<b>G</b>,8 x 10-6,(IGP73),0.201848923,'-,0.2007 unit decrease,[0.11-0.29],IGFBP7,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:57073697
rs3097645-<b>C</b>,6 x 10-6,(IGP61),0.873550829,'-,0.206 unit increase,[0.12-0.3],"BRD2, HLA-DOA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32985503
rs9490860-<b>C</b>,4 x 10-6,(IGP61),0.231696267,'-,0.17 unit decrease,[0.098-0.242],TRDN,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:123668596
rs11880637-<b>T</b>,6 x 10-6,(IGP62),0.011251,'-,3.8696 unit decrease,[2.2-5.54],CNN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,19:11544195
rs2186369-<b>G</b>,8 x 10-15,(IGP68),0.18958099,'-,0.324 unit decrease,[0.24-0.41],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs909674-<b>C</b>,6 x 10-10,(IGP68),0.298923976,'-,0.2094 unit increase,[0.14-0.28],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs17348299-<b>C</b>,2 x 10-6,(IGP69),0.836804684,'-,0.2129 unit decrease,[0.12-0.3],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs7582701-<b>C</b>,1 x 10-6,(IGP69),0.037337044,'-,0.4547 unit decrease,[0.27-0.64],EPAS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:46323630
rs10511052-<b>G</b>,6 x 10-6,(IGP7),0.950688225,'-,0.3598 unit increase,[0.2-0.52],ROBO2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:76676752
rs2937550-<b>C</b>,9 x 10-6,(IGP72),0.537253261,'-,0.1807 unit decrease,[0.1-0.26],RNA5SP181,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:36473135
rs909674-<b>C</b>,2 x 10-15,(IGP72),0.299146276,'-,0.2695 unit decrease,[0.2-0.34],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs4720952-<b>G</b>,4 x 10-7,(IGP73),0.419614955,'-,0.1566 unit decrease,[0.096-0.217],"PHF14, NPM1P11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:11251773
rs11635553-<b>G</b>,4 x 10-6,(IGP74),0.992804207,'-,1.0812 unit decrease,[0.62-1.54],REC114,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:73457267
rs17348299-<b>C</b>,2 x 10-6,(IGP74),0.836669484,'-,0.2132 unit decrease,[0.13-0.3],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs4699982-<b>T</b>,9 x 10-6,(IGP74),0.158658867,'-,0.1943 unit decrease,[0.11-0.28],C5orf64,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:61729255
rs10813951-<b>G</b>,3 x 10-6,(IGP76),0.262743396,'-,0.1669 unit decrease,[0.097-0.237],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33128023
rs6547115-<b>G</b>,8 x 10-6,(IGP76),0.391438525,'-,0.1432 unit decrease,[0.08-0.206],LRRTM4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:77019205
rs10198756-<b>C</b>,3 x 10-6,(IGP77),0.139068532,'-,0.2053 unit increase,[0.12-0.29],MIR4268,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:219999933
rs9284954-<b>C</b>,5 x 10-6,(IGP77),0.444965493,'-,0.1418 unit decrease,[0.081-0.203],GPM6A,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:175727181
rs12213468-<b>G</b>,7 x 10-6,(IGP8),0.655773469,'-,0.1455 unit decrease,[0.082-0.209],SNORD28B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:156336708
rs672561-<b>C</b>,9 x 10-6,(IGP8),0.25774049,'-,0.1677 unit increase,[0.094-0.242],PTGFR,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:78521617
rs6466479-<b>G</b>,5 x 10-7,(IGP17),0.122643248,'-,0.2414 unit increase,[0.15-0.34],FOXP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:114101050
rs137699-<b>G</b>,8 x 10-6,(IGP18),0.69071036,'-,0.1564 unit decrease,[0.088-0.225],SYNGR1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39352849
rs1550584-<b>C</b>,7 x 10-6,(IGP18),0.469772139,'-,0.1382 unit decrease,[0.078-0.198],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:85216709
rs2862035-<b>C</b>,8 x 10-6,(IGP18),0.024632245,'-,0.4382 unit decrease,[0.25-0.63],LRRC4C,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:41203883
rs444881-<b>C</b>,4 x 10-6,(IGP18),0.58553459,'-,0.1441 unit decrease,[0.083-0.206],CDH13,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:83737891
rs6065945-<b>C</b>,5 x 10-6,(IGP18),0.47016367,'-,0.141 unit increase,[0.081-0.201],CDH22,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:46292992
rs7895244-<b>T</b>,5 x 10-6,(IGP18),0.929057661,'-,0.2836 unit increase,[0.16-0.41],PIK3AP1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:96672946
rs9296009-<b>T</b>,4 x 10-6,(IGP18),0.196796488,'-,0.1779 unit decrease,[0.1-0.25],"FKBPL, PRRT1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32146738
rs17835853-<b>G</b>,4 x 10-6,(IGP30),0.956794058,'-,0.4778 unit increase,[0.27-0.68],RNA5SP182,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:51877490
rs2841233-<b>C</b>,7 x 10-6,(IGP30),0.642908958,'-,0.1475 unit decrease,[0.083-0.212],CEP170B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:104880570
rs7249142-<b>G</b>,9 x 10-6,(IGP30),0.619273395,'-,0.1523 unit increase,[0.085-0.219],"MEF2B, BORCS8-MEF2B",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,19:19165550
rs7734156-<b>C</b>,7 x 10-6,(IGP30),0.049957186,'-,0.3437 unit decrease,[0.19-0.49],COMMD10,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:116398108
rs846271-<b>C</b>,2 x 10-6,(IGP30),0.628956224,'-,0.1538 unit decrease,[0.09-0.218],GLI3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:41997238
rs909674-<b>C</b>,2 x 10-6,(IGP30),0.29910049,'-,0.1606 unit decrease,[0.095-0.227],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs9394438-<b>G</b>,7 x 10-6,(IGP30),0.713317013,'-,0.1671 unit decrease,[0.094-0.24],"MDGA1, MIR4462",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:37564327
rs10131728-<b>C</b>,2 x 10-7,(IGP31),0.872444874,'-,0.2398 unit increase,[0.15-0.33],"TSHR, GTF2A1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:81168979
rs10877839-<b>C</b>,9 x 10-6,(IGP31),0.324798388,'-,0.1459 unit decrease,[0.082-0.21],"MON2, USP15",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:62424701
rs11169838-<b>C</b>,2 x 10-6,(IGP31),0.680521641,'-,0.1764 unit increase,[0.1-0.25],CPNE8,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:38859306
rs11710456-<b>G</b>,6 x 10-17,(IGP31),0.699014551,'-,0.2934 unit decrease,[0.22-0.36],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs17666538-<b>C</b>,7 x 10-6,(IGP31),0.073151367,'-,0.2848 unit decrease,[0.16-0.41],ERICH1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:616207
rs2430457-<b>G</b>,5 x 10-6,(IGP31),0.006978,'-,2.6041 unit increase,[1.48-3.73],PDSS2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:107339442
rs255982-<b>G</b>,8 x 10-6,(IGP31),0.848905209,'-,0.2077 unit increase,[0.12-0.3],"FAM81B, MCTP1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:95318169
rs3780486-<b>C</b>,1 x 10-6,(IGP31),0.737357338,'-,0.1725 unit decrease,[0.1-0.24],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33139455
rs3851357-<b>G</b>,9 x 10-6,(IGP31),0.805635592,'-,0.1814 unit decrease,[0.1-0.26],PLCH1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:155549651
rs6687262-<b>C</b>,2 x 10-6,(IGP31),0.552969396,'-,0.1461 unit decrease,[0.085-0.207],ADGRL4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:79043424
rs7108470-<b>G</b>,3 x 10-6,(IGP31),0.423505771,'-,0.1516 unit decrease,[0.088-0.215],"TRIM6-TRIM34, TRIM6",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:5604373
rs11675841-<b>C</b>,5 x 10-6,(IGP70),0.607345677,'-,0.1458 unit decrease,[0.083-0.208],FMNL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:152580056
rs1747683-<b>G</b>,6 x 10-7,(IGP70),0.414548764,'-,0.1581 unit increase,[0.096-0.22],SEPHS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13319976
rs2186369-<b>G</b>,1 x 10-16,(IGP70),0.189496821,'-,0.3451 unit decrease,[0.26-0.43],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs2745851-<b>G</b>,9 x 10-6,(IGP70),0.63917289,'-,0.1435 unit increase,[0.08-0.207],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17848636
rs3213473-<b>G</b>,7 x 10-6,(IGP70),0.851097327,'-,0.2016 unit decrease,[0.11-0.29],ABCC6,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:16162910
rs435066-<b>C</b>,5 x 10-6,(IGP70),0.196103508,'-,0.1801 unit decrease,[0.1-0.26],"DEPDC1, RPE65",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:68461830
rs9832314-<b>G</b>,9 x 10-6,(IGP66),0.055934899,'-,0.2992 unit decrease,[0.17-0.43],"RYBP, VEPH1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:72468889
rs2186369-<b>G</b>,1 x 10-12,(IGP62),0.189579642,'-,0.2948 unit increase,[0.21-0.38],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs435066-<b>C</b>,4 x 10-6,(IGP62),0.195964786,'-,0.1812 unit increase,[0.1-0.26],"DEPDC1, RPE65",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:68461830
rs6059594-<b>G</b>,3 x 10-6,(IGP62),0.962780757,'-,0.4999 unit decrease,[0.29-0.71],"PIGPP3, RALY-AS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:33968971
rs6421315-<b>C</b>,8 x 10-12,(IGP62),0.368343116,'-,0.2202 unit increase,[0.16-0.28],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs10796849-<b>C</b>,6 x 10-6,(IGP73),0.111934,'-,0.6132 unit decrease,[0.35-0.88],"FGF3, FGF4",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:69787644
rs11188352-<b>G</b>,3 x 10-6,(IGP73),0.042598345,'-,0.4377 unit increase,[0.25-0.62],SORBS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:95541247
rs2110166-<b>C</b>,6 x 10-6,(IGP73),0.983043627,'-,0.562 unit decrease,[0.32-0.81],ANO2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:5642176
rs7301016-<b>G</b>,8 x 10-6,(IGP73),0.206214031,'-,0.1687 unit decrease,[0.095-0.243],MON2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:62492343
rs9403856-<b>C</b>,7 x 10-7,(IGP73),0.861471281,'-,0.341 unit increase,[0.21-0.48],"SAMD5, YAP1P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:147438398
rs10113903-<b>C</b>,7 x 10-6,(IGP74),0.308537514,'-,0.1529 unit increase,[0.086-0.22],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33122647
rs11706018-<b>C</b>,9 x 10-6,(IGP74),0.934284045,'-,0.2773 unit increase,[0.15-0.4],MRPS22,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:139197551
rs12127944-<b>C</b>,6 x 10-6,(IGP74),0.911099744,'-,0.3115 unit increase,[0.18-0.45],CDK18,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:205514467
rs16944158-<b>G</b>,4 x 10-6,(IGP74),0.271065156,'-,0.162 unit decrease,[0.093-0.231],ZNF423,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:49618868
rs2072209-<b>G</b>,2 x 10-6,(IGP74),0.058406316,'-,0.3125 unit decrease,[0.18-0.44],LAMB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:107951753
rs2090104-<b>G</b>,5 x 10-6,(IGP74),0.335522303,'-,0.1533 unit decrease,[0.087-0.219],INTU,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:127545545
rs2186369-<b>G</b>,2 x 10-8,(IGP74),0.190211497,'-,0.2357 unit decrease,[0.15-0.32],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs11199254-<b>C</b>,2 x 10-6,(IGP40),0.994468963,'-,1.5588 unit increase,[0.91-2.21],RPL21P16,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:120283977
rs2186369-<b>G</b>,1 x 10-10,(IGP40),0.189496821,'-,0.2653 unit decrease,[0.18-0.35],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs6928844-<b>C</b>,7 x 10-6,(IGP40),0.828248278,'-,0.2768 unit increase,[0.16-0.4],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:114748553
rs1001579-<b>G</b>,7 x 10-6,(IGP43),0.167464012,'-,0.182 unit increase,[0.1-0.26],FBXL17,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:108396257
rs17348299-<b>C</b>,3 x 10-10,(IGP43),0.836731981,'-,0.2804 unit decrease,[0.19-0.37],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs2965260-<b>C</b>,9 x 10-6,(IGP44),0.898395714,'-,0.2293 unit decrease,[0.13-0.33],"FAM90A27P, VN1R4",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,19:53276773
rs13272236-<b>G</b>,6 x 10-7,(IGP45),0.036715812,'-,0.8377 unit increase,[0.51-1.17],SNTG1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:50472427
rs17403780-<b>T</b>,6 x 10-6,(IGP45),0.910603886,'-,0.3134 unit decrease,[0.18-0.45],LINC02770,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:191970658
rs4730268-<b>C</b>,5 x 10-6,(IGP48),0.783243083,'-,0.1679 unit decrease,[0.096-0.24],SLC26A3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:107802941
rs10115586-<b>C</b>,5 x 10-7,(IGP7),0.702736223,'-,0.1676 unit decrease,[0.1-0.23],TLR4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:117796733
rs11260603-<b>C</b>,4 x 10-7,(IGP7),0.217058243,'-,0.2608 unit increase,[0.16-0.36],LINC01342,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:1143818
rs13272623-<b>G</b>,2 x 10-6,(IGP7),0.154915349,'-,0.2155 unit increase,[0.13-0.3],LACTB2-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:70632513
rs404256-<b>C</b>,7 x 10-9,(IGP7),0.559129675,'-,0.2094 unit decrease,[0.14-0.28],BACH2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:89948064
rs6030171-<b>C</b>,3 x 10-6,(IGP7),0.359936574,'-,0.148 unit decrease,[0.086-0.21],PTPRT,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:42365454
rs10852453-<b>T</b>,1 x 10-6,(IGP20),0.502934348,'-,0.1462 unit decrease,[0.088-0.205],CHD9,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:53039876
rs11781525-<b>G</b>,6 x 10-6,(IGP59),0.974401829,'-,0.6033 unit increase,[0.34-0.87],MTSS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:124709125
rs7700895-<b>T</b>,1 x 10-6,(IGP35),0.783746748,'-,0.1776 unit decrease,[0.11-0.25],ELL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:95937706
rs7215286-<b>C</b>,3 x 10-6,(IGP65),0.961960846,'-,0.4016 unit increase,[0.23-0.57],COX10-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:13805544
rs2745851-<b>G</b>,2 x 10-6,(IGP66),0.63917289,'-,0.1529 unit increase,[0.089-0.216],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17848636
rs11710456-<b>G</b>,2 x 10-6,(IGP36),0.698889241,'-,0.1678 unit decrease,[0.099-0.237],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs17558301-<b>C</b>,7 x 10-6,(IGP36),0.961067,'-,1.5855 unit decrease,[0.9-2.28],GPR158,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:25591530
rs304172-<b>G</b>,8 x 10-6,(IGP36),0.956126387,'-,0.3337 unit decrease,[0.19-0.48],CADPS,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:62796793
rs7111562-<b>C</b>,2 x 10-6,(IGP36),0.139875875,'-,0.2255 unit decrease,[0.13-0.32],MRGPRX9P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:19030325
rs2744203-<b>C</b>,7 x 10-6,(IGP39),0.095996384,'-,0.2327 unit decrease,[0.13-0.33],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:104215903
rs6928844-<b>C</b>,4 x 10-6,(IGP39),0.828187722,'-,0.285 unit increase,[0.16-0.41],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:114748553
rs4076555-<b>C</b>,7 x 10-6,(IGP4),0.336591108,'-,0.1591 unit decrease,[0.09-0.229],SYT9,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:7443141
rs17348299-<b>C</b>,2 x 10-9,(IGP3),0.836659127,'-,0.2658 unit decrease,[0.18-0.35],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs6466479-<b>G</b>,3 x 10-6,(IGP3),0.122476576,'-,0.2229 unit decrease,[0.13-0.32],FOXP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:114101050
rs9886428-<b>G</b>,3 x 10-6,(IGP3),0.455031557,'-,0.1428 unit decrease,[0.083-0.203],SGCZ,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:14256307
rs10822136-<b>C</b>,5 x 10-7,(IGP30),0.805344703,'-,0.2106 unit increase,[0.13-0.29],"RNU6-543P, NRBF2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:63112651
rs11710456-<b>G</b>,3 x 10-6,(IGP30),0.698844,'-,0.164 unit increase,[0.095-0.233],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs11820502-<b>C</b>,2 x 10-6,(IGP30),0.287788676,'-,0.1821 unit decrease,[0.11-0.26],TRIM5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:5666794
rs1319535-<b>C</b>,4 x 10-6,(IGP30),0.345748861,'-,0.1509 unit increase,[0.087-0.215],LINGO2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:28181087
rs17038828-<b>C</b>,8 x 10-6,(IGP30),0.979741981,'-,0.56 unit decrease,[0.31-0.81],"RPSA, MOBP",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:39433851
rs12750249-<b>C</b>,4 x 10-6,(IGP32),0.256632782,'-,0.165 unit decrease,[0.095-0.235],"ARHGAP29-AS1, ARHGAP29",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:94256104
rs16906415-<b>G</b>,6 x 10-6,(IGP32),0.10782258,'-,0.2296 unit decrease,[0.13-0.33],LINC02055,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:136837768
rs1904173-<b>G</b>,7 x 10-6,(IGP32),0.860063717,'-,0.201 unit increase,[0.11-0.29],LINC02211,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:25419980
rs4466877-<b>G</b>,9 x 10-7,(IGP32),0.880799535,'-,0.2413 unit increase,[0.15-0.34],"NXPE1, NXPE2P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:114516380
rs6132333-<b>C</b>,3 x 10-6,(IGP32),0.025083717,'-,0.5085 unit decrease,[0.29-0.72],RALGAPA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:20653462
rs9492645-<b>G</b>,5 x 10-6,(IGP8),0.947434827,'-,0.3363 unit decrease,[0.19-0.48],"CPNE5, Y_RNA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:130565292
rs4650376-<b>C</b>,2 x 10-6,(IGP21),0.126317908,'-,0.2355 unit decrease,[0.14-0.33],IFI44,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:78711183
rs10108033-<b>C</b>,3 x 10-6,(IGP22),0.990183,'-,2.8474 unit increase,[1.65-4.05],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:131318469
rs10758189-<b>C</b>,2 x 10-6,(IGP22),0.31099529,'-,0.1679 unit decrease,[0.099-0.236],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33125806
rs10834691-<b>G</b>,4 x 10-6,(IGP22),0.459134585,'-,0.1479 unit increase,[0.085-0.211],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:25468936
rs11710456-<b>G</b>,9 x 10-7,(IGP22),0.698789226,'-,0.1723 unit increase,[0.1-0.24],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs3793039-<b>G</b>,2 x 10-6,(IGP22),0.253061539,'-,0.2388 unit increase,[0.14-0.34],COL19A1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:70031317
rs6072161-<b>C</b>,3 x 10-7,(IGP22),0.573146759,'-,0.1589 unit decrease,[0.098-0.22],RNA5SP484,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:40842787
rs722599-<b>C</b>,8 x 10-6,(IGP22),0.430150146,'-,0.1395 unit increase,[0.078-0.201],PROX2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:74860740
rs909674-<b>C</b>,5 x 10-10,(IGP22),0.298923567,'-,0.2099 unit decrease,[0.14-0.28],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs10002492-<b>G</b>,8 x 10-6,(IGP23),0.167227182,'-,0.1837 unit decrease,[0.1-0.26],ECM1P2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:12578222
rs11710456-<b>G</b>,6 x 10-11,(IGP23),0.699064072,'-,0.2297 unit increase,[0.16-0.3],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs1174864-<b>G</b>,5 x 10-6,(IGP23),0.491903416,'-,0.1417 unit increase,[0.081-0.203],POM121L12,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:53059866
rs12451840-<b>C</b>,3 x 10-6,(IGP23),0.041794159,'-,0.7321 unit increase,[0.42-1.04],LINC00469,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:73811574
rs13072512-<b>G</b>,6 x 10-6,(IGP23),0.576619429,'-,0.1484 unit increase,[0.084-0.212],FOXP1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:71364894
rs6132333-<b>C</b>,1 x 10-6,(IGP23),0.025150714,'-,0.5267 unit decrease,[0.31-0.74],RALGAPA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:20653462
rs7072055-<b>C</b>,2 x 10-6,(IGP23),0.831620999,'-,0.2045 unit increase,[0.12-0.29],SLIT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:97148976
rs7111562-<b>C</b>,4 x 10-7,(IGP23),0.140150398,'-,0.2417 unit decrease,[0.15-0.34],MRGPRX9P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:19030325
rs9263963-<b>T</b>,1 x 10-6,(IGP23),0.113293343,'-,0.2567 unit increase,[0.15-0.36],HLA-C,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31218249
rs10464366-<b>T</b>,3 x 10-6,(IGP24),0.230053603,'-,0.1748 unit decrease,[0.1-0.25],POU6F2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:39081900
rs7845056-<b>C</b>,9 x 10-6,(IGP48),0.409235015,'-,0.1776 unit increase,[0.099-0.256],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:141939370
rs11910494-<b>G</b>,8 x 10-6,(IGP49),0.288747077,'-,0.1483 unit increase,[0.083-0.213],HUNK,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,21:31923801
rs4789580-<b>G</b>,9 x 10-6,(IGP49),0.20387851,'-,0.2275 unit increase,[0.13-0.33],"SOCS3, LINC01993",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:78315910
rs7532570-<b>G</b>,6 x 10-6,(IGP49),0.06261147,'-,0.2924 unit increase,[0.17-0.42],USH2A,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:216330927
rs2110166-<b>C</b>,5 x 10-6,(IGP52),0.983043523,'-,0.5673 unit decrease,[0.32-0.81],ANO2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:5642176
rs586446-<b>C</b>,5 x 10-6,(IGP52),0.118307048,'-,0.2226 unit decrease,[0.13-0.32],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:4406487
rs11212260-<b>C</b>,9 x 10-6,(IGP53),0.028142852,'-,0.4437 unit increase,[0.25-0.64],"ALKBH8, CWF19L2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:107476551
rs2530545-<b>C</b>,7 x 10-6,(IGP53),0.806018538,'-,0.1859 unit increase,[0.11-0.27],NPSR1-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:34657528
rs10504390-<b>G</b>,2 x 10-7,(IGP54),0.080479506,'-,0.2877 unit decrease,[0.18-0.4],MTFR1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:65711997
rs11212260-<b>C</b>,7 x 10-6,(IGP57),0.028142852,'-,0.4507 unit increase,[0.25-0.65],"ALKBH8, CWF19L2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:107476551
rs4878639-<b>C</b>,1 x 10-6,(IGP57),0.263725273,'-,0.1734 unit decrease,[0.1-0.24],RECK,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:36099402
rs11847263-<b>G</b>,2 x 10-19,(IGP58),0.393368996,'-,0.2852 unit decrease,[0.22-0.35],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs2887004-<b>G</b>,2 x 10-6,(IGP58),0.181545601,'-,0.193 unit decrease,[0.11-0.27],LINC01899,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:71712154
rs11774682-<b>C</b>,1 x 10-6,(IGP59),0.966250893,'-,0.827 unit increase,[0.49-1.16],"KCTD9P6, WRN",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:31176759
rs6583437-<b>G</b>,7 x 10-6,(IGP61),0.636609334,'-,0.143 unit decrease,[0.081-0.205],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs2677247-<b>C</b>,9 x 10-6,(IGP62),0.60224514,'-,0.1417 unit decrease,[0.079-0.204],CADM2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:103731747
rs7159888-<b>G</b>,2 x 10-6,(IGP62),0.550559035,'-,0.1465 unit increase,[0.086-0.207],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65291924
rs12455580-<b>C</b>,2 x 10-6,(IGP65),0.662723559,'-,0.1716 unit increase,[0.1-0.24],"LINC01029, RNA5SP461",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:77926067
rs3097645-<b>C</b>,6 x 10-7,(IGP65),0.872971129,'-,0.2253 unit increase,[0.14-0.31],"BRD2, HLA-DOA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32985503
rs7224668-<b>C</b>,3 x 10-8,(IGP31),0.524575415,'-,0.1729 unit increase,[0.11-0.23],SLC38A10,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:81261988
rs7652995-<b>G</b>,4 x 10-7,(IGP31),0.176763001,'-,0.2226 unit decrease,[0.14-0.31],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs8067912-<b>C</b>,5 x 10-7,(IGP31),0.030723018,'-,0.4565 unit increase,[0.28-0.63],LPO,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:58236543
rs11710456-<b>G</b>,3 x 10-37,(IGP32),0.699319078,'-,0.4479 unit increase,[0.38-0.52],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs11738945-<b>C</b>,1 x 10-6,(IGP32),0.785892907,'-,0.1818 unit increase,[0.11-0.25],ELL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:95926809
rs12207186-<b>T</b>,5 x 10-6,(IGP32),0.067710091,'-,0.2882 unit decrease,[0.16-0.41],PRKN,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:161893889
rs435066-<b>C</b>,7 x 10-6,(IGP63),0.195829322,'-,0.1765 unit increase,[0.1-0.253],"DEPDC1, RPE65",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:68461830
rs4821897-<b>G</b>,3 x 10-12,(IGP63),0.707128728,'-,0.2388 unit increase,[0.17-0.31],"TAB1, MGAT3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39439582
rs6421315-<b>C</b>,2 x 10-13,(IGP63),0.368316756,'-,0.2363 unit increase,[0.17-0.3],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs7021663-<b>C</b>,3 x 10-6,(IGP63),0.209934371,'-,0.1807 unit decrease,[0.1-0.26],VAV2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:133810892
rs11581667-<b>C</b>,4 x 10-6,(IGP64),0.745277717,'-,0.196 unit increase,[0.11-0.28],"LINC01354, U8",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:234590610
rs1747683-<b>G</b>,3 x 10-7,(IGP64),0.414548764,'-,0.1637 unit decrease,[0.1-0.23],SEPHS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13319976
rs2186369-<b>G</b>,2 x 10-14,(IGP64),0.189496821,'-,0.3184 unit increase,[0.24-0.4],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs27323-<b>G</b>,9 x 10-6,(IGP64),0.42166121,'-,0.1399 unit decrease,[0.078-0.202],WDR41,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:53256409
rs5771040-<b>G</b>,2 x 10-6,(IGP64),0.660043691,'-,0.1595 unit decrease,[0.093-0.226],SBF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:50463961
rs6421315-<b>C</b>,2 x 10-7,(IGP64),0.368179075,'-,0.1714 unit increase,[0.11-0.23],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs909674-<b>C</b>,3 x 10-8,(IGP64),0.29901312,'-,0.1872 unit decrease,[0.12-0.25],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs11847263-<b>G</b>,1 x 10-10,(IGP65),0.393717724,'-,0.2023 unit decrease,[0.14-0.26],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs11880637-<b>T</b>,6 x 10-6,(IGP65),0.011251,'-,3.9206 unit decrease,[2.22-5.62],CNN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,19:11544195
rs12465996-<b>C</b>,5 x 10-6,(IGP1),0.864479921,'-,0.2431 unit increase,[0.14-0.35],TMEM182,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:102772135
rs12600635-<b>G</b>,2 x 10-7,(IGP1),0.145264718,'-,0.2272 unit decrease,[0.14-0.31],"FLCN, ACTG1P24",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:17239582
rs12828421-<b>C</b>,9 x 10-7,(IGP1),0.513425077,'-,0.1591 unit decrease,[0.096-0.223],"PEX5, CLSTN3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:7182621
rs1794265-<b>C</b>,8 x 10-6,(IGP1),0.945894808,'-,0.3014 unit decrease,[0.17-0.43],"HLA-DQB3, MTCO3P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32706960
rs459482-<b>C</b>,2 x 10-6,(IGP1),0.594937724,'-,0.1509 unit decrease,[0.089-0.213],MX1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,21:41421864
rs7652995-<b>G</b>,9 x 10-15,(IGP32),0.176843186,'-,0.3392 unit increase,[0.25-0.42],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs7749924-<b>C</b>,8 x 10-6,(IGP32),0.851598583,'-,0.2204 unit increase,[0.12-0.32],LINC00243,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30830214
rs6797769-<b>T</b>,3 x 10-6,(IGP74),0.548041473,'-,0.1661 unit decrease,[0.097-0.235],ZNF385D,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:22129805
rs7582701-<b>C</b>,4 x 10-6,(IGP74),0.037394345,'-,0.4338 unit decrease,[0.25-0.62],EPAS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:46323630
rs9468811-<b>C</b>,3 x 10-6,(IGP74),0.937725588,'-,0.3262 unit decrease,[0.19-0.46],"RPL7P4, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30698892
rs10813951-<b>G</b>,4 x 10-7,(IGP75),0.262766006,'-,0.1812 unit increase,[0.11-0.25],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33128023
rs10817408-<b>C</b>,6 x 10-6,(IGP75),0.149506685,'-,0.2271 unit increase,[0.13-0.33],"SLC46A2, ZNF883",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:112925455
rs11710456-<b>G</b>,4 x 10-31,(IGP24),0.698883767,'-,0.4048 unit increase,[0.34-0.47],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs12342831-<b>C</b>,3 x 10-10,(IGP24),0.262634642,'-,0.2233 unit decrease,[0.15-0.29],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33124874
rs2219937-<b>G</b>,4 x 10-6,(IGP24),0.984667459,'-,0.7496 unit increase,[0.43-1.07],NRG3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:82659654
rs6853847-<b>C</b>,2 x 10-6,(IGP24),0.030451378,'-,0.4788 unit decrease,[0.28-0.67],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:91996064
rs7652995-<b>G</b>,4 x 10-16,(IGP24),0.176834709,'-,0.3532 unit increase,[0.27-0.44],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs10822136-<b>C</b>,7 x 10-7,(IGP25),0.805465853,'-,0.2085 unit increase,[0.13-0.29],"RNU6-543P, NRBF2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:63112651
rs11942476-<b>C</b>,6 x 10-6,(IGP25),0.855854377,'-,0.2144 unit decrease,[0.12-0.31],KCNIP4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:21453634
rs12580240-<b>G</b>,2 x 10-6,(IGP25),0.013985091,'-,0.895 unit decrease,[0.53-1.26],TMEM132D,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:129162027
rs2504183-<b>G</b>,7 x 10-6,(IGP25),0.719338172,'-,0.1943 unit increase,[0.11-0.28],LINC00836,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:25713319
rs6102185-<b>G</b>,2 x 10-6,(IGP25),0.422812171,'-,0.1489 unit increase,[0.088-0.21],RNA5SP484,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:40849893
rs6132333-<b>C</b>,1 x 10-6,(IGP25),0.025094889,'-,0.5296 unit decrease,[0.31-0.75],RALGAPA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:20653462
rs9296009-<b>T</b>,4 x 10-6,(IGP25),0.196764209,'-,0.1773 unit decrease,[0.1-0.25],"FKBPL, PRRT1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32146738
rs11678036-<b>C</b>,6 x 10-6,(IGP26),0.390262876,'-,0.1459 unit increase,[0.082-0.209],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:185160008
rs11710456-<b>G</b>,2 x 10-13,(IGP26),0.698789226,'-,0.2563 unit increase,[0.19-0.32],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs12342831-<b>C</b>,3 x 10-11,(IGP26),0.262517754,'-,0.2358 unit decrease,[0.17-0.31],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33124874
rs17161553-<b>C</b>,1 x 10-6,(IGP26),0.007597863,'-,1.6947 unit increase,[1.01-2.38],ST8SIA4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:100966102
rs909674-<b>C</b>,2 x 10-10,(IGP62),0.299146468,'-,0.2148 unit decrease,[0.15-0.28],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs11079764-<b>G</b>,5 x 10-6,(IGP63),0.513371146,'-,0.1833 unit decrease,[0.1-0.26],"ITGB3, MYL4",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:47232327
rs11128271-<b>C</b>,6 x 10-6,(IGP63),0.936242533,'-,0.3063 unit decrease,[0.17-0.44],RYBP,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:72460120
rs11847263-<b>G</b>,3 x 10-8,(IGP63),0.393668566,'-,0.1747 unit decrease,[0.11-0.24],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs11899928-<b>C</b>,8 x 10-6,(IGP63),0.021518484,'-,0.6871 unit decrease,[0.39-0.99],CNTNAP5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:124499159
rs1475911-<b>C</b>,9 x 10-6,(IGP63),0.154651563,'-,0.2012 unit decrease,[0.11-0.29],UMODL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,21:42093370
rs17120471-<b>C</b>,6 x 10-6,(IGP63),0.101965396,'-,0.2366 unit increase,[0.13-0.34],LINC00681,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:12834362
rs2186369-<b>G</b>,4 x 10-9,(IGP63),0.189663333,'-,0.2445 unit increase,[0.16-0.33],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs300032-<b>G</b>,9 x 10-8,(IGP63),0.146304786,'-,0.2433 unit decrease,[0.15-0.33],"FOXL1, LINC02188",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:86647390
rs11635553-<b>G</b>,6 x 10-6,(IGP75),0.992814619,'-,1.0594 unit decrease,[0.6-1.52],REC114,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:73457267
rs11706018-<b>C</b>,7 x 10-6,(IGP75),0.934430633,'-,0.2799 unit increase,[0.16-0.4],MRPS22,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:139197551
rs12127944-<b>C</b>,4 x 10-6,(IGP75),0.911226779,'-,0.3151 unit increase,[0.18-0.45],CDK18,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:205514467
rs17348299-<b>C</b>,4 x 10-6,(IGP75),0.836657881,'-,0.2064 unit decrease,[0.12-0.29],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs2072209-<b>G</b>,2 x 10-7,(IGP75),0.058275994,'-,0.3382 unit decrease,[0.21-0.47],LAMB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:107951753
rs2080501-<b>G</b>,4 x 10-6,(IGP75),0.532295847,'-,0.1421 unit increase,[0.082-0.203],ZNF423,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:49609655
rs2186369-<b>G</b>,4 x 10-9,(IGP75),0.189826452,'-,0.2454 unit decrease,[0.16-0.33],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs738144-<b>G</b>,7 x 10-6,(IGP75),0.204838377,'-,0.1878 unit increase,[0.11-0.27],"DNAL4, SUN2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:38782370
rs7582701-<b>C</b>,2 x 10-6,(IGP75),0.037318558,'-,0.4488 unit decrease,[0.27-0.63],EPAS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:46323630
rs8010715-<b>C</b>,9 x 10-6,(IGP75),0.262775408,'-,0.1664 unit increase,[0.093-0.24],EMC9,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:24139938
rs9468811-<b>C</b>,2 x 10-6,(IGP75),0.937641318,'-,0.3304 unit decrease,[0.19-0.47],"RPL7P4, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30698892
rs11635553-<b>G</b>,9 x 10-6,(IGP76),0.992824915,'-,1.0357 unit increase,[0.58-1.49],REC114,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:73457267
rs2072209-<b>G</b>,8 x 10-6,(IGP76),0.058172497,'-,0.2906 unit increase,[0.16-0.42],LAMB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:107951753
rs2080501-<b>G</b>,5 x 10-6,(IGP76),0.532905723,'-,0.141 unit decrease,[0.081-0.201],ZNF423,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:49609655
rs2186369-<b>G</b>,2 x 10-8,(IGP76),0.189496821,'-,0.2333 unit increase,[0.15-0.31],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs7137515-<b>G</b>,6 x 10-6,(IGP76),0.260927854,'-,0.1637 unit decrease,[0.093-0.235],LINC02426,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:82068447
rs7582701-<b>C</b>,4 x 10-6,(IGP76),0.037278381,'-,0.4309 unit increase,[0.25-0.61],EPAS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:46323630
rs9468811-<b>C</b>,5 x 10-7,(IGP76),0.937308426,'-,0.3469 unit increase,[0.21-0.48],"RPL7P4, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30698892
rs11847263-<b>G</b>,6 x 10-6,(IGP77),0.394003752,'-,0.1425 unit increase,[0.081-0.204],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs13245023-<b>C</b>,9 x 10-6,(IGP77),0.964100804,'-,0.4218 unit decrease,[0.24-0.61],LINC01162,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:20845476
rs1012583-<b>G</b>,4 x 10-6,(IGP8),0.70257304,'-,0.1552 unit increase,[0.089-0.221],"LINC01214, TSC22D2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:150369221
rs1035275-<b>C</b>,9 x 10-6,(IGP8),0.444727228,'-,0.1416 unit decrease,[0.079-0.204],"PRICKLE2-AS3, PRICKLE2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:64188225
rs13148252-<b>G</b>,6 x 10-6,(IGP8),0.745779246,'-,0.171 unit decrease,[0.097-0.245],"ENPEP, ZBED1P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:110306660
rs139014-<b>C</b>,5 x 10-6,(IGP8),0.16701817,'-,0.1994 unit decrease,[0.11-0.28],SCUBE1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:43228759
rs16863118-<b>C</b>,8 x 10-6,(IGP8),0.836539205,'-,0.1835 unit increase,[0.1-0.26],CLRN1-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:150979421
rs3813009-<b>C</b>,4 x 10-7,(IGP8),0.223729929,'-,0.2122 unit decrease,[0.13-0.29],PLCG2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:81927353
rs6787231-<b>C</b>,5 x 10-6,(IGP8),0.900662046,'-,0.261 unit decrease,[0.15-0.37],SGO1-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:20916318
rs7964407-<b>G</b>,6 x 10-6,(IGP8),0.620613411,'-,0.2061 unit decrease,[0.12-0.3],"PTHLH, CCDC91",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:28040056
rs1650123-<b>C</b>,6 x 10-6,(IGP8),0.577816125,'-,0.1516 unit decrease,[0.086-0.218],STAB2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:103640541
rs9636252-<b>C</b>,3 x 10-6,(IGP8),0.641289432,'-,0.1514 unit increase,[0.087-0.215],"ASAP2, RPL30P3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:9119469
rs4711279-<b>C</b>,4 x 10-6,(IGP1),0.824401249,'-,0.1774 unit decrease,[0.1-0.25],SNHG32,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31834688
rs4930561-<b>G</b>,1 x 10-8,(IGP1),0.510670339,'-,0.1714 unit increase,[0.11-0.23],KMT5B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:68164294
rs6502557-<b>G</b>,6 x 10-6,(IGP1),0.861939099,'-,0.2172 unit increase,[0.12-0.31],MPRIP,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:17057664
rs9948784-<b>G</b>,1 x 10-6,(IGP1),0.9873089,'-,1.8106 unit decrease,[1.08-2.54],ZADH2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:75185206
rs17025548-<b>G</b>,8 x 10-6,(IGP10),0.165189309,'-,0.1954 unit decrease,[0.11-0.28],USH2A,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:215883006
rs17403780-<b>T</b>,1 x 10-6,(IGP10),0.910622743,'-,0.3351 unit decrease,[0.2-0.47],LINC02770,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:191970658
rs2077147-<b>C</b>,3 x 10-6,(IGP10),0.336549315,'-,0.1568 unit decrease,[0.091-0.223],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17844499
rs2186369-<b>G</b>,9 x 10-10,(IGP10),0.189377545,'-,0.2557 unit decrease,[0.17-0.34],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs4745661-<b>G</b>,3 x 10-6,(IGP10),0.684846625,'-,0.1618 unit decrease,[0.094-0.23],"GNAQ, GNA14",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:77705449
rs7902627-<b>C</b>,8 x 10-6,(IGP10),0.135378764,'-,0.1989 unit decrease,[0.11-0.29],IATPR,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:33116159
rs10861337-<b>G</b>,2 x 10-7,(IGP11),0.900366845,'-,0.2653 unit decrease,[0.16-0.37],"C12orf45, ALDH1L2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:105058664
rs11651000-<b>G</b>,8 x 10-6,(IGP11),0.840287136,'-,0.1911 unit decrease,[0.11-0.27],"OSBPL7, TBX21",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:47757912
rs16844841-<b>C</b>,4 x 10-6,(IGP11),0.058314657,'-,0.3163 unit increase,[0.18-0.45],LBR,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:225402973
rs4143912-<b>G</b>,7 x 10-6,(IGP45),0.417046733,'-,0.1425 unit increase,[0.08-0.205],MDGA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:47584956
rs6084946-<b>C</b>,5 x 10-6,(IGP45),0.233844371,'-,0.2176 unit increase,[0.12-0.31],"TCF15, CSNK2A1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:569274
rs6479779-<b>C</b>,1 x 10-6,(IGP45),0.345248463,'-,0.1943 unit increase,[0.12-0.27],ARID5B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:61935289
rs7781977-<b>C</b>,5 x 10-7,(IGP45),0.695324748,'-,0.1658 unit increase,[0.1-0.23],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50306538
rs8140172-<b>C</b>,6 x 10-6,(IGP45),0.985708289,'-,0.8795 unit decrease,[0.5-1.26],EFCAB6,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:43808439
rs909674-<b>C</b>,3 x 10-13,(IGP45),0.29901312,'-,0.2468 unit increase,[0.18-0.31],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs10236237-<b>T</b>,5 x 10-6,(IGP46),0.267777819,'-,0.1613 unit decrease,[0.092-0.23],ZNF804B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:89065756
rs11651000-<b>G</b>,9 x 10-6,(IGP46),0.83992863,'-,0.1897 unit decrease,[0.11-0.27],"OSBPL7, TBX21",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:47757912
rs11847263-<b>G</b>,2 x 10-13,(IGP46),0.393307344,'-,0.2328 unit increase,[0.17-0.29],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs2389339-<b>G</b>,2 x 10-6,(IGP46),0.790110046,'-,0.1846 unit decrease,[0.11-0.26],RNU6-119P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:116928293
rs6583437-<b>G</b>,4 x 10-8,(IGP46),0.637533008,'-,0.1744 unit increase,[0.11-0.24],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs11710456-<b>G</b>,5 x 10-6,(IGP47),0.698919993,'-,0.1609 unit increase,[0.092-0.23],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs11711311-<b>G</b>,4 x 10-7,(IGP47),0.396079672,'-,0.1632 unit decrease,[0.1-0.227],"NAA50, USF3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:113711752
rs11890081-<b>C</b>,8 x 10-6,(IGP47),0.017212944,'-,0.6811 unit increase,[0.38-0.98],DNER,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:229485273
rs13272623-<b>G</b>,2 x 10-6,(IGP47),0.154915349,'-,0.218 unit increase,[0.13-0.31],LACTB2-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:70632513
rs1673866-<b>C</b>,7 x 10-6,(IGP47),0.638781963,'-,0.1439 unit increase,[0.081-0.206],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:103794592
rs1952138-<b>C</b>,3 x 10-6,(IGP47),0.766987149,'-,0.1724 unit decrease,[0.1-0.24],PRKG1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:51502873
rs4972806-<b>C</b>,8 x 10-6,(IGP47),0.63516143,'-,0.1425 unit increase,[0.08-0.205],HOXD3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:176147850
rs1650123-<b>C</b>,1 x 10-6,(IGP48),0.577816125,'-,0.1628 unit decrease,[0.097-0.229],STAB2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:103640541
rs16863118-<b>C</b>,7 x 10-7,(IGP48),0.836539205,'-,0.2044 unit increase,[0.12-0.29],CLRN1-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:150979421
rs2163237-<b>C</b>,5 x 10-6,(IGP48),0.671727696,'-,0.1519 unit decrease,[0.087-0.217],PNPT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:55746597
rs308097-<b>G</b>,2 x 10-6,(IGP48),0.966564075,'-,0.4299 unit decrease,[0.25-0.61],ZNF815P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:5840746
rs3813009-<b>C</b>,4 x 10-6,(IGP48),0.223729929,'-,0.1929 unit decrease,[0.11-0.27],PLCG2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:81927353
rs6787231-<b>C</b>,5 x 10-6,(IGP48),0.900662046,'-,0.2602 unit decrease,[0.15-0.37],SGO1-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:20916318
rs7194356-<b>C</b>,7 x 10-6,(IGP48),0.895432402,'-,0.2261 unit decrease,[0.13-0.32],RPL7P47,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:17968279
rs9492645-<b>G</b>,7 x 10-6,(IGP48),0.947434827,'-,0.3293 unit decrease,[0.19-0.47],"CPNE5, Y_RNA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:130565292
rs1095368-<b>C</b>,7 x 10-7,(IGP49),0.437467494,'-,0.1528 unit increase,[0.092-0.213],"RBISP1, SEPHS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13313131
rs11568995-<b>G</b>,4 x 10-7,(IGP49),0.9884981,'-,1.802 unit decrease,[1.11-2.5],EGF,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:109976429
rs11958404-<b>T</b>,8 x 10-6,(IGP49),0.113988282,'-,0.231 unit increase,[0.13-0.33],"RNU2-48P, MARK2P11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:157983270
rs1339738-<b>C</b>,7 x 10-6,(IGP49),0.08575498,'-,0.2911 unit increase,[0.16-0.42],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:239233804
rs2186369-<b>G</b>,7 x 10-16,(IGP49),0.18966089,'-,0.3363 unit decrease,[0.25-0.42],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs4832928-<b>C</b>,2 x 10-6,(IGP49),0.701397954,'-,0.1627 unit increase,[0.096-0.229],RELL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:37643767
rs4862046-<b>G</b>,6 x 10-7,(IGP49),0.907610376,'-,0.2767 unit increase,[0.17-0.39],TENM3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:182379461
rs5764106-<b>C</b>,2 x 10-6,(IGP49),0.229970761,'-,0.1956 unit decrease,[0.12-0.28],PARVB,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:44165407
rs909674-<b>C</b>,3 x 10-9,(IGP49),0.299056983,'-,0.2003 unit increase,[0.13-0.27],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs11700462-<b>G</b>,5 x 10-6,(IGP33),0.896982454,'-,0.2827 unit decrease,[0.16-0.4],DYRK1A,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,21:37445510
rs12580533-<b>C</b>,8 x 10-6,(IGP33),0.014010396,'-,0.8247 unit increase,[0.46-1.19],TMEM132D,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:129162056
rs1739654-<b>G</b>,5 x 10-6,(IGP33),0.958833931,'-,0.4461 unit increase,[0.26-0.64],LBP,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:38349567
rs1823874-<b>C</b>,3 x 10-6,(IGP33),0.428499306,'-,0.1478 unit increase,[0.086-0.209],DNM1P46,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:99817230
rs2028414-<b>C</b>,8 x 10-6,(IGP33),0.635674106,'-,0.1399 unit increase,[0.079-0.201],CEP170B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:104883051
rs1054052-<b>T</b>,6 x 10-6,(IGP33),0.284224934,'-,0.1566 unit increase,[0.089-0.224],ARMC3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:23014324
rs10995439-<b>G</b>,1 x 10-7,(IGP33),0.500403761,'-,0.1635 unit increase,[0.1-0.22],RNU6-543P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:63107152
rs6132333-<b>C</b>,7 x 10-7,(IGP33),0.025106104,'-,0.5397 unit increase,[0.33-0.75],RALGAPA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:20653462
rs10995439-<b>G</b>,3 x 10-6,(IGP34),0.500403761,'-,0.1441 unit increase,[0.084-0.205],RNU6-543P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:63107152
rs1319535-<b>C</b>,9 x 10-6,(IGP34),0.34530051,'-,0.1458 unit decrease,[0.081-0.21],LINGO2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:28181087
rs17594709-<b>G</b>,5 x 10-6,(IGP34),0.283855288,'-,0.1572 unit decrease,[0.09-0.225],TMEM106B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:12179909
rs17835853-<b>G</b>,6 x 10-6,(IGP34),0.956751274,'-,0.4694 unit decrease,[0.27-0.67],RNA5SP182,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:51877490
rs6102185-<b>G</b>,5 x 10-6,(IGP34),0.422547655,'-,0.1429 unit decrease,[0.082-0.204],RNA5SP484,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:40849893
rs6132333-<b>C</b>,8 x 10-6,(IGP34),0.025106104,'-,0.4924 unit increase,[0.28-0.71],RALGAPA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:20653462
rs6983039-<b>G</b>,9 x 10-6,(IGP34),0.971469,'-,0.4445 unit decrease,[0.25-0.64],TRPS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:115318626
rs909674-<b>C</b>,2 x 10-10,(IGP34),0.298878223,'-,0.2136 unit increase,[0.15-0.28],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs11169838-<b>C</b>,8 x 10-6,(IGP35),0.680712065,'-,0.1671 unit increase,[0.094-0.24],CPNE8,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:38859306
rs11710456-<b>G</b>,5 x 10-44,(IGP35),0.699243829,'-,0.4893 unit decrease,[0.42-0.56],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs16906415-<b>G</b>,3 x 10-6,(IGP35),0.107695718,'-,0.235 unit increase,[0.14-0.33],LINC02055,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:136837768
rs2279913-<b>C</b>,4 x 10-7,(IGP35),0.439263302,'-,0.1579 unit increase,[0.097-0.219],CEP131,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:81194468
rs7314811-<b>C</b>,4 x 10-6,(IGP35),0.350102786,'-,0.1452 unit decrease,[0.083-0.207],ETV6,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:11809639
rs7652995-<b>G</b>,7 x 10-17,(IGP35),0.176986749,'-,0.3659 unit decrease,[0.28-0.45],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs10203166-<b>C</b>,4 x 10-6,(IGP5),0.974135913,'-,0.7988 unit increase,[0.46-1.14],RNU6-508P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:59562570
rs1023721-<b>T</b>,1 x 10-6,(IGP5),0.941465292,'-,0.3141 unit increase,[0.19-0.44],KCNIP4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:21204867
rs1122979-<b>G</b>,2 x 10-9,(IGP5),0.875342207,'-,0.2945 unit increase,[0.2-0.39],"ABCF2-H2BE1, ABCF2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:151217985
rs13272236-<b>G</b>,2 x 10-6,(IGP5),0.036515495,'-,0.7872 unit increase,[0.46-1.11],SNTG1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:50472427
rs1547201-<b>C</b>,4 x 10-6,(IGP5),0.530244326,'-,0.1449 unit decrease,[0.083-0.206],ERCC6L2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:96054202
rs16884711-<b>C</b>,2 x 10-6,(IGP5),0.189044272,'-,0.1931 unit increase,[0.11-0.27],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56028975
rs4143912-<b>G</b>,6 x 10-6,(IGP5),0.41678713,'-,0.1434 unit increase,[0.081-0.206],MDGA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:47584956
rs6421315-<b>C</b>,7 x 10-6,(IGP5),0.368136455,'-,0.1445 unit decrease,[0.081-0.208],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs6479779-<b>C</b>,2 x 10-6,(IGP5),0.345369661,'-,0.1909 unit increase,[0.11-0.27],ARID5B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:61935289
rs909674-<b>C</b>,1 x 10-10,(IGP5),0.298923567,'-,0.2178 unit increase,[0.15-0.28],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs1039443-<b>C</b>,8 x 10-6,(IGP50),0.105031482,'-,0.2223 unit decrease,[0.12-0.32],"RNA5SP178, MARCHF11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:16037993
rs2186369-<b>G</b>,5 x 10-10,(IGP50),0.18964067,'-,0.2588 unit decrease,[0.18-0.34],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs2302105-<b>C</b>,4 x 10-6,(IGP50),0.768104533,'-,0.1688 unit decrease,[0.097-0.24],GFRA1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:116065377
rs10861342-<b>C</b>,2 x 10-6,(IGP51),0.09906875,'-,0.2456 unit increase,[0.14-0.35],"ALDH1L2, C12orf45",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:105065019
rs11651000-<b>G</b>,8 x 10-6,(IGP51),0.840144331,'-,0.1906 unit decrease,[0.11-0.27],"OSBPL7, TBX21",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:47757912
rs11847263-<b>G</b>,2 x 10-13,(IGP51),0.392332365,'-,0.2323 unit increase,[0.17-0.29],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs2577704-<b>G</b>,5 x 10-6,(IGP51),0.90097999,'-,0.2366 unit decrease,[0.14-0.34],KLHL29,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:23369274
rs6969802-<b>G</b>,3 x 10-6,(IGP51),0.078843763,'-,0.2669 unit decrease,[0.16-0.38],"GPR85, HRAT17",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:113009359
rs7179432-<b>C</b>,4 x 10-6,(IGP51),0.455903208,'-,0.1569 unit decrease,[0.09-0.224],CHD2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:93021742
rs9563960-<b>G</b>,4 x 10-6,(IGP51),0.296508163,'-,0.1591 unit increase,[0.092-0.226],"SQSTM1P1, LINC00459",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:62356167
rs10796849-<b>C</b>,6 x 10-6,(IGP52),0.111934,'-,0.6111 unit decrease,[0.35-0.88],"FGF3, FGF4",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:69787644
rs11188352-<b>G</b>,5 x 10-6,(IGP52),0.042598385,'-,0.4264 unit increase,[0.24-0.61],SORBS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:95541247
rs2184180-<b>G</b>,5 x 10-6,(IGP52),0.362504259,'-,0.1637 unit increase,[0.093-0.234],LINC00331,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:78806681
rs38989-<b>G</b>,7 x 10-6,(IGP52),0.405296778,'-,0.1524 unit decrease,[0.086-0.219],DPP6,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:153881331
rs4720952-<b>G</b>,7 x 10-7,(IGP52),0.419614749,'-,0.1534 unit decrease,[0.093-0.214],"PHF14, NPM1P11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:11251773
rs8067912-<b>C</b>,1 x 10-6,(IGP35),0.030542306,'-,0.4386 unit increase,[0.26-0.62],LPO,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:58236543
rs9326244-<b>C</b>,5 x 10-7,(IGP35),0.878929753,'-,0.237 unit decrease,[0.14-0.33],"NXPE1, NXPE2P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:114519384
rs1054052-<b>T</b>,6 x 10-7,(IGP36),0.285274903,'-,0.1727 unit decrease,[0.1-0.24],ARMC3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:23014324
rs2189812-<b>C</b>,6 x 10-6,(IGP11),0.258550538,'-,0.1624 unit increase,[0.092-0.233],GRM3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:86719683
rs2577704-<b>G</b>,3 x 10-6,(IGP11),0.900847768,'-,0.2408 unit decrease,[0.14-0.34],KLHL29,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:23369274
rs11825685-<b>C</b>,9 x 10-6,(IGP36),0.889723713,'-,0.227 unit decrease,[0.13-0.33],"LINC02706, SLC22A24",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:134703916
rs12342831-<b>C</b>,1 x 10-10,(IGP36),0.262554413,'-,0.2299 unit increase,[0.16-0.3],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33124874
rs12772243-<b>G</b>,5 x 10-6,(IGP36),0.087122418,'-,0.2472 unit increase,[0.14-0.35],SORBS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:95535832
rs13178541-<b>C</b>,5 x 10-6,(IGP36),0.811571763,'-,0.1833 unit increase,[0.1-0.26],SLC25A48,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:135828929
rs2060070-<b>G</b>,9 x 10-7,(IGP36),0.762304219,'-,0.1789 unit decrease,[0.11-0.25],ANKFN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:56046612
rs2514895-<b>C</b>,2 x 10-6,(IGP36),0.812138922,'-,0.1858 unit decrease,[0.11-0.26],LINC02712,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:127240288
rs4710520-<b>C</b>,6 x 10-6,(IGP36),0.00803558,'-,2.107 unit increase,[1.2-3.02],EYS,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:65468587
rs5757676-<b>C</b>,1 x 10-7,(IGP36),0.77568242,'-,0.1968 unit decrease,[0.12-0.27],"TAB1, MGAT3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39445695
rs6547537-<b>G</b>,4 x 10-6,(IGP36),0.784824533,'-,0.1881 unit increase,[0.11-0.27],FUNDC2P2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:84217762
rs1054052-<b>T</b>,3 x 10-6,(IGP37),0.285370676,'-,0.1625 unit decrease,[0.094-0.231],ARMC3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:23014324
rs10508459-<b>T</b>,2 x 10-6,(IGP9),0.47438586,'-,0.1446 unit decrease,[0.085-0.204],SEPHS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13321046
rs11568995-<b>G</b>,5 x 10-6,(IGP9),0.9884981,'-,1.6228 unit decrease,[0.93-2.32],EGF,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:109976429
rs11958404-<b>T</b>,1 x 10-6,(IGP9),0.113988282,'-,0.2522 unit increase,[0.15-0.35],"RNU2-48P, MARK2P11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:157983270
rs13144232-<b>G</b>,6 x 10-7,(IGP9),0.638051146,'-,0.1638 unit increase,[0.1-0.228],RELL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:37645612
rs2186369-<b>G</b>,3 x 10-13,(IGP9),0.18966089,'-,0.304 unit decrease,[0.22-0.39],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs2280655-<b>C</b>,4 x 10-6,(IGP9),0.977065699,'-,0.6294 unit increase,[0.36-0.9],AGR2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:16797830
rs2745851-<b>G</b>,9 x 10-7,(IGP9),0.639296878,'-,0.1593 unit increase,[0.096-0.223],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17848636
rs2919856-<b>T</b>,2 x 10-6,(IGP9),0.54500228,'-,0.1475 unit increase,[0.087-0.208],SMYD1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:88089019
rs5764106-<b>C</b>,5 x 10-6,(IGP9),0.229970761,'-,0.1865 unit decrease,[0.11-0.27],PARVB,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:44165407
rs627386-<b>G</b>,4 x 10-6,(IGP9),0.974019461,'-,0.5473 unit increase,[0.32-0.78],ABI3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:49213433
rs7325564-<b>C</b>,5 x 10-6,(IGP9),0.748729805,'-,0.2463 unit increase,[0.14-0.35],C13orf42,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:51150528
rs909674-<b>C</b>,3 x 10-9,(IGP9),0.299056983,'-,0.2011 unit increase,[0.13-0.27],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs4760854-<b>G</b>,9 x 10-6,(IGP11),0.270106625,'-,0.1574 unit decrease,[0.088-0.227],PTPRR,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:70895776
rs4875857-<b>C</b>,5 x 10-6,(IGP11),0.177865536,'-,0.1846 unit increase,[0.11-0.26],CSMD1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:2962287
rs6969802-<b>G</b>,5 x 10-6,(IGP11),0.079220534,'-,0.2608 unit decrease,[0.15-0.37],"GPR85, HRAT17",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:113009359
rs9563960-<b>G</b>,7 x 10-6,(IGP11),0.296353502,'-,0.1546 unit increase,[0.087-0.222],"SQSTM1P1, LINC00459",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:62356167
rs11188352-<b>G</b>,6 x 10-6,(IGP12),0.042712514,'-,0.4192 unit increase,[0.24-0.6],SORBS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:95541247
rs11710456-<b>G</b>,5 x 10-6,(IGP12),0.69962619,'-,0.1589 unit decrease,[0.09-0.227],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs17776120-<b>C</b>,2 x 10-6,(IGP12),0.637453049,'-,0.1649 unit decrease,[0.097-0.233],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187014891
rs2692194-<b>G</b>,9 x 10-6,(IGP12),0.626112834,'-,0.1502 unit decrease,[0.084-0.217],RNU6-667P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:79721080
rs4720952-<b>G</b>,3 x 10-7,(IGP12),0.419193109,'-,0.1583 unit decrease,[0.098-0.219],"PHF14, NPM1P11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:11251773
rs586446-<b>C</b>,2 x 10-6,(IGP12),0.118161679,'-,0.2296 unit decrease,[0.13-0.33],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:4406487
rs9403856-<b>C</b>,4 x 10-7,(IGP12),0.86167474,'-,0.3492 unit increase,[0.21-0.48],"SAMD5, YAP1P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:147438398
rs9574309-<b>C</b>,2 x 10-6,(IGP12),0.432876342,'-,0.1596 unit increase,[0.093-0.226],LINC00331,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:78807966
rs10813957-<b>G</b>,5 x 10-8,(IGP13),0.738414639,'-,0.196 unit increase,[0.13-0.27],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33153529
rs17348299-<b>C</b>,1 x 10-10,(IGP13),0.836731981,'-,0.2875 unit increase,[0.2-0.38],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs1953652-<b>C</b>,5 x 10-6,(IGP13),0.653295152,'-,0.147 unit increase,[0.084-0.21],CLCA4-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:86585518
rs3821819-<b>G</b>,3 x 10-6,(IGP13),0.632029344,'-,0.1633 unit decrease,[0.095-0.231],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187014937
rs4878639-<b>C</b>,6 x 10-6,(IGP13),0.263725273,'-,0.1615 unit decrease,[0.092-0.231],RECK,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:36099402
rs10504390-<b>G</b>,1 x 10-7,(IGP14),0.080479506,'-,0.2953 unit decrease,[0.19-0.4],MTFR1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:65711997
rs11710456-<b>G</b>,9 x 10-7,(IGP14),0.698919993,'-,0.1715 unit decrease,[0.1-0.24],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs11899928-<b>C</b>,9 x 10-6,(IGP14),0.021523168,'-,0.685 unit increase,[0.38-0.99],CNTNAP5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:124499159
rs11994937-<b>C</b>,5 x 10-6,(IGP14),0.978061912,'-,0.5011 unit decrease,[0.29-0.72],NSMAF,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:58596021
rs2186369-<b>G</b>,3 x 10-8,(IGP14),0.189496821,'-,0.2294 unit decrease,[0.15-0.31],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs278541-<b>C</b>,4 x 10-8,(IGP14),0.979063006,'-,0.8017 unit decrease,[0.52-1.09],"C8orf87, LINC00535",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:93210716
rs7661864-<b>G</b>,5 x 10-6,(IGP52),0.699190686,'-,0.3307 unit increase,[0.19-0.47],"KIAA0232, BLOC1S4",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:6734638
rs9403856-<b>C</b>,2 x 10-6,(IGP52),0.861277425,'-,0.3292 unit increase,[0.19-0.46],"SAMD5, YAP1P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:147438398
rs10813957-<b>G</b>,2 x 10-9,(IGP53),0.738414639,'-,0.2163 unit increase,[0.15-0.29],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33153529
rs17348299-<b>C</b>,7 x 10-11,(IGP53),0.836731981,'-,0.2916 unit increase,[0.2-0.38],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs1953652-<b>C</b>,4 x 10-6,(IGP53),0.653295152,'-,0.1488 unit increase,[0.086-0.212],CLCA4-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:86585518
rs4878639-<b>C</b>,6 x 10-7,(IGP53),0.263725273,'-,0.1779 unit decrease,[0.11-0.25],RECK,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:36099402
rs6466479-<b>G</b>,4 x 10-6,(IGP53),0.122643248,'-,0.2224 unit increase,[0.13-0.32],FOXP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:114101050
rs918304-<b>C</b>,8 x 10-6,(IGP53),0.009638201,'-,1.5994 unit decrease,[0.9-2.3],LINC01498,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:108483764
rs9886428-<b>G</b>,5 x 10-6,(IGP53),0.455051607,'-,0.1403 unit increase,[0.08-0.201],SGCZ,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:14256307
rs11763760-<b>C</b>,2 x 10-6,(IGP54),0.797056939,'-,0.1815 unit decrease,[0.11-0.26],IGF2BP3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:23440848
rs11710456-<b>G</b>,8 x 10-17,(IGP37),0.698797578,'-,0.2929 unit decrease,[0.22-0.36],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs2060070-<b>G</b>,2 x 10-6,(IGP37),0.761979804,'-,0.1745 unit decrease,[0.1-0.25],ANKFN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:56046612
rs3780486-<b>C</b>,9 x 10-11,(IGP37),0.737437251,'-,0.2309 unit decrease,[0.16-0.3],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33139455
rs4710520-<b>C</b>,3 x 10-6,(IGP37),0.00804562,'-,2.1675 unit increase,[1.26-3.08],EYS,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:65468587
rs6687262-<b>C</b>,4 x 10-7,(IGP37),0.553310386,'-,0.1576 unit decrease,[0.097-0.219],ADGRL4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:79043424
rs7652995-<b>G</b>,5 x 10-8,(IGP37),0.176702207,'-,0.2394 unit decrease,[0.15-0.33],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs1054052-<b>T</b>,2 x 10-6,(IGP38),0.285116272,'-,0.1661 unit decrease,[0.098-0.234],ARMC3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:23014324
rs11710456-<b>G</b>,5 x 10-17,(IGP38),0.698840199,'-,0.2948 unit decrease,[0.23-0.36],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs11745890-<b>C</b>,4 x 10-6,(IGP38),0.030167879,'-,0.5502 unit increase,[0.32-0.78],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:99380064
rs2060070-<b>G</b>,2 x 10-6,(IGP38),0.761965888,'-,0.1748 unit decrease,[0.1-0.25],ANKFN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:56046612
rs3780486-<b>C</b>,5 x 10-11,(IGP38),0.737450811,'-,0.2341 unit decrease,[0.16-0.3],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33139455
rs4710520-<b>C</b>,5 x 10-6,(IGP38),0.00803558,'-,2.1251 unit increase,[1.21-3.04],EYS,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:65468587
rs6687262-<b>C</b>,5 x 10-7,(IGP38),0.553040158,'-,0.1567 unit decrease,[0.096-0.218],ADGRL4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:79043424
rs7652995-<b>G</b>,5 x 10-8,(IGP38),0.176770524,'-,0.2399 unit decrease,[0.15-0.33],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs10813951-<b>G</b>,1 x 10-9,(IGP39),0.262554376,'-,0.2169 unit increase,[0.15-0.29],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33128023
rs11199254-<b>C</b>,3 x 10-6,(IGP39),0.994452838,'-,1.5568 unit increase,[0.9-2.21],RPL21P16,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:120283977
rs11765886-<b>C</b>,4 x 10-6,(IGP39),0.665165837,'-,0.1625 unit increase,[0.094-0.231],AUTS2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:69773172
rs137686-<b>C</b>,1 x 10-11,(IGP39),0.241738566,'-,0.2524 unit increase,[0.18-0.33],"RPL3, SYNGR1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39343633
rs2186369-<b>G</b>,1 x 10-10,(IGP39),0.189518248,'-,0.267 unit decrease,[0.19-0.35],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs1470506-<b>C</b>,4 x 10-7,(IGP65),0.595063458,'-,0.16 unit increase,[0.098-0.222],"LRRTM4, LRRTM4-AS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:76996812
rs16839553-<b>G</b>,8 x 10-6,(IGP65),0.992978201,'-,1.1375 unit increase,[0.64-1.64],TBC1D14,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:7016458
rs2610739-<b>G</b>,4 x 10-6,(IGP65),0.187486864,'-,0.1852 unit decrease,[0.11-0.26],RNGTT,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:88543930
rs3094093-<b>T</b>,8 x 10-6,(IGP65),0.107712366,'-,0.2214 unit decrease,[0.12-0.32],"MDC1-AS1, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30711851
rs3777193-<b>G</b>,4 x 10-6,(IGP65),0.71211365,'-,0.1592 unit increase,[0.092-0.227],ELL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:95911056
rs4954683-<b>C</b>,9 x 10-6,(IGP65),0.172162724,'-,0.1823 unit increase,[0.1-0.26],LRP1B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:140984021
rs6421315-<b>C</b>,5 x 10-7,(IGP65),0.36812112,'-,0.1615 unit increase,[0.099-0.224],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs11675841-<b>C</b>,6 x 10-6,(IGP66),0.607345677,'-,0.1448 unit decrease,[0.082-0.208],FMNL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:152580056
rs1747683-<b>G</b>,2 x 10-7,(IGP66),0.414548764,'-,0.1661 unit increase,[0.1-0.23],SEPHS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13319976
rs2186369-<b>G</b>,9 x 10-17,(IGP66),0.189496821,'-,0.3473 unit decrease,[0.27-0.43],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs4917017-<b>G</b>,2 x 10-7,(IGP66),0.705765807,'-,0.1816 unit increase,[0.11-0.25],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50295636
rs6059594-<b>G</b>,9 x 10-6,(IGP66),0.962797339,'-,0.4792 unit increase,[0.27-0.69],"PIGPP3, RALY-AS1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:33968971
rs909674-<b>C</b>,1 x 10-16,(IGP66),0.29901312,'-,0.281 unit increase,[0.21-0.35],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs12600635-<b>G</b>,4 x 10-7,(IGP41),0.145679882,'-,0.2221 unit decrease,[0.14-0.31],"FLCN, ACTG1P24",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:17239582
rs1794265-<b>C</b>,3 x 10-7,(IGP41),0.945425812,'-,0.3448 unit decrease,[0.21-0.48],"HLA-DQB3, MTCO3P1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32706960
rs2764743-<b>T</b>,8 x 10-7,(IGP41),0.936472894,'-,0.346 unit decrease,[0.21-0.48],GPR139,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:20019883
rs459482-<b>C</b>,3 x 10-7,(IGP41),0.594327337,'-,0.1627 unit decrease,[0.1-0.22],MX1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,21:41421864
rs4711279-<b>C</b>,1 x 10-6,(IGP41),0.824607759,'-,0.1858 unit decrease,[0.11-0.26],SNHG32,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31834688
rs4930561-<b>G</b>,9 x 10-10,(IGP41),0.511382618,'-,0.185 unit increase,[0.13-0.24],KMT5B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:68164294
rs7973719-<b>C</b>,4 x 10-8,(IGP41),0.487491612,'-,0.1772 unit increase,[0.11-0.24],"CLSTN3, PEX5",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:7182217
rs9947954-<b>C</b>,8 x 10-6,(IGP41),0.425160203,'-,0.1398 unit decrease,[0.078-0.201],CTIF,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:48714340
rs2659005-<b>C</b>,2 x 10-6,(IGP17),0.517316186,'-,0.1537 unit decrease,[0.09-0.217],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,Mapping not available
rs11255400-<b>G</b>,7 x 10-6,(IGP2),0.931314253,'-,0.2863 unit increase,[0.16-0.41],TAF3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:7845658
rs1436958-<b>G</b>,9 x 10-6,(IGP2),0.573531977,'-,0.1389 unit increase,[0.078-0.2],VPS13C,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:62046598
rs6494964-<b>G</b>,6 x 10-6,(IGP2),0.686050906,'-,0.1846 unit increase,[0.1-0.26],"FMN1, TMCO5B",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:33201020
rs2919024-<b>G</b>,7 x 10-6,(IGP20),0.012337327,'-,0.6788 unit decrease,[0.38-0.97],PLD5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:242358740
rs1853639-<b>G</b>,8 x 10-6,(IGP21),0.359453093,'-,0.1761 unit decrease,[0.099-0.254],HTR1E,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:86897124
rs1122979-<b>G</b>,1 x 10-9,(IGP42),0.874862055,'-,0.2982 unit increase,[0.2-0.39],"ABCF2-H2BE1, ABCF2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:151217985
rs11774682-<b>C</b>,3 x 10-6,(IGP42),0.966180189,'-,0.8017 unit decrease,[0.47-1.14],"KCTD9P6, WRN",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:31176759
rs11847263-<b>G</b>,3 x 10-21,(IGP42),0.391170598,'-,0.3025 unit increase,[0.24-0.37],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs3094093-<b>T</b>,3 x 10-6,(IGP42),0.10732588,'-,0.2336 unit increase,[0.14-0.33],"MDC1-AS1, MDC1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:30711851
rs3097645-<b>C</b>,2 x 10-6,(IGP42),0.874270331,'-,0.2151 unit decrease,[0.13-0.3],"BRD2, HLA-DOA",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32985503
rs592229-<b>G</b>,4 x 10-6,(IGP42),0.370399655,'-,0.1536 unit increase,[0.088-0.219],SKIV2L,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:31962664
rs909674-<b>C</b>,1 x 10-24,(IGP40),0.29901312,'-,0.3447 unit increase,[0.28-0.41],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs12465996-<b>C</b>,5 x 10-6,(IGP41),0.864380325,'-,0.2423 unit increase,[0.14-0.35],TMEM182,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:102772135
rs6494964-<b>G</b>,8 x 10-6,(IGP42),0.685883861,'-,0.1819 unit increase,[0.1-0.26],"FMN1, TMCO5B",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:33201020
rs6583437-<b>G</b>,7 x 10-10,(IGP42),0.636802753,'-,0.197 unit increase,[0.13-0.26],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50310671
rs7731390-<b>C</b>,2 x 10-6,(IGP42),0.947771455,'-,0.3846 unit increase,[0.23-0.54],SLC22A5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:132386057
rs9308433-<b>C</b>,2 x 10-6,(IGP42),0.408306479,'-,0.1494 unit decrease,[0.088-0.211],SMYD2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:214283666
rs10206020-<b>C</b>,3 x 10-6,(IGP43),0.188382479,'-,0.1805 unit increase,[0.1-0.26],"TPO, PXDN",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:1554155
rs10813957-<b>G</b>,7 x 10-6,(IGP43),0.738414639,'-,0.1601 unit decrease,[0.09-0.23],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33153529
rs16949825-<b>C</b>,3 x 10-6,(IGP43),0.902274751,'-,0.2547 unit increase,[0.15-0.36],CTIF,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:48701073
rs6466479-<b>G</b>,6 x 10-6,(IGP43),0.122643248,'-,0.2172 unit decrease,[0.12-0.31],FOXP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:114101050
rs9886428-<b>G</b>,1 x 10-6,(IGP43),0.455051607,'-,0.1476 unit decrease,[0.088-0.208],SGCZ,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:14256307
rs2093746-<b>C</b>,2 x 10-7,(IGP44),0.265047575,'-,0.2917 unit decrease,[0.18-0.4],"CHORDC2P, EFCAB11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:89760907
rs404256-<b>C</b>,5 x 10-6,(IGP44),0.558885632,'-,0.1659 unit increase,[0.095-0.237],BACH2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:89948064
rs9948784-<b>G</b>,2 x 10-6,(IGP41),0.9873229,'-,1.7711 unit decrease,[1.04-2.5],ZADH2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,18:75185206
rs1049110-<b>C</b>,2 x 10-8,(IGP42),0.346381764,'-,0.1909 unit increase,[0.12-0.26],HLA-DQB2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32759026
rs2614463-<b>T</b>,7 x 10-6,(IGP39),0.396310788,'-,0.1731 unit increase,[0.098-0.249],BCL11B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:99279937
rs2745851-<b>G</b>,1 x 10-6,(IGP39),0.639545839,'-,0.1562 unit increase,[0.093-0.22],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17848636
rs3767633-<b>T</b>,8 x 10-6,(IGP39),0.145416418,'-,0.2053 unit increase,[0.12-0.3],ATF6,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:161856825
rs3788556-<b>C</b>,5 x 10-8,(IGP39),0.560380343,'-,0.1799 unit increase,[0.12-0.24],CACNA1I,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39576157
rs909674-<b>C</b>,9 x 10-24,(IGP39),0.298476015,'-,0.3388 unit increase,[0.27-0.4],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39463164
rs2093746-<b>C</b>,3 x 10-7,(IGP4),0.265059655,'-,0.2878 unit decrease,[0.18-0.4],"CHORDC2P, EFCAB11",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:89760907
rs4779031-<b>C</b>,2 x 10-6,(IGP4),0.211701583,'-,0.1832 unit increase,[0.11-0.26],ANKRD34C-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:79241030
rs6794649-<b>C</b>,1 x 10-6,(IGP4),0.159420807,'-,0.2074 unit decrease,[0.12-0.29],LINC02006,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:153760634
rs10813951-<b>G</b>,5 x 10-10,(IGP40),0.262743396,'-,0.2193 unit increase,[0.15-0.29],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33128023
rs10817408-<b>C</b>,7 x 10-6,(IGP40),0.149460513,'-,0.2234 unit increase,[0.13-0.32],"SLC46A2, ZNF883",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:112925455
rs11765886-<b>C</b>,5 x 10-6,(IGP40),0.665062906,'-,0.1591 unit increase,[0.091-0.228],AUTS2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:69773172
rs12530-<b>C</b>,3 x 10-6,(IGP40),0.184323969,'-,0.1828 unit increase,[0.11-0.26],RTCB,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:32387917
rs17153352-<b>T</b>,7 x 10-6,(IGP40),0.822655938,'-,0.2041 unit increase,[0.12-0.29],BEND7,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:13488217
rs2664299-<b>C</b>,9 x 10-6,(IGP40),0.404780829,'-,0.1673 unit increase,[0.094-0.241],BCL11B,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:99275850
rs2745851-<b>G</b>,4 x 10-6,(IGP40),0.63917289,'-,0.1483 unit increase,[0.085-0.212],RNU6-192P,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:17848636
rs4684059-<b>C</b>,8 x 10-6,(IGP40),0.369267114,'-,0.1691 unit increase,[0.095-0.243],HRH1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:11191093
rs11847263-<b>G</b>,7 x 10-14,(IGP11),0.39175751,'-,0.2381 unit increase,[0.18-0.3],"PTBP1P, MIR4708",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:65308977
rs918304-<b>C</b>,9 x 10-6,(IGP13),0.009638201,'-,1.5827 unit decrease,[0.88-2.28],LINC01498,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:108483764
rs13174348-<b>G</b>,3 x 10-6,(IGP14),0.784686077,'-,0.1823 unit increase,[0.11-0.26],"CDO1, RNU2-49P",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:115803051
rs1672743-<b>T</b>,6 x 10-6,(IGP16),0.053157,'-,1.1657 unit increase,[0.66-1.67],CRBN,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:3190154
rs4869266-<b>G</b>,3 x 10-6,(IGP16),0.664911824,'-,0.1519 unit increase,[0.088-0.216],MIR583HG,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:96151236
rs12431702-<b>C</b>,8 x 10-6,(IGP17),0.380447777,'-,0.1459 unit increase,[0.082-0.21],PRKD1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:29618932
rs17348299-<b>C</b>,2 x 10-7,(IGP17),0.836731981,'-,0.2309 unit increase,[0.14-0.32],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56027067
rs6794649-<b>C</b>,2 x 10-6,(IGP44),0.159404027,'-,0.2013 unit decrease,[0.12-0.28],LINC02006,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:153760634
rs1023721-<b>T</b>,1 x 10-6,(IGP45),0.941491348,'-,0.312 unit increase,[0.19-0.44],KCNIP4,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:21204867
rs1122979-<b>G</b>,6 x 10-10,(IGP45),0.875396395,'-,0.3046 unit increase,[0.21-0.4],"ABCF2-H2BE1, ABCF2",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:151217985
rs1547201-<b>C</b>,7 x 10-6,(IGP45),0.530022081,'-,0.1416 unit decrease,[0.08-0.203],ERCC6L2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:96054202
rs16884711-<b>C</b>,3 x 10-6,(IGP45),0.188959846,'-,0.1908 unit increase,[0.11-0.27],"ANKRD55, FLJ31104",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:56028975
rs2186369-<b>G</b>,4 x 10-6,(IGP45),0.189496821,'-,0.1924 unit decrease,[0.11-0.27],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs9296009-<b>T</b>,4 x 10-8,(IGP23),0.196432337,'-,0.2111 unit decrease,[0.14-0.29],"FKBPL, PRRT1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32146738
rs2659005-<b>C</b>,3 x 10-7,(IGP24),0.51735815,'-,0.1648 unit decrease,[0.1-0.23],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,Mapping not available
rs11820502-<b>C</b>,1 x 10-6,(IGP25),0.287492851,'-,0.1836 unit decrease,[0.11-0.26],TRIM5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:5666794
rs2540552-<b>C</b>,8 x 10-6,(IGP25),0.581040742,'-,0.1381 unit increase,[0.078-0.199],"MTERF1, RNA5SP231",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:91610982
rs980952-<b>G</b>,5 x 10-6,(IGP25),0.975374876,'-,0.4489 unit increase,[0.26-0.64],LRRC4C,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:41204404
rs1531590-<b>C</b>,3 x 10-6,(IGP26),0.227292733,'-,0.1794 unit decrease,[0.1-0.25],CASC9,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:75124209
rs2361701-<b>G</b>,4 x 10-6,(IGP28),0.823049887,'-,0.1856 unit decrease,[0.11-0.26],CCDC40,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:80092818
rs11710456-<b>G</b>,6 x 10-75,(IGP29),0.699317447,'-,0.6427 unit increase,[0.57-0.71],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs6859704-<b>C</b>,8 x 10-6,(IGP29),0.076924038,'-,0.2598 unit decrease,[0.15-0.37],TENT2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:79647825
rs10206020-<b>C</b>,4 x 10-6,(IGP3),0.188020995,'-,0.1798 unit increase,[0.1-0.26],"TPO, PXDN",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:1554155
rs10764775-<b>C</b>,6 x 10-6,(IGP31),0.340436586,'-,0.1435 unit increase,[0.081-0.206],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:128435544
rs17621444-<b>C</b>,3 x 10-6,(IGP31),0.72232959,'-,0.164 unit increase,[0.095-0.233],NACAP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,10:120062026
rs3845441-<b>C</b>,7 x 10-6,(IGP31),0.127711493,'-,0.2083 unit increase,[0.12-0.3],CACNA1E,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:181686616
rs10488029-<b>G</b>,4 x 10-6,(IGP35),0.105787906,'-,0.2329 unit increase,[0.13-0.33],ELMO1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:37027790
rs16982515-<b>C</b>,3 x 10-6,(IGP35),0.91902475,'-,0.3117 unit decrease,[0.18-0.44],ISCA2P1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:26645319
rs2833991-<b>C</b>,5 x 10-6,(IGP14),0.044673871,'-,0.3471 unit decrease,[0.2-0.5],C21orf62-AS1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,21:32890379
rs2900-<b>G</b>,4 x 10-6,(IGP14),0.860145731,'-,0.2021 unit decrease,[0.12-0.29],MKRN3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:23572574
rs909814-<b>C</b>,7 x 10-6,(IGP14),0.574609658,'-,0.1421 unit increase,[0.08-0.204],MIR4418,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:22247449
rs2659005-<b>C</b>,4 x 10-7,(IGP26),0.517323975,'-,0.1653 unit decrease,[0.1-0.23],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,Mapping not available
rs12342831-<b>C</b>,5 x 10-7,(IGP3),0.262517807,'-,0.1777 unit increase,[0.11-0.25],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:33124874
rs1368304-<b>G</b>,9 x 10-6,(IGP3),0.915930538,'-,0.2439 unit increase,[0.14-0.35],MARCOL,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:148223504
rs10065350-<b>C</b>,9 x 10-6,(IGP67),0.841900657,'-,0.2004 unit decrease,[0.11-0.29],RAB3C,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:58786896
rs10903027-<b>C</b>,5 x 10-6,(IGP67),0.707795287,'-,0.1594 unit increase,[0.091-0.228],"LINC02793, IFITM3P7",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:25076133
rs11128271-<b>C</b>,6 x 10-7,(IGP67),0.93627698,'-,0.338 unit increase,[0.21-0.47],RYBP,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:72460120
rs11899928-<b>C</b>,3 x 10-6,(IGP67),0.021523168,'-,0.7169 unit increase,[0.42-1.02],CNTNAP5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:124499159
rs12528714-<b>G</b>,8 x 10-6,(IGP67),0.991049,'-,2.4277 unit decrease,[1.36-3.49],TTLL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:167341487
rs16871226-<b>G</b>,2 x 10-6,(IGP67),0.024482123,'-,0.5182 unit increase,[0.3-0.73],"HLA-DMA, HLA-DMB",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,6:32948074
rs2186369-<b>G</b>,1 x 10-12,(IGP67),0.189496821,'-,0.2938 unit decrease,[0.21-0.38],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:23828809
rs300032-<b>G</b>,3 x 10-7,(IGP67),0.146183376,'-,0.2336 unit increase,[0.14-0.32],"FOXL1, LINC02188",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,16:86647390
rs4821897-<b>G</b>,4 x 10-18,(IGP67),0.707166483,'-,0.2976 unit decrease,[0.23-0.36],"TAB1, MGAT3",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,22:39439582
rs4899329-<b>C</b>,5 x 10-6,(IGP67),0.399541382,'-,0.142 unit increase,[0.081-0.203],SLC8A3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,14:70153925
rs6421315-<b>C</b>,7 x 10-11,(IGP67),0.368179075,'-,0.2096 unit decrease,[0.15-0.27],IKZF1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:50315611
rs7397814-<b>C</b>,4 x 10-6,(IGP67),0.791488588,'-,0.188 unit increase,[0.11-0.27],LINC02367,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:9394366
rs756777-<b>G</b>,1 x 10-6,(IGP67),0.208834557,'-,0.1868 unit increase,[0.11-0.26],VAV2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:133813958
rs10504390-<b>G</b>,8 x 10-6,(IGP68),0.080292632,'-,0.2503 unit decrease,[0.14-0.36],MTFR1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:65711997
rs11568995-<b>G</b>,1 x 10-6,(IGP68),0.9883953,'-,1.7191 unit decrease,[1.02-2.41],EGF,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:109976429
rs11675841-<b>C</b>,8 x 10-6,(IGP68),0.607171815,'-,0.1429 unit decrease,[0.08-0.206],FMNL2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,2:152580056
rs11710456-<b>G</b>,8 x 10-7,(IgG1G2),0.6936,'-,0.044 unit decrease,[0.027-0.061],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001849,3:187008099
rs12342831-<b>T</b>,5 x 10-8,(IgG1G2),0.73755,'-,0.0496 unit increase,[0.032-0.068],B4GALT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001849,9:33124874
rs909674-<b>C</b>,3 x 10-8,(IgG1G0N),0.29096,'-,0.083 unit increase,[0.054-0.112],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001849,22:39463164
rs2186369-<b>T</b>,2 x 10-7,(IgG1G1N),0.81823,'-,0.0667 unit increase,[0.042-0.092],SMARCB1,IgG glycosylation,serum IgG glycosylation measurement,GCST001849,22:23828809
rs909674-<b>C</b>,2 x 10-10,(IgG1G1N),0.29096,'-,0.0721 unit increase,[0.050-0.094],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001849,22:39463164
rs909674-<b>C</b>,9 x 10-6,(IgG1G2N),0.29096,'-,0.0651 unit increase,[0.036-0.094],MGAT3,IgG glycosylation,serum IgG glycosylation measurement,GCST001849,22:39463164
rs6466479-<b>G</b>,2 x 10-6,(IGP26),0.122475888,'-,0.23 unit increase,[0.14-0.32],FOXP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,7:114101050
rs6853847-<b>C</b>,5 x 10-6,(IGP26),0.030437859,'-,0.4557 unit decrease,[0.26-0.65],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,4:91996064
rs8076431-<b>C</b>,2 x 10-6,(IGP26),0.851273368,'-,0.2132 unit increase,[0.12-0.3],SHISA6,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:11346902
rs871012-<b>C</b>,5 x 10-6,(IGP26),0.446030929,'-,0.1473 unit increase,[0.084-0.21],CYFIP2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,5:157388755
rs10108033-<b>C</b>,1 x 10-6,(IGP27),0.990183,'-,2.9565 unit increase,[1.76-4.15],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:131318469
rs11820502-<b>C</b>,3 x 10-6,(IGP27),0.287504189,'-,0.1762 unit decrease,[0.1-0.25],TRIM5,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:5666794
rs17124610-<b>C</b>,8 x 10-6,(IGP27),0.983922183,'-,0.6724 unit decrease,[0.38-0.97],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:61155300
rs6102185-<b>G</b>,1 x 10-6,(IGP27),0.423097752,'-,0.151 unit increase,[0.09-0.212],RNA5SP484,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:40849893
rs6132333-<b>C</b>,5 x 10-6,(IGP27),0.025072539,'-,0.5005 unit decrease,[0.29-0.72],RALGAPA2,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:20653462
rs7032871-<b>T</b>,5 x 10-6,(IGP27),0.278857773,'-,0.1579 unit increase,[0.09-0.226],ACO1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,9:32422692
rs7623788-<b>G</b>,5 x 10-6,(IGP27),0.134195012,'-,0.2057 unit decrease,[0.12-0.29],LINC02006,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:153632327
rs909848-<b>C</b>,7 x 10-6,(IGP27),0.607072543,'-,0.1434 unit increase,[0.081-0.206],PTGER3,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,1:70977467
rs11710456-<b>G</b>,9 x 10-37,(IGP28),0.698982463,'-,0.4436 unit increase,[0.37-0.51],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187008099
rs13323323-<b>G</b>,4 x 10-6,(IGP28),0.732786566,'-,0.1593 unit increase,[0.091-0.227],TOPAZ1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:44291832
rs1467979-<b>C</b>,3 x 10-6,(IGP28),0.823196467,'-,0.186 unit decrease,[0.11-0.26],CCDC40,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,17:80086944
rs1604897-<b>C</b>,8 x 10-6,(IGP28),0.836453156,'-,0.1864 unit decrease,[0.1-0.27],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:121170070
rs6993449-<b>C</b>,3 x 10-6,(IGP28),0.65041529,'-,0.1528 unit increase,[0.088-0.217],ANGPT1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,8:107269199
rs7652995-<b>G</b>,2 x 10-20,(IGP28),0.176683507,'-,0.4042 unit increase,[0.32-0.49],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs16952065-<b>C</b>,1 x 10-6,(IGP28),0.937426751,'-,0.4401 unit decrease,[0.26-0.62],ITGA11,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,15:68426648
rs13328933-<b>C</b>,5 x 10-6,(IGP29),0.948348054,'-,0.3116 unit increase,[0.18-0.45],CNTN1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,12:40959947
rs2659005-<b>C</b>,9 x 10-6,(IGP29),0.517261684,'-,0.1441 unit decrease,[0.08-0.208],'-,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,Mapping not available
rs6064045-<b>C</b>,7 x 10-6,(IGP29),0.521164665,'-,0.137 unit decrease,[0.077-0.197],"BCAS1, CYP24A1",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,20:54084754
rs7101378-<b>G</b>,7 x 10-6,(IGP29),0.531881765,'-,0.1398 unit increase,[0.079-0.201],"RNA5SP349, RNU6-654P",IgG glycosylation,serum IgG glycosylation measurement,GCST001848,11:109022640
rs7331540-<b>C</b>,5 x 10-6,(IGP29),0.442209461,'-,0.1407 unit increase,[0.08-0.201],FRY,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,13:32136383
rs7652995-<b>G</b>,3 x 10-40,(IGP29),0.17684106,'-,0.5797 unit increase,[0.49-0.67],ST6GAL1,IgG glycosylation,serum IgG glycosylation measurement,GCST001848,3:187005156
rs7621161-<b>A</b>,5 x 10-276,,0.284,'-,0.653 unit decrease,[NR],ST6GAL1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,3:187009382
rs7758383-<b>A</b>,1 x 10-13,,0.521,'-,0.125 unit increase,[NR],HIVEP2,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,6:142848586
rs6421315-<b>C</b>,5 x 10-27,,0.383,'-,0.192 unit increase,[NR],IKZF1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,7:50315611
rs7812088-<b>A</b>,2 x 10-22,,0.119,'-,0.25 unit decrease,[NR],'-,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,Mapping not available
rs10813951-<b>A</b>,9 x 10-34,,0.732,'-,0.23 unit increase,[NR],B4GALT1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,9:33128023
rs11847263-<b>T</b>,1 x 10-58,,0.647,'-,0.283 unit decrease,[NR],"PTBP1P, MIR4708",IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,14:65308977
rs4074453-<b>T</b>,4 x 10-29,,0.758,'-,0.218 unit decrease,[NR],"ATP5MC1P1, TMEM121",IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,14:105532207
rs2725391-<b>T</b>,1 x 10-15,,0.46,'-,0.133 unit increase,[NR],'-,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,Mapping not available
rs7281587-<b>A</b>,1 x 10-13,,0.247,'-,0.144 unit decrease,[NR],RUNX1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,21:35192981
rs17630758-<b>A</b>,1 x 10-41,,0.152,'-,0.308 unit decrease,[NR],SMARCB1,IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,22:23794355
rs5750830-<b>A</b>,8 x 10-69,,0.74,'-,0.344 unit decrease,[NR],"TAB1, MGAT3",IgG N-glycosylation phenotypes (multivariate analysis),serum IgG glycosylation measurement,GCST009860,22:39444823
rs248386-<b>C</b>,1 x 10-12,(dimethylglycine),0.81,'-,0.349 unit decrease,[0.25-0.44],DMGDH,Salivary metabolite levels,"salivary metabolite measurement, dimethylglycine measurement",GCST009885,5:79034404
rs12085006-<b>?</b>,6 x 10-10,(Plasma homocysteine),0.43,'-,0.04 unit increase,[0.020-0.060],"SBF1P2, RNU5E-1",Folate pathway vitamin levels,homocysteine measurement,GCST000483,1:11898666
rs10986018-<b>?</b>,2 x 10-8,(plasma homocysteine),0.22,'-,0.06 unit decrease,[0.040-0.080],GABBR2,Folate pathway vitamin levels,homocysteine measurement,GCST000483,9:98361054
rs71640036-<b>G</b>,2 x 10-22,(random effects model),0.5,'-,1.4 μmol/l decrease,[0.42-2.38],KLKB1,L-arginine levels,L-arginine measurement,GCST003793,4:186239966
rs2545801-<b>T</b>,1 x 10-12,(random effects model),0.16,'-,2.2 μmol/l decrease,[0.83-3.57],GRK6,L-arginine levels,L-arginine measurement,GCST003793,5:177414338
rs5743467-<b>G</b>,2 x 10-7,,0.25,'-,0.46 unit increase,[NR],"GS1-24F4.2, DEFB1",Plasma kynurenine to tryptophan ratio in major depressive disorder,"unipolar depression, kynurenine:tryptophan ratio",GCST005343,8:6874007
rs75921243-<b>G</b>,6 x 10-8,,0.02,'-,1.51 unit decrease,[NR],"MIR124-1HG, MSRA",Plasma kynurenine to tryptophan ratio in major depressive disorder,"unipolar depression, kynurenine:tryptophan ratio",GCST005343,8:9988356
rs116609693-<b>T</b>,5 x 10-7,,0.03,'-,1.35 unit decrease,[NR],ANKRD19P,Plasma kynurenine to tryptophan ratio in major depressive disorder,"unipolar depression, kynurenine:tryptophan ratio",GCST005343,9:92811394
rs1047891-<b>A</b>,4 x 10-41,(Glycine),0.1672,'-,0.2295 unit increase,[0.2-0.26],CPS1,Metabolite levels,glycine measurement,GCST009698,2:210675783
rs10172053-<b>T</b>,5 x 10-26,(Glycine),0.8286,'-,0.1699 unit decrease,[0.14-0.2],'-,Metabolite levels,glycine measurement,GCST009698,2:210779923
rs111552533-<b>?</b>,3 x 10-6,,'-,'-,1.26 unit increase,'-,TMEFF2,CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,2:192131789
rs13156386-<b>?</b>,4 x 10-6,,'-,'-,1.6 unit increase,'-,KRT18P16,CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,5:123682194
rs141710116-<b>?</b>,6 x 10-6,,'-,'-,1.94 unit decrease,'-,'-,CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,7:81237740
rs3815652-<b>?</b>,1 x 10-7,,'-,'-,1.83 unit increase,'-,BBS9,CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,7:33873792
rs2391754-<b>?</b>,3 x 10-6,,'-,'-,1.73 unit increase,'-,CHN2,CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,7:29363572
rs10998941-<b>?</b>,7 x 10-6,,'-,'-,1.22 unit increase,'-,"LINC02651, RPL5P26",CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,10:69735970
rs12814611-<b>?</b>,6 x 10-6,,'-,'-,1.28 unit increase,'-,"RN7SL734P, PHLDA1",CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,12:75991069
rs11838725-<b>?</b>,2 x 10-6,,'-,'-,1.89 unit decrease,'-,"WBP4, MIR3168",CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,13:41096949
rs147182487-<b>?</b>,3 x 10-6,,'-,'-,2.35 unit increase,'-,LINC00558,CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,13:53973439
rs55854133-<b>?</b>,5 x 10-6,,'-,'-,1.87 unit increase,'-,MYHAS,CSF tryptophan concentration in tuberculous meningitis,"tryptophan measurement, meningeal tuberculosis",GCST005331,17:10594428
rs1801133-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,MTHFR,Homocysteine levels,homocysteine measurement,GCST009171,1:11796321
rs1801133-<b>?</b>,1 x 10-19,,NR,'-,0.03087 μmol/L increase,[0.024-0.037],MTHFR,Plasma homocysteine levels,homocysteine measurement,GCST007578,1:11796321
rs1999594-<b>?</b>,1 x 10-11,,NR,'-,0.02195 μmol/L decrease,[0.016-0.028],"RNU5E-1, SBF1P2",Plasma homocysteine levels,homocysteine measurement,GCST007578,1:11899159
rs730123-<b>?</b>,7 x 10-9,,NR,'-,0.01915 μmol/L increase,[0.013-0.026],MFN2,Plasma homocysteine levels,homocysteine measurement,GCST007578,1:12010235
rs164746-<b>?</b>,4 x 10-8,,NR,'-,0.01776 μmol/L increase,[0.011-0.024],CHMP1A,Plasma homocysteine levels,homocysteine measurement,GCST007578,16:89642611
rs17354370-<b>?</b>,4 x 10-9,,NR,'-,0.02096 μmol/L decrease,[0.014-0.028],'-,Plasma homocysteine levels,homocysteine measurement,GCST007578,7:19560244
rs1801133-<b>A</b>,8 x 10-35,(WGHS),0.33,'-,0.05 unit increase,[NR],MTHFR,Homocysteine levels,homocysteine measurement,GCST000367,1:11796321
rs6586282-<b>?</b>,3 x 10-10,(WGHS),0.18,'-,0.03 unit decrease,[NR],CBS,Homocysteine levels,homocysteine measurement,GCST000367,21:43058387
rs7422339-<b>A</b>,5 x 10-9,,0.24,'-,0.05 log(Hcy) increase,[0.03-0.07],CPS1,Homocysteine levels,homocysteine measurement,GCST000594,2:210675783
rs4646961-<b>A</b>,8 x 10-19,,0.297,'-,0.048 unit increase,[0.036-0.06],ACADM,Glycine levels,glycine measurement,GCST007638,1:75751484
rs561931-<b>G</b>,8 x 10-14,,0.593,'-,0.033 unit increase,[0.021-0.045],PHGDH,Glycine levels,glycine measurement,GCST007638,1:119711883
rs10184004-<b>T</b>,2 x 10-9,,0.4,'-,0.036 unit increase,[0.024-0.048],"GRB14, COBLL1",Glycine levels,glycine measurement,GCST007638,2:164651879
rs715-<b>C</b>,3 x 10-1632,,0.313,'-,0.444 unit increase,[0.43-0.46],CPS1,Glycine levels,glycine measurement,GCST007638,2:210678331
rs9862438-<b>T</b>,1 x 10-30,,0.416,'-,0.058 unit increase,[0.046-0.07],"ALDH1L1-AS2, ALDH1L1",Glycine levels,glycine measurement,GCST007638,3:126191538
rs148685782-<b>G</b>,2 x 10-10,,0.996,'-,0.309 unit increase,[0.21-0.41],FGG,Glycine levels,glycine measurement,GCST007638,4:154611883
rs71640034-<b>A</b>,6 x 10-10,,0.511,'-,0.034 unit increase,[0.022-0.046],KLKB1,Glycine levels,glycine measurement,GCST007638,4:186239894
rs156380-<b>C</b>,5 x 10-8,,0.807,'-,0.031 unit increase,[0.017-0.045],ARL15,Glycine levels,glycine measurement,GCST007638,5:54082620
rs3105793-<b>A</b>,4 x 10-8,,0.273,'-,0.028 unit increase,[0.016-0.04],ADGRV1,Glycine levels,glycine measurement,GCST007638,5:90930244
rs10900807-<b>G</b>,1 x 10-9,,0.805,'-,0.036 unit increase,[0.022-0.05],"IRF1-AS1, LINC02863",Glycine levels,glycine measurement,GCST007638,5:132421788
rs2545801-<b>C</b>,7 x 10-14,,0.747,'-,0.042 unit increase,[0.028-0.056],GRK6,Glycine levels,glycine measurement,GCST007638,5:177414338
rs543159-<b>A</b>,4 x 10-10,,0.482,'-,0.035 unit increase,[0.023-0.047],SLC22A3,Glycine levels,glycine measurement,GCST007638,6:160354985
rs4947534-<b>C</b>,7 x 10-34,,0.76,'-,0.072 unit increase,[0.058-0.086],PSPH,Glycine levels,glycine measurement,GCST007638,7:56011401
rs9987289-<b>A</b>,2 x 10-49,,0.1,'-,0.124 unit increase,[0.1-0.14],"RNU6-526P, RNU6-1151P",Glycine levels,glycine measurement,GCST007638,8:9325848
rs28601761-<b>G</b>,8 x 10-30,,0.416,'-,0.063 unit increase,[0.051-0.075],'-,Glycine levels,glycine measurement,GCST007638,Mapping not available
rs17591030-<b>C</b>,2 x 10-40,,0.715,'-,0.08 unit increase,[0.068-0.092],GLDC,Glycine levels,glycine measurement,GCST007638,9:6550024
rs676996-<b>T</b>,4 x 10-15,,0.668,'-,0.04 unit increase,[0.028-0.052],ABO,Glycine levels,glycine measurement,GCST007638,9:133270647
rs190595610-<b>A</b>,9 x 10-9,,0.997,'-,0.253 unit increase,[0.14-0.36],"RPL34P19, RN7SL825P",Glycine levels,glycine measurement,GCST007638,10:31985952
rs10740134-<b>T</b>,1 x 10-12,,0.515,'-,0.038 unit increase,[0.026-0.05],REEP3,Glycine levels,glycine measurement,GCST007638,10:63555673
rs12297321-<b>T</b>,7 x 10-13,,0.152,'-,0.048 unit increase,[0.032-0.064],"MARK3P1, SLC38A4",Glycine levels,glycine measurement,GCST007638,12:46715604
rs2638314-<b>A</b>,2 x 10-8,,0.182,'-,0.042 unit increase,[0.028-0.056],"SPRYD4, GLS2",Glycine levels,glycine measurement,GCST007638,12:56472550
rs9514191-<b>C</b>,3 x 10-8,,0.312,'-,0.034 unit increase,[0.022-0.046],'-,Glycine levels,glycine measurement,GCST007638,13:103867788
rs201393666-<b>A</b>,3 x 10-8,,0.029,'-,0.097 unit increase,[0.064-0.13],TUBGCP4,Glycine levels,glycine measurement,GCST007638,15:43385781
rs2280195-<b>A</b>,3 x 10-9,,0.441,'-,0.028 unit increase,[0.016-0.04],"AQP9, ALDH1A2",Glycine levels,glycine measurement,GCST007638,15:58174896
rs9923732-<b>A</b>,1 x 10-41,,0.914,'-,0.119 unit increase,[0.097-0.141],"C16orf46, GCSH",Glycine levels,glycine measurement,GCST007638,16:81077298
rs8078686-<b>C</b>,4 x 10-11,,0.509,'-,0.035 unit increase,[0.023-0.047],KPNB1,Glycine levels,glycine measurement,GCST007638,17:47658340
rs273510-<b>A</b>,4 x 10-9,,0.708,'-,0.034 unit increase,[0.022-0.046],MAST3,Glycine levels,glycine measurement,GCST007638,19:18112540
rs1861072-<b>T</b>,3 x 10-12,(conditional),0.5906,'-,'-,'-,UNC80,Glycine levels,glycine measurement,GCST007638,2:209986910
rs62202111-<b>C</b>,6 x 10-10,(conditional),0.0235,'-,'-,'-,LANCL1-AS1,Glycine levels,glycine measurement,GCST007638,2:210421058
rs1509820-<b>A</b>,2 x 10-52,(conditional),0.53,'-,'-,'-,CPS1,Glycine levels,glycine measurement,GCST007638,2:210521760
rs62177991-<b>G</b>,7 x 10-14,(conditional),0.5169,'-,'-,'-,'-,Glycine levels,glycine measurement,GCST007638,2:211019507
rs115683961-<b>A</b>,3 x 10-8,(conditional),0.9383,'-,'-,'-,ERBB4,Glycine levels,glycine measurement,GCST007638,2:211521195
rs141015398-<b>A</b>,3 x 10-8,(conditional),0.9894,'-,'-,'-,"ENPP7P4, LINC02614",Glycine levels,glycine measurement,GCST007638,3:125899882
rs2276724-<b>T</b>,2 x 10-11,(conditional),0.8414,'-,'-,'-,ALDH1L1,Glycine levels,glycine measurement,GCST007638,3:126135566
rs4646705-<b>A</b>,2 x 10-8,(conditional),0.4966,'-,'-,'-,ALDH1L1,Glycine levels,glycine measurement,GCST007638,3:126156988
rs79064296-<b>T</b>,2 x 10-10,(conditional),0.0446,'-,'-,'-,"KLF15, ALDH1L1-AS2",Glycine levels,glycine measurement,GCST007638,3:126266226
rs1912826-<b>A</b>,7 x 10-10,(conditional),0.5217,'-,'-,'-,KLKB1,Glycine levels,glycine measurement,GCST007638,4:186228386
rs4689-<b>T</b>,3 x 10-12,(conditional),0.7706,'-,'-,'-,NIPSNAP2,Glycine levels,glycine measurement,GCST007638,7:55999323
rs62457261-<b>G</b>,2 x 10-8,(conditional),0.5704,'-,'-,'-,PSPH,Glycine levels,glycine measurement,GCST007638,7:56012733
rs7012637-<b>G</b>,2 x 10-15,(conditional),0.525,'-,'-,'-,"RNU6-526P, RNU6-1151P",Glycine levels,glycine measurement,GCST007638,8:9315699
rs55748921-<b>C</b>,3 x 10-11,(conditional),0.693,'-,'-,'-,TRIB1,Glycine levels,glycine measurement,GCST007638,8:125480685
rs13299380-<b>T</b>,4 x 10-11,(conditional),0.0534,'-,'-,'-,RANBP6,Glycine levels,glycine measurement,GCST007638,9:6078779
rs113626350-<b>A</b>,5 x 10-12,(conditional),0.0458,'-,'-,'-,UHRF2,Glycine levels,glycine measurement,GCST007638,9:6490491
rs143119940-<b>A</b>,1 x 10-19,(conditional),0.0109,'-,'-,'-,GLDC,Glycine levels,glycine measurement,GCST007638,9:6554781
rs67506027-<b>A</b>,2 x 10-11,(conditional),0.6074,'-,'-,'-,"RN7SL123P, GLDC",Glycine levels,glycine measurement,GCST007638,9:6657690
rs6479877-<b>C</b>,1 x 10-10,(conditional),0.5322,'-,'-,'-,"NRBF2, RNU6-543P",Glycine levels,glycine measurement,GCST007638,10:63118358
rs4520846-<b>A</b>,3 x 10-8,(conditional),0.3534,'-,'-,'-,PKD1L2,Glycine levels,glycine measurement,GCST007638,16:81108753
rs11647428-<b>G</b>,2 x 10-28,(conditional),0.4904,'-,'-,'-,PKD1L2,Glycine levels,glycine measurement,GCST007638,16:81116954
rs62051533-<b>C</b>,3 x 10-11,(conditional),0.3231,'-,'-,'-,PKD1L2,Glycine levels,glycine measurement,GCST007638,16:81118674
rs16954688-<b>G</b>,5 x 10-14,(conditional),0.9528,'-,'-,'-,PKD1L2,Glycine levels,glycine measurement,GCST007638,16:81123203
rs12126607-<b>A</b>,1 x 10-9,,0.268139,'-,0.071685 unit increase,[0.049-0.095],ACADM,Glycine levels,glycine measurement,GCST007838,1:75751412
rs1047891-<b>A</b>,6 x 10-189,,0.341987,'-,0.322023 unit increase,[0.3-0.34],CPS1,Glycine levels,glycine measurement,GCST007838,2:210675783
rs2364368-<b>T</b>,2 x 10-22,,0.402329,'-,0.103751 unit increase,[0.083-0.125],"ALDH1L1-AS2, ALDH1L1",Glycine levels,glycine measurement,GCST007838,3:126186237
rs143424675-<b>T</b>,1 x 10-11,,0.028306,'-,0.212665 unit increase,[0.15-0.27],"HNRNPA1P67, RNU4ATAC9P",Glycine levels,glycine measurement,GCST007838,4:72883702
rs6955423-<b>A</b>,1 x 10-9,,0.813183,'-,0.080595 unit increase,[0.055-0.107],PSPH,Glycine levels,glycine measurement,GCST007838,7:56031659
rs2126263-<b>G</b>,5 x 10-38,,0.151966,'-,0.183572 unit increase,[0.16-0.21],"RNU6-526P, RNU6-1151P",Glycine levels,glycine measurement,GCST007838,8:9324101
rs28601761-<b>G</b>,4 x 10-12,,0.414553,'-,0.073183 unit increase,[0.052-0.094],'-,Glycine levels,glycine measurement,GCST007838,Mapping not available
rs71503800-<b>T</b>,3 x 10-85,,0.048942,'-,0.465484 unit increase,[0.42-0.51],"RANBP6, GTF3AP1",Glycine levels,glycine measurement,GCST007838,9:6102648
rs492488-<b>G</b>,5 x 10-6,,0.552182,'-,0.049598 unit increase,[0.028-0.071],ABO,Glycine levels,glycine measurement,GCST007838,9:133269548
rs11860711-<b>C</b>,1 x 10-18,,0.799952,'-,0.116159 unit increase,[0.09-0.142],"PKD1L2, GCSH",Glycine levels,glycine measurement,GCST007838,16:81098888
rs478093-<b>G</b>,2 x 10-6,,0.671738,'-,0.07016 unit increase,[0.041-0.099],PHGDH,Glycine levels,glycine measurement,GCST007837,1:119712503
rs1047891-<b>A</b>,1 x 10-300,,0.341987,'-,0.572425 unit increase,[0.54-0.6],CPS1,Glycine levels,glycine measurement,GCST007837,2:210675783
rs2364368-<b>T</b>,2 x 10-9,,0.402329,'-,0.084058 unit increase,[0.057-0.112],"ALDH1L1-AS2, ALDH1L1",Glycine levels,glycine measurement,GCST007837,3:126186237
rs2126263-<b>G</b>,4 x 10-11,,0.151966,'-,0.13079 unit increase,[0.092-0.17],"RNU6-526P, RNU6-1151P",Glycine levels,glycine measurement,GCST007837,8:9324101
rs71503800-<b>T</b>,1 x 10-42,,0.048942,'-,0.446134 unit increase,[0.38-0.51],"RANBP6, GTF3AP1",Glycine levels,glycine measurement,GCST007837,9:6102648
rs12003835-<b>T</b>,8 x 10-6,,0.026406,'-,0.199303 unit increase,[0.11-0.29],PTPRD,Glycine levels,glycine measurement,GCST007837,9:8424378
rs11860711-<b>C</b>,7 x 10-15,,0.799952,'-,0.136637 unit increase,[0.1-0.17],"PKD1L2, GCSH",Glycine levels,glycine measurement,GCST007837,16:81098888
rs12126607-<b>A</b>,1 x 10-11,,0.268139,'-,0.064801 unit increase,[0.046-0.083],ACADM,Glycine levels,glycine measurement,GCST007836,1:75751412
rs478093-<b>G</b>,3 x 10-10,,0.671738,'-,0.056269 unit increase,[0.039-0.074],PHGDH,Glycine levels,glycine measurement,GCST007836,1:119712503
rs1047891-<b>A</b>,1 x 10-300,,0.341987,'-,0.425094 unit increase,[0.41-0.44],CPS1,Glycine levels,glycine measurement,GCST007836,2:210675783
rs2364368-<b>T</b>,2 x 10-28,,0.402329,'-,0.094881 unit increase,[0.078-0.112],"ALDH1L1-AS2, ALDH1L1",Glycine levels,glycine measurement,GCST007836,3:126186237
rs143424675-<b>T</b>,7 x 10-13,,0.028306,'-,0.185475 unit increase,[0.13-0.24],"HNRNPA1P67, RNU4ATAC9P",Glycine levels,glycine measurement,GCST007836,4:72883702
rs6955423-<b>A</b>,2 x 10-11,,0.813183,'-,0.072 unit increase,[0.051-0.093],PSPH,Glycine levels,glycine measurement,GCST007836,7:56031659
rs2126263-<b>G</b>,6 x 10-44,,0.151966,'-,0.162543 unit increase,[0.14-0.19],"RNU6-526P, RNU6-1151P",Glycine levels,glycine measurement,GCST007836,8:9324101
rs28601761-<b>G</b>,2 x 10-13,,0.414553,'-,0.06324 unit increase,[0.046-0.08],'-,Glycine levels,glycine measurement,GCST007836,Mapping not available
rs71503800-<b>T</b>,8 x 10-121,,0.048942,'-,0.455393 unit increase,[0.42-0.49],"RANBP6, GTF3AP1",Glycine levels,glycine measurement,GCST007836,9:6102648
rs12003835-<b>T</b>,8 x 10-9,,0.026406,'-,0.151422 unit increase,[0.1-0.203],PTPRD,Glycine levels,glycine measurement,GCST007836,9:8424378
rs492488-<b>G</b>,1 x 10-8,,0.552182,'-,0.051118 unit increase,[0.034-0.069],ABO,Glycine levels,glycine measurement,GCST007836,9:133269548
rs11860711-<b>C</b>,4 x 10-31,,0.799952,'-,0.123689 unit increase,[0.1-0.14],"PKD1L2, GCSH",Glycine levels,glycine measurement,GCST007836,16:81098888
rs505922-<b>C</b>,2 x 10-30,,NR,'-,0.3315 unit decrease,[0.28-0.39],ABO,vWF levels in ischaemic stroke and hyperhomocysteinaemia,"Ischemic stroke, von Willebrand factor measurement, homocysteine measurement",GCST004598,9:133273813
rs1063856-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,VWF,vWF levels in ischaemic stroke and hyperhomocysteinaemia,"Ischemic stroke, von Willebrand factor measurement, homocysteine measurement",GCST004598,12:6044368
rs4962153-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,ADAMTS13,vWF levels in ischaemic stroke and hyperhomocysteinaemia,"Ischemic stroke, von Willebrand factor measurement, homocysteine measurement",GCST004598,9:133458632
rs9296404-<b>T</b>,2 x 10-63,,0.48,'-,0.356 unit increase,[0.31-0.41],"GNMT, RPL24P4",Plasma homocysteine levels (post-methionine load test),homocysteine measurement,GCST002391,6:42958065
rs234714-<b>T</b>,3 x 10-26,,0.2,'-,0.404 unit increase,[0.31-0.49],CBS,Plasma homocysteine levels (post-methionine load test),homocysteine measurement,GCST002391,21:43067923
rs4948102-<b>?</b>,1 x 10-16,,'-,'-,'-,'-,PSPH,Plasma homocysteine levels (post-methionine load test),homocysteine measurement,GCST002391,7:56029572
rs10934753-<b>A</b>,7 x 10-13,,0.43,'-,0.193 unit increase,[0.14-0.25],"ALDH1L1, ALDH1L1-AS2",Plasma homocysteine levels (post-methionine load test),homocysteine measurement,GCST002391,3:126187336
rs1047891-<b>A</b>,9 x 10-13,,0.306,'-,0.191 unit increase,[0.12-0.26],CPS1,Plasma homocysteine levels (post-methionine load test),homocysteine measurement,GCST002391,2:210675783
rs1801133-<b>A</b>,4 x 10-104,,0.34,'-,0.1583 unit increase,[0.14-0.17],MTHFR,Homocysteine levels,homocysteine measurement,GCST002087,1:11796321
rs2275565-<b>T</b>,2 x 10-10,,0.21,'-,0.0542 unit decrease,[0.037-0.072],MTR,Homocysteine levels,homocysteine measurement,GCST002087,1:236885376
rs7422339-<b>A</b>,5 x 10-27,,0.33,'-,0.0864 unit increase,[0.071-0.102],CPS1,Homocysteine levels,homocysteine measurement,GCST002087,2:210675783
rs9369898-<b>A</b>,2 x 10-10,,0.62,'-,0.0449 unit increase,[0.031-0.059],"EEF1A1P42, MMUT",Homocysteine levels,homocysteine measurement,GCST002087,6:49414480
rs7130284-<b>T</b>,2 x 10-20,,0.07,'-,0.1242 unit decrease,[0.099-0.15],NOX4,Homocysteine levels,homocysteine measurement,GCST002087,11:89415204
rs154657-<b>A</b>,2 x 10-43,,0.47,'-,0.0963 unit increase,[0.083-0.11],CHMP1A,Homocysteine levels,homocysteine measurement,GCST002087,16:89641688
rs234709-<b>T</b>,4 x 10-24,,0.45,'-,0.0718 unit decrease,[0.058-0.086],CBS,Homocysteine levels,homocysteine measurement,GCST002087,21:43066854
rs4660306-<b>T</b>,2 x 10-9,,0.33,'-,0.0435 unit increase,[0.03-0.057],"MMACHC, PRDX1",Homocysteine levels,homocysteine measurement,GCST002087,1:45513003
rs548987-<b>C</b>,1 x 10-8,,0.13,'-,0.0597 unit increase,[0.04-0.079],SLC17A3,Homocysteine levels,homocysteine measurement,GCST002087,6:25869143
rs42648-<b>A</b>,2 x 10-8,,0.4,'-,0.0395 unit decrease,[0.026-0.053],GTPBP10,Homocysteine levels,homocysteine measurement,GCST002087,7:90348446
rs1801222-<b>A</b>,8 x 10-10,,0.34,'-,0.0453 unit increase,[0.032-0.059],CUBN,Homocysteine levels,homocysteine measurement,GCST002087,10:17114152
rs2251468-<b>A</b>,1 x 10-12,,0.65,'-,0.0512 unit decrease,[0.037-0.065],HNF1A-AS1,Homocysteine levels,homocysteine measurement,GCST002087,12:120967323
rs838133-<b>A</b>,7 x 10-9,,0.45,'-,0.0422 unit increase,[0.028-0.056],FGF21,Homocysteine levels,homocysteine measurement,GCST002087,19:48756272
rs12134663-<b>A</b>,3 x 10-21,,0.8,'-,0.101 unit decrease,[0.079-0.123],"C1orf167-AS1, C1orf167",Homocysteine levels,homocysteine measurement,GCST002087,1:11778589
rs12780845-<b>A</b>,8 x 10-10,,0.65,'-,0.0529 unit increase,[0.035-0.071],TRDMT1,Homocysteine levels,homocysteine measurement,GCST002087,10:17181245
rs957140-<b>A</b>,2 x 10-8,,0.45,'-,0.045 unit decrease,[0.029-0.061],NOX4,Homocysteine levels,homocysteine measurement,GCST002087,11:89468459
rs12921383-<b>T</b>,8 x 10-11,,0.87,'-,0.09 unit decrease,[0.063-0.117],FANCA,Homocysteine levels,homocysteine measurement,GCST002087,16:89793345
rs2851391-<b>T</b>,2 x 10-12,,0.47,'-,0.056 unit increase,[0.04-0.072],CBS,Homocysteine levels,homocysteine measurement,GCST002087,21:43067294
rs7678928-<b>T</b>,6 x 10-19,,0.46,'-,0.09 unit increase,[0.065-0.115],PPM1K-DT,Branched-chain amino acid levels (Isoleucine),amino acid measurement,GCST006077,4:88301675
rs1260326-<b>T</b>,1 x 10-9,,0.41,'-,0.06 unit increase,[0.036-0.084],'-,Branched-chain amino acid levels (Isoleucine),amino acid measurement,GCST006077,Mapping not available
rs75950518-<b>C</b>,2 x 10-8,,0.11,'-,0.11 unit increase,[0.073-0.147],DDX19A-DT,Branched-chain amino acid levels (Isoleucine),amino acid measurement,GCST006077,16:70345014
rs58101275-<b>G</b>,3 x 10-8,,0.79,'-,0.09 unit increase,[0.061-0.119],"TRMT61A, RNU7-160P",Branched-chain amino acid levels (Isoleucine),amino acid measurement,GCST006077,14:103542083
rs1420601-<b>C</b>,4 x 10-8,,0.4,'-,0.07 unit increase,[0.045-0.095],MTND4LP25,Branched-chain amino acid levels (Isoleucine),amino acid measurement,GCST006077,16:49051738
rs1440581-<b>C</b>,4 x 10-25,,0.53,'-,0.08 unit increase,[0.055-0.105],PPM1K-DT,Branched-chain amino acid levels (Leucine),amino acid measurement,GCST006076,4:88305270
rs1260326-<b>T</b>,2 x 10-7,,NR,'-,0.049 unit increase,[0.023-0.075],'-,Branched-chain amino acid levels (Leucine),amino acid measurement,GCST006076,Mapping not available
rs75950518-<b>C</b>,3 x 10-6,,NR,'-,0.096 unit increase,[0.056-0.136],DDX19A-DT,Branched-chain amino acid levels (Valine),amino acid measurement,GCST006078,16:70345014
rs1440581-<b>C</b>,4 x 10-24,,0.53,'-,0.1 unit increase,[-0.15480-0.35480],PPM1K-DT,Branched-chain amino acid levels (Valine),amino acid measurement,GCST006078,4:88305270
rs1260326-<b>T</b>,9 x 10-7,,NR,'-,0.05 unit increase,[0.024-0.076],'-,Branched-chain amino acid levels (Valine),amino acid measurement,GCST006078,Mapping not available
rs28929474-<b>T</b>,3 x 10-13,(Glycoprotein acetyls),0.02,'-,0.29 unit decrease,[0.21-0.37],'-,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,Mapping not available
rs77303550-<b>T</b>,4 x 10-30,(Glycoprotein acetyls),0.19,'-,0.15 unit increase,[0.13-0.17],TXNL4B,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,16:72045758
rs2079742-<b>C</b>,9 x 10-14,(Creatinine),0.18,'-,0.1 unit increase,[0.08-0.12],BCAS3,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,17:61388336
rs2072510-<b>?</b>,5 x 10-11,"(Histidine, conditioned)",NR,'-,0.0689075 unit decrease,[0.048-0.089],LTA4H,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,12:96009421
rs1260326-<b>C</b>,7 x 10-26,(Alanine),0.64,'-,0.1 unit decrease,[0.08-0.12],'-,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,Mapping not available
rs10211524-<b>A</b>,5 x 10-20,(Valine),0.41,'-,0.09 unit increase,[0.07-0.11],LINC02245,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,2:64980940
rs7954638-<b>A</b>,7 x 10-15,(Histidine),0.48,'-,0.08 unit decrease,[0.06-0.1],CCDC38,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,12:95921017
rs1047891-<b>A</b>,1 x 10-300,(Glycine),0.33,'-,0.49 unit increase,[0.47-0.51],CPS1,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,2:210675783
rs74249229-<b>T</b>,2 x 10-11,(Pyruvate),0.05,'-,0.15 unit decrease,[0.11-0.19],"WWP2, CLEC18A",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,16:69945368
rs10083777-<b>T</b>,3 x 10-13,(Glycine),0.17,'-,0.11 unit decrease,[0.09-0.13],"CENPN, CENPN-AS1",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,16:81031677
rs34226052-<b>?</b>,5 x 10-12,"(Valine, conditioned)",NR,'-,0.0967459 unit decrease,[0.069-0.124],"ABCG2, PPM1K",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,4:88242371
rs9637599-<b>C</b>,2 x 10-35,(Valine),0.47,'-,0.11 unit increase,[0.09-0.13],PPM1K-DT,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,4:88285078
rs2921604-<b>C</b>,4 x 10-25,(Citrate),0.44,'-,0.1 unit increase,[0.08-0.12],ANKH,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,5:14867839
rs14399-<b>A</b>,1 x 10-24,(Tyrosine),0.39,'-,0.1 unit decrease,[0.08-0.12],SLC16A10,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,6:111222741
rs10466351-<b>T</b>,3 x 10-13,(Glucose),0.38,'-,0.07 unit increase,[0.05-0.09],"MTNR1B, SNRPGP16",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,11:92964815
rs2657879-<b>G</b>,3 x 10-70,(Glutamine),0.18,'-,0.22 unit decrease,[0.2-0.24],"SPRYD4, GLS2",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,12:56471554
rs1718309-<b>G</b>,3 x 10-15,(Phenylalanine),0.6,'-,0.08 unit decrease,[0.06-0.1],PAH,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,12:102848618
rs61524473-<b>C</b>,1 x 10-15,(Creatinine),0.26,'-,0.09 unit increase,[0.07-0.11],"RNU6-953P, SLC28A2",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,15:45354085
rs172642-<b>C</b>,5 x 10-18,(Citrate),0.48,'-,0.08 unit increase,[0.06-0.1],"SLC13A5, ALOX15P1, C17orf100",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,17:6692079
rs2040771-<b>T</b>,1 x 10-22,(Citrate),0.48,'-,0.09 unit decrease,[0.07-0.11],"SLC25A1, LINC01311",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,22:19174422
chr3:125905336-<b>A</b>,1 x 10-9,(Glycine),0.4,'-,0.07 unit increase,[0.05-0.09],'-,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,Mapping not available
rs140348140-<b>TA</b>,4 x 10-40,(Glycine),0.05,'-,0.33 unit increase,[0.27-0.39],"KIAA2026, AK4P4",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,9:5877296
rs4554975-<b>G</b>,6 x 10-13,(Alanine),0.64,'-,0.07 unit decrease,[0.05-0.09],SLC38A4,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,12:46808031
rs560887-<b>C</b>,3 x 10-32,(Glucose),0.7,'-,0.12 unit increase,[0.1-0.14],"SPC25, G6PC2",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,2:168906638
rs1998848-<b>A</b>,5 x 10-10,(Histidine),0.05,'-,0.15 unit increase,[0.11-0.19],NDRG2,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,14:21024070
rs184650103-<b>T</b>,1 x 10-36,(Albumin),0.01,'-,0.6 unit decrease,[0.5-0.7],"PPBP, PF4",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,4:73984932
rs1986734-<b>T</b>,3 x 10-10,(Creatinine),0.56,'-,0.06 unit increase,[0.04-0.08],SHROOM3,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,4:76499631
rs3733402-<b>A</b>,9 x 10-15,(Histidine),0.57,'-,0.08 unit increase,[0.06-0.1],KLKB1,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,4:186236880
rs2731672-<b>C</b>,4 x 10-16,(Phenylalanine),0.74,'-,0.09 unit increase,[0.07-0.11],GRK6,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,5:177415473
rs878521-<b>A</b>,8 x 10-14,(Glucose),0.22,'-,0.09 unit increase,[0.07-0.11],"CAMK2B, YKT6",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,7:44216044
rs10265221-<b>C</b>,8 x 10-11,(Creatinine),0.24,'-,0.07 unit increase,[0.05-0.09],PRKAG2,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,7:151717243
rs2169387-<b>G</b>,1 x 10-16,(Glycine),0.87,'-,0.13 unit decrease,[0.091-0.169],"RNU6-1151P, RNU6-526P",Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,8:9323885
rs7078003-<b>T</b>,3 x 10-10,(Glutamine),0.2,'-,0.07 unit increase,[0.05-0.09],HOGA1,Metabolite levels (small molecules and protein measures),"blood metabolite measurement, protein measurement, amino acid measurement",GCST003666,10:97599655
rs12613336-<b>?</b>,2 x 10-7,(Cit (adjusted for Gly)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"amino acid measurement, citrulline measurement",GCST007383,2:210704675
rs1744297-<b>?</b>,2 x 10-6,(Cit (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"amino acid measurement, citrulline measurement",GCST007383,14:104102135
rs1744297-<b>?</b>,9 x 10-24,(Met (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"methionine measurement, amino acid measurement",GCST007383,14:104102135
rs17450273-<b>?</b>,2 x 10-9,(Met (adjusted for Phe)),'-,'-,'-,'-,ASCL1,Plasma free amino acid levels (adjusted for one other PFAA),"methionine measurement, amino acid measurement",GCST007383,12:102967601
rs13244654-<b>?</b>,2 x 10-7,(Met (adjusted for Ser)),'-,'-,'-,'-,SUMF2,Plasma free amino acid levels (adjusted for one other PFAA),"methionine measurement, amino acid measurement",GCST007383,7:56079263
rs62149891-<b>A</b>,6 x 10-9,(Met),0.29,'-,0.23 unit decrease,[0.15-0.31],CCT4,Plasma free amino acid levels,"methionine measurement, amino acid measurement",GCST007385,2:61877999
rs588682-<b>G</b>,3 x 10-8,(Ala),0.09,'-,0.38 unit increase,[0.24-0.52],DLGAP1,Plasma free amino acid levels,"alanine measurement, amino acid measurement",GCST007385,18:3558080
rs2238732-<b>C</b>,7 x 10-11,(Ala),'-,'-,0.25 unit decrease,[0.17-0.33],PRODH,Plasma free amino acid levels (adjusted for twenty other PFAAs),"alanine measurement, amino acid measurement",GCST007382,22:18927834
rs2238732-<b>?</b>,7 x 10-11,(Ala),'-,'-,0.25 unit decrease,[0.17-0.33],PRODH,Plasma free amino acid levels (adjusted for twenty other PFAAs),"alanine measurement, amino acid measurement",GCST007382,22:18927834
rs2238732-<b>?</b>,7 x 10-19,(Ala (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"alanine measurement, amino acid measurement",GCST007383,22:18927834
rs1744297-<b>?</b>,2 x 10-8,(Ala (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"alanine measurement, amino acid measurement",GCST007383,14:104102135
rs75444260-<b>A</b>,7 x 10-9,(His),0.11,'-,0.42 unit increase,[0.28-0.56],PRKAR1B,Plasma free amino acid levels,"histidine measurement, amino acid measurement",GCST007385,7:635944
rs1744297-<b>?</b>,1 x 10-12,(His (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"histidine measurement, amino acid measurement",GCST007383,14:104102135
rs2238732-<b>?</b>,3 x 10-6,(His (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"histidine measurement, amino acid measurement",GCST007383,22:18927834
rs1744297-<b>?</b>,8 x 10-27,(Thr (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"amino acid measurement, threonine measurement",GCST007383,14:104102135
rs12613336-<b>?</b>,6 x 10-11,(Thr (adjusted for Gly)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"amino acid measurement, threonine measurement",GCST007383,2:210704675
rs2238732-<b>?</b>,1 x 10-8,(Thr (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"amino acid measurement, threonine measurement",GCST007383,22:18927834
rs13244654-<b>?</b>,4 x 10-8,(Thr (adjusted for Ser)),'-,'-,'-,'-,SUMF2,Plasma free amino acid levels (adjusted for one other PFAA),"amino acid measurement, threonine measurement",GCST007383,7:56079263
rs12613336-<b>?</b>,5 x 10-8,(Thr (adjusted for Ser)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"amino acid measurement, threonine measurement",GCST007383,2:210704675
rs62149891-<b>A</b>,2 x 10-8,(Thr),0.29,'-,0.23 unit decrease,[0.15-0.31],CCT4,Plasma free amino acid levels,"amino acid measurement, threonine measurement",GCST007385,2:61877999
rs1744297-<b>?</b>,5 x 10-6,(Thr),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for twenty other PFAAs),"amino acid measurement, threonine measurement",GCST007382,14:104102135
rs56335308-<b>G</b>,5 x 10-14,(Orn),0.93,'-,0.35 unit decrease,[0.25-0.45],SLC7A2,Plasma free amino acid levels (adjusted for twenty other PFAAs),"ornithine measurement, amino acid measurement",GCST007382,8:17561952
rs7008481-<b>G</b>,2 x 10-8,(Orn),'-,'-,0.18 unit decrease,[0.12-0.24],"PDGFRL, SLC7A2",Plasma free amino acid levels (adjusted for twenty other PFAAs),"ornithine measurement, amino acid measurement",GCST007382,8:17574169
rs2238732-<b>?</b>,7 x 10-11,(Leu (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"leucine measurement, amino acid measurement",GCST007383,22:18927834
rs10437868-<b>T</b>,3 x 10-8,(Leu),0.02,'-,0.79 unit increase,[0.52-1.06],NAV3,Plasma free amino acid levels,"leucine measurement, amino acid measurement",GCST007385,12:77508538
rs117936590-<b>C</b>,2 x 10-8,(Leu),0.04,'-,0.52 unit increase,[0.34-0.7],"LINC02067, SPTSSB",Plasma free amino acid levels,"leucine measurement, amino acid measurement",GCST007385,3:161421071
rs1744297-<b>?</b>,2 x 10-8,(Trp (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"tryptophan measurement, amino acid measurement",GCST007383,14:104102135
rs75444260-<b>A</b>,3 x 10-8,(Trp),0.11,'-,0.39 unit increase,[0.25-0.53],PRKAR1B,Plasma free amino acid levels,"tryptophan measurement, amino acid measurement",GCST007385,7:635944
rs1744297-<b>?</b>,2 x 10-14,(Lys (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"lysine measurement, amino acid measurement",GCST007383,14:104102135
rs12613336-<b>?</b>,9 x 10-6,(Lys (adjusted for Gly)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"lysine measurement, amino acid measurement",GCST007383,2:210704675
rs9549153-<b>G</b>,3 x 10-8,(Lys),0.26,'-,0.22 unit increase,[0.14-0.3],LINC00598,Plasma free amino acid levels,"lysine measurement, amino acid measurement",GCST007385,13:40293411
rs2657879-<b>A</b>,3 x 10-11,(Gln),0.09,'-,0.41 unit decrease,[0.29-0.53],"SPRYD4, GLS2",Plasma free amino acid levels,"glutamine measurement, amino acid measurement",GCST007385,12:56471554
rs7302925-<b>A</b>,1 x 10-10,(Gln),0.1,'-,0.39 unit decrease,[0.27-0.51],MIP,Plasma free amino acid levels,"glutamine measurement, amino acid measurement",GCST007385,12:56467674
rs7302925-<b>?</b>,1 x 10-13,(Gln (adjusted for Ser)),'-,'-,'-,'-,MIP,Plasma free amino acid levels (adjusted for one other PFAA),"glutamine measurement, amino acid measurement",GCST007383,12:56467674
rs7302925-<b>?</b>,2 x 10-13,(Gln (adjusted for Asn)),'-,'-,'-,'-,MIP,Plasma free amino acid levels (adjusted for one other PFAA),"glutamine measurement, amino acid measurement",GCST007383,12:56467674
rs7302925-<b>?</b>,4 x 10-13,(Gln (adjusted for Gly)),'-,'-,'-,'-,MIP,Plasma free amino acid levels (adjusted for one other PFAA),"glutamine measurement, amino acid measurement",GCST007383,12:56467674
rs1744297-<b>?</b>,1 x 10-11,(Gln (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"glutamine measurement, amino acid measurement",GCST007383,14:104102135
rs7302925-<b>?</b>,2 x 10-11,(Gln (adjusted for Phe)),'-,'-,'-,'-,MIP,Plasma free amino acid levels (adjusted for one other PFAA),"glutamine measurement, amino acid measurement",GCST007383,12:56467674
rs7302925-<b>?</b>,3 x 10-11,(Gln (adjusted for Pro)),'-,'-,'-,'-,MIP,Plasma free amino acid levels (adjusted for one other PFAA),"glutamine measurement, amino acid measurement",GCST007383,12:56467674
rs12613336-<b>?</b>,2 x 10-9,(Gln (adjusted for Gly)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"glutamine measurement, amino acid measurement",GCST007383,2:210704675
rs7302925-<b>A</b>,2 x 10-18,(Gln),'-,'-,0.41 unit decrease,[0.31-0.51],MIP,Plasma free amino acid levels (adjusted for twenty other PFAAs),"glutamine measurement, amino acid measurement",GCST007382,12:56467674
rs774211-<b>T</b>,4 x 10-13,(Gln),'-,'-,0.3 unit decrease,[0.22-0.38],RBMS2,Plasma free amino acid levels (adjusted for twenty other PFAAs),"glutamine measurement, amino acid measurement",GCST007382,12:56527155
rs2657879-<b>A</b>,2 x 10-18,(Gln),'-,'-,0.41 unit decrease,[0.31-0.51],"SPRYD4, GLS2",Plasma free amino acid levels (adjusted for twenty other PFAAs),"glutamine measurement, amino acid measurement",GCST007382,12:56471554
rs12587001-<b>C</b>,2 x 10-37,(Asn),0.13,'-,0.69 unit increase,[0.59-0.79],"KIF26A, MIR203A",Plasma free amino acid levels,"asparagine measurement, amino acid measurement",GCST007385,14:104135840
rs61997624-<b>C</b>,3 x 10-45,(Asn),0.13,'-,0.78 unit increase,[0.68-0.88],"MIR203A, ASPG",Plasma free amino acid levels,"asparagine measurement, amino acid measurement",GCST007385,14:104116049
rs33984773-<b>G</b>,2 x 10-8,(Asn),'-,'-,0.15 unit increase,[0.091-0.209],ATP5MJ,Plasma free amino acid levels (adjusted for twenty other PFAAs),"asparagine measurement, amino acid measurement",GCST007382,14:103927429
rs1744297-<b>T</b>,3 x 10-107,(Asn),'-,'-,0.77 unit increase,[0.71-0.83],ASPG,Plasma free amino acid levels (adjusted for twenty other PFAAs),"asparagine measurement, amino acid measurement",GCST007382,14:104102135
rs12587001-<b>C</b>,5 x 10-74,(Asn),'-,'-,0.65 unit increase,[0.59-0.71],"KIF26A, MIR203A",Plasma free amino acid levels (adjusted for twenty other PFAAs),"asparagine measurement, amino acid measurement",GCST007382,14:104135840
rs61997624-<b>C</b>,2 x 10-91,(Asn),'-,'-,0.73 unit increase,[0.67-0.79],"MIR203A, ASPG",Plasma free amino acid levels (adjusted for twenty other PFAAs),"asparagine measurement, amino acid measurement",GCST007382,14:104116049
rs7838611-<b>?</b>,1 x 10-7,(Arg),NR,'-,'-,'-,SLC7A2,Plasma free amino acid levels,"L-arginine measurement, amino acid measurement",GCST007385,8:17565208
rs56335308-<b>G</b>,3 x 10-16,(Arg),0.93,'-,0.43 unit decrease,[0.33-0.53],SLC7A2,Plasma free amino acid levels (adjusted for twenty other PFAAs),"L-arginine measurement, amino acid measurement",GCST007382,8:17561952
rs12613336-<b>?</b>,1 x 10-6,(Arg),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for twenty other PFAAs),"L-arginine measurement, amino acid measurement",GCST007382,2:210704675
rs9792282-<b>G</b>,3 x 10-8,(Arg),'-,'-,0.18 unit decrease,[0.12-0.24],PDGFRL,Plasma free amino acid levels (adjusted for twenty other PFAAs),"L-arginine measurement, amino acid measurement",GCST007382,8:17580930
rs12613336-<b>?</b>,1 x 10-13,(Arg (adjusted for Gly)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,2:210704675
rs7838611-<b>?</b>,4 x 10-9,(Arg (adjusted for Asn)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,8:17565208
rs7838611-<b>?</b>,3 x 10-8,(Arg (adjusted for Gln)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,8:17565208
rs12613336-<b>?</b>,5 x 10-8,(Arg (adjusted for Ser)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,2:210704675
rs7838611-<b>?</b>,1 x 10-7,(Arg (adjusted for Phe)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,8:17565208
rs7838611-<b>?</b>,1 x 10-7,(Arg (adjusted for Ser)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,8:17565208
rs7838611-<b>?</b>,2 x 10-7,(Arg (adjusted for Pro)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,8:17565208
rs7838611-<b>?</b>,4 x 10-7,(Arg (adjusted for Gly)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),"L-arginine measurement, amino acid measurement",GCST007383,8:17565208
rs2238732-<b>?</b>,2 x 10-45,(Pro (adjusted for Phe)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"proline measurement, amino acid measurement",GCST007383,22:18927834
rs2238732-<b>?</b>,1 x 10-43,(Pro (adjusted for Asn)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"proline measurement, amino acid measurement",GCST007383,22:18927834
rs2238732-<b>?</b>,2 x 10-43,(Pro (adjusted for Gln)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"proline measurement, amino acid measurement",GCST007383,22:18927834
rs2238732-<b>?</b>,9 x 10-41,(Pro (adjusted for Ser)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"proline measurement, amino acid measurement",GCST007383,22:18927834
rs2238732-<b>?</b>,1 x 10-39,(Pro (adjusted for Gly)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"proline measurement, amino acid measurement",GCST007383,22:18927834
rs1744297-<b>?</b>,5 x 10-6,(Pro (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"proline measurement, amino acid measurement",GCST007383,14:104102135
rs2080346-<b>G</b>,3 x 10-10,(Pro),0.31,'-,0.26 unit increase,[0.18-0.34],"DGCR6, FAM230F",Plasma free amino acid levels,"proline measurement, amino acid measurement",GCST007385,22:18905062
rs116267673-<b>C</b>,2 x 10-12,(Pro),'-,'-,0.4 unit increase,[0.28-0.52],"DGCR6, FAM230F",Plasma free amino acid levels (adjusted for twenty other PFAAs),"proline measurement, amino acid measurement",GCST007382,22:18902454
rs2238732-<b>C</b>,1 x 10-69,(Pro),'-,'-,0.72 unit increase,[0.64-0.8],PRODH,Plasma free amino acid levels (adjusted for twenty other PFAAs),"proline measurement, amino acid measurement",GCST007382,22:18927834
rs17450273-<b>?</b>,4 x 10-13,(Phe (adjusted for Asn)),'-,'-,'-,'-,ASCL1,Plasma free amino acid levels (adjusted for one other PFAA),"phenylalanine measurement, amino acid measurement",GCST007383,12:102967601
rs17450273-<b>?</b>,1 x 10-11,(Phe (adjusted for Gln)),'-,'-,'-,'-,ASCL1,Plasma free amino acid levels (adjusted for one other PFAA),"phenylalanine measurement, amino acid measurement",GCST007383,12:102967601
rs17450273-<b>?</b>,3 x 10-11,(Phe (adjusted for Pro)),'-,'-,'-,'-,ASCL1,Plasma free amino acid levels (adjusted for one other PFAA),"phenylalanine measurement, amino acid measurement",GCST007383,12:102967601
rs17450273-<b>?</b>,7 x 10-11,(Phe (adjusted for Ser)),'-,'-,'-,'-,ASCL1,Plasma free amino acid levels (adjusted for one other PFAA),"phenylalanine measurement, amino acid measurement",GCST007383,12:102967601
rs17450273-<b>?</b>,8 x 10-10,(Phe (adjusted for Gly)),'-,'-,'-,'-,ASCL1,Plasma free amino acid levels (adjusted for one other PFAA),"phenylalanine measurement, amino acid measurement",GCST007383,12:102967601
rs1744297-<b>?</b>,5 x 10-8,(Phe (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"phenylalanine measurement, amino acid measurement",GCST007383,14:104102135
rs2238732-<b>?</b>,6 x 10-7,(Phe (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"phenylalanine measurement, amino acid measurement",GCST007383,22:18927834
rs17450122-<b>A</b>,3 x 10-12,(Phe),0.09,'-,0.41 unit increase,[0.29-0.53],ASCL1,Plasma free amino acid levels,"phenylalanine measurement, amino acid measurement",GCST007385,12:102960616
rs1718302-<b>G</b>,6 x 10-10,(Phe),0.14,'-,0.31 unit increase,[0.21-0.41],PAH,Plasma free amino acid levels,"phenylalanine measurement, amino acid measurement",GCST007385,12:102878908
rs78985461-<b>G</b>,8 x 10-12,(Phe),'-,'-,0.34 unit increase,[0.26-0.42],PAH,Plasma free amino acid levels (adjusted for twenty other PFAAs),"phenylalanine measurement, amino acid measurement",GCST007382,12:102901858
rs17450122-<b>A</b>,3 x 10-25,(Phe),'-,'-,0.42 unit increase,[0.34-0.5],ASCL1,Plasma free amino acid levels (adjusted for twenty other PFAAs),"phenylalanine measurement, amino acid measurement",GCST007382,12:102960616
rs11761352-<b>C</b>,9 x 10-17,(Ser),0.38,'-,0.3 unit decrease,[0.22-0.38],"SEPTIN14, ZNF713",Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:55883254
rs7793921-<b>G</b>,2 x 10-21,(Ser),0.39,'-,0.34 unit decrease,[0.28-0.4],CCT6A,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56053188
rs816411-<b>C</b>,4 x 10-20,(Ser),0.37,'-,0.33 unit decrease,[0.27-0.39],CHCHD2,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56103796
rs12613336-<b>T</b>,5 x 10-12,(Ser),0.15,'-,0.34 unit increase,[0.24-0.44],CPS1,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,2:210704675
rs4535700-<b>T</b>,4 x 10-21,(Ser),0.37,'-,0.34 unit decrease,[0.26-0.42],NIPSNAP2,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:55977755
rs816396-<b>T</b>,8 x 10-11,(Ser),0.2,'-,0.29 unit decrease,[0.21-0.37],"CCNJP1, IFITM3P4",Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56169587
rs7782243-<b>A</b>,8 x 10-12,(Ser),0.28,'-,0.27 unit decrease,[0.19-0.35],"CHCHD2, NUPR2",Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56114152
rs2538054-<b>A</b>,2 x 10-11,(Ser),0.22,'-,0.29 unit decrease,[0.21-0.37],"IFITM3P4, NUPR2",Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56142748
rs34148685-<b>T</b>,2 x 10-8,(Ser),0.2,'-,0.25 unit increase,[0.17-0.33],"IFITM3P4, NUPR2",Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56156046
rs12671091-<b>T</b>,2 x 10-16,(Ser),0.48,'-,0.29 unit decrease,[0.23-0.35],"NIPSNAP2, ZNF713",Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:55950973
rs2242508-<b>A</b>,2 x 10-21,(Ser),0.33,'-,0.36 unit decrease,[0.28-0.44],PHKG1,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56083796
rs35210477-<b>A</b>,7 x 10-11,(Ser),0.2,'-,0.29 unit increase,[0.21-0.37],PSPH,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56044524
rs11766051-<b>G</b>,9 x 10-15,(Ser),0.41,'-,0.28 unit decrease,[0.2-0.36],PSPHP1,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:55770852
rs13244654-<b>?</b>,1 x 10-24,(Ser (adjusted for Asn)),'-,'-,'-,'-,SUMF2,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,7:56079263
rs13244654-<b>?</b>,4 x 10-22,(Ser (adjusted for Gln)),'-,'-,'-,'-,SUMF2,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,7:56079263
rs13244654-<b>?</b>,5 x 10-22,(Ser (adjusted for Pro)),'-,'-,'-,'-,SUMF2,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,7:56079263
rs13244654-<b>?</b>,7 x 10-21,(Ser (adjusted for Phe)),'-,'-,'-,'-,SUMF2,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,7:56079263
rs13244654-<b>?</b>,3 x 10-18,(Ser (adjusted for Gly)),'-,'-,'-,'-,SUMF2,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,7:56079263
rs12613336-<b>?</b>,5 x 10-17,(Ser (adjusted for Asn)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,2:210704675
rs12613336-<b>?</b>,9 x 10-14,(Ser (adjusted for Pro)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,2:210704675
rs12613336-<b>?</b>,2 x 10-13,(Ser (adjusted for Phe)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,2:210704675
rs12613336-<b>?</b>,4 x 10-13,(Ser (adjusted for Gln)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,2:210704675
rs1744297-<b>?</b>,1 x 10-11,(Ser (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"serine measurement, amino acid measurement",GCST007383,14:104102135
rs13244654-<b>T</b>,2 x 10-21,(Ser),0.31,'-,0.36 unit decrease,[0.28-0.44],SUMF2,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:56079263
rs2135116-<b>A</b>,1 x 10-19,(Ser),0.36,'-,0.33 unit decrease,[0.25-0.41],ZNF713,Plasma free amino acid levels,"serine measurement, amino acid measurement",GCST007385,7:55923451
rs13244654-<b>?</b>,1 x 10-25,(Ser),'-,'-,0.28 unit decrease,[-0.3668-0.9268],SUMF2,Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56079263
rs6966061-<b>A</b>,9 x 10-13,(Ser),'-,'-,0.18 unit decrease,[0.14-0.22],"PSPHP1, RNU6-1126P",Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:55781097
rs11761352-<b>C</b>,4 x 10-19,(Ser),'-,'-,0.23 unit decrease,[0.19-0.27],"SEPTIN14, ZNF713",Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:55883254
rs2135116-<b>A</b>,1 x 10-22,(Ser),'-,'-,0.25 unit decrease,[0.19-0.31],ZNF713,Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:55923451
rs12671091-<b>T</b>,4 x 10-20,(Ser),'-,'-,0.23 unit decrease,[0.19-0.27],"NIPSNAP2, ZNF713",Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:55950973
rs4535700-<b>T</b>,5 x 10-22,(Ser),'-,'-,0.25 unit decrease,[0.19-0.31],NIPSNAP2,Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:55977755
rs35210477-<b>A</b>,7 x 10-12,(Ser),'-,'-,0.21 unit increase,[0.15-0.27],PSPH,Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56044524
rs7793921-<b>G</b>,1 x 10-24,(Ser),'-,'-,0.26 unit decrease,[0.22-0.3],CCT6A,Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56053188
rs13244654-<b>T</b>,1 x 10-25,(Ser),'-,'-,0.28 unit decrease,[0.22-0.34],SUMF2,Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56079263
rs2242508-<b>A</b>,1 x 10-25,(Ser),'-,'-,0.28 unit decrease,[0.22-0.34],PHKG1,Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56083796
rs4948106-<b>T</b>,5 x 10-21,(Ser),'-,'-,0.24 unit decrease,[0.2-0.28],"CHCHD2, PHKG1",Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56099902
rs7782243-<b>A</b>,3 x 10-13,(Ser),'-,'-,0.2 unit decrease,[0.14-0.26],"CHCHD2, NUPR2",Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56114152
rs2538054-<b>A</b>,8 x 10-14,(Ser),'-,'-,0.23 unit decrease,[0.17-0.29],"IFITM3P4, NUPR2",Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56142748
rs816396-<b>T</b>,2 x 10-11,(Ser),'-,'-,0.21 unit decrease,[0.15-0.27],"CCNJP1, IFITM3P4",Plasma free amino acid levels (adjusted for twenty other PFAAs),"serine measurement, amino acid measurement",GCST007382,7:56169587
rs4673546-<b>C</b>,6 x 10-71,(Gly),0.16,'-,0.9 unit increase,[0.8-1],CPS1,Plasma free amino acid levels,"glycine measurement, amino acid measurement",GCST007385,2:210700968
rs1657863-<b>T</b>,3 x 10-8,(Gly),0.21,'-,0.26 unit increase,[0.16-0.36],'-,Plasma free amino acid levels,"glycine measurement, amino acid measurement",GCST007385,2:210995002
rs12613336-<b>?</b>,2 x 10-82,(Gly (adjusted for Asn)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,2:210704675
rs12613336-<b>?</b>,2 x 10-80,(Gly (adjusted for Gln)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,2:210704675
rs12613336-<b>?</b>,4 x 10-75,(Gly (adjusted for Pro)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,2:210704675
rs12613336-<b>?</b>,2 x 10-70,(Gly (adjusted for Phe)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,2:210704675
rs12613336-<b>?</b>,4 x 10-61,(Gly (adjusted for Ser)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,2:210704675
rs8059153-<b>?</b>,8 x 10-8,(Gly (adjusted for Ser)),'-,'-,'-,'-,PKD1L2,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,16:81112070
rs8059153-<b>?</b>,9 x 10-7,(Gly (adjusted for Phe)),'-,'-,'-,'-,PKD1L2,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,16:81112070
rs8059153-<b>?</b>,4 x 10-6,(Gly (adjusted for Pro)),'-,'-,'-,'-,PKD1L2,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,16:81112070
rs8059153-<b>?</b>,8 x 10-6,(Gly (adjusted for Asn)),'-,'-,'-,'-,PKD1L2,Plasma free amino acid levels (adjusted for one other PFAA),"glycine measurement, amino acid measurement",GCST007383,16:81112070
rs8059153-<b>?</b>,9 x 10-7,(Gly),NR,'-,'-,'-,PKD1L2,Plasma free amino acid levels,"glycine measurement, amino acid measurement",GCST007385,16:81112070
rs715-<b>T</b>,2 x 10-75,(Gly),'-,'-,0.72 unit increase,[0.64-0.8],CPS1,Plasma free amino acid levels (adjusted for twenty other PFAAs),"glycine measurement, amino acid measurement",GCST007382,2:210678331
rs10172053-<b>T</b>,2 x 10-50,(Gly),'-,'-,0.64 unit increase,[0.56-0.72],'-,Plasma free amino acid levels (adjusted for twenty other PFAAs),"glycine measurement, amino acid measurement",GCST007382,2:210779923
rs4310999-<b>G</b>,1 x 10-12,(Gly),'-,'-,0.3 unit increase,[0.22-0.38],'-,Plasma free amino acid levels (adjusted for twenty other PFAAs),"glycine measurement, amino acid measurement",GCST007382,2:210885574
rs651797-<b>G</b>,7 x 10-10,(Gly),'-,'-,0.26 unit increase,[0.18-0.34],'-,Plasma free amino acid levels (adjusted for twenty other PFAAs),"glycine measurement, amino acid measurement",GCST007382,2:210992001
rs8059153-<b>T</b>,1 x 10-8,(Gly),'-,'-,0.21 unit decrease,[0.13-0.29],PKD1L2,Plasma free amino acid levels (adjusted for twenty other PFAAs),"glycine measurement, amino acid measurement",GCST007382,16:81112070
rs145273360-<b>A</b>,2 x 10-8,(Methionine),0.9768,'-,0.2177 unit increase,[0.14-0.29],NKAIN3,Metabolite levels,methionine measurement,GCST009698,8:62339883
rs139435405-<b>C</b>,2 x 10-8,(S-adenosylhomocysteine),0.75,'-,0.23 unit increase,[0.15-0.31],"RN7SKP21, PTCSC3",Blood metabolite levels,"S-adenosylhomocysteine measurement, blood metabolite measurement",GCST009318,14:36186245
rs17636097-<b>?</b>,4 x 10-7,(S adenosylhomocysteine),NR,'-,1.041641 unit decrease,[0.64-1.44],"UBA52P9, LINC01908",Metabolite levels,S-adenosylhomocysteine measurement,GCST009391,18:27311642
rs11788188-<b>?</b>,1 x 10-6,(S adenosylhomocysteine),NR,'-,2.2683039 unit decrease,[1.36-3.18],CACNA1B,Metabolite levels,S-adenosylhomocysteine measurement,GCST009391,9:138039405
rs6772767-<b>?</b>,5 x 10-6,(S adenosylhomocysteine),NR,'-,3.25514 unit increase,[1.86-4.65],'-,Metabolite levels,S-adenosylhomocysteine measurement,GCST009391,3:191904583
rs2039860-<b>?</b>,9 x 10-6,(S adenosylhomocysteine),NR,'-,0.38154858 unit decrease,[0.21-0.55],GNG5P5,Metabolite levels,S-adenosylhomocysteine measurement,GCST009391,13:47325742
rs28391580-<b>T</b>,3 x 10-8,(cystathionine),0.27,'-,0.24 unit decrease,[0.16-0.32],'-,Blood metabolite levels,"cystathionine measurement, blood metabolite measurement",GCST009318,15:37741755
rs6573237-<b>?</b>,2 x 10-7,(argininosuccinate),NR,'-,0.90234065 unit increase,[0.56-1.24],LINC01500,Metabolite levels,argininosuccinate measurement,GCST009391,14:59025469
rs11680717-<b>?</b>,8 x 10-7,(argininosuccinate),NR,'-,0.832219 unit increase,[0.5-1.16],ALK,Metabolite levels,argininosuccinate measurement,GCST009391,2:29455065
rs6014682-<b>?</b>,3 x 10-6,(argininosuccinate),NR,'-,0.28241277 unit increase,[0.16-0.4],"MC3R, FAM210B",Metabolite levels,argininosuccinate measurement,GCST009391,20:56313111
rs17451237-<b>?</b>,5 x 10-6,(argininosuccinate),NR,'-,0.39027146 unit decrease,[0.22-0.56],'-,Metabolite levels,argininosuccinate measurement,GCST009391,1:55606522
rs6946431-<b>?</b>,8 x 10-6,(argininosuccinate),NR,'-,0.28468686 unit increase,[0.16-0.41],SLC26A4-AS1,Metabolite levels,argininosuccinate measurement,GCST009391,7:67943833
rs311837-<b>?</b>,9 x 10-6,(argininosuccinate),NR,'-,0.7805107 unit increase,[0.44-1.12],LINC01500,Metabolite levels,argininosuccinate measurement,GCST009391,14:58678237
rs6990439-<b>?</b>,3 x 10-6,(cystathionine),NR,'-,0.33615646 unit decrease,[0.19-0.48],"GFRA2, DOK2",Metabolite levels,cystathionine measurement,GCST009391,8:21854782
rs1376184-<b>?</b>,5 x 10-6,(cystathionine),NR,'-,0.45783824 unit decrease,[0.26-0.65],"SNORA75B, RPS7P6",Metabolite levels,cystathionine measurement,GCST009391,4:17366912
rs10214334-<b>?</b>,5 x 10-6,(cystathionine),NR,'-,0.23944381 unit decrease,[0.14-0.34],LINC02240,Metabolite levels,cystathionine measurement,GCST009391,5:125628839
rs17016534-<b>?</b>,5 x 10-6,(cystathionine),NR,'-,0.36163652 unit decrease,[0.21-0.52],CTNNA2,Metabolite levels,cystathionine measurement,GCST009391,2:79198332
rs2130846-<b>?</b>,5 x 10-6,(cystathionine),NR,'-,0.1896969 unit decrease,[0.11-0.27],LINC02240,Metabolite levels,cystathionine measurement,GCST009391,5:125528679
rs9581297-<b>T</b>,7 x 10-9,(Proline),0.2477,'-,0.0902 unit increase,[0.058-0.123],LINC01076,Metabolite levels,proline measurement,GCST009698,13:25209944
rs2277834-<b>T</b>,1 x 10-63,(Proline),0.1982,'-,0.2592 unit increase,[0.23-0.29],PRODH,Metabolite levels,proline measurement,GCST009698,22:18923032
rs12642791-<b>?</b>,1 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.23718525 unit decrease,[0.14-0.33],'-,Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,4:12884648
rs9964060-<b>?</b>,2 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.6452096 unit increase,[0.38-0.91],CTBP2P3,Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,18:60649112
rs11194188-<b>?</b>,5 x 10-6,(3-hydroxyanthranilic acid),NR,'-,5.5981274 unit increase,[3.19-8],'-,Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,10:108595604
rs12733028-<b>?</b>,9 x 10-8,(aminoadipic acid),NR,'-,0.24019045 unit decrease,[0.15-0.33],SPATA6,Metabolite levels,aminoadipic acid measurement,GCST009391,1:48318409
rs7553443-<b>?</b>,9 x 10-8,(aminoadipic acid),NR,'-,0.23994917 unit decrease,[0.15-0.33],SPATA6,Metabolite levels,aminoadipic acid measurement,GCST009391,1:48421447
rs10888599-<b>?</b>,3 x 10-7,(aminoadipic acid),NR,'-,0.23805691 unit decrease,[0.15-0.33],"SLC5A9, SKINT1L",Metabolite levels,aminoadipic acid measurement,GCST009391,1:48183818
rs17045020-<b>?</b>,8 x 10-7,(aminoadipic acid),NR,'-,0.71686244 unit increase,[0.43-1],RPL21P41,Metabolite levels,aminoadipic acid measurement,GCST009391,3:66705359
rs942123-<b>?</b>,5 x 10-6,(aminoadipic acid),NR,'-,0.5429422 unit decrease,[0.31-0.78],LINC01135,Metabolite levels,aminoadipic acid measurement,GCST009391,1:58839095
rs156121-<b>?</b>,7 x 10-6,(aminoadipic acid),NR,'-,0.1726992 unit increase,[0.097-0.248],RPS10-NUDT3,Metabolite levels,aminoadipic acid measurement,GCST009391,6:104364564
rs11223339-<b>?</b>,8 x 10-6,(aminoadipic acid),NR,'-,0.20125207 unit increase,[0.11-0.29],OPCML,Metabolite levels,aminoadipic acid measurement,GCST009391,11:133048569
rs16976298-<b>?</b>,6 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.39045116 unit decrease,[0.22-0.56],"DNAAF4-CCPG1, CCPG1",Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,15:55368028
rs7546115-<b>?</b>,8 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.20171025 unit increase,[0.11-0.29],PCNX2,Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,1:233251820
rs2140297-<b>?</b>,8 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.25133663 unit decrease,[0.14-0.36],TG,Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,8:132954659
rs2144019-<b>?</b>,8 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.5310788 unit increase,[0.3-0.76],TNFRSF21,Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,6:47177636
rs751-<b>?</b>,8 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.27447256 unit decrease,[0.15-0.4],"LINC01364, RNA5SP52",Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,1:87392286
rs6754354-<b>?</b>,9 x 10-6,(3-hydroxyanthranilic acid),NR,'-,0.21706262 unit decrease,[0.12-0.31],CREG2,Metabolite levels,3-hydroxyanthranilic acid measurement,GCST009391,2:101355870
rs9918159-<b>?</b>,3 x 10-7,(phosphocreatine),NR,'-,0.34641212 unit increase,[0.21-0.48],"LINC01333, LINC01331",Metabolite levels,phosphocreatine measurement,GCST009391,5:74335859
rs1780316-<b>?</b>,9 x 10-7,(phosphocreatine),NR,'-,0.45708147 unit decrease,[0.27-0.64],ALPL,Metabolite levels,phosphocreatine measurement,GCST009391,1:21563142
rs1514665-<b>?</b>,1 x 10-6,(phosphocreatine),NR,'-,0.20823045 unit decrease,[0.12-0.29],LINC02461,Metabolite levels,phosphocreatine measurement,GCST009391,12:43188590
rs12214992-<b>?</b>,2 x 10-6,(phosphocreatine),NR,'-,0.20993039 unit decrease,[0.12-0.3],TRDN,Metabolite levels,phosphocreatine measurement,GCST009391,6:123301920
rs6106143-<b>?</b>,2 x 10-6,(phosphocreatine),NR,'-,0.89169174 unit increase,[0.52-1.26],RIN2,Metabolite levels,phosphocreatine measurement,GCST009391,20:19847818
rs10058151-<b>?</b>,4 x 10-6,(phosphocreatine),NR,'-,0.35339555 unit increase,[0.2-0.5],TENM2,Metabolite levels,phosphocreatine measurement,GCST009391,5:167705221
rs13387947-<b>?</b>,6 x 10-6,(phosphocreatine),NR,'-,0.21780132 unit decrease,[0.12-0.31],MIR3681HG,Metabolite levels,phosphocreatine measurement,GCST009391,2:12583623
rs10928474-<b>?</b>,8 x 10-6,(phosphocreatine),NR,'-,0.27479473 unit increase,[0.15-0.4],MGAT5,Metabolite levels,phosphocreatine measurement,GCST009391,2:134030465
rs7086063-<b>?</b>,9 x 10-6,(phosphocreatine),NR,'-,0.19189748 unit increase,[0.11-0.28],"ADRB1, RNU6-709P",Metabolite levels,phosphocreatine measurement,GCST009391,10:114084286
rs18582-<b>?</b>,2 x 10-11,(NG monomethyl arginine),NR,'-,0.23768964 unit increase,[0.17-0.31],DDAH1,Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,1:85329136
rs1146382-<b>?</b>,1 x 10-9,(NG monomethyl arginine),NR,'-,0.20716208 unit increase,[0.14-0.27],DDAH1,Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,1:85452418
rs8101881-<b>?</b>,5 x 10-9,(NG monomethyl arginine),NR,'-,0.19934595 unit decrease,[0.13-0.27],"SLC7A9, CEP89",Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,19:32873722
rs2188699-<b>?</b>,3 x 10-7,(NG monomethyl arginine),NR,'-,0.7307675 unit increase,[0.45-1.01],MAP2K6,Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,17:69549213
rs4254433-<b>?</b>,1 x 10-6,(NG monomethyl arginine),NR,'-,0.18067572 unit decrease,[0.11-0.25],TDRD12,Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,19:32749082
rs586023-<b>?</b>,2 x 10-6,(NG monomethyl arginine),NR,'-,0.7197639 unit increase,[0.43-1.01],"ST20-MTHFS, MTHFS",Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,15:79858095
rs1700072-<b>?</b>,3 x 10-6,(NG monomethyl arginine),NR,'-,0.25580314 unit increase,[0.15-0.36],CSMD1,Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,8:4211191
rs12103566-<b>?</b>,3 x 10-6,(NG monomethyl arginine),NR,'-,0.29899794 unit increase,[0.17-0.42],ANKFN1,Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,17:56429426
rs10186240-<b>?</b>,7 x 10-6,(NG monomethyl arginine),NR,'-,0.15325338 unit increase,[0.086-0.22],SPRED2,Metabolite levels,NG-monomethyl-arginine measurement,GCST009391,2:65350517
rs11687765-<b>?</b>,3 x 10-8,(Valine),NR,'-,'-,'-,'-,Serum metabolite levels,"serum metabolite measurement, valine measurement",GCST009893,2:82098407
rs1859294-<b>?</b>,2 x 10-6,(glutamate),NR,'-,0.21520782 unit increase,[0.13-0.3],COG5,Metabolite levels,glutamate measurement,GCST009391,7:107208740
rs4524199-<b>?</b>,2 x 10-6,(glutamate),NR,'-,0.2042888 unit increase,[0.12-0.29],"BNIP3P3, RNU6-721P",Metabolite levels,glutamate measurement,GCST009391,18:15318269
rs9518259-<b>?</b>,5 x 10-6,(glutamate),NR,'-,0.17699133 unit increase,[0.1-0.25],NALCN-AS1,Metabolite levels,glutamate measurement,GCST009391,13:100979080
rs211215-<b>?</b>,6 x 10-6,(glutamate),NR,'-,0.17349628 unit increase,[0.099-0.248],'-,Metabolite levels,glutamate measurement,GCST009391,6:98527934
rs17085064-<b>?</b>,6 x 10-6,(glutamate),NR,'-,0.1610073 unit increase,[0.091-0.231],"GLRX, RHOBTB3",Metabolite levels,glutamate measurement,GCST009391,5:95785831
rs11024326-<b>?</b>,7 x 10-6,(glutamate),NR,'-,0.26519236 unit decrease,[0.15-0.38],OTOG,Metabolite levels,glutamate measurement,GCST009391,11:17575834
rs12000260-<b>?</b>,8 x 10-6,(glutamate),NR,'-,0.22215691 unit increase,[0.12-0.32],"NDUFB6, TAF1L",Metabolite levels,glutamate measurement,GCST009391,9:32586824
rs13165648-<b>?</b>,9 x 10-6,(glutamate),NR,'-,0.24042165 unit increase,[0.13-0.35],PARP8,Metabolite levels,glutamate measurement,GCST009391,5:50569325
rs12130574-<b>?</b>,1 x 10-6,(aspartate),NR,'-,2.4232416 unit increase,[1.45-3.39],GRIK3,Metabolite levels,aspartate measurement,GCST009391,1:36910701
rs956177-<b>?</b>,1 x 10-6,(aspartate),NR,'-,0.59474504 unit increase,[0.35-0.84],LINC02676,Metabolite levels,aspartate measurement,GCST009391,10:8859415
rs4683074-<b>?</b>,2 x 10-6,(aspartate),NR,'-,0.23032415 unit increase,[0.14-0.32],"RPS24P8, TMEM158",Metabolite levels,aspartate measurement,GCST009391,3:45163496
rs17117973-<b>?</b>,3 x 10-6,(aspartate),NR,'-,1.2359394 unit increase,[0.72-1.75],RNU7-51P,Metabolite levels,aspartate measurement,GCST009391,14:83109259
rs12500470-<b>?</b>,3 x 10-6,(aspartate),NR,'-,0.23139063 unit decrease,[0.13-0.33],NDUFB5P1,Metabolite levels,aspartate measurement,GCST009391,4:180664162
rs138921-<b>?</b>,3 x 10-6,(aspartate),NR,'-,1.0142969 unit decrease,[0.59-1.44],"TTLL12, TSPO",Metabolite levels,aspartate measurement,GCST009391,22:43165753
rs1859294-<b>?</b>,3 x 10-6,(aspartate),NR,'-,0.2824502 unit increase,[0.16-0.4],COG5,Metabolite levels,aspartate measurement,GCST009391,7:107208740
rs2389487-<b>?</b>,4 x 10-6,(aspartate),NR,'-,0.28921983 unit increase,[0.17-0.41],NDST3,Metabolite levels,aspartate measurement,GCST009391,4:118018897
rs6584192-<b>?</b>,4 x 10-33,(asymmetric dimethylarginine),NR,'-,0.41370013 unit decrease,[0.35-0.48],PYROXD2,Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,10:98392616
rs6045682-<b>?</b>,1 x 10-7,(asymmetric dimethylarginine),NR,'-,0.88601893 unit decrease,[0.56-1.22],SCP2D1-AS1,Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,20:18908409
rs3762222-<b>?</b>,2 x 10-6,(asymmetric dimethylarginine),NR,'-,0.78228337 unit decrease,[0.46-1.1],"SCP2D1-AS1, LINC00653",Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,20:18798623
rs2176324-<b>?</b>,3 x 10-6,(asymmetric dimethylarginine),NR,'-,0.20159674 unit decrease,[0.12-0.29],ZZEF1,Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,17:4040249
rs17647667-<b>?</b>,4 x 10-6,(asymmetric dimethylarginine),NR,'-,0.2625587 unit decrease,[0.15-0.37],PRKN,Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,6:161438785
rs2068906-<b>?</b>,5 x 10-6,(asymmetric dimethylarginine),NR,'-,4.6671824 unit decrease,[2.67-6.67],HACL1,Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,3:15586942
rs1020812-<b>?</b>,6 x 10-6,(asymmetric dimethylarginine),NR,'-,0.20737495 unit decrease,[0.12-0.3],VAV3,Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,1:107942010
rs1188568-<b>?</b>,8 x 10-6,(asymmetric dimethylarginine),NR,'-,0.17943536 unit increase,[0.1-0.26],"OR11P1P, OR11G2",Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,14:20188486
rs12349140-<b>?</b>,8 x 10-6,(asymmetric dimethylarginine),NR,'-,0.1708516 unit decrease,[0.096-0.246],MAP1LC3BP1,Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,9:19461195
rs586023-<b>?</b>,8 x 10-6,(asymmetric dimethylarginine),NR,'-,0.67305094 unit increase,[0.38-0.97],"ST20-MTHFS, MTHFS",Metabolite levels,asymmetric dimethylarginine measurement,GCST009391,15:79858095
rs1293298-<b>?</b>,9 x 10-6,(citrulline),NR,'-,0.18033922 unit increase,[0.1-0.26],CTSB,Metabolite levels,citrulline measurement,GCST009391,8:11854934
rs12488402-<b>?</b>,2 x 10-6,(citrulline),NR,'-,0.50942034 unit increase,[0.3-0.72],MECOM,Metabolite levels,citrulline measurement,GCST009391,3:169515765
rs10924173-<b>?</b>,5 x 10-6,(citrulline),NR,'-,0.26739246 unit increase,[0.15-0.38],KIF26B,Metabolite levels,citrulline measurement,GCST009391,1:245327338
rs7432244-<b>?</b>,7 x 10-6,(citrulline),NR,'-,0.5898453 unit decrease,[0.33-0.85],RBMS3,Metabolite levels,citrulline measurement,GCST009391,3:30020180
rs7099752-<b>?</b>,9 x 10-6,(citrulline),NR,'-,0.2844023 unit increase,[0.16-0.41],PTPRE,Metabolite levels,citrulline measurement,GCST009391,10:127953067
rs238142-<b>?</b>,2 x 10-6,(citrulline),NR,'-,0.3153002 unit increase,[0.18-0.45],"GAPLINC, DLGAP1",Metabolite levels,citrulline measurement,GCST009391,18:3482788
rs7789575-<b>?</b>,3 x 10-6,(valine),NR,'-,0.18397489 unit decrease,[0.11-0.26],CCDC71L,Metabolite levels,valine measurement,GCST009391,7:106648584
rs11664153-<b>?</b>,3 x 10-6,(valine),NR,'-,0.24553396 unit increase,[0.14-0.35],NFATC1,Metabolite levels,valine measurement,GCST009391,18:79435813
rs4980054-<b>?</b>,6 x 10-6,(valine),NR,'-,0.17006509 unit decrease,[0.096-0.244],ZMIZ1,Metabolite levels,valine measurement,GCST009391,10:79262084
rs2627244-<b>?</b>,7 x 10-6,(valine),NR,'-,0.7380642 unit decrease,[0.42-1.06],UBA6-AS1,Metabolite levels,valine measurement,GCST009391,4:67778372
rs6977081-<b>?</b>,5 x 10-9,(gamma aminoisobutyric acid),NR,'-,0.233875 unit increase,[0.16-0.31],AOC1,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,7:150845427
rs17587049-<b>?</b>,3 x 10-7,(gamma aminoisobutyric acid),NR,'-,0.76709396 unit increase,[0.47-1.06],U3,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,14:101224960
rs257950-<b>?</b>,2 x 10-6,(gamma aminoisobutyric acid),NR,'-,1.3947778 unit increase,[0.81-1.97],LINC02409,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,12:97324387
rs10019772-<b>?</b>,3 x 10-6,(gamma aminoisobutyric acid),NR,'-,3.6517565 unit decrease,[2.13-5.18],LETM1,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,4:1833819
rs8106338-<b>?</b>,3 x 10-6,(gamma aminoisobutyric acid),NR,'-,1.9730343 unit increase,[1.15-2.8],AP3D1,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,19:2103187
rs2912200-<b>?</b>,3 x 10-6,(gamma aminoisobutyric acid),NR,'-,0.20186603 unit increase,[0.12-0.29],LINC01085,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,4:14141741
rs12073624-<b>?</b>,4 x 10-6,(gamma aminoisobutyric acid),NR,'-,0.28409573 unit decrease,[0.16-0.4],ADGRL4,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,1:78997471
rs201762-<b>?</b>,7 x 10-6,(gamma aminoisobutyric acid),NR,'-,0.1918443 unit decrease,[0.11-0.28],DLEU1,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,13:50491700
rs927428-<b>?</b>,9 x 10-6,(gamma aminoisobutyric acid),NR,'-,0.39482433 unit decrease,[0.22-0.57],TACC2,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,10:122177329
rs8051603-<b>?</b>,9 x 10-6,(gamma aminoisobutyric acid),NR,'-,0.5814163 unit decrease,[0.32-0.84],LINC02181,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,16:87014952
rs2553640-<b>?</b>,9 x 10-6,(gamma aminoisobutyric acid),NR,'-,0.31390497 unit decrease,[0.18-0.45],LRRC52-AS1,Metabolite levels,gamma-aminoisobutyric acid measurement,GCST009391,1:165497640
rs13035033-<b>?</b>,6 x 10-7,(anthranilic acid),NR,'-,0.2286808 unit decrease,[0.14-0.32],MYO3B,Metabolite levels,anthranilic acid measurement,GCST009391,2:170475778
rs4852019-<b>?</b>,9 x 10-7,(anthranilic acid),NR,'-,0.16454206 unit increase,[0.099-0.23],HDAC4,Metabolite levels,anthranilic acid measurement,GCST009391,2:239098926
rs17101702-<b>?</b>,1 x 10-6,(anthranilic acid),NR,'-,1.8428589 unit decrease,[1.1-2.58],LINC01153,Metabolite levels,anthranilic acid measurement,GCST009391,10:121244193
rs6848923-<b>?</b>,2 x 10-6,(anthranilic acid),NR,'-,0.16042373 unit decrease,[0.094-0.227],'-,Metabolite levels,anthranilic acid measurement,GCST009391,4:53804874
rs1859294-<b>?</b>,3 x 10-6,(anthranilic acid),NR,'-,0.2093303 unit increase,[0.12-0.3],COG5,Metabolite levels,anthranilic acid measurement,GCST009391,7:107208740
rs2023685-<b>?</b>,4 x 10-6,(anthranilic acid),NR,'-,0.22028525 unit decrease,[0.13-0.31],COG5,Metabolite levels,anthranilic acid measurement,GCST009391,7:107527890
rs2829495-<b>?</b>,4 x 10-6,(anthranilic acid),NR,'-,0.3576919 unit decrease,[0.21-0.51],LINC01692,Metabolite levels,anthranilic acid measurement,GCST009391,21:24983865
rs7130232-<b>?</b>,5 x 10-6,(anthranilic acid),NR,'-,1.1864697 unit increase,[0.68-1.69],KCNQ1,Metabolite levels,anthranilic acid measurement,GCST009391,11:2605561
rs17402390-<b>?</b>,6 x 10-6,(anthranilic acid),NR,'-,0.8544818 unit increase,[0.49-1.22],KIF1B,Metabolite levels,anthranilic acid measurement,GCST009391,1:10338902
rs9918731-<b>?</b>,8 x 10-6,(anthranilic acid),NR,'-,0.15629943 unit decrease,[0.088-0.225],GDI2P1,Metabolite levels,anthranilic acid measurement,GCST009391,7:48885805
rs7127296-<b>?</b>,8 x 10-6,(anthranilic acid),NR,'-,0.20721538 unit decrease,[0.12-0.3],"PDGFD, MIR4693",Metabolite levels,anthranilic acid measurement,GCST009391,11:103900193
rs4871580-<b>?</b>,8 x 10-6,(anthranilic acid),NR,'-,0.47612324 unit increase,[0.27-0.69],NSMCE2,Metabolite levels,anthranilic acid measurement,GCST009391,8:125321670
rs12576623-<b>C</b>,1 x 10-12,,0.05368,'-,0.7294112 unit decrease,'-,'-,Taurine levels,taurine measurement,GCST90013577,11:81225207
rs12740439-<b>?</b>,6 x 10-7,(taurine),NR,'-,0.16903092 unit decrease,[0.1-0.24],KCNK1,Metabolite levels,taurine measurement,GCST009391,1:233559648
rs12145104-<b>?</b>,9 x 10-7,(taurine),NR,'-,0.22467732 unit increase,[0.14-0.31],SLC35F3,Metabolite levels,taurine measurement,GCST009391,1:234088222
rs10466408-<b>?</b>,2 x 10-6,(taurine),NR,'-,0.27448824 unit increase,[0.16-0.39],TEAD1,Metabolite levels,taurine measurement,GCST009391,11:12817980
rs10494201-<b>?</b>,2 x 10-6,(taurine),NR,'-,0.17869082 unit decrease,[0.11-0.25],"PNRC2P1, VDAC2P3",Metabolite levels,taurine measurement,GCST009391,1:117709635
rs2233250-<b>?</b>,3 x 10-6,(taurine),NR,'-,0.7566792 unit decrease,[0.44-1.07],"MS4A14, MS4A6E, MS4A7",Metabolite levels,taurine measurement,GCST009391,11:60389228
rs12240141-<b>?</b>,4 x 10-6,(taurine),NR,'-,0.22551793 unit increase,[0.13-0.32],"PDE4DIPP10, NBPF2P",Metabolite levels,taurine measurement,GCST009391,1:21418172
rs7483049-<b>?</b>,4 x 10-6,(taurine),NR,'-,0.17745079 unit increase,[0.1-0.25],'-,Metabolite levels,taurine measurement,GCST009391,11:80300746
rs13088785-<b>?</b>,6 x 10-6,(taurine),NR,'-,0.8602381 unit decrease,[0.49-1.23],"RPL21P17, RPL23AP39",Metabolite levels,taurine measurement,GCST009391,3:1807487
rs6878458-<b>?</b>,7 x 10-6,(taurine),NR,'-,0.22499359 unit decrease,[0.13-0.32],LINC01019,Metabolite levels,taurine measurement,GCST009391,5:3363910
rs17110309-<b>?</b>,7 x 10-6,(taurine),NR,'-,0.36736205 unit decrease,[0.21-0.53],LINC02306,Metabolite levels,taurine measurement,GCST009391,14:25695553
rs7520806-<b>?</b>,6 x 10-6,(methionine),NR,'-,0.1611729 unit increase,[0.091-0.231],AXDND1,Metabolite levels,methionine measurement,GCST009391,1:179447243
rs11746609-<b>?</b>,8 x 10-6,(methionine),NR,'-,0.7340689 unit increase,[0.41-1.06],"ANKHD1, ANKHD1-EIF4EBP3",Metabolite levels,methionine measurement,GCST009391,5:140498438
rs11574651-<b>?</b>,9 x 10-6,(methionine),NR,'-,2.1571739 unit increase,[1.21-3.11],"HAUS1P1, CD14",Metabolite levels,methionine measurement,GCST009391,5:140630684
rs2703384-<b>?</b>,3 x 10-6,(methionine),NR,'-,0.17099173 unit increase,[0.099-0.243],SYBU,Metabolite levels,methionine measurement,GCST009391,8:109587830
rs7922420-<b>?</b>,6 x 10-6,(methionine),NR,'-,0.20548637 unit increase,[0.12-0.29],PCDH15,Metabolite levels,methionine measurement,GCST009391,10:53766797
rs538508-<b>?</b>,4 x 10-7,(methionine),NR,'-,0.3830438 unit increase,[0.23-0.53],LINC02397,Metabolite levels,methionine measurement,GCST009391,12:92470442
rs2722651-<b>?</b>,2 x 10-7,(methionine),NR,'-,0.28981137 unit increase,[0.18-0.4],ZNF285,Metabolite levels,methionine measurement,GCST009391,19:44397392
rs1260326-<b>?</b>,8 x 10-12,(alanine),NR,'-,0.23077767 unit increase,[0.16-0.3],'-,Metabolite levels,alanine measurement,GCST009391,Mapping not available
rs11226171-<b>?</b>,2 x 10-6,(alanine),NR,'-,1.9834033 unit decrease,[1.17-2.79],PDGFD,Metabolite levels,alanine measurement,GCST009391,11:104113826
rs7437468-<b>?</b>,5 x 10-6,(alanine),NR,'-,0.29617608 unit increase,[0.17-0.42],"PPIAP76, LINC01091",Metabolite levels,alanine measurement,GCST009391,4:123971176
rs1544017-<b>?</b>,5 x 10-6,(alanine),NR,'-,0.20320787 unit decrease,[0.12-0.29],CCSER1,Metabolite levels,alanine measurement,GCST009391,4:91238679
rs2432144-<b>?</b>,6 x 10-6,(alanine),NR,'-,0.24516481 unit increase,[0.14-0.35],ITGA1,Metabolite levels,alanine measurement,GCST009391,5:52837432
rs1374538-<b>?</b>,7 x 10-6,(alanine),NR,'-,0.3168161 unit increase,[0.18-0.45],RPL31P17,Metabolite levels,alanine measurement,GCST009391,2:222736086
rs560404165-<b>CA</b>,8 x 10-11,(Serine),0.6051,'-,0.0721 unit increase,[0.05-0.094],ZNF713,Metabolite levels,serine measurement,GCST009698,7:55932525
rs57427081-<b>CT</b>,9 x 10-13,(Serine),0.3008,'-,0.0754 unit decrease,[0.055-0.096],CHCHD2,Metabolite levels,serine measurement,GCST009698,7:56102349
rs12083204-<b>?</b>,2 x 10-7,(histidine),NR,'-,0.23814233 unit decrease,[0.15-0.33],VAV3,Metabolite levels,histidine measurement,GCST009391,1:107903172
rs13144926-<b>?</b>,4 x 10-7,(histidine),NR,'-,0.1734831 unit increase,[0.11-0.24],'-,Metabolite levels,histidine measurement,GCST009391,4:115340263
rs10733628-<b>?</b>,1 x 10-6,(histidine),NR,'-,0.16996329 unit increase,[0.1-0.24],ASTN2,Metabolite levels,histidine measurement,GCST009391,9:117306075
rs1464738-<b>?</b>,2 x 10-6,(histidine),NR,'-,0.669563 unit decrease,[0.39-0.95],CNOT2,Metabolite levels,histidine measurement,GCST009391,12:70283853
rs8016484-<b>?</b>,4 x 10-6,(histidine),NR,'-,0.1763917 unit decrease,[0.1-0.25],'-,Metabolite levels,histidine measurement,GCST009391,14:83401052
rs10931352-<b>?</b>,5 x 10-6,(histidine),NR,'-,0.2884714 unit decrease,[0.16-0.41],UBQLN4P2,Metabolite levels,histidine measurement,GCST009391,2:152875130
rs6846038-<b>?</b>,5 x 10-6,(histidine),NR,'-,0.18352754 unit increase,[0.1-0.26],KCNIP4,Metabolite levels,histidine measurement,GCST009391,4:21112248
rs7076997-<b>?</b>,7 x 10-6,(histidine),NR,'-,0.3701986 unit decrease,[0.21-0.53],STK32C,Metabolite levels,histidine measurement,GCST009391,10:132233204
rs2107638-<b>?</b>,7 x 10-6,(histidine),NR,'-,0.16133654 unit increase,[0.091-0.232],PFKM,Metabolite levels,histidine measurement,GCST009391,12:48114136
rs222837-<b>?</b>,7 x 10-6,(histidine),NR,'-,0.20187464 unit decrease,[0.11-0.29],DVL2,Metabolite levels,histidine measurement,GCST009391,17:7229237
rs248386-<b>?</b>,2 x 10-19,(Dimethyl-glycine),NR,'-,'-,'-,DMGDH,Serum metabolite levels,"serum metabolite measurement, dimethylglycine measurement",GCST009893,5:79034404
rs248386-<b>?</b>,7 x 10-33,(dimethylglycine),NR,'-,0.5037517 unit increase,[0.42-0.59],DMGDH,Metabolite levels,dimethylglycine measurement,GCST009391,5:79034404
rs2364832-<b>?</b>,7 x 10-7,(dimethylglycine),NR,'-,0.19738977 unit decrease,[0.12-0.28],DMGDH,Metabolite levels,dimethylglycine measurement,GCST009391,5:79186876
rs2111583-<b>?</b>,1 x 10-6,(dimethylglycine),NR,'-,0.1624348 unit increase,[0.096-0.228],SAMMSON,Metabolite levels,dimethylglycine measurement,GCST009391,3:70432226
rs10242213-<b>?</b>,1 x 10-6,(dimethylglycine),NR,'-,0.20618367 unit decrease,[0.12-0.29],ZNF804B,Metabolite levels,dimethylglycine measurement,GCST009391,7:89107878
rs13095800-<b>?</b>,2 x 10-6,(dimethylglycine),NR,'-,0.17563671 unit decrease,[0.1-0.25],ZNF385D,Metabolite levels,dimethylglycine measurement,GCST009391,3:21981109
rs10214760-<b>?</b>,3 x 10-6,(dimethylglycine),NR,'-,0.3002602 unit decrease,[0.17-0.43],"PPP1R2P1, HLA-Z",Metabolite levels,dimethylglycine measurement,GCST009391,6:32889759
rs1288524-<b>?</b>,3 x 10-6,(dimethylglycine),NR,'-,0.7165881 unit increase,[0.41-1.02],FOXP1,Metabolite levels,dimethylglycine measurement,GCST009391,3:71388883
rs11959628-<b>?</b>,4 x 10-6,(dimethylglycine),NR,'-,0.17566223 unit increase,[0.1-0.25],JMY,Metabolite levels,dimethylglycine measurement,GCST009391,5:79287010
rs7592574-<b>?</b>,5 x 10-6,(dimethylglycine),NR,'-,0.1577824 unit decrease,[0.09-0.226],"RN7SKP168, LINC01866",Metabolite levels,dimethylglycine measurement,GCST009391,2:17067306
rs16875961-<b>?</b>,5 x 10-6,(dimethylglycine),NR,'-,0.60875225 unit increase,[0.35-0.87],ARSB,Metabolite levels,dimethylglycine measurement,GCST009391,5:78819688
rs9355333-<b>?</b>,7 x 10-6,(dimethylglycine),NR,'-,0.23399176 unit increase,[0.13-0.34],ZDHHC14,Metabolite levels,dimethylglycine measurement,GCST009391,6:157671948
rs7604882-<b>?</b>,7 x 10-6,(dimethylglycine),NR,'-,3.0246174 unit increase,[1.7-4.35],GALNT14,Metabolite levels,dimethylglycine measurement,GCST009391,2:31130163
rs345066-<b>?</b>,8 x 10-6,(dimethylglycine),NR,'-,0.16323641 unit decrease,[0.092-0.235],"RAD18, CAV3",Metabolite levels,dimethylglycine measurement,GCST009391,3:8818555
rs17640016-<b>?</b>,8 x 10-6,(dimethylglycine),NR,'-,0.17403881 unit decrease,[0.097-0.251],CSMD3,Metabolite levels,dimethylglycine measurement,GCST009391,8:112385862
rs2936953-<b>?</b>,9 x 10-6,(dimethylglycine),NR,'-,0.16321583 unit increase,[0.091-0.235],LINC01411,Metabolite levels,dimethylglycine measurement,GCST009391,5:174379071
rs11003226-<b>?</b>,9 x 10-6,(dimethylglycine),NR,'-,0.15750997 unit decrease,[0.088-0.227],Y_RNA,Metabolite levels,dimethylglycine measurement,GCST009391,10:52864862
rs927671-<b>?</b>,8 x 10-6,(beta aminoisobutyric acid),NR,'-,0.6215357 unit decrease,[0.35-0.89],STXBP5-AS1,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,6:146894760
rs7257658-<b>?</b>,8 x 10-6,(beta aminoisobutyric acid),NR,'-,0.341841 unit decrease,[0.19-0.49],FBN3,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,19:8088439
rs358818-<b>?</b>,8 x 10-6,(beta aminoisobutyric acid),NR,'-,0.49635717 unit increase,[0.28-0.71],HTR1A,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,5:63859557
rs3742406-<b>?</b>,2 x 10-7,(threonine),NR,'-,0.18659452 unit increase,[0.12-0.26],MEG9,Metabolite levels,threonine measurement,GCST009391,14:101071520
rs1464738-<b>?</b>,2 x 10-6,(threonine),NR,'-,0.67131096 unit decrease,[0.4-0.95],CNOT2,Metabolite levels,threonine measurement,GCST009391,12:70283853
rs348651-<b>?</b>,3 x 10-6,(threonine),NR,'-,0.16081195 unit decrease,[0.094-0.228],TAFA2,Metabolite levels,threonine measurement,GCST009391,12:62066361
rs4345013-<b>?</b>,3 x 10-6,(threonine),NR,'-,0.18618023 unit decrease,[0.11-0.26],"LINC01422, RNU6-1066P",Metabolite levels,threonine measurement,GCST009391,22:26985874
rs1607187-<b>?</b>,3 x 10-6,(threonine),NR,'-,0.15605024 unit increase,[0.091-0.221],"GLS, STAT1",Metabolite levels,threonine measurement,GCST009391,2:190950312
rs12523573-<b>?</b>,4 x 10-6,(threonine),NR,'-,0.4407701 unit decrease,[0.25-0.63],"LINC01485, CPEB4",Metabolite levels,threonine measurement,GCST009391,5:173842293
rs11743598-<b>?</b>,7 x 10-6,(threonine),NR,'-,0.1716747 unit decrease,[0.097-0.246],"C6, MROH2B",Metabolite levels,threonine measurement,GCST009391,5:41126367
rs6962531-<b>?</b>,8 x 10-6,(threonine),NR,'-,0.21609482 unit decrease,[0.12-0.31],'-,Metabolite levels,threonine measurement,GCST009391,7:13058172
rs749629-<b>?</b>,9 x 10-6,(threonine),NR,'-,0.16394803 unit decrease,[0.092-0.236],C6,Metabolite levels,threonine measurement,GCST009391,5:41250619
rs37370-<b>?</b>,6 x 10-83,(beta aminoisobutyric acid),NR,'-,1.0223343 unit increase,[0.92-1.13],AGXT2,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,5:35039381
rs40202-<b>?</b>,1 x 10-20,(beta aminoisobutyric acid),NR,'-,0.33769745 unit increase,[0.27-0.41],DNAJC21,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,5:34938268
rs11613331-<b>?</b>,2 x 10-12,(beta aminoisobutyric acid),NR,'-,0.23065287 unit decrease,[0.17-0.29],SLC6A13,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,12:242301
rs4140962-<b>?</b>,4 x 10-10,(beta aminoisobutyric acid),NR,'-,0.21354419 unit decrease,[0.15-0.28],KDM5A,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,12:366413
rs2726687-<b>?</b>,6 x 10-7,(beta aminoisobutyric acid),NR,'-,0.20358409 unit increase,[0.12-0.28],PAPSS1,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,4:107577683
rs6913481-<b>?</b>,2 x 10-6,(beta aminoisobutyric acid),NR,'-,0.57882833 unit increase,[0.34-0.82],NT5DC1,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,6:116227480
rs1041250-<b>?</b>,3 x 10-6,(beta aminoisobutyric acid),NR,'-,0.20424515 unit increase,[0.12-0.29],CR2,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,1:207482470
rs13101170-<b>?</b>,3 x 10-6,(beta aminoisobutyric acid),NR,'-,0.21512079 unit decrease,[0.12-0.31],"RNF10P1, BHLHE40",Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,3:5002222
rs11067538-<b>?</b>,4 x 10-6,(beta aminoisobutyric acid),NR,'-,0.25854418 unit decrease,[0.15-0.37],'-,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,12:115341234
rs17182325-<b>?</b>,4 x 10-6,(beta aminoisobutyric acid),NR,'-,0.17897579 unit decrease,[0.1-0.25],"MTRF1LP2, CCDC26",Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,8:129690512
rs248491-<b>?</b>,4 x 10-6,(beta aminoisobutyric acid),NR,'-,0.31497708 unit increase,[0.18-0.45],PCDH1,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,5:141787128
rs10521017-<b>?</b>,5 x 10-6,(beta aminoisobutyric acid),NR,'-,0.16161422 unit decrease,[0.092-0.231],RAI14,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,5:34789073
rs10454818-<b>?</b>,5 x 10-6,(beta aminoisobutyric acid),NR,'-,0.51298326 unit increase,[0.29-0.73],ZSWIM6,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,5:61485167
rs8023274-<b>?</b>,7 x 10-6,(beta aminoisobutyric acid),NR,'-,0.3352153 unit decrease,[0.19-0.48],SEMA7A,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,15:74425561
rs179158-<b>?</b>,8 x 10-6,(beta aminoisobutyric acid),NR,'-,0.19706695 unit decrease,[0.11-0.28],SYNE3,Metabolite levels,beta-aminoisobutyric acid measurement,GCST009391,14:95507273
rs2017301-<b>?</b>,1 x 10-7,(isoleucine),NR,'-,0.2062796 unit increase,[0.13-0.28],SELENOM,Metabolite levels,isoleucine measurement,GCST009391,22:31118491
rs11222660-<b>?</b>,1 x 10-7,(isoleucine),NR,'-,0.26215872 unit decrease,[0.16-0.36],NTM,Metabolite levels,isoleucine measurement,GCST009391,11:131473384
rs3747156-<b>?</b>,3 x 10-7,(isoleucine),NR,'-,0.3224227 unit increase,[0.2-0.45],PISD,Metabolite levels,isoleucine measurement,GCST009391,22:31630938
rs5753630-<b>?</b>,4 x 10-7,(isoleucine),NR,'-,0.1755459 unit decrease,[0.11-0.24],"EIF4ENIF1, DRG1",Metabolite levels,isoleucine measurement,GCST009391,22:31465964
rs12202176-<b>?</b>,1 x 10-6,(isoleucine),NR,'-,0.76705813 unit decrease,[0.46-1.08],"TREM2, TREML2",Metabolite levels,isoleucine measurement,GCST009391,6:41170311
rs12724763-<b>?</b>,1 x 10-6,(isoleucine),NR,'-,0.3927345 unit decrease,[0.23-0.55],"MYBPH, CHI3L1",Metabolite levels,isoleucine measurement,GCST009391,1:203176584
rs11761593-<b>?</b>,2 x 10-6,(isoleucine),NR,'-,0.39738086 unit increase,[0.23-0.56],ZNF804B,Metabolite levels,isoleucine measurement,GCST009391,7:89217757
rs4147531-<b>?</b>,5 x 10-6,(isoleucine),NR,'-,0.15412723 unit increase,[0.088-0.22],"ADH1A, ADH1B",Metabolite levels,isoleucine measurement,GCST009391,4:99291040
rs2247554-<b>?</b>,5 x 10-6,(isoleucine),NR,'-,0.5928334 unit decrease,[0.34-0.85],IZUMO3,Metabolite levels,isoleucine measurement,GCST009391,9:24512880
rs1909169-<b>?</b>,7 x 10-6,(isoleucine),NR,'-,0.17900209 unit decrease,[0.1-0.26],'-,Metabolite levels,isoleucine measurement,GCST009391,12:29986814
rs12134739-<b>?</b>,7 x 10-6,(isoleucine),NR,'-,0.69697773 unit increase,[0.39-1],"CFAP57, EBNA1BP2",Metabolite levels,isoleucine measurement,GCST009391,1:43211804
rs11703847-<b>?</b>,7 x 10-6,(isoleucine),NR,'-,0.29312903 unit increase,[0.17-0.42],LIMK2,Metabolite levels,isoleucine measurement,GCST009391,22:31269801
rs12656164-<b>?</b>,9 x 10-6,(isoleucine),NR,'-,1.2172161 unit increase,[0.68-1.75],NSG2,Metabolite levels,isoleucine measurement,GCST009391,5:174189255
rs10415368-<b>?</b>,9 x 10-6,(isoleucine),NR,'-,0.9002211 unit decrease,[0.5-1.3],"TUBB4A, TNFSF9",Metabolite levels,isoleucine measurement,GCST009391,19:6516583
rs12943077-<b>?</b>,4 x 10-7,(ornithine),NR,'-,0.17202415 unit decrease,[0.11-0.24],SMIM36,Metabolite levels,ornithine measurement,GCST009391,17:55470881
rs11761593-<b>?</b>,1 x 10-6,(ornithine),NR,'-,0.40693048 unit increase,[0.24-0.57],ZNF804B,Metabolite levels,ornithine measurement,GCST009391,7:89217757
rs6766498-<b>?</b>,3 x 10-6,(ornithine),NR,'-,0.18861154 unit increase,[0.11-0.27],TAFA1,Metabolite levels,ornithine measurement,GCST009391,3:68448689
rs11883563-<b>?</b>,4 x 10-6,(ornithine),NR,'-,1.2645266 unit increase,[0.73-1.8],HDAC4,Metabolite levels,ornithine measurement,GCST009391,2:239295342
rs16942134-<b>?</b>,4 x 10-6,(ornithine),NR,'-,3.8848815 unit increase,[2.23-5.54],LINC02188,Metabolite levels,ornithine measurement,GCST009391,16:86786057
rs2282661-<b>?</b>,4 x 10-6,(ornithine),NR,'-,0.3491206 unit increase,[0.2-0.5],NELL1,Metabolite levels,ornithine measurement,GCST009391,11:20670662
rs12493300-<b>?</b>,4 x 10-6,(ornithine),NR,'-,0.482888 unit increase,[0.28-0.69],MECOM,Metabolite levels,ornithine measurement,GCST009391,3:169522689
rs680030-<b>?</b>,4 x 10-6,(ornithine),NR,'-,0.20852086 unit decrease,[0.12-0.3],'-,Metabolite levels,ornithine measurement,GCST009391,9:108416398
rs16897381-<b>?</b>,5 x 10-6,(ornithine),NR,'-,0.3199984 unit increase,[0.18-0.46],"CDK5P1, LINC01151",Metabolite levels,ornithine measurement,GCST009391,8:122758767
rs6866981-<b>?</b>,8 x 10-6,(ornithine),NR,'-,0.24622153 unit decrease,[0.14-0.35],"JAKMIP2-AS1, DPYSL3",Metabolite levels,ornithine measurement,GCST009391,5:147548798
rs6812240-<b>?</b>,9 x 10-6,(ornithine),NR,'-,0.18351218 unit increase,[0.1-0.26],GPAT3,Metabolite levels,ornithine measurement,GCST009391,4:83556989
rs3799239-<b>?</b>,9 x 10-6,(ornithine),NR,'-,0.15341657 unit increase,[0.086-0.221],WRNIP1,Metabolite levels,ornithine measurement,GCST009391,6:2780727
rs1558339-<b>?</b>,9 x 10-6,(ornithine),NR,'-,0.25363964 unit increase,[0.14-0.37],RBFOX1,Metabolite levels,ornithine measurement,GCST009391,16:7442976
rs7022126-<b>?</b>,3 x 10-7,(ornithine),NR,'-,0.23126408 unit decrease,[0.14-0.32],'-,Metabolite levels,ornithine measurement,GCST009391,9:108517159
rs972925-<b>?</b>,4 x 10-7,(ornithine),NR,'-,0.21451586 unit increase,[0.13-0.3],OR1Q1,Metabolite levels,ornithine measurement,GCST009391,9:122614808
rs17356983-<b>G</b>,2 x 10-6,(Hcy ),0.158,'-,0.03 µmol/L increase,[NR],LINC00539,Obesity-related traits,homocysteine measurement,GCST001762,13:21340975
rs1429107-<b>A</b>,8 x 10-6,(Hcy ),0.086,'-,0.02 µmol/L increase,[NR],"PRMT5P1, MIR548G",Obesity-related traits,homocysteine measurement,GCST001762,4:147401235
rs13054085-<b>A</b>,2 x 10-6,(Hcy ),0.236,'-,0.03 µmol/L increase,[NR],MIR3201,Obesity-related traits,homocysteine measurement,GCST001762,22:48234372
rs79079833-<b>G</b>,2 x 10-6,(Hcy ),0.011,'-,0.03 µmol/L increase,[NR],"OLFML3, SYT6",Obesity-related traits,homocysteine measurement,GCST001762,1:114064742
rs621636-<b>A</b>,3 x 10-6,(Hcy ),0.131,'-,0.03 µmol/L increase,[NR],COLEC12,Obesity-related traits,homocysteine measurement,GCST001762,18:322522
rs2851391-<b>G</b>,4 x 10-6,(Hcy ),0.365,'-,0.02 µmol/L increase,[NR],CBS,Obesity-related traits,homocysteine measurement,GCST001762,21:43067294
rs17394429-<b>A</b>,7 x 10-6,(Hcy ),0.11,'-,0.03 µmol/L increase,[NR],CSMD1,Obesity-related traits,homocysteine measurement,GCST001762,8:3459464
rs10830265-<b>A</b>,8 x 10-6,(Hcy ),0.187,'-,0.02 µmol/L increase,[NR],NOX4,Obesity-related traits,homocysteine measurement,GCST001762,11:89379482
rs2404916-<b>G</b>,9 x 10-6,(Hcy ),0.334,'-,0.02 µmol/L increase,[NR],'-,Obesity-related traits,homocysteine measurement,GCST001762,4:154074311
rs9822723-<b>?</b>,4 x 10-7,(leucine),NR,'-,0.3257336 unit decrease,[0.2-0.45],U3,Metabolite levels,leucine measurement,GCST009391,3:45263398
rs5753630-<b>?</b>,1 x 10-6,(leucine),NR,'-,0.16622065 unit decrease,[0.099-0.234],"EIF4ENIF1, DRG1",Metabolite levels,leucine measurement,GCST009391,22:31465964
rs10192769-<b>?</b>,2 x 10-6,(leucine),NR,'-,0.21402222 unit decrease,[0.13-0.3],"RHBDD1, IRS1",Metabolite levels,leucine measurement,GCST009391,2:226835202
rs7806881-<b>?</b>,2 x 10-6,(leucine),NR,'-,0.1864289 unit increase,[0.11-0.26],"RPL31P35, SEC61G",Metabolite levels,leucine measurement,GCST009391,7:54738583
rs2017301-<b>?</b>,2 x 10-6,(leucine),NR,'-,0.18385477 unit increase,[0.11-0.26],SELENOM,Metabolite levels,leucine measurement,GCST009391,22:31118491
rs10208061-<b>?</b>,3 x 10-6,(leucine),NR,'-,0.61242366 unit increase,[0.36-0.87],LYARP1,Metabolite levels,leucine measurement,GCST009391,2:82250820
rs11222660-<b>?</b>,3 x 10-6,(leucine),NR,'-,0.23220143 unit decrease,[0.13-0.33],NTM,Metabolite levels,leucine measurement,GCST009391,11:131473384
rs6538281-<b>?</b>,3 x 10-6,(leucine),NR,'-,0.168386 unit increase,[0.098-0.239],'-,Metabolite levels,leucine measurement,GCST009391,12:91510013
rs16970294-<b>?</b>,4 x 10-6,(leucine),NR,'-,0.2907072 unit increase,[0.17-0.41],LINC01531,Metabolite levels,leucine measurement,GCST009391,19:35407997
rs11052322-<b>?</b>,5 x 10-6,(leucine),NR,'-,0.17871884 unit decrease,[0.1-0.26],"PKP2, ASS1P14",Metabolite levels,leucine measurement,GCST009391,12:32938084
rs2214873-<b>?</b>,5 x 10-6,(leucine),NR,'-,0.22676843 unit decrease,[0.13-0.32],INHBA-AS1,Metabolite levels,leucine measurement,GCST009391,7:41779313
rs2204113-<b>?</b>,6 x 10-6,(leucine),NR,'-,0.15407622 unit decrease,[0.087-0.221],SERP1,Metabolite levels,leucine measurement,GCST009391,3:150602535
rs12202176-<b>?</b>,6 x 10-6,(leucine),NR,'-,0.70535505 unit decrease,[0.4-1.01],"TREM2, TREML2",Metabolite levels,leucine measurement,GCST009391,6:41170311
rs174574-<b>?</b>,3 x 10-6,(tryptophan),NR,'-,0.1679416 unit increase,[0.098-0.238],FADS2,Metabolite levels,tryptophan measurement,GCST009391,11:61832870
rs8007381-<b>?</b>,4 x 10-6,(tryptophan),NR,'-,2.111864 unit increase,[1.22-3.01],'-,Metabolite levels,tryptophan measurement,GCST009391,14:62338765
rs12601874-<b>?</b>,5 x 10-6,(tryptophan),NR,'-,0.19234568 unit increase,[0.11-0.27],ALOXE3P1,Metabolite levels,tryptophan measurement,GCST009391,17:8068231
rs12324479-<b>?</b>,6 x 10-6,(tryptophan),NR,'-,0.17128569 unit increase,[0.097-0.246],LINC01852,Metabolite levels,tryptophan measurement,GCST009391,15:38105799
rs2585349-<b>?</b>,8 x 10-6,(tryptophan),NR,'-,0.31579173 unit decrease,[0.18-0.45],'-,Metabolite levels,tryptophan measurement,GCST009391,14:48655682
rs8056893-<b>?</b>,2 x 10-8,(Lysine),NR,'-,'-,'-,SLC7A6,Serum metabolite levels,"lysine measurement, serum metabolite measurement",GCST009893,16:68270489
rs12460876-<b>C</b>,4 x 10-25,,0.4057,'-,0.47798073 unit increase,'-,SLC7A9,Lysine levels,lysine measurement,GCST90013564,19:32865985
rs11947954-<b>?</b>,6 x 10-7,(lysine),NR,'-,2.722168 unit decrease,[1.66-3.79],BANK1,Metabolite levels,lysine measurement,GCST009391,4:101842389
rs8011442-<b>?</b>,2 x 10-6,(lysine),NR,'-,1.9800227 unit decrease,[1.17-2.79],"RGS6, DPF3",Metabolite levels,lysine measurement,GCST009391,14:72582386
rs6794676-<b>?</b>,3 x 10-6,(lysine),NR,'-,0.21243167 unit decrease,[0.12-0.3],SRPRB,Metabolite levels,lysine measurement,GCST009391,3:133799155
rs17004060-<b>?</b>,3 x 10-6,(lysine),NR,'-,0.22298808 unit decrease,[0.13-0.32],LINC02469,Metabolite levels,lysine measurement,GCST009391,4:79684426
rs6129460-<b>?</b>,4 x 10-6,(lysine),NR,'-,0.18169512 unit decrease,[0.1-0.26],LINC01370,Metabolite levels,lysine measurement,GCST009391,20:40006189
rs7101520-<b>?</b>,4 x 10-6,(lysine),NR,'-,3.9668021 unit decrease,[2.29-5.65],"LINC02684, LINC02717",Metabolite levels,lysine measurement,GCST009391,11:135022897
rs3736840-<b>?</b>,4 x 10-6,(lysine),NR,'-,0.19237694 unit decrease,[0.11-0.27],REC8,Metabolite levels,lysine measurement,GCST009391,14:24178316
rs12592256-<b>?</b>,5 x 10-6,(lysine),NR,'-,0.33427674 unit increase,[0.19-0.48],MTND5P40,Metabolite levels,lysine measurement,GCST009391,15:46379408
rs17379690-<b>?</b>,5 x 10-6,(lysine),NR,'-,0.3649121 unit increase,[0.21-0.52],ROBO1,Metabolite levels,lysine measurement,GCST009391,3:78975391
rs1563336-<b>?</b>,9 x 10-6,(lysine),NR,'-,0.32391796 unit increase,[0.18-0.47],LINC01550,Metabolite levels,lysine measurement,GCST009391,14:97912314
rs9869461-<b>?</b>,9 x 10-6,(lysine),NR,'-,0.48130056 unit increase,[0.27-0.69],MECOM,Metabolite levels,lysine measurement,GCST009391,3:169604374
rs992037-<b>?</b>,1 x 10-7,(Lysine),0.35,'-,'-,'-,PRKN,Metabolite levels,lysine measurement,GCST000274,6:161580404
rs3914144-<b>?</b>,1 x 10-6,(glutamine),NR,'-,0.35411626 unit decrease,[0.21-0.5],PDE10A,Metabolite levels,glutamine measurement,GCST009391,6:165954909
rs3852025-<b>?</b>,1 x 10-6,(glutamine),NR,'-,0.26609278 unit decrease,[0.16-0.37],CNTN6,Metabolite levels,glutamine measurement,GCST009391,3:1276953
rs6712563-<b>?</b>,4 x 10-6,(glutamine),NR,'-,1.5364938 unit decrease,[0.88-2.19],'-,Metabolite levels,glutamine measurement,GCST009391,2:6207697
rs707123-<b>?</b>,8 x 10-6,(glutamine),NR,'-,0.16342953 unit increase,[0.092-0.235],RND3,Metabolite levels,glutamine measurement,GCST009391,2:150472479
rs17333206-<b>?</b>,8 x 10-6,(glutamine),NR,'-,0.45578438 unit decrease,[0.26-0.66],PLEKHA6,Metabolite levels,glutamine measurement,GCST009391,1:204222256
rs10485509-<b>?</b>,9 x 10-6,(glutamine),NR,'-,0.60731363 unit increase,[0.34-0.88],UQCC1,Metabolite levels,glutamine measurement,GCST009391,20:35381136
rs1744297-<b>T</b>,1 x 10-74,,0.13,'-,0.81 unit increase,[0.73-0.89],ASPG,Plasma free asparagine levels,asparagine measurement,GCST007386,14:104102135
rs4690522-<b>?</b>,1 x 10-10,(asparagine),NR,'-,0.25030407 unit increase,[0.17-0.33],AGA,Metabolite levels,asparagine measurement,GCST009391,4:177439897
rs1364095-<b>?</b>,1 x 10-7,(asparagine),NR,'-,0.18250181 unit decrease,[0.11-0.25],MAF,Metabolite levels,asparagine measurement,GCST009391,16:79532253
rs16872665-<b>?</b>,5 x 10-7,(asparagine),NR,'-,0.4670182 unit increase,[0.29-0.65],ANKDD1B,Metabolite levels,asparagine measurement,GCST009391,5:75630421
rs10516005-<b>?</b>,8 x 10-7,(asparagine),NR,'-,0.26423714 unit decrease,[0.16-0.37],DSEL-AS1,Metabolite levels,asparagine measurement,GCST009391,18:67704300
rs17671845-<b>?</b>,1 x 10-6,(asparagine),NR,'-,0.45391425 unit increase,[0.27-0.64],CERT1,Metabolite levels,asparagine measurement,GCST009391,5:75405941
rs12608204-<b>?</b>,3 x 10-6,(asparagine),NR,'-,0.20172809 unit increase,[0.12-0.29],"RN7SL551P, TIMM21",Metabolite levels,asparagine measurement,GCST009391,18:74195982
rs7625523-<b>?</b>,3 x 10-6,(asparagine),NR,'-,0.18920614 unit decrease,[0.11-0.27],CNTN6,Metabolite levels,asparagine measurement,GCST009391,3:1274704
rs429977-<b>?</b>,4 x 10-6,(asparagine),NR,'-,0.24620596 unit increase,[0.14-0.35],FRAS1,Metabolite levels,asparagine measurement,GCST009391,4:78340169
rs17715667-<b>?</b>,5 x 10-6,(asparagine),NR,'-,0.5658418 unit decrease,[0.32-0.81],RFX3,Metabolite levels,asparagine measurement,GCST009391,9:3397067
rs11773301-<b>?</b>,5 x 10-6,(asparagine),NR,'-,0.2077397 unit increase,[0.12-0.3],RPL32P17,Metabolite levels,asparagine measurement,GCST009391,7:148578574
rs10982850-<b>?</b>,8 x 10-6,(asparagine),NR,'-,1.8792149 unit decrease,[1.06-2.7],U2,Metabolite levels,asparagine measurement,GCST009391,9:115636888
rs591584-<b>?</b>,8 x 10-6,(asparagine),NR,'-,0.15306784 unit increase,[0.086-0.22],PIWIL4,Metabolite levels,asparagine measurement,GCST009391,11:94592673
rs10743549-<b>?</b>,8 x 10-6,(asparagine),NR,'-,0.20239519 unit increase,[0.11-0.29],"PHC1, A2ML1",Metabolite levels,asparagine measurement,GCST009391,12:8899241
rs6562541-<b>?</b>,8 x 10-7,(arginine),NR,'-,0.21326911 unit decrease,[0.13-0.3],"ZDHHC20P4, LINC02342",Metabolite levels,L-arginine measurement,GCST009391,13:68915627
rs1531427-<b>?</b>,2 x 10-6,(arginine),NR,'-,0.34849447 unit increase,[0.2-0.49],KCNS3,Metabolite levels,L-arginine measurement,GCST009391,2:17944448
rs17488507-<b>?</b>,3 x 10-6,(arginine),NR,'-,0.1912635 unit increase,[0.11-0.27],VLDLR-AS1,Metabolite levels,L-arginine measurement,GCST009391,9:2565938
rs6005054-<b>?</b>,4 x 10-6,(arginine),NR,'-,0.9968213 unit increase,[0.57-1.42],HPS4,Metabolite levels,L-arginine measurement,GCST009391,22:26466004
rs12838632-<b>?</b>,7 x 10-6,(arginine),NR,'-,7.1332664 unit increase,[4.03-10.24],PDHA1,Metabolite levels,L-arginine measurement,GCST009391,X:19285853
rs2540641-<b>?</b>,1 x 10-19,(Proline),NR,'-,'-,'-,DGCR5,Serum metabolite levels,"serum metabolite measurement, proline measurement",GCST009893,22:18972171
rs2238732-<b>C</b>,2 x 10-54,,0.87,'-,0.65 unit increase,[0.57-0.73],PRODH,Plasma free proline levels,proline measurement,GCST007384,22:18927834
rs2540641-<b>?</b>,7 x 10-15,(proline),NR,'-,0.49159074 unit increase,[0.37-0.62],DGCR5,Metabolite levels,proline measurement,GCST009391,22:18972171
rs12416242-<b>?</b>,7 x 10-8,(proline),NR,'-,0.35694906 unit increase,[0.23-0.49],PTPRE,Metabolite levels,proline measurement,GCST009391,10:127956592
rs328731-<b>?</b>,7 x 10-7,(proline),NR,'-,0.3284148 unit increase,[0.2-0.46],"TBC1D15, RAB21",Metabolite levels,proline measurement,GCST009391,12:71806180
rs2800960-<b>?</b>,1 x 10-6,(proline),NR,'-,0.29655266 unit increase,[0.18-0.42],DGCR2,Metabolite levels,proline measurement,GCST009391,22:19089536
rs6953355-<b>?</b>,2 x 10-6,(proline),NR,'-,0.40446785 unit decrease,[0.24-0.57],MYL7,Metabolite levels,proline measurement,GCST009391,7:44139624
rs3823441-<b>?</b>,3 x 10-6,(proline),NR,'-,0.3171229 unit increase,[0.18-0.45],TBC1D7,Metabolite levels,proline measurement,GCST009391,6:13317798
rs947612-<b>?</b>,5 x 10-6,(proline),NR,'-,0.18461584 unit increase,[0.11-0.26],KCNQ5,Metabolite levels,proline measurement,GCST009391,6:73028938
rs6894154-<b>?</b>,6 x 10-6,(proline),NR,'-,0.19694181 unit increase,[0.11-0.28],STK32A,Metabolite levels,proline measurement,GCST009391,5:147307796
rs17115279-<b>?</b>,6 x 10-6,(proline),NR,'-,0.30845284 unit increase,[0.17-0.44],NCAM1,Metabolite levels,proline measurement,GCST009391,11:113255552
rs10086189-<b>?</b>,8 x 10-6,(proline),NR,'-,1.3084868 unit increase,[0.73-1.88],LINC01288,Metabolite levels,proline measurement,GCST009391,8:34790175
rs638284-<b>?</b>,5 x 10-8,(phenylalanine),NR,'-,1.1620127 unit decrease,[0.75-1.58],'-,Metabolite levels,phenylalanine measurement,GCST009391,18:10140781
rs2039970-<b>?</b>,5 x 10-7,(phenylalanine),NR,'-,0.19028907 unit decrease,[0.12-0.26],"TDRD3, TARDBPP2",Metabolite levels,phenylalanine measurement,GCST009391,13:60336157
rs348688-<b>?</b>,5 x 10-7,(phenylalanine),NR,'-,0.17950986 unit decrease,[0.11-0.25],TAFA2,Metabolite levels,phenylalanine measurement,GCST009391,12:62033261
rs12743504-<b>?</b>,2 x 10-6,(phenylalanine),NR,'-,0.43941638 unit decrease,[0.26-0.62],"CHI3L1, MYBPH",Metabolite levels,phenylalanine measurement,GCST009391,1:203176865
rs2043997-<b>?</b>,2 x 10-6,(phenylalanine),NR,'-,0.16560501 unit decrease,[0.098-0.233],PCDH15,Metabolite levels,phenylalanine measurement,GCST009391,10:54278692
rs4841005-<b>?</b>,2 x 10-6,(phenylalanine),NR,'-,0.16529119 unit increase,[0.097-0.234],"RN7SL178P, CLDN23",Metabolite levels,phenylalanine measurement,GCST009391,8:8643720
rs1112065-<b>?</b>,2 x 10-6,(phenylalanine),NR,'-,0.1649151 unit decrease,[0.096-0.233],PCDH15,Metabolite levels,phenylalanine measurement,GCST009391,10:54381331
rs9822723-<b>?</b>,4 x 10-6,(phenylalanine),NR,'-,0.29956588 unit decrease,[0.17-0.43],U3,Metabolite levels,phenylalanine measurement,GCST009391,3:45263398
rs4924512-<b>?</b>,4 x 10-6,(phenylalanine),NR,'-,0.73933786 unit increase,[0.42-1.05],VPS18,Metabolite levels,phenylalanine measurement,GCST009391,15:40903248
rs7047189-<b>?</b>,6 x 10-6,(phenylalanine),NR,'-,0.18626855 unit increase,[0.11-0.27],'-,Metabolite levels,phenylalanine measurement,GCST009391,9:73854997
rs6807064-<b>?</b>,1 x 10-7,(phenylalanine),0.29,'-,'-,'-,ATP2B2,Metabolite levels,phenylalanine measurement,GCST000274,3:10494087
rs715-<b>?</b>,1 x 10-8,(Creatine),NR,'-,'-,'-,CPS1,Serum metabolite levels,"serum metabolite measurement, creatine measurement",GCST009893,2:210678331
rs10172053-<b>?</b>,5 x 10-8,(creatine),NR,'-,0.25138626 unit increase,[0.16-0.34],'-,Metabolite levels,creatine measurement,GCST009391,2:210779923
rs16904247-<b>?</b>,2 x 10-6,(creatine),NR,'-,0.24830018 unit decrease,[0.15-0.35],ASAP1,Metabolite levels,creatine measurement,GCST009391,8:130317219
rs4559587-<b>?</b>,3 x 10-6,(creatine),NR,'-,0.30495447 unit increase,[0.18-0.43],AKR1C3,Metabolite levels,creatine measurement,GCST009391,10:5100663
rs11687741-<b>?</b>,6 x 10-6,(creatine),NR,'-,0.18215604 unit decrease,[0.1-0.26],"LINC01804, RNU5E-7P",Metabolite levels,creatine measurement,GCST009391,2:15811933
rs10444512-<b>?</b>,6 x 10-6,(creatine),NR,'-,0.8396262 unit increase,[0.48-1.2],MGAT4C,Metabolite levels,creatine measurement,GCST009391,12:86626727
rs6664119-<b>?</b>,8 x 10-6,(creatine),NR,'-,0.14978866 unit increase,[0.084-0.216],"C1orf141, IL23R",Metabolite levels,creatine measurement,GCST009391,1:67190212
rs7422339-<b>?</b>,2 x 10-11,(creatine),NR,'-,0.2392103 unit increase,[0.17-0.31],CPS1,Metabolite levels,creatine measurement,GCST009391,2:210675783
rs16894865-<b>?</b>,2 x 10-6,(creatine),NR,'-,7.7136736 unit increase,[4.55-10.88],"FOXP4, MDFI",Metabolite levels,creatine measurement,GCST009391,6:41630786
rs1321348-<b>?</b>,2 x 10-6,(creatine),NR,'-,0.22998326 unit increase,[0.13-0.33],SLC24A3,Metabolite levels,creatine measurement,GCST009391,20:19626497
rs12991443-<b>?</b>,5 x 10-6,(creatine),NR,'-,0.1699887 unit decrease,[0.097-0.243],'-,Metabolite levels,creatine measurement,GCST009391,2:210976026
rs11103954-<b>?</b>,6 x 10-6,(creatine),NR,'-,0.83543336 unit increase,[0.47-1.2],MGAT4C,Metabolite levels,creatine measurement,GCST009391,12:86416252
rs7938405-<b>?</b>,7 x 10-6,(creatine),NR,'-,1.0493137 unit increase,[0.59-1.51],"LINC02758, METTL15",Metabolite levels,creatine measurement,GCST009391,11:28594482
rs1204134-<b>?</b>,9 x 10-6,(creatine),NR,'-,0.19879016 unit increase,[0.11-0.29],KHDRBS2,Metabolite levels,creatine measurement,GCST009391,6:61700426
rs4888124-<b>A</b>,2 x 10-11,(Glycine),0.2266,'-,0.1034 unit decrease,[0.073-0.134],PKD1L2,Metabolite levels,glycine measurement,GCST009698,16:81110356
rs477992-<b>?</b>,7 x 10-9,(serine),NR,'-,0.21140407 unit decrease,[0.14-0.28],PHGDH,Metabolite levels,serine measurement,GCST009391,1:119714953
rs12221386-<b>?</b>,4 x 10-7,(serine),NR,'-,0.52170086 unit increase,[0.32-0.72],LHPP,Metabolite levels,serine measurement,GCST009391,10:124546064
rs4549762-<b>?</b>,5 x 10-7,(serine),NR,'-,0.31163913 unit decrease,[0.19-0.43],'-,Metabolite levels,serine measurement,GCST009391,8:21543991
rs17407816-<b>?</b>,5 x 10-7,(serine),NR,'-,0.27883992 unit decrease,[0.17-0.39],PIP5K1B,Metabolite levels,serine measurement,GCST009391,9:68999340
rs3814739-<b>?</b>,5 x 10-7,(serine),NR,'-,0.18890886 unit increase,[0.12-0.26],"RAB1B, KLC2",Metabolite levels,serine measurement,GCST009391,11:66268508
rs526200-<b>?</b>,1 x 10-6,(serine),NR,'-,0.17861132 unit increase,[0.11-0.25],PACS1,Metabolite levels,serine measurement,GCST009391,11:66160302
rs11806656-<b>?</b>,1 x 10-6,(serine),NR,'-,0.5646209 unit increase,[0.34-0.79],PATJ,Metabolite levels,serine measurement,GCST009391,1:62144566
rs12996484-<b>?</b>,3 x 10-6,(serine),NR,'-,0.16581649 unit increase,[0.096-0.235],'-,Metabolite levels,serine measurement,GCST009391,2:210989210
rs4836254-<b>?</b>,6 x 10-6,(serine),NR,'-,0.20837158 unit increase,[0.12-0.3],GRAMD2B,Metabolite levels,serine measurement,GCST009391,5:126402247
rs898889-<b>?</b>,7 x 10-6,(serine),NR,'-,0.19439718 unit decrease,[0.11-0.28],LINC02206,Metabolite levels,serine measurement,GCST009391,15:66921770
rs808764-<b>?</b>,8 x 10-6,(serine),NR,'-,1.1408733 unit increase,[0.64-1.64],Y_RNA,Metabolite levels,serine measurement,GCST009391,X:94190938
rs17009032-<b>?</b>,8 x 10-6,(serine),NR,'-,0.4651881 unit increase,[0.26-0.67],"ZNF385D-AS1, ZNF385D",Metabolite levels,serine measurement,GCST009391,3:21563784
rs1171614-<b>?</b>,5 x 10-14,(Carnitine),NR,'-,'-,'-,SLC16A9,Serum metabolite levels,"carnitine measurement, serum metabolite measurement",GCST009893,10:59709780
rs6959875-<b>?</b>,8 x 10-7,(carnitine),NR,'-,0.27015445 unit increase,[0.16-0.38],TMEM196,Metabolite levels,carnitine measurement,GCST009391,7:19782382
rs2450454-<b>?</b>,1 x 10-6,(carnitine),NR,'-,0.45938626 unit increase,[0.27-0.65],"ANK3, LINC01553",Metabolite levels,carnitine measurement,GCST009391,10:59961779
rs6108228-<b>?</b>,3 x 10-6,(carnitine),NR,'-,0.1752237 unit decrease,[0.1-0.25],"PLCB1, Metazoa_SRP",Metabolite levels,carnitine measurement,GCST009391,20:8997416
rs10521507-<b>?</b>,4 x 10-6,(carnitine),NR,'-,0.68613416 unit decrease,[0.4-0.98],"SERPINA7, NRK",Metabolite levels,carnitine measurement,GCST009391,X:105984659
rs274554-<b>?</b>,5 x 10-6,(carnitine),NR,'-,0.21081184 unit decrease,[0.12-0.3],SLC22A5,Metabolite levels,carnitine measurement,GCST009391,5:132389258
rs11733138-<b>?</b>,6 x 10-6,(carnitine),NR,'-,0.22510558 unit increase,[0.13-0.32],'-,Metabolite levels,carnitine measurement,GCST009391,4:23159038
rs16913790-<b>?</b>,7 x 10-6,(carnitine),NR,'-,0.2156484 unit increase,[0.12-0.31],"MRPL50P4, SLC16A9",Metabolite levels,carnitine measurement,GCST009391,10:59586424
rs562672-<b>?</b>,7 x 10-6,(carnitine),NR,'-,0.23367436 unit decrease,[0.13-0.34],"RPUSD4, NAP1L1P1",Metabolite levels,carnitine measurement,GCST009391,11:126113569
rs4656852-<b>?</b>,8 x 10-6,(carnitine),NR,'-,0.50755376 unit decrease,[0.28-0.73],"SNHG28, SLAMF8",Metabolite levels,carnitine measurement,GCST009391,1:159834863
rs1171617-<b>?</b>,6 x 10-26,(carnitine),NR,'-,0.41752112 unit decrease,[0.34-0.5],SLC16A9,Metabolite levels,carnitine measurement,GCST009391,10:59707424
rs9879988-<b>?</b>,3 x 10-7,(carnitine),NR,'-,0.23913525 unit increase,[0.15-0.33],RN7SL553P,Metabolite levels,carnitine measurement,GCST009391,3:5267871
rs920964-<b>?</b>,6 x 10-7,(carnitine),NR,'-,0.51892984 unit increase,[0.32-0.72],CCDC6,Metabolite levels,carnitine measurement,GCST009391,10:59821209
rs35976024-<b>A</b>,5 x 10-8,(total homocysteine),0.32,'-,0.1 unit decrease,[0.061-0.139],ATOH8,Blood metabolite levels,"blood metabolite measurement, homocysteine measurement",GCST009318,2:85776848
rs6940729-<b>T</b>,5 x 10-8,,0.4775,'-,0.027 unit decrease,[NR],CD2AP,Plasma homocysteine levels,homocysteine measurement,GCST003157,6:47585184
rs2640806-<b>A</b>,5 x 10-6,(Methionine ),0.317,'-,0.03 µmol/L increase,[NR],"RNU6-1172P, PTDSS1",Obesity-related traits,amino acid measurement,GCST001762,8:96357406
rs7915137-<b>G</b>,7 x 10-6,(Methionine ),0.333,'-,0.03 µmol/L increase,[NR],RNU6-478P,Obesity-related traits,amino acid measurement,GCST001762,10:83110320
rs2241941-<b>A</b>,8 x 10-6,(Methionine ),0.339,'-,0.03 µmol/L increase,[NR],SLC6A5,Obesity-related traits,amino acid measurement,GCST001762,11:20601477
rs478881-<b>A</b>,7 x 10-6,(Cystathionine ),0.141,'-,0.03 µmol/L increase,[NR],"ACAD8, GLB1L3",Obesity-related traits,amino acid measurement,GCST001762,11:134269886
rs8016620-<b>G</b>,5 x 10-6,(Total cysteine ),0.033,'-,0.03 µmol/L increase,[NR],VRK1,Obesity-related traits,amino acid measurement,GCST001762,14:96927348
rs12586774-<b>A</b>,4 x 10-7,(Total cysteine ),0.094,'-,0.03 µmol/L increase,[NR],LINC02306,Obesity-related traits,amino acid measurement,GCST001762,14:25660360
rs433755-<b>C</b>,5 x 10-7,(Total cysteine ),0.451,'-,0.03 µmol/L increase,[NR],SEMA5A,Obesity-related traits,amino acid measurement,GCST001762,5:9474834
rs12079716-<b>C</b>,2 x 10-6,(Total cysteine ),0.003,'-,0.03 µmol/L increase,[NR],AP4B1,Obesity-related traits,amino acid measurement,GCST001762,1:113901972
rs7542375-<b>C</b>,2 x 10-6,(Total cysteine ),0.431,'-,0.02 µmol/L increase,[NR],HLX,Obesity-related traits,amino acid measurement,GCST001762,1:220938438
rs12767760-<b>G</b>,7 x 10-6,(Total cysteine ),0.364,'-,0.02 µmol/L increase,[NR],UBTD1,Obesity-related traits,amino acid measurement,GCST001762,10:97535040
rs11006747-<b>A</b>,8 x 10-6,(Total cysteine ),0.383,'-,0.02 µmol/L increase,[NR],ODAD2,Obesity-related traits,amino acid measurement,GCST001762,10:27862006
rs6683225-<b>G</b>,2 x 10-6,(Cystathionine ),0.433,'-,0.03 µmol/L increase,[NR],RYR2,Obesity-related traits,amino acid measurement,GCST001762,1:237186438
rs4841398-<b>G</b>,3 x 10-6,(Cystathionine ),0.16,'-,0.02 µmol/L increase,[NR],"PRSS55, RP1L1",Obesity-related traits,amino acid measurement,GCST001762,8:10605296
rs3824789-<b>A</b>,6 x 10-6,(Cystathionine ),0.248,'-,0.03 µmol/L increase,[NR],SLIT1,Obesity-related traits,amino acid measurement,GCST001762,10:97040342
rs61999321-<b>A</b>,8 x 10-6,(Cystathionine ),0.015,'-,0.03 µmol/L increase,[NR],MTUS2,Obesity-related traits,amino acid measurement,GCST001762,13:29324646
rs2248551-<b>A</b>,4 x 10-19,,0.146,'-,4.022 unit increase,[2.97-5.07],MED23,L-arginine levels,L-arginine measurement,GCST002623,6:131603549
rs715-<b>?</b>,1 x 10-32,(Glycine),NR,'-,'-,'-,CPS1,Serum metabolite levels,"serum metabolite measurement, glycine measurement",GCST009893,2:210678331
rs12655635-<b>T</b>,1 x 10-6,,0.1616,'-,0.2929091 unit decrease,'-,"SLC36A2, SLC36A3",Glycine levels,glycine measurement,GCST90013559,5:151314345
rs4475903-<b>?</b>,6 x 10-6,(glycine),NR,'-,0.40291318 unit decrease,[0.23-0.58],GVINP1,Metabolite levels,glycine measurement,GCST009391,11:6735343
rs10499297-<b>?</b>,6 x 10-6,(glycine),NR,'-,0.3430123 unit decrease,[0.19-0.49],'-,Metabolite levels,glycine measurement,GCST009391,6:155839958
rs10839830-<b>?</b>,6 x 10-6,(glycine),NR,'-,0.14990726 unit decrease,[0.085-0.215],PPFIBP2,Metabolite levels,glycine measurement,GCST009391,11:7647293
rs2286868-<b>?</b>,7 x 10-6,(glycine),NR,'-,0.23392038 unit decrease,[0.13-0.34],INPP5K,Metabolite levels,glycine measurement,GCST009391,17:1508303
rs6592847-<b>?</b>,4 x 10-7,(glycine),NR,'-,0.1983622 unit decrease,[0.12-0.27],TENM4,Metabolite levels,glycine measurement,GCST009391,11:79500962
rs4956029-<b>?</b>,3 x 10-6,(glycine),NR,'-,0.19575763 unit increase,[0.11-0.28],CYP2U1-AS1,Metabolite levels,glycine measurement,GCST009391,4:107930418
rs11820697-<b>?</b>,5 x 10-6,(glycine),NR,'-,0.25294122 unit decrease,[0.14-0.36],PPFIBP2,Metabolite levels,glycine measurement,GCST009391,11:7543190
rs17814846-<b>?</b>,5 x 10-6,(glycine),NR,'-,0.15897329 unit decrease,[0.091-0.227],'-,Metabolite levels,glycine measurement,GCST009391,18:64642106
rs7422339-<b>?</b>,2 x 10-58,(glycine),NR,'-,0.5312233 unit increase,[0.47-0.6],CPS1,Metabolite levels,glycine measurement,GCST009391,2:210675783
rs10172053-<b>?</b>,8 x 10-19,(glycine),NR,'-,0.39763543 unit increase,[0.31-0.49],'-,Metabolite levels,glycine measurement,GCST009391,2:210779923
rs1437370-<b>?</b>,8 x 10-13,(glycine),NR,'-,0.24703373 unit increase,[0.18-0.31],'-,Metabolite levels,glycine measurement,GCST009391,2:210961491
rs2280068-<b>?</b>,3 x 10-7,(glycine),NR,'-,0.43536425 unit decrease,[0.27-0.6],PPM1H,Metabolite levels,glycine measurement,GCST009391,12:62703702
rs2238732-<b>?</b>,1 x 10-14,(Ile (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,22:18927834
rs1744297-<b>?</b>,1 x 10-12,(Orn (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,14:104102135
rs12613336-<b>?</b>,3 x 10-9,(Orn (adjusted for Gly)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,2:210704675
rs2238732-<b>?</b>,5 x 10-9,(Orn (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,22:18927834
rs7838611-<b>?</b>,1 x 10-6,(Orn (adjusted for Asn)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,8:17565208
rs7838611-<b>?</b>,3 x 10-6,(Orn (adjusted for Gln)),'-,'-,'-,'-,SLC7A2,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,8:17565208
rs1744297-<b>?</b>,9 x 10-11,(Tyr (adjusted for Asn)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),"tyrosine measurement, amino acid measurement",GCST007383,14:104102135
rs2238732-<b>?</b>,5 x 10-10,(Tyr (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),"tyrosine measurement, amino acid measurement",GCST007383,22:18927834
rs17450273-<b>?</b>,1 x 10-7,(Tyr (adjusted for Phe)),'-,'-,'-,'-,ASCL1,Plasma free amino acid levels (adjusted for one other PFAA),"tyrosine measurement, amino acid measurement",GCST007383,12:102967601
rs2238732-<b>?</b>,6 x 10-14,(Val (adjusted for Pro)),'-,'-,'-,'-,PRODH,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,22:18927834
rs1744297-<b>?</b>,2 x 10-60,(Asn (adjusted for Phe)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,14:104102135
rs1744297-<b>?</b>,2 x 10-57,(Asn (adjusted for Pro)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,14:104102135
rs1744297-<b>?</b>,8 x 10-56,(Asn (adjusted for Gly)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,14:104102135
rs12613336-<b>?</b>,2 x 10-10,(Asn (adjusted for Gly)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,2:210704675
rs12613336-<b>?</b>,4 x 10-6,(Asn (adjusted for Ser)),'-,'-,'-,'-,CPS1,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,2:210704675
rs1744297-<b>?</b>,9 x 10-63,(Asn (adjusted for Gln)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,14:104102135
rs1744297-<b>?</b>,3 x 10-62,(Asn (adjusted for Ser)),'-,'-,'-,'-,ASPG,Plasma free amino acid levels (adjusted for one other PFAA),amino acid measurement,GCST007383,14:104102135
rs13329952-<b>T</b>,2 x 10-17,,0.79,1.101,'-,NR,UMOD,"Estimated glomerular filtration rate (creatinine, Rapid3)","glomerular filtration rate, creatine measurement",GCST011749,16:20355185
rs141809766-<b>G</b>,6 x 10-9,,0.02,1.222,'-,NR,"PGAM1P2, SPAAR","Estimated glomerular filtration rate (creatinine, Rapid3)","glomerular filtration rate, creatine measurement",GCST011749,9:35937934
rs12922822-<b>C</b>,4 x 10-33,,0.81,1.224,'-,NR,"UMOD, PDILT","Estimated glomerular filtration rate (creatinine, CKDi25)","glomerular filtration rate, creatine measurement",GCST011748,16:20356323
rs77593734-<b>T</b>,1 x 10-11,,0.72,1.102,'-,NR,WDR72,"Estimated glomerular filtration rate (creatinine, CKDi25)","glomerular filtration rate, creatine measurement",GCST011748,15:53710409
rs56012466-<b>A</b>,2 x 10-9,,0.27,1.09,'-,NR,PRKAG2,"Estimated glomerular filtration rate (creatinine, CKDi25)","glomerular filtration rate, creatine measurement",GCST011748,7:151709702
rs77924615-<b>G</b>,1 x 10-28,,0.79,1.26,'-,NR,PDILT,"Estimated glomerular filtration rate (creatinine, CKDi25)","glomerular filtration rate, creatine measurement",GCST011748,16:20381010
rs13329952-<b>T</b>,1 x 10-15,,NR,1.099,'-,[1.08-1.12],UMOD,"Estimated glomerular filtration rate (creatinine, Rapid3)","glomerular filtration rate, creatine measurement",GCST011747,16:20355185
rs141809766-<b>G</b>,4 x 10-9,,NR,1.229,'-,[1.16-1.30],"PGAM1P2, SPAAR","Estimated glomerular filtration rate (creatinine, Rapid3)","glomerular filtration rate, creatine measurement",GCST011747,9:35937934
rs13329952-<b>T</b>,4 x 10-30,,NR,1.21,'-,[1.18-1.24],UMOD,"Estimated glomerular filtration rate (creatinine, CKDi25)","glomerular filtration rate, creatine measurement",GCST011746,16:20355185
rs56012466-<b>A</b>,4 x 10-9,,NR,1.09,'-,[1.06-1.12],PRKAG2,"Estimated glomerular filtration rate (creatinine, CKDi25)","glomerular filtration rate, creatine measurement",GCST011746,7:151709702
rs690428-<b>A</b>,4 x 10-6,,NR,1.09,'-,[1.05-1.13],WDR72,"Estimated glomerular filtration rate (creatinine, CKDi25)","glomerular filtration rate, creatine measurement",GCST011746,15:53658381
rs477992-<b>A</b>,3 x 10-21,(Serine),0.3081,'-,0.0397 unit decrease,[0.031-0.048],PHGDH,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,1:119714953
rs715-<b>T</b>,3 x 10-11,(Serine),0.6925,'-,0.0311 unit decrease,[0.022-0.04],CPS1,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,2:210678331
rs16844839-<b>T</b>,3 x 10-99,(Glycine),0.1995,'-,0.1212 unit increase,[0.11-0.13],CPS1,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,2:210716521
rs9400467-<b>T</b>,2 x 10-10,(Tyrosine),0.7048,'-,0.0297 unit decrease,[0.02-0.039],SLC16A10,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,6:111102812
rs4947534-<b>T</b>,4 x 10-18,(Serine),0.2426,'-,0.0406 unit decrease,[0.031-0.05],PSPH,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,7:56011401
rs2657879-<b>A</b>,2 x 10-14,(Glutamine),0.8097,'-,0.0342 unit increase,[0.025-0.043],"SPRYD4, GLS2",Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,12:56471554
rs12297049-<b>T</b>,1 x 10-10,(Phenylalanine),0.5875,'-,0.0202 unit decrease,[0.014-0.026],PAH,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,12:102857897
rs2238732-<b>T</b>,3 x 10-39,(Proline),0.0524,'-,0.1815 unit increase,[0.15-0.21],PRODH,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,22:18927834
rs2540641-<b>A</b>,2 x 10-59,(Proline),0.0927,'-,0.147 unit increase,[0.13-0.16],DGCR5,Amino acid levels,"blood metabolite measurement, amino acid measurement",GCST002966,22:18972171
